＜リサーチユニット・リサーチグループ＞	
 
	
 
	
 
	
 
	
 
	
 
	
 
	
 
	
 
	
 

	
 
＜リサーチユニット・リサーチグループ＞	
 	
  感染生物学	 ３	 	  神経分子病態解析学	
 

５	
 

	
  難治性免疫疾患・アレルギー	
 

８	
 

	
  腫瘍特異的ヘム‐ポルフィリン代謝を利用した診断・治療法開発	
 

１６	
 

	
  次世代型粒子線がん治療の確立研究	
 

２４	
 

	
  ゲノム医科学	
 

３５	
 

	
  分子スポトロジー	
 

４３	
 

	
  脂質エネルギー代謝	
 

４６	
 

	
  ヘルスサービス	
 

６０	
 

	
  生体機能制御・再生研究グループ	
 

７５	
 

	
  筑波発ナノ粒子の包括的臨床応用	
 

８１	
 

	
  先端医療技術・生体材料・医療機器臨床応用	
 

８８	
 

	
  絆社会継続発展モデルとしての小児難病総合	
 

９１	
 

	
  血小板による新規肝疾患治療法開発	
 

１０７	
 

	
  シグナル伝達と疾患	
 

１１０	
 

	
  前臨床がん研究	
 

１１４	
 

	
  ３Ｄ‐ＣＧバーチャル手術シミュレーションシステム	
 

１２４	
 

	
  神経生理学	
 

１２７	
 

	
  行動決定の脳内情報処理機構	
 

１２９	
 

	
  統合的神経回路	
 

１３１	
 

	
  基礎・社会・臨床医学の連携による健康長寿の実現	
 

１３４	
 

	
  心臓血管	
 

１４８	
 

	
  女性の健康と母性看護学に関連する研究	
 

１６５	
 

	
  聴覚障害発症機序の解明に関する検討	
 

１６７	
 

	
  がん看護・緩和ケア	
 

１６９	
 

	
  レギュラトリーサイエンス	
 

１７０	
 

	
  心肺脳蘇生	
 

１７３	
 

	
  ソーシャルインクルージョン	
 

１７４	
 

	
  ニュートリゲノミクス	
 

１７７	
 

	
  脳腫瘍研究	
 

１７９	
 

	
  放射線基礎医学	
 

１８１	
 

	
  肺高血圧症・肺循環障害	
 

１８６	
 

	
  脊髄脊椎疾患	
 

１８８	
 

	
  角化制御因子	
 

１８９	
 

	
  気候変動と健康	
 

１９５	
 

	
 
	
 
2

感染生物学	 1) 英文論文	 1. Binh NT, Wakai C, Kawaguchi A, Nagata K. The N-terminal region of influenza virus
polymerase PB1 adjacent to the PA binding site is involved in replication but nottranscription of the viral genome. Front Microbiol 4:398, 2013
2. Binh NT, Wakai C, Kawaguchi A, Nagata K. Involvement of the N-terminal portion of
influenza virus RNA polymerase subunit PB1 in nucleotide recognition. Biochem Biophys
Res Commun doi: 10.1016/j.bbrc.2013.12.071, 2013
3. Czene A, Nemeth E, Zoka IG, Jakab-Simon NI, Kortvelyesi T, Nagata K, Christensen HE,
Gyurcsik B. The role of the N-terminal loop in the function of the colicin E7 nucleasedomain. J Biol Inorg Chem 18(3):309-321, 2013
4. Czene A, Toth E, Gyurcsik B, Otten H, Poulsen JC, Lo Leggio L, Larsen S, Christensen HE,
Nagata K. Crystallization and preliminary crystallographic analysis of an Escherichia
coli-selected mutant of the nuclease domain of the metallonuclease colicin E7. Acta
Crystallogr Sect F Struct Biol Cryst Commun 69(Pt 5):551-554, 2013
5. Haruyama T, Nagata K. Anti-influenza virus activity of Ginkgo biloba leaf extracts. J Nat
Med 67(3):636-642, 2013
6. Hisaoka M, Nagata K, Okuwaki M. Intrinsically disordered regions of nucleophosmin/B23
regulate its RNA binding activity through their inter- and intra-molecular association.
Nucleic Acids Res doi: 10.1093/nar/gkt897, 2013
7. Komaki-Yasuda K, Okuwaki M, Nagata K, Kawazu S, Kano S. Identification of a novel andunique transcription factor in the intraerythrocytic stage of Plasmodium falciparum. PLoS
One 8(9):e74701, 2013
8. Komatsu T, Sekiya T, Nagata K. DNA replication-dependent binding of CTCF plays a criticalrole in adenovirus genome functions. Sci Rep 3:2187, 2013
9. Matsubara K, Fujino M, Takeuchi K, Iwata S, Nakayama T. A new method for the detectionof neutralizing antibodies against mumps virus. PLoS One 8(7):e65281, 2013
10. Nagata S, Maedera T, Nagata N, Kidokoro M, Takeuchi K, Kuranaga M, Takeda M, Kato A.
Comparison of the live attenuated mumps vaccine (Miyahara strain) with its preattenuatedparental strain. J Vaccines Immun 1(2):13-21, 2013
11. Oaks JJ, Santhanam R, Walker CJ, Roof S, Harb JG, Ferenchak G, Eisfeld AK, Van
Brocklyn JR, Briesewitz R, Saddoughi SA, Nagata K, Bittman R, Caligiuri MA,
Abdel-Wahab O, Levine R, Arlinghaus RB, Quintas-Cardama A, Goldman JM, Apperley J,
3

Reid A, Milojkovic D, Ziolo MT, Marcucci G, Ogretmen B, Neviani P, Perrotti D.
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720(Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood 122(11):1923-1934,
2013
12. Ohkura T, Kokuho T, Konishi M, Kameyama K, Takeuchi K. Complete Genome Sequencesof Bovine Parainfluenza Virus Type 3 Strain BN-1 and Vaccine Strain BN-CE. Genome
Announc 1(1): e00247-12, 2013
13. Ohniwa RL, Muchaku H, Saito S, Wada C, Morikawa K. Atomic force microscopy analysisof the role of major DNA-binding proteins in organization of the nucleoid in Escherichia coli.
PLoS One 8(8):e72954, 2013
14. Ueshima S, Nagata K, Okuwaki M. Upstream binding factor-dependent and pre-rRNA
transcription-independent association of pre-rRNA processing factors with rRNA gene.
Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2013.11.039, 2013
15. Ueta M, Wada C, Daifuku T, Sako Y, Bessho Y, Kitamura A, Ohniwa RL, Morikawa K,
Yoshida H, Kato T, Miyata T, Namba K, Wada A. Conservation of two distinct types of 100S
ribosome in bacteria. Genes Cells 18(7):554-574, 2013
16. Vong LB, Yoshitomi T, Morikawa K, Saito S, Matsui H, Nagasaki Y. Oral nanotherapeutics:
effect of redox nanoparticle on microflora in mice with dextran sodium sulfate-induced
colitis. J Gastroenterol doi: 10.1007/s00535-013-0836-8, 2013
17. Wakimoto H, Shimodo M, Satoh Y, Kitagawa Y, Takeuchi K, Gotoh B, Itoh M. F-actin
modulates measles virus cell-cell fusion and assembly by altering the interaction between thematrix protein and the cytoplasmic tail of hemagglutinin. J Virol 87(4):1974-1984, 2013
18. Yageta Y, Ishii Y, Morishima Y, Ano S, Ohtsuka S, Matsuyama M, Takeuchi K, Itoh K,
Yamamoto M, Hizawa N. Carbocisteine Reduces Viral-Induced Pulmonary Inflammation in
Mice

ExposedtoCigarette

Smoke.

Am

10.1165/rcmb.2012-0292OC, 2013

4J

Respir

Cell

Mol

Biol

doi:

神経分子病態解析学	 1) 英文論文
1. Akamatsu M, Takuma H, Yamashita T, Okada T, Keino-Masu K, Ishii K, Kwak S, Masu M,
Tamaoka A. A unique mouse model for investigating the properties of amyotrophic lateralsclerosis-associatedproteinTDP-43,

by

in

utero

electroporation.

NeurosciRes

77(4):234-241, 2013
2. Baba O, Yamagata K, Tomidokoro Y, Tamaoka A, Itoh H, Yanagawa T, Onizawa K, Bukawa
H. Neuroleptic malignant syndrome in a patient with tongue cancer: a report of a rare case.
Case Rep Dent 2013:542130, 2013
3. Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T,
Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H,
Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K,
Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A,
Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, Inoue H.
Response to comment on "Drug screening for ALS using patient-specific induced pluripotent
stem cells". Sci Transl Med 5(188):188lr182, 2013
4. Hosaka A, Araki W, Oda A, Tomidokoro Y, Tamaoka A. Statins reduce amyloid β-peptide
production by modulating amyloid precursor protein maturation and phosphorylation througha cholesterol-independent mechanism in cultured neurons. Neurochem Res 38(3):589-600,
2013
5. Hoshino S, Sakamoto K, Vassilopoulos S, Camus SM, Griffin CA, Esk C, Torres JA, Ohkoshi
N, Ishii A, Tamaoka A, Funke BH, Kucherlapati R, Margeta M, Rando TA, Brodsky FM. The
CHC22 clathrin-GLUT4 transport pathway contributes to skeletal muscle regeneration. PLoS
One 8(10):e77787, 2013
6. Hosokawa M, Arai T, Yamashita M, Tsuji H, Nonaka T, Masuda-Suzukake M, Tamaoka A,
Hasegawa M, Akiyama H. Differential diagnosis of amyotrophic lateral sclerosis from
Guillain-Barre syndrome by quantitative determination of TDP-43 in cerebrospinal fluid. Int
J Neurosci doi: 10.3109/00207454.2013.848440, 2013
7. Ishii A, Ohkoshi N, Yoshida M, Tamaoka A. The effect of water-soluble fullerene withdifferentnumber of hydroxyl groups in muscle regeneration process of experimantal murine
skeletal muscle. Neuromuscular Disorders 23(9-10):838, 2013	 8. Ichikawa Y, Ishiura H, Mitsui J, Takahashi Y, Kobayashi S, Takuma H, Kanazawa I, Doi K,
Yoshimura J, Morishita S, Goto J, Tsuji S. Exome analysis reveals a Japanese family with5

spinocerebellar ataxia, autosomal recessive 1. J Neurol Sci 331(1-2):158-160, 2013
9. Iwata A, Nagata K, Hatsuta H, Takuma H, Bundo M, Iwamoto K, Tamaoka A, Murayama S,
Saido T, Tsuji S. Altered CpG methylation in sporadic Alzheimer's disease is associated with
APP and MAPT dysregulation. Hum Mol Genet doi: 10.1093/hmg/ddt451, 2013
10. Nakamagoe K, Fujizuka N, Koganezawa T, Shimizu K, Takiguchi S, Horaguchi T, Ishii K,
Tamaoka A. Residual central nervous system damage due to organoarsenic poisoning.
Neurotoxicol Teratol 37:33-38, 2013
11. Nakamagoe K, Fujizuka N, Koganezawa T, Yamaguchi T, Tamaoka A. Downbeat nystagmus
associated with damage to the medial longitudinal fasciculus of the pons: a vestibular balance
control mechanism via the lower brainstem paramedian tract neurons. J Neurol Sci
328(1-2):98-101, 2013
12. Umeda T, Yamashita T, Kimura T, Ohnishi K, Takuma H, Ozeki T, Takashima A, Tomiyama
T, Mori H. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C --> T mutation
increases tau exon 10 splicing and causes tauopathy in transgenic mice. Am J Pathol
183(1):211-225, 2013	 2) 英文以外の論文
1. 塩谷彩子, 詫間浩, 石井亜紀子, 山口清次, 玉岡晃. 緩徐進行性の筋力低下を主訴とし、
ETFDH 遺伝子に変異を認めた成人発症グルタル酸尿症 2 型の 31 歳男性例. 臨床神経学 53(2):167, 2013
2. 山口哲人, 石井一弘, 河野豊, 玉岡晃. 歩行開始困難を認めた Orthostatic tremor の 75 歳
男性例. 運動障害 23(1):15-19, 2013
3. 山本詞子, 山口哲人, 玉岡晃. 多彩な自己抗体陽性を示した抗グルタミン酸受容体抗体
陽性辺縁系脳炎の 1 例. 日本内科学会雑誌 102(8):2057-2059, 20134) 英文以外の著書
1. 玉岡晃. Part 4. アルツハイマー病の症状、検査、診断. アルツハイマー病による認知症の診断; "からだの科学 (2013 SUMMER)” (山田正仁 編), 日本評論社 (東京) 2013;
pp27878-27883
2. 玉岡晃. J. 神経・精神・運動器疾患. Alzheimer 病; "イヤーノート TOPICS	  2013-2014	
 内科・外科疾患 (第 3 版)” (編集 岡庭豊, 荒瀬康司, 三角和雄), MEDICMEDIA (東京)2013; pp296-298
3. 玉岡晃. II. 本年の動向. 新しいアルツハイマー病の診断基準; "Annual Review 2013	  神6

経” (編集 鈴木則宏, 祖父江元, 荒木信夫, 宇川義一, 川原信隆), 中外医学社 (東京) 2013;
pp81-91
4. 玉岡晃. 第 14 章. 代謝性疾患. 葉酸欠乏; "今日の神経疾患治療指針 (第 2 版)” (編集 水澤
英洋, 鈴木則宏, 梶龍兒, 吉良潤一, 神田隆, 斉藤延人), 医学書院 (東京) 2103 pp761-763
5. 山本詞子, 石井亜紀子, 玉岡晃. 小児-9. 骨格筋画像検査が診断に有用であった小児型
ポンぺ病の 1 例; "ポンぺ病症例集	
  早期診断・早期治療のために (第 1 版)” (編集 埜中征哉), Medical Tribune (東京) 2013; pp60-64

7難治性免疫疾患・アレルギー	 1) 英文論文
1. Ano S, Morishima Y, Ishii Y, Kawaguchi M, Matsuno Y, Hizawa N. Defecation-related
asthma. Intern Med 52(6):685-687, 2013
2. Ano S, Morishima Y, Ishii Y, Yoh K, Yageta Y, Ohtsuka S, Matsuyama M, Kawaguchi M,
Takahashi S, Hizawa N. Transcription factors GATA-3 and RORgammat are important for
determining the phenotype of allergic airway inflammation in a murine model of asthma. J
Immunol 190(3):1056-1065, 2013
3. Arai S, Maehara N, Iwamura Y, Honda S, Nakashima K, Kai T, Ogishi M, Morita K,
Kurokawa J, Mori M, Motoi Y, Miyake K, Matsuhashi N, Yamamura K, Ohara O, Shibuya A,
Wakeland EK, Li QZ, Miyazaki T. Obesity-associated autoantibody production requires AIM
to retain the immunoglobulin M immune complex on follicular dendritic cells. Cell Rep
3(4):1187-1198, 2013
4. Danisch S, Qiu Q, Seth S, Ravens I, Dorsch M, Shibuya A, Shibuya K, Forster R, Bernhardt
G. CD226 interaction with CD155 impacts on retention and negative selection of CD8
positive thymocytes as well as T cell differentiation to follicular helper cells in Peyer's
Patches. Immunobiology 218(2):152-158, 2013
5. Fujishiro SH, Nakano K, Mizukami Y, Azami T, Arai Y, Matsunari H, Ishino R, Nishimura T,
Watanabe M, Abe T, Furukawa Y, Umeyama K, Yamanaka S, Ema M, Nagashima H,
Hanazono Y. Generation of naive-like porcine-induced pluripotent stem cells capable ofcontributing to embryonic and fetal development. Stem Cells Dev 22(3):473-482, 2013
6. Fukushima H, Fukushima T, Sakai A, Suzuki R, Nakajima-Yamaguchi R, Kobayashi C,
Iwabuchi A, Saito M, Yoshimi A, Nakao T, Kato K, Tsuchida M, Takahashi H, Koike K,
Kiyokawa N, Noguchi E, Sumazaki R. Polymorphisms of MTHFR Associated with Higher
Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid
Malignancies. Leuk Res Treatment 2013:238528, 2013
7. Furukawa H, Kawasaki A, Oka S, Shimada K, Matsui T, Ikenaka T, Hashimoto A, Okazaki Y,
Takaoka H, Futami H, Komiya A, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M,
Takasaki Y, Nagai T, Hirohata S, Setoguchi K, Suda A, Nagaoka S, Kono H, Okamoto A,
Chiba N, Suematsu E, Fukui N, Hashimoto H, Sumida T, Ono M, Tsuchiya N, Tohma S.
Association of a single nucleotide polymorphism in the SH2D1A intronic region withsystemic lupus erythematosus. Lupus 22(5):497-503, 2013
8. Furukawa H, Oka S, Matsui T, Hashimoto A, Arinuma Y, Komiya A, Fukui N, Tsuchiya N,
8Tohma S. Genome, epigenome and transcriptome analyses of a pair of monozygotic twins
discordant for systemic lupus erythematosus. Hum Immunol 74(2):170-175, 2013
9. Furukawa H, Oka S, Shimada K, Rheumatoid Arthritis-Interstitial Lung Disease Study C,
Tsuchiya N, Tohma S. HLA-A*31:01 and methotrexate-induced interstitial lung disease inJapanese rheumatoid arthritis patients: a multidrug hypersensitivity marker? Ann Rheum Dis
72(1):153-155, 2013
10. Furukawa H, Oka S, Shimada K, Sugii S, Hashimoto A, Komiya A, Fukui N, Nagai T,
Hirohata S, Setoguchi K, Okamoto A, Chiba N, Suematsu E, Miyashita T, Migita K, Suda A,
Nagaoka S, Tsuchiya N, Tohma S. Association of increased frequencies of HLA-DPB1*05:01
with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in Japanese rheumatoid
arthritis and systemic lupus erythematosus patients. PLoS One 8(1):e53910, 2013
11. Furukawa H, Oka S, Takehana K, Muramatsu T, Shimada K, Komiya A, Fukui N, Tsuchiya
N, Tohma S. Plasma amino acid profiles in collagen disease patients with interstitial lungdisease. Immunome Research 9:64, 2013
12. Furukawa M, Tochigi M, Otowa T, Arinami T, Inada T, Ujike H, Watanabe Y, Iwata N,
Itokawa M, Kunugi H, Hashimoto R, Ozaki N, Kakiuchi C, Kasai K, Sasaki T. An
association analysis of the cardiomyopathy-associated 5 (CMYA5) gene with schizophrenia
in a Japanese population. Psychiatr Genet 23(4):179-180, 2013
13. Furusawa T, Naka I, Yamauchi T, Natsuhara K, Eddie R, Kimura R, Nakazawa M, Ishida T,
Inaoka T, Matsumura Y, Ataka Y, Ohtsuka R, Ohashi J. Hypertension-susceptibility geneprevalence in the Pacific Islands and associations with hypertension in Melanesia. J Hum
Genet 58(3):142-149, 2013
14. Genin E, Coustet B, Allanore Y, Ito I, Teruel M, Constantin A, Schaeverbeke T,
Ruyssen-Witrand A, Tohma S, Cantagrel A, Vittecoq O, Barnetche T, Le Loet X, Fardellone
P, Furukawa H, Meyer O, Fernandez-Gutierrez B, Balsa A, Gonzalez-Gay MA, Chiocchia G,
Tsuchiya N, Martin J, Dieude P. Epistatic interaction between BANK1 and BLK inrheumatoid arthritis: results from a large trans-ethnic meta-analysis. PLoS One 8(4):e61044,
2013
15. Georgiev H, Danisch S, Chambers BJ, Shibuya A, Forster R, Bernhardt G. To the editor:
TIGIT

versus

CD226:

hegemonyor

coexistence?

Eur

J

Immunoldoi:

10.1002/eji.201343925, 2013
16. Hamanaka S, Ooehara J, Morita Y, Ema H, Takahashi S, Miyawaki A, Otsu M, Yamaguchi
T, Onodera M, Nakauchi H. Generation of transgenic mouse line expressing Kusabira Orange
9throughout body, including erythrocytes, by random segregation of provirus method.
Biochem Biophys Res Commun 435(4):586-591, 2013
17. Hasegawa Y, Daitoku Y, Sekiguchi K, Tanimoto Y, Mizuno-Iijima S, Mizuno S, Kajiwara
N, Ema M, Miwa Y, Mekada K, Yoshiki A, Takahashi S, Sugiyama F, Yagami K. NovelROSA26 Cre-reporter knock-in C57BL/6N mice exhibiting green emission before and red
emission after Cre-mediated recombination. Exp Anim 62(4):295-304, 2013
18. Hayashi M, Hirota T, Saeki H, Nakagawa H, Ishiuji Y, Matsuzaki H, Tsunemi Y, Kato T,
Shibata S, Sugaya M, Sato S, Tada Y, Doi S, Miyatake A, Ebe K, Noguchi E, Ebihara T,
Amagai M, Esaki H, Takeuchi S, Furue M, Tamari M. Genetic polymorphism in the
TRAF3IP2 gene is associated with psoriasis vulgaris in a Japanese population. J DermatolSci doi: 10.1016/j.jdermsci.2013.11.012, 2013
19.

HizawaN.

Pharmacogenetics

ofchronic

obstructive

pulmonarydisease.

Pharmacogenomics 14(10):1215-1225, 2013
20. Horiuchi Y, Ishikawa M, Kaito N, Iijima Y, Tanabe Y, Ishiguro H, Arinami T. Experimental
evidence for the involvement of PDLIM5 in mood disorders in hetero knockout mice. PLoS
One 8(4):e59320, 2013
21. Iijima H, Kaneko Y, Yamada H, Yatagai Y, Masuko H, Sakamoto T, Naito T, Hirota T,
Tamari M, Konno S, Nishimura M, Noguchi E, Hizawa N. A distinct sensitization patternassociated with asthma and the thymic stromal lymphopoietin (TSLP) genotype. Allergol Int
62(1):123-130, 2013
22. Imoto Y, Tokunaga T, Matsumoto Y, Hamada Y, Ono M, Yamada T, Ito Y, Arinami T, Okano
M, Noguchi E, Fujieda S. Cystatin SN upregulation in patients with seasonal allergic rhinitis.
PLoS One 8(8):e67057, 2013
23. Inoue Y, Nakagawara R, Kambara T, Tanaka K, Seki K, Enomoto H, Noguchi E, Aihara M,
Ikezawa Z. Prevalence of atopic dermatitis in Japanese infants treated with moisturizer sincebirth and its relation to FLG mutations. Eur J Dermatol 23(2):288-289, 201324. Jimbo T, Masumoto K, Urita Y, Takayasu H, Shinkai T, Uesugi T, Gotoh C, Sakamoto N,
Sasaki T, Oto T, Fukushima T, Noguchi E, Nakano Y. Nevoid basal cell carcinoma syndrome
with a unilateral giant ovarian fibroma in a Japanese 6-year-old girl. Eur J Pediatr doi:
10.1007/s00431-013-2200-7, 2013
25. Kaneko Y, Masuko H, Sakamoto T, Iijima H, Naito T, Yatagai Y, Yamada H, Konno S,
Nishimura M, Noguchi E, Hizawa N. Asthma phenotypes in Japanese adults - theirassociations with the CCL5 and ADRB2 genotypes. Allergol Int 62(1):113-121, 201310

26. Kaneko Y, Yatagai Y, Yamada H, Iijima H, Masuko H, Sakamoto T, Hizawa N. The searchfor common pathways underlying asthma and COPD. Int J Chron Obstruct Pulmon Dis
8:65-78, 2013
27. Katsumata T, Oishi H, Sekiguchi Y, Nagasaki H, Daassi D, Tai PH, Ema M, Kudo T,
Takahashi S. Bioluminescence imaging of beta cells and intrahepatic insulin gene activity
under normal and pathological conditions. PLoS One 8(4):e60411, 2013
28. Kawaku S, Sato R, Song H, Bando Y, Arinami T, Noguchi E. Functional analysis of BRCA1
missense variants of uncertain significance in Japanese breast cancer families. J Hum Genet
58(9):618-621, 2013
29. Kawasaki A, Inoue N, Ajimi C, Sada KE, Kobayashi S, Yamada H, Furukawa H, Sumida T,
Tohma S, Miyasaka N, Matsuo S, Ozaki S, Hashimoto H, Makino H, Harigai M, Tsuchiya N.
Association of IRF5 polymorphism with MPO-ANCA-positive vasculitis in a Japanese
population. Genes Immun 14(8):527-529, 2013
30. Kudo T, Sato T, Hagiwara K, Kozuma Y, Yamaguchi T, Ikehara Y, Hamada M, Matsumoto
K, Ema M, Murata S, Ohkohchi N, Narimatsu H, Takahashi S. C1galt1-deficient mice exhibit
thrombocytopenia due to abnormal terminal differentiation of megakaryocytes. Blood
122(9):1649-1657, 2013
31. Kurokawa M, Matsukura S, Kawaguchi M, Ieki K, Suzuki S, Watanabe S, Homma T,
Yamaguchi M, Takeuchi H, Adachi M. Interleukin-33-activated dendritic cells induce theproduction of thymus and activation-regulated chemokine and macrophage-derived
chemokine. Int Arch Allergy Immunol 161 Suppl 2:52-57, 2013
32. Matsukura S, Kurokawa M, Homma T, Watanabe S, Suzuki S, Ieki K, Takeuchi H, Notomi
K, Schleimer RP, Kawaguchi M, Kokubu F. Basic research on virus-induced asthma
exacerbation: inhibition of inflammatory chemokine expression by fluticasone propionate.
Int Arch Allergy Immunol 161 Suppl 2:84-92, 2013
33. Morishima Y, Ano S, Ishii Y, Ohtsuka S, Matsuyama M, Kawaguchi M, Hizawa N.
Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma. Clin Dev
Immunol 2013:609395, 2013
34. Nagai K, Tahara-Hanaoka S, Morishima Y, Tokunaga T, Imoto Y, Noguchi E, Kanemaru K,
Imai M, Shibayama S, Hizawa N, Fujieda S, Yamagata K, Shibuya A. Expression andfunction of Allergin-1 on human primary mast cells. PLoS One 8(10):e76160, 2013
35. Naka I, Hikami K, Nakayama K, Koga M, Nishida N, Kimura R, Furusawa T, Natsuhara K,
Yamauchi T, Nakazawa M, Ataka Y, Ishida T, Inaoka T, Iwamoto S, Matsumura Y, Ohtsuka
11

R, Tsuchiya N, Ohashi J. A functional SNP upstream of the beta-2 adrenergic receptor gene
(ADRB2) is associated with obesity in Oceanic populations. Int J Obes (Lond)
37(9):1204-1210, 2013
36. Naka I, Ohashi J, Kimura R, Inaoka T, Matsumura Y. Association of ADRB2 polymorphismwith triglyceride levels in Tongans. Lipids Health Dis 12(1):110, 2013
37. Nishimoto M, Katano M, Yamagishi T, Hishida T, Kamon M, Suzuki A, Hirasaki M,
Nabeshima Y, Nabeshima Y, Katsura Y, Satta Y, Deakin JE, Graves JA, Kuroki Y, Ono R,
Ishino F, Ema M, Takahashi S, Kato H, Okuda A. In vivo function and evolution of theeutherian-specific pluripotency marker UTF1. PLoS One 8(7):e68119, 2013
38. Noguchi S, Hijikata M, Hamano E, Matsushita I, Ito H, Ohashi J, Nagase T, Keicho N. MxAtranscripts with distinct first exons and modulation of gene expression levels bysingle-nucleotide polymorphisms in human bronchial epithelial cells. Immunogenetics
65(2):107-114, 2013
39. Oishi H, Tsubaki T, Miyazaki T, Ono M, Nose M, Takahashi S. A bacterial artificial
chromosometransgenewithpolymorphic

Cd72

inhibits

thedevelopmentof

glomerulonephritis and vasculitis in MRL-Faslpr lupus mice. J Immunol 190(5):2129-2137,
2013
40. Oka S, Furukawa H, Kashiwase K, Tsuchiya N, Tohma S. A novel HLA-DQB1*04 allele,
DQB1*04:10, identified in a Japanese individual. Tissue Antigens 82(2):148-149, 2013
41. Oka S, Furukawa H, Shimada K, Hayakawa H, Fukui N, Tsuchiya N, Tohma S. Serumbiomarker analysis of collagen disease patients with acute-onset diffuse interstitial lungdisease. BMC Immunol 14:9, 2013
42. Onuma H, Tabara Y, Kawamura R, Ohashi J, Nishida W, Takata Y, Ochi M, Nishimiya T,
Kawamoto R, Kohara K, Miki T, Osawa H. Plasma resistin is associated with single
nucleotide polymorphisms of a possible resistin receptor, the decorin gene, in the general
Japanese population. Diabetes 62(2):649-652, 2013
43. Saeki H, Hirota T, Nakagawa H, Tsunemi Y, Kato T, Shibata S, Sugaya M, Sato S, Doi S,
Miyatake A, Ebe K, Noguchi E, Ebihara T, Amagai M, Esaki H, Takeuchi S, Furue M,
Nakamura Y, Tamari M. Genetic polymorphisms in the IL22 gene are associated withpsoriasis vulgaris in a Japanese population. J Dermatol Sci 71(2):148-150, 2013
44. Sakurai H, Morishima Y, Itoguchi N, Ohtsuka S, Yamadori I, Oto T, Ishii Y, Sakamoto T,
Noguchi M, Hizawa N. Broncho-bronchiolitis obliterans after living-donor lungtransplantation: a unique manifestation of chronic allograft rejection. Transplantation12

96(4):e29-30, 2013
45. Satoh H, Kagohashi K, Ohara G, Sato S, Miyazaki K, Nakazawa K, Tamura T, Kurishima K,
Kawaguchi M, Hizawa N. Use of tiotropium in patients with COPD aged 80 years and older.
Exp Ther Med 5(4):997-1000, 2013
46. Shibata H, Yamamoto K, Sun Z, Oka A, Inoko H, Arinami T, Inada T, Ujike H, Itokawa M,
Tochigi M, Watanabe Y, Someya T, Kunugi H, Suzuki T, Iwata N, Ozaki N, Fukumaki Y.
Genome-wide association study of schizophrenia using microsatellite markers in the Japanese
population. Psychiatr Genet 23(3):117-123, 2013
47. Shimbo M, Ando S, Sugiura N, Kimata K, Ichijo H. Moderate repulsive effects of
E-unit-containing chondroitin sulfate (CSE) on behavior of retinal growth cones. Brain Res
1491:34-43, 2013
48. Suzuki T, Iyoda M, Shibata T, Ohtaki H, Matsumoto K, Shindo-Hirai Y, Kuno Y, Wada Y,
Yamamoto Y, Kawaguchi M, Shioda S, Akizawa T. Therapeutic effects of humanmesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane
glomerulonephritis. PLoS One 8(6):e67475, 2013
49. Takagaki K, Satoh K, Honda S, Shibuya A. Molecular characterization of the dimer
formation of Fcalpha/mu receptor (CD351). Mol Immunol 56(1-2):23-27, 2013
50. Taniguchi N, Konno S, Hattori T, Isada A, Shimizu K, Shimizu K, Shijubo N, Huang SK,
Hizawa N, Nishimura M. The CC16 A38G polymorphism is associated with asymptomatic
airway hyper-responsiveness and development of late-onset asthma. Ann Allergy Asthma
Immunol 111(5):376-381 e371, 2013
51. Teramoto S, Hida N, Ishikawa H, Hizawa N. Inverse U shape of the trachea during anasthma attack. Intern Med 52(19):2289-2290, 2013
52. Terao C, Ohmura K, Kawaguchi Y, Nishimoto T, Kawasaki A, Takehara K, Furukawa H,
Kochi Y, Ota Y, Ikari K, Sato S, Tohma S, Yamada R, Yamamoto K, Kubo M, Yamanaka H,
Kuwana M, Tsuchiya N, Matsuda F, Mimori T. PLD4 as a novel susceptibility gene forsystemic sclerosis in a Japanese population. Arthritis Rheum 65(2):472-480, 2013
53. Tomita K, Sakashita M, Hirota T, Tanaka S, Masuyama K, Yamada T, Fujieda S, Miyatake
A, Hizawa N, Kubo M, Nakamura Y, Tamari M. Variants in the 17q21 asthma susceptibility
locus are associated with allergic rhinitis in the Japanese population. Allergy 68(1):92-100,
2013
54. Tsuchiya N. Genetics of ANCA-associated vasculitis in Japan: a role for HLA-DRB1*09:01
haplotype. Clin Exp Nephrol 17(5):628-630, 201313

55. Umeda N, Matsumoto I, Ito I, Kawasaki A, Tanaka Y, Inoue A, Tsuboi H, Suzuki T, Hayashi
T, Ito S, Tsuchiya N, Sumida T. Anti-citrullinated glucose-6-phosphate isomerase peptide
antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 sharedepitope alleles and disease activity. Clin Exp Immunol 172(1):44-53, 2013
56. Watanabe Y, Iijima Y, Egawa J, Nunokawa A, Kaneko N, Arinami T, Ujike H, Inada T, Iwata
N, Kunugi H, Itokawa M, Sasaki T, Ozaki N, Hashimoto R, Shibuya M, Igeta H, Someya T.
Replication in a Japanese population that a MIR30E gene variation is associated withschizophrenia. Schizophr Res 150(2-3):596-597, 2013
57. Yageta Y, Ishii Y, Morishima Y, Ano S, Ohtsuka S, Matsuyama M, Takeuchi K, Itoh K,
Yamamoto M, Hizawa N. Carbocisteine Reduces Viral-Induced Pulmonary Inflammation in
Mice

ExposedtoCigarette

Smoke.

AmJ

Respir

Cell

Mol

Biol

doi:

10.1165/rcmb.2012-0292OC, 2013
58. Yamashita Y, Abe F, Hirochika R, Tahara-Hanaoka S, Shibuya A, Shibuya K. Establishment
and characterization of a novel anti-DNAM-1 monoclonal antibody. Monoclon AntibImmunodiagn Immunother 32(1):60-64, 2013
59. Yatagai Y, Sakamoto T, Masuko H, Kaneko Y, Yamada H, Iijima H, Naito T, Noguchi E,
Hirota T, Tamari M, Imoto Y, Tokunaga T, Fujieda S, Konno S, Nishimura M, Hizawa N.
Genome-wide association study for levels of total serum IgE identifies HLA-C in a Japanese
population. PLoS One 8(12):e80941, 2013
60. Yoon JH, Jung SM, Park SH, Kato M, Yamashita T, Lee IK, Sudo K, Nakae S, Han JS, Kim
OH, Oh BC, Sumida T, Kuroda M, Ju JH, Jung KC, Park SH, Kim DK, Mamura M. Activin
receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of
Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes. EMBO Mol Med
5(11):1720-1739, 2013
61. Yoshizawa Y, Honda S, Shibuya A. Involvement of Fcα/µR (CD351) in autoantibody
production. Mol Immunol doi: 10.1016/j.molimm.2013.10.002, 2013	 2) 英文以外の論文
1. 阿野哲士, 森島祐子, 石井幸雄, 大塚茂男, 松山政史, 中澤健介, 川口未央, 坂本透, 檜澤伸之. 気管支喘息	  動物モデル OVA 誘導性好中球性気道炎症に対する抗 IL-6 受容体
抗体の抑制効果に関する検討. 日本呼吸器学会誌 2(増刊):133, 2013
2. 飯島弘晃, 山田英恵, 谷田貝洋平, 金子美子, 坂本透, 内藤隆志, 今野哲, 西村正治, 檜澤伸之. 吸入抗原感作数からみた喘息フェノタイプ分類について. 日本呼吸器学会誌
14

2(増刊):283, 2013
3. 籠橋克紀, 熊谷亮, 糸井覚, 宮崎邦彦, 大原元, 金本幸司, 栗島浩一, 石川博一, 佐藤浩昭,
檜 澤 伸 之. BUD/FM の 長 期 投 与 時 の 安 全 性 に 関 す る 検 討. 日 本 内 科 学 会 雑 誌
102(Suppl.):228, 2013
4. 金子美子, 山田英恵, 谷田貝洋平, 増子裕典, 飯島弘晃, 内藤隆志, 坂本透, 広田朝光, 玉利真由美, 檜澤伸之. 健常成人の総 IgE 値、一秒量における MUC5B 遺伝子の役割. 日
本呼吸器学会誌 2(増刊):251, 2013
5. 坪井洋人, 飯塚麻菜, 浅島弘充, 住田孝之.【自己抗体】抗 M3 ムスカリン作働性アセチ
ルコリン受容体抗体とシェーグレン症候群. 日本臨床免疫学会会誌 36(2):77-85, 2013
6. 檜澤伸之. 【気管支喘息:診断と治療の進歩】 病因と病態	
  喘息関連遺伝子. 日本内科学会雑誌 102(6):1365-1369, 2013
7. 檜澤伸之. 気管支喘息・COPD 治療へのアプローチ	  ICS/LABA 配合剤の可能性
Phenotype に基づく喘息診療. 日本呼吸器学会誌 2(増刊):102, 2013
8. 檜澤伸之. 長びく咳への対応. 日本耳鼻咽喉科学会会報 116(4):380, 2013
9. 藤田純一, 川口未央, 國分二三男, 松倉聡, 黒川真嗣, 太田恭子, 阿野哲士, 金子美子, 森
島祐子, 石井幸雄, 坂本透, 佐藤浩昭, 檜澤伸之. 気道平滑筋細胞からの IL-17F による
IL-6、IL-8 産生. 日本呼吸器学会誌 2(増刊):236, 2013
10. 谷田貝洋平, 金子美子, 飯島弘晃, 山田英恵, 坂本透, 今野哲, 西村正治, 檜澤伸之. 気管支喘息	
  病態 成人気管支喘息患者 phenotype と ADRB 2 遺伝子多型の検討. 日本呼吸器学会誌 2(増刊):139, 2013
11. 山田英恵, 谷田貝洋平, 増子裕典, 金子美子, 飯島弘晃, 内藤隆志, 坂本透, 野口恵美子,
広田朝光, 玉利真由美, 檜澤伸之. 日本人における閉塞性換気障害に影響を与える遺伝
因子. 日本呼吸器学会誌 2(増刊):270, 201315

腫瘍特異的ヘム‐ポルフィリン代謝を利用した診断・治療法開発	 1) 英文論文
1. Akimoto K, Kimura K, Nagano M, Takano S, To'a Salazar G, Yamashita T, Ohneda O.
Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived
mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells Dev
22(9):1370-1386, 2013
2. Aoki T, Nishikawa R, Sugiyama K, Nonoguchi N, Kawabata N, Mishima K, Adachi JI,
Kurisu K, Yamasaki F, Tominaga T, Kumabe T, Ueki K, Higuchi F, Yamamoto T, Ishikawa E,
Takeshima H, Yamashita S, Arita K, Hirano H, Yamada S, Matsutani M. A Multicenter Phase
I/II Study of the BCNU Implant (Gliadel Wafer) for Japanese Patients with Malignant
Gliomas. Neurol Med Chir (Tokyo) doi:10.2176/nmc.oa2013-0112, 2013	 3. Bodhak S, Kikuchi M, Sogo Y, Tsurushima H, Ito A, Oyane A. Calcium phosphate coating on
a bioresorbable hudroxyapatite/collagen nanocomposite for surface functionalization. Chem
Lett 42:1029-1031, 2013
4. Fujimoto H, Nakanishi H, Miki T, Kanayama HO, Ohyama C, Suzuki K, Nishiyama H, Eto
M, Naito S, Fukumori T, Kubota Y, Takahashi S, Homma Y, Kamoi K. Oncological outcomesof renal pelvic and ureteral cancer patients registered in 2005: The first large population
report from the Cancer Registration Committee of the Japanese Urological Association. Int J
Urol doi: 10.1111/iju.12367, 2013
5. Hara T, Akutsu H, Yamamoto T, Ishikawa E, Matsuda M, Matsumura A. Cushing’s disease
presenting with gastrointestinal perforation: a case report. Endocrinology, diabetes andmetabolism. Case reports Nov(?):1-4, 2013
6. Hara T, Matsuda M, Watanabe S, Nakai K, Yamamoto T, Matsumura A. Remote cerebellar
hemorrhage after removal of a supratentorial glioma without perioperative CSF loss: A casereport. Case Rep Surg 2013:305039, 2013
7. Hinotsu S, Kawai K, Ozono S, Tsushima T, Tokuda N, Nomata K, Naito S, Akaza H.
Randomized controlled study of natural interferon α as adjuvant treatment for stage II or III
renal cell carcinoma. Int J Clin Oncol 18(1):68-74, 2013
8. Hirohata T, Asano K, Ogawa Y, Takano S, Amano K, Isozaki O, Iwai Y, Sakata K, Fukuhara
N, Nishioka H, Yamada S, Fujio S, Arita K, Takano K, Tominaga A, Hizuka N, Ikeda H,
Osamura RY, Tahara S, Ishii Y, Kawamata T, Shimatsu A, Teramoto A, Matsuno A. DNA
mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas
and pituitary carcinomas to temozolomide: the national cooperative study by the Japan16

Society for Hypothalamic and Pituitary Tumors. J Clin Endocrinol Metab 98(3):1130-1136,
2013
9. Inai H, Kawai K, Ikeda A, Ando S, Kimura T, Oikawa T, Onozawa M, Miyazaki J, Uchida K,
Nishiyama H. Risk factors for chronic kidney disease after chemotherapy for testicularcancer. Int J Urol 20(7):716-722, 2013
10. Inai H, Kawai K, Kojima T, Joraku A, Shimazui T, Yamauchi A, Miyagawa T, Endo T,
Fukuhara Y, Miyazaki J, Uchida K, Nishiyama H. Oncological outcomes of metastatic
testicular cancers under centralized management through regional medical network. Jpn J
Clin Oncol 43(12):1249-1254, 2013
11. Indo H, Nakanishi I, Yen H, Nyui M, Manda S, Matsumoto K, Anzai K, Ikota N, Matsui H,
Minamiyama Y, Nakajima A, Ichikawa I, Ozawa T, Mukai C, HJ. M. Comparison of in Vivo
and in Vitro Antioxidative Parameters for Eleven Food Factors.,. RSC Adv 3:4535-4538,
2013
12. Ito Y, Kato N, Matsumura A, Sonobe M. Hemodynamic instability increases new ischemic
brain lesions on diffusion-weighted imaging after carotid artery stenting. Neurol Med Chir
(Tokyo) 53(6):375-380, 2013
13. Ito Y, Tsurushima H, Sato M, Ito A, Oyane A, Sogo Y, Matsumura A. Angiogenesis therapy
for brain infarction using a slow-releasing drug delivery system for fibroblast growth factor
2. Biochem Biophys Res Commun 432(1):182-187, 2013
14. Kajita Y, Kato T, Jr., Tamaki S, Furu M, Takahashi R, Nagayama S, Aoyama T, Nishiyama
H, Nakamura E, Katagiri T, Nakamura Y, Ogawa O, Toguchida J. The transcription factor
Sp3 regulates the expression of a metastasis-related marker of sarcoma, actin
filament-associated protein 1-like 1 (AFAP1L1). PLoS One 8(1):e49709, 2013
15. Kaneko MK, Morita S, Tsujimoto Y, Yanagiya R, Nasu K, Sasaki H, Hozumi Y, Goto K,
Natsume A, Watanabe M, Kumabe T, Takano S, Kato Y. Establishment of novel monoclonal
antibodies KMab-1 and MMab-1 specific for IDH2 mutations. Biol Biophys Res Commun
432:40-45, 2013
16. Kawai K, Ichioka D, Inai H, Miyazaki J, Nishiyama H. Assessment and management of
renal

impairmentinchemotherapy

forurogenitalcancer.

Jpn

J

Clin

Oncol

43(11):1055-1063, 2013
17. Kawai K, Miyazaki J, Joraku A, Nishiyama H, Akaza H. Bacillus Calmette-Guerin (BCG)
immunotherapy for bladder cancer: current understanding and perspectives on engineered
BCG vaccine. Cancer Sci 104(1):22-27, 201317

18. Kimura T, Onozawa M, Miyazaki J, Kawai K, Nishiyama H, Hinotsu S, Akaza H. Validationof the prognostic grouping of the seventh edition of the tumor-nodes-metastasis classification
using a large-scale prospective cohort study database of prostate cancer treated with primary
androgen deprivation therapy. Int J Urol 20(9):880-888, 2013
19. Kin H, Ishikawa E, Takano S, Ayuzawa S, Matsushita A, Muragaki Y, Aiyama H, Sakamoto
N, Yamamoto T, Matsumura A. Language areas involving the inferior temporal cortex on
intraoperative mapping in a bilingual patient with glioblastoma. Neurol Med Chir (Tokyo)
53(4):256-258, 2013
20. Matsubara T, Ayuzawa S, Aoki T, Fujimoto A, Osuka S, Matsumura A. The patient had anormal magnetic resonance imaging and temporal lobe epilepsy secondaru to a porencephaliccyst but showed structural lesions (hippocampal sclerosis). Epilepsy & Behavior Case
Reports 1:153-156, 2013
21. Matsubara T, Ayuzawa S, Aoki T, Ikeda G, Shiigai M, Matsumura A. Cerebral Venous
Thrombosis after Ventriculoperitoneal Shunting: A Case Report. Neurol Med Chir (Tokyo)
doi:20.2176/nmc.cr.2012-0312, 2013	 22. Matsubara T, Ishikawa E, Hirata K, Matsuda M, Akutsu H, Masumoto T, Zaboronok A,
Matsumura A. A New Mechanism of Cerebrospinal Fluid Leakage after Lumboperitoneal
Shunt: A Theory of Shunt Side Hole-Case Report. Neurol Med Chir (Tokyo)
doi:10.2176/nmc.2013-0067, 2013
23. Miyazaki J, Hinotsu S, Ishizuka N, Naito S, Ozono S, Akaza H, Nishiyama H. Adverse
reactions related to treatment compliance during BCG maintenance therapy fornon-muscle-invasive bladder cancer. Jpn J Clin Oncol 43(8):827-834, 2013
24. Mizumoto M, Okumura T, Ishikawa E, Yamamoto T, Takano S, Matsumura A, Oshiro Y,
Ishikawa H, Sakurai H, Tsuboi K. Reirradiation for recurrent malignant brain tumor withradiotherapy or proton beam therapy. Technical considerations based on experience at asingle institution. Strahlenther Onkol 189(8):656-663, 2013
25. Muragaki Y, Akimoto J, Maruyama T, Iseki H, Ikuta S, Nitta M, Maebayashi K, Saito T,
Okada Y, Kaneko S, Matsumura A, Kuroiwa T, Karasawa K, Nakazato Y, Kayama T. Phase II
clinical study on intraoperative photodynamic therapy with talaporfin sodium andsemiconductor laser in patients with malignant brain tumors. J Neurosurg 119(4):845-852,
2013
26. Nakajima J, Hitomi S, Koganemaru H, Nakai Y. Isolation of Staphylococcus epidermidis
intermediately resistant to vancomycin in a case of central venous catheter-associated18

bloodstream infection. J Infect Chemother 19(5):983-986, 2013
27. Nakamura T, Fukiage M, Higuchi M, Nakaya A, Yano I, Miyazaki J, Nishiyama H, Akaza
H, Ito T, Hosokawa H, Nakayama T, Harashima H. Nanoparticulation of BCG-CWS for
application to bladder cancer therapy. J Control Release doi: 10.1016/j.jconrel.2013.12.027,
2013
28. Nguyen TNH, Akutsu H, Nouguch iS, Tsunoda T, Sasak iM, Tsurushima H, Matsumura A.
Reversible focal radiological changes due to non-convulsive status epilepticus of the rightparietooccipital lobe. Turk Neurosurg 23(2):278-281, 2013
29. Onuma K, Ishikawa E, Matsuda M, Hirata K, Osuka S, Yamamoto T, Masumoto T,
Zaboronok A, Matsumura A. Clinical characteristics and neuroimaging findings in 12 casesof recurrent glioblastoma with communicating hydrocephalus. Neurol Med Chir (Tokyo)
53(7):474-481, 2013
30. Osuka S, Sampetrean O, Shimizu T, Saga I, Onishi N, Sugihara E, Okubo J, Fujita S, Takano
S, Matsumura A, Saya H. IGF1 receptor signaling regulates adaptive radioprotection inglioma stem cells. Stem Cells 31(4):627-640, 2013
31. Ota T, Komori H, Rii J, Ochi A, Suzuki K, Shiga N, Nishiyama H. Soft coagulation inpartial nephrectomy without renorrhaphy: Feasibility of a new technique and early outcomes.
Int J Urol doi: 10.1111/iju.12276, 2013
32. Oyane A, Araki H, Sogo Y, Ito A, Tsurushima H. Spontaneous assembly of DNA-amorphous
calcium phosphate nanocomposite spheres for surface-mediated genetransfer. Cryst Eng
Comm 15(25):4994-4997, 2013
33. Saito R, Nonaka S, Fujinami Y, Matsuoka S, Nakajima S, Nishiyama H, Okamura N. The
frequency of BRO beta-lactamase and its relationship to antimicrobial susceptibility andserum

resistanceinMoraxellacatarrhalis.

J

InfectChemotherdoi:

10.1016/j.jiac.2013.06.003, 201334. Saito R, Suzuki H, Yamada T, Endo S, Moriwaki T, Ueno T, Hirose M, Hirai S, Yamato K,
Mizokami Y, Hyodo I. Predicting skin toxicity according to EGFR polymorphisms inpatients with colorectal cancer receiving antibody against EGFR. Anticancer Res
33(11):4995-4998, 201335. Sakamoto N, Akutsu H, Takano S, Yamamoto T, Matsumura A. Useful 'sliding-lock-knot'
technique for suturing dural patch to prevent cerebrospinal fluid leakage after extended
transsphenoidal surgery. Surg Neurol Int 4:19, 2013
36. Sakamoto N, Ishikawa E, Aoki K, Uemae Y, Komatsu Y, Matsumura A. Clinical Outcomes19

ofIntracerebral

HemorrhageinHemodialysis

Patients.

World

Neurosurgdoi:

10.1016/j.wneu.2013.10.033, 201337. Sato M, Nakai Y, Tsurushima H, Shiigai M, Masumoto T, Matsumura A. Risk factors ofischemic lesions related to cerebral angiography and neuro-interventional procedures. Neurol
Med Chir (Tokyo) 53(6):381-387, 2013
38. Sato M, Takigawa T, Shiigai M, Tamura G, Masumoto T, Nakai Y, Zaboronok A,
Tsurushima H, Matsumura A. Spinal dural arteriovenous fistula with lipomyelodysplasia.
Neurol Med Chir (Tokyo) 53(2):107-109, 2013
39. Sha S, Vong LB, Chonpathompikunlert P, Yoshitomi T, Matsui H, Nagasaki Y. Suppressionof NSAID-induced small intestinal inflammation by orally administered redox nanoparticles.
Biomaterials 34(33):8393-8400, 2013
40. Shibui S, Narita Y, Mizusawa J, Beppu T, Ogasawara K, Sawamura Y, Kobayashi H,
Nishikawa R, Mishima K, Muragaki Y, Maruyama T, Kuratsu J, Nakamura H, Kochi M,
Minamida Y, Yamaki T, Kumabe T, Tominaga T, Kayama T, Sakurada K, Nagane M,
Kobayashi K, Nakamura H, Ito T, Yazaki T, Sasaki H, Tanaka K, Takahashi H, Asai A, Todo
T, Wakabayashi T, Takahashi J, Takano S, Fujimaki T, Sumi M, Miyakita Y, Nakazato Y, Sato
A, Fukuda H, Nomura K. Randomized trial of chemoradiotherapy and adjuvant
chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly
diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305). Cancer ChemotherPharmacol 71(2):511-521, 2013
41. Shimazui T, Yoshikawa K, Miyazaki J, Kojima T, Inai H, Ando S, Uemura H, Uchida K,
Nishiyama H. Systemic transduction of p16INK4A antitumor peptide inhibits the growth of
MBT-2 mouse bladder tumor cell line grafts. Int J Oncol 42(2):543-548, 2013
42. Suzuki H, Kaneko T, Mizokami Y, Narasaka T, Endo S, Matsui H, Yanaka A, Hirayama A,
Hyodo I. Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis.
World J Gastroenterol 19(17):2718-2722, 2013
43. Takano S, Kimu H, Tsuda K, Osuka S, Nakai K, Yamamoto T, Ishikawa E, Akutsu H,
Matsuda M, Matsumura A. Decrease in the apparent diffusion coefficient in peritumoral
edema for the assessment of recurrent glioblastoma treated by bevacizumab. Acta Neurochir
Suppl 118:185-189, 2013
44. Takaoka E, Matsui Y, Inoue T, Miyazaki J, Nakashima M, Kimura T, Oikawa T, Kawai K,
Yoshimura K, Habuchi T, Ogawa O, Nishiyama H. Risk factors for intravesical recurrence inpatients with high-grade T1 bladder cancer in the second TUR era. Jpn J Clin Oncol20

43(4):404-409, 2013
45. Tamura M, Matsui H, Kaneko T, Hyodo I. Alcohol is an oxidative stressor for gastricepithelial cells: detection of superoxide in living cells. J Clin Biochem Nutr 53(2):75-80,
2013
46. Tamura M, Matsui H, Nagano YN, Kaneko T, Indo HP, Majima HJ, Hyodo I. Salt is anoxidative stressor for gastric epithelial cells. J Physiol Pharmacol 64(1):89-94, 2013
47. Tamura M, Matsui H, Tomita T, Sadakata H, Indo HP, Majima HJ, Kaneko T, Hyodo I.
Mitochondrial reactive oxygen species accelerate gastric cancer cell invasion. J Clin
Biochem Nutr doi: 10.3164/jcbn.13-36, 2013
48. Tamura M, Yanagawa F, Sugiura S, Takagi T, Sumaru K, Matsui H, Kanamori T. Opticalcell picking in photodegrable hydrogels based on cellular morphology in 3D culture
environment. Proc mTAS:1929–1931, 2013
49. Tsuda K, Akutsu H, Yamamoto T, Ishikawa E, Saito A, Nakai K, Takano S, Matsumura A.
Benign spinal meningioma without dural attachment presenting delayed CSF disseminationand malignant transformation. Brain Tumor Pathol 30(3):185-191, 2013
50. Tsuda K, Tsurushima H, Takano S, Tsuboi K, Matsumura A. Brain metastasis from papillary
thyroid carcinomas. Molecular and clinical oncology 1:817-819, 2013
51. Tsuruta W, Matsumaru Y, Hamada Y, Hayakawa M, Kamiya Y. Analysis of closed-cell
intracranial stent characteristics using cone-beam computed tomography with contrast
material. Neurol Med Chir (Tokyo) 53(6):403-408, 2013
52. Vong LB, Yoshitomi T, Morikawa K, Saito S, Matsui H, Nagasaki Y. Oral nanotherapeutics:
effect of redox nanoparticle on microflora in mice with dextran sodium sulfate-induced
colitis. J Gastroenterol doi: 10.1007/s00535-013-0836-8, 2013
53. Wang X, Ito A, Sogo Y, Hirose M, Oyane A, Tsurushima H. DNA-lipid-apatitie composite
layers enhance gene expression of mesenchymal stem cells. Mat Sci Eng C 33:512-518,
2013
54. Yamamoto T, Tsuboi K, Nakai K, Kumada H, Sakurai H, Matsumura A. Boron neutron
capture therapy for brain tumors. Transl Cancer Res 2:80-86, 2013
55. Yamazaki T, Sonobe M, Kato N, Kasuya H, Ikeda G, Nakamura K, Ito Y, Tsuruta W, Nakai
Y, Matsumura A. Endovascular coiling as the first treatment strategy for ruptured pericallosalartery aneurysms: results, complications, and follow up. Neurol Med Chir (Tokyo)
53(6):409-417, 2013
56. Zaboronok A, Isobe T, Yamamoto T, Sato E, Takada K, Sakae T, Tsurushima H, Matsumura
21

A. Proton beam irradiation stimulates migration and invasion of human U87 malignant
glioma cells. J Radiat Res doi: 10.1093/jrr/rrt119, 2013
57. Zaboronok A, Tsurushima H, Yamamoto T, Isobe T, Takada K, Sakae T, Yoshida F,
Matsumura A. Size-dependent radiosensitization effects of gold nanoparticles on humanU251 malignant glioma cells. Nanosci nanotech lett 5(9):9904, 2013	 2) 英文以外の論文
1. 池田剛, 園部眞, 加藤徳之, 山崎友郷, 粕谷泰道, 中居康展, 松村明. 脳動脈瘤コイル塞栓術 後 の 破 裂 ・ 再 治 療 と Volume Embolization Ratio(VER)の 関 連 性. 脳 卒 中 の 外 科
41(6):440-446, 2013
2. 伊藤嘉朗, 加藤徳之, 中居康展, 松村明, 園部眞. Closed-cell stent を用いた頸動脈ステン
ト 留 置 術 に お け る 頸 動 脈 の 屈 曲 度 と 微 小 脳 塞 栓 の 関 係. JNET: Journal of
Neuroendovascular Therapy 7(2):75-80, 2013
3. 伊藤嘉朗, 加藤徳之, 松村明, 園部眞. ドーナツ型巨大脳動脈瘤に対してコイルとラッ
ピング術を施行した 1 例. 脳神経外科 41(5):415-420, 2013
4. 小松洋治, 中村和弘, 伊藤嘉朗, 益子良太, 上村和也, 松村明. 【光線力学診断・治療の最新動向】 脳神経外科手術におけるインドシアニングリーン術中蛍光血管撮影の有用性と課題. 日本レーザー医学会誌 34(2):141-147, 2013
5. 鶴田和太郎, 松丸祐司, 上坂義和, 松村明. 神経放射線診断	
  進行する脊髄症状を呈し、MRI にて上部頸髄に異常を認めた症例. 脳神経外科ジャーナル 22(11):873-877, 2013
6. 益子良太, 中居康展, 原拓真, 今井資, 松原鉄平, 松田真秀, 上村和也, 小松洋治, 松村明.
錐体骨部特発性内頸動脈解離に対するステント留置術の 1 例. 脳神経外科ジャーナル
22(7):557-561, 2013
7. 松丸祐司, 原貴行, 松村明. 【血管奇形の基礎と臨床】 脊髄動静脈シャント	  何が治せて何が治療困難か. 脳神経外科ジャーナル 22(1):44-51, 2013
8. 三木俊一郎, 山崎友郷, 加藤徳之, 池田剛, 粕谷泰道, 園部眞, 中居康展, 松村明. Double
catheter technique を応用した coil-assist technique で治療を行ったブレブをネック近傍に伴う破裂脳動脈瘤の 1 例. JNET: Journal of Neuroendovascular Therapy 7(3):186-191,
20134) 英文以外の著書
1. 阿久津博義. 第 7 章. 神経内視鏡における止血・凝固機器; "先端医療シリーズ 45	
  臨
床医のための最新脳神経外科 シリーズ 45” (編集 橋本信夫, 寺本明, 小川彰, 嘉山孝
22正), （株）寺田国際事務所/先端医療技術研究所 (東京) 2013; pp151-154
2. 河合弘二, 西山博之. Ⅲ 章.分子生物学の基盤的手法と泌尿器科領域への応用	  3. 遺伝
子発現の解析法とその応用; "ベッドサイド泌尿器科学 (第 4 版)” (編集 小川修, 岡田裕
作, 荒井陽一, 寺地敏郎, 松田公志, 筧善行, 羽渕友則／吉田修), 南江堂 (東京) 2013;
pp146-148
3. 中居康展. 3(5). ②セットアップ	
  "特集	  よくわかる脳血管内治療. BRAIN 3(5)” 医学出版 (東京) 2013; pp 366-70
4. 西山博之, 宮﨑淳. Ⅰ. 症例と病理カンファレンス編	
  B.尿路上皮癌 CPC	  症例 2．. CIS（primary,concomitant）の診断と治療について; "実践的泌尿器腫瘍病理診断―カンフ
ァレンス形式で学ぶ (第 1 版)” (編集 筧善行, 賀本敏行), 中山書店 (東京) 2013; pp66-72
5. 松村明, 松田真秀. 17. 脳神経外科分野における陽子線治療の適用; "定位的放射線治療学会” 2013; pp11-19
6. 松村明, 山本哲哉. 小児脳腫瘍に対する放射線治療; " 小児脳神経外科診療ガイドブッ
ク (第 1 版)” (編集 新井一, 伊達裕昭, 西本博) メジカルビュー社 (東京) 2013; pp14-21
7. 宮﨑淳, 西山博之, 松本光司. 子宮頚部腫瘍. 前方骨盤除臓術：CCRT 後の再発―膀胱・尿管の手術; "OGS NOW 14	  婦人科がん手術	  こんなときどうする？がんの根治とQOL の改善をめざして (第 1 版)” (編集 小西郁生), メジカルビュー社 (東京) 2013;
pp74-79
8. 室井愛. 3(4). 頭部外傷（偶発性）; "小児科学レクチャー	  読影の極意を学ぶ	  小児の画像診断—頭部・頭頸部編—Q&A 3(4)” (編集 河野達夫), 総合医学社 (東京) 2013; pp822-82823

次世代型粒子線がん治療の確立研究	 1) 英文論文
1. Abei M, Okumura T, Fukuda K, Hashimoto T, Araki M, Ishige K, Hyodo I, Kanemoto A,
Numajiri H, Mizumoto M, Sakae T, Sakurai H, Zenkoh J, Ariungerel G, Sogo Y, Ito A, Ohno
T, Tsuboi K. A phase I study on combined therapy with proton-beam radiotherapy and in situ
tumor vaccination for locally advanced recurrent hepatocellular carcinoma. Radiat Oncol
8:239, 2013
2. Aihara T, Morita N, Kamitani N, Kumada H, Ono K, Hiratsuka J, Harada T. Boron neutron
capture therapy for advanced salivary gland carcinoma in head and neck. Int J Clin Oncol
doi: 10.1007/s10147-013-0580-3, 2013	  	 3. Bialek-Pietras M, Olejniczak AB, Tachikawa S, Nakamura H, Lesnikowski ZJ. Towards newboron carriers for boron neutron capture therapy: metallacarboranes bearing cobalt, iron andchromium and their cholesterol conjugates. Bioorg Med Chem 21(5):1136-1142, 2013
4. Furumoto T, Ozawa N, Inami Y, Toyoshima M, Fujita K, Zaiki K, Sahara S, Akita M,
Kitamura K, Nakaoji K, Hamada K, Tamai K, Kaneda Y, Maeda A. Mallotus philippinensis
bark extracts promote preferential migration of mesenchymal stem cells and improve woundhealing in mice. Phytomedicine doi: 10.1016/j.phymed.2013.09.003, 2013
5. Fushiki H, Miyoshi S, Noda A, Murakami Y, Sasaki H, Jitsuoka M, Mitsuoka K, Matsunari I,
Nishimura S. Pre-clinical validation of orthotopically-implanted pulmonary tumor byimaging with 18F-fluorothymidine-positron emission tomography/computed tomography.
Anticancer Res 33(11):4741-4749, 2013
6. Hara T, Akutsu H, Yamamoto T, Ishikawa E, Matsuda M, Matsumura A. Cushing’s disease
presenting with gastrointestinal perforation: a case report. Endocrinology, diabetes andmetabolism. Case reports Nov:1-4, 2013
7. Hara T, Matsuda M, Watanabe S, Nakai K, Yamamoto T, Matsumura A. Remote cerebellar
hemorrhage after removal of a supratentorial glioma without perioperative CSF loss: A casereport. Case Rep Surg 2013:305039, 2013
8. Hashii H, Hashimoto T, Okawa A, Shida K, Isobe T, Hanmura M, Nishimura T, Aonuma K,
Sakae T, Sakurai H. Comparison of the effects of high-energy photon beam irradiation (10and 18 MV) on 2 types of implantable cardioverter-defibrillators. Int J Radiat Oncol Biol
Phys 85(3):840-845, 2013
9. Hatano K, Yamaguchi S, Nimura K, Murakami K, Nagahara A, Fujita K, Uemura M, Nakai
Y, Tsuchiya M, Nakayama M, Nonomura N, Kaneda Y. Residual prostate cancer cells after24

docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4,
ERK1/2 and c-Myc. Mol Cancer Res 11(9):1088-1100, 2013
10. Hong Z, Kase Y, Moritake T, Gerelchuluun A, Sun L, Suzuki K, Terunuma T, Yasuoka K,
Kumada H, Anzai K, Sakurai H, Sakae T, Tsuboi K. Lineal energy-based evaluation ofoxidative DNA damage induced by proton beams and X-rays. Int J Radiat Biol 89(1):36-43,
2013
11. Horiguchi Y, Miyachi S, Nagasaki Y. High-performance surface acoustic wave
immunosensing system on a PEG/aptamer hybridized surface. Langmuir 29(24):7369-7376,
2013
12. Hossain MA, Ikeda Y, Hara T, Nagasaki Y. Novel biocompatible nanoreactor for silica/gold
hybrid nanoparticles preparation. Colloids Surf B Biointerfaces 102:778-782, 2013
13. Ikeda Y, Katamachi J, Kawasaki H, Nagasaki Y. Novel protein PEGylation chemistry via
glutalaldehyde-functionalized PEG. Bioconjug Chem 24(11):1824-1827, 2013
14. Ikeda Y, Kawasaki H, Ichinohe S, Nagasaki Y. Facile solid-phase synthesis of a highly stablepoly(ethylene glycol)-oligonucleotide conjugate. J Mater Chem B 1:529-535, 2013
15. Ikeda Y, Kubota D, Nagasaki Y. Design of sugar-oligonucleotide conjugates installed gold
nanoparticle for effective delivery to hepatic parenchymal cells. Colloid Polym Sci
291(12):2959-2964, 2013
16. Ikeda Y, Nagasaki Y. Impacts of PEGylation on the gene and oligonucleotide delivery
system. J Appl Polym Sci doi:10.1002/app.40293, 2013 	
 17. Isobe T, Mori Y, Takada K, Sato E, Sakurai H, Sakae T. Robust technique using an imaging
plate to detect environmental radioactivity. Health Phys 104(4):362-365, 2013
18. Isobe T, Mori Y, Takada K, Sato E, Takahashi H, Sekiguchi T, Yoshimura Y, Sakurai H,
Sakae T. Evaluation of vegetables in Tsukuba for contamination with radioactive materials
from the accident at Fukushima Daiichi nuclear power plant. Health Phys 105(4):311-317,
2013
19. Ito Y, Kato N, Matsumura A, Sonobe M. Hemodynamic instability increases new ischemic
brain lesions on diffusion-weighted imaging after carotid artery stenting. Neurol Med Chir
(Tokyo) 53(6):375-380, 2013
20. Ito Y, Tsurushima H, Sato M, Ito A, Oyane A, Sogo Y, Matsumura A. Angiogenesis therapy
for brain infarction using a slow-releasing drug delivery system for fibroblast growth factor
2. Biochem Biophys Res Commun 432(1):182-187, 2013
21. Kamimura M, Furukawa T, Akiyama S, Nagasaki Y. pH-sensitive doxorubicin/poly(ethylene
25glycol)-block-poly(4-vinylbenzylphosphonate) nanoparticles in multi-drug resistant humanepidermoid KB carcinoma cells. Biomaterials Science 1(4):361-367, 2013
22. Kaneda Y. The RIG-I/MAVS signaling pathway in cancer cell-selective apoptosis.
Oncoimmunology 2(4):e23566, 2013
23. Kanemoto A, Mizumoto M, Okumura T, Takahashi H, Hashimoto T, Oshiro Y, Fukumitsu N,
Moritake T, Tsuboi K, Sakae T, Sakurai H. Dose-volume histogram analysis for risk factorsof radiation-induced rib fracture after hypofractionated proton beam therapy forhepatocellular carcinoma. Acta Oncol 52(3):538-544, 2013
24. Kanemoto A, Okumura T, Ishikawa H, Mizumoto M, Oshiro Y, Kurishima K, Homma S,
Hashimoto T, Ohkawa A, Numajiri H, Ohno T, Moritake T, Tsuboi K, Sakae T, Sakurai H.
Outcomes and prognostic factors for recurrence after high-dose proton beam therapy forcentrally and peripherally located stage I non-small-cell lung cancer. Clin Lung Cancer doi:
10.1016/j.cllc.2013.11.002, 2013
25. Kase Y, Yamashita W, Matsufuji N, Takada K, Sakae T, Furusawa Y, Yamashita H,
Murayama S. Microdosimetric calculation of relative biological effectiveness for design oftherapeutic proton beams. J Radiat Res 54(3):485-493, 2013
26. Kato M, Konishi S, Matsumura A, Hayashi K, Tamai K, Shintani K, Kazuki K, Nakamura
H. Clinical characteristics of intraspinal facet cysts following microsurgical bilateraldecompression via a unilateral approach for treatment of degenerative lumbar disease. Eur
Spine J 22(8):1750-1757, 2013
27. Kin H, Ishikawa E, Takano S, Ayuzawa S, Matsushita A, Muragaki Y, Aiyama H, Sakamoto
N, Yamamoto T, Matsumura A. Language areas involving the inferior temporal cortex on
intraoperative mapping in a bilingual patient with glioblastoma. Neurol Med Chir (Tokyo)
53(4):256-258, 2013
28. Koganei H, Ueno M, Tachikawa S, Tasaki L, Ban HS, Suzuki M, Shiraishi K, Kawano K,
Yokoyama M, Maitani Y, Ono K, Nakamura H. Development of high boron content
liposomes and their promising antitumor effect for neutron capture therapy of cancers.
Bioconjug Chem 24(1):124-132, 2013
29. Lakshmipriya T, Fujimaki M, Gopinath SC, Awazu K, Horiguchi Y, Nagasaki Y. A
high-performance waveguide-mode biosensor for detection of factor IX using PEG-based
blocking agents to suppress non-specific binding and improve sensitivity. Analyst
138(10):2863-2870, 2013
30. Makishima H, Ishikawa H, Terunuma T, Hashimoto T, Yamanashi K, Sekiguchi T,
26

Mizumoto M, Okumura T, Tsuboi K, Sakurai H. Comparison of adverse effects of proton and
X-ray chemoradiotherapy for oesophageal cancer using an adaptive dose-volume histogram
analysis. Eur J Cancer 49(2):S576, 2013
31. Matsubara T, Ayuzawa S, Aoki T, Ikeda G, Shiigai M, Matsumura A. Cerebral Venous
Thrombosis after Ventriculoperitoneal Shunting: A Case Report. Neurol Med Chir (Tokyo)
doi:10.2176/nmc.cr.2012-0312, 2013 	
 32. Matsubara T, Ishikawa E, Hirata K, Matsuda M, Akutsu H, Masumoto T, Zaboronok A,
Matsumura A. A New Mechanism of Cerebrospinal Fluid Leakage after Lumboperitoneal
Shunt: A Theory of Shunt Side Hole-Case Report. Neurol Med Chir (Tokyo)
doi:10.2176/nmc.cr.2013-0067, 2013 	
 33. Minegishi H, Fukashiro S, Ban HS, Nakamura H. Discovery of Indenopyrazoles as a New
Class of Hypoxia Inducible Factor (HIF)-1 Inhibitors. ACS Med Chem Lett 4:297-301, 2013
34. Minegishi H, Matsukawa T, Nakamura H. Synthesis and biological evaluation ofdiaryl-substituted carboranes as inhibitors of hypoxia inducible factor (HIF)-1 transcriptional
activity. Chem Med Chem 8(2):265-271, 2013
35. Mizumoto M, Okumura T, Ishikawa E, Yamamoto T, Takano S, Matsumura A, Oshiro Y,
Ishikawa H, Sakurai H, Tsuboi K. Reirradiation for recurrent malignant brain tumor withradiotherapy or proton beam therapy. Technical considerations based on experience at asingle institution. Strahlenther Onkol 189(8):656-663, 2013
36. Muragaki Y, Akimoto J, Maruyama T, Iseki H, Ikuta S, Nitta M, Maebayashi K, Saito T,
Okada Y, Kaneko S, Matsumura A, Kuroiwa T, Karasawa K, Nakazato Y, Kayama T. Phase II
clinical study on intraoperative photodynamic therapy with talaporfin sodium andsemiconductor laser in patients with malignant brain tumors. J Neurosurg 119(4):845-852,
2013
37. Murakami Y, Matsuya T, Kita A, Yamanaka K, Noda A, Mitsuoka K, Nakahara T, Miyoshi
S, Nishimura S. Radiosynthesis, biodistribution and imaging of [11C]YM155, a novel
survivin suppressant, in a human prostate tumor-xenograft mouse model. Nucl Med Biol40(2):221-226, 2013
38. Nakamura H. Boron Cluster Lipid Liposomes as New Vehicles for Boron Delivery System
of Neutron Capture Therapy. Future Med Chem 5(6):715-730 2013
39. Nakamura H, Minegishi H. HSP60 as a drug target. Curr Pharm Des 19(3):441-451, 2013
40. Nakamura H, Yasui Y, Ban HS. Synthesis and Biological Evaluation of ortho-Carborane
Containing Benzoxazole as an Inhibitor of Hypoxia Inducible Factor (HIF)-1Transcriptional
27

Activity. J Organomet Chem 747(special issue ):189-194, 2013
41. Nakamura H, Yasui Y, Maruyama M, Minegishi H, Ban HS, Sato S. Development of
hypoxia-inducible factor (HIF)-1alpha inhibitors: effect of ortho-carborane substituents on
HIF transcriptional activity under hypoxia. Bioorg Med Chem Lett 23(3):806-810, 2013
42. Nomura M, Shimbo T, Miyamoto Y, Fukuzawa M, Kaneda Y. 13-Cis retinoic acid canenhance the antitumor activity of non-replicating Sendai virus particle against neuroblastoma.
Cancer Sci 104(2):238-244, 2013
43. Nomura M, Ueno A, Saga K, Fukuzawa M, Kaneda Y. Accumulation of cytosolic calcium
inducesnecroptotic

cell

death

in

human

neuroblastoma.

CancerRes

doi:

10.1158/0008-5472.CAN-13-1283, 2013
44. Onuma K, Ishikawa E, Matsuda M, Hirata K, Osuka S, Yamamoto T, Masumoto T,
Zaboronok A, Matsumura A. Clinical characteristics and neuroimaging findings in 12 casesof recurrent glioblastoma with communicating hydrocephalus. Neurol Med Chir (Tokyo)
53(7):474-481, 2013
45. Oshiro Y, Mizumoto M, Okumura T, Sugahara S, Fukushima T, Ishikawa H, Nakao T,
Hashimoto T, Tsuboi K, Ohkawa H, Kaneko M, Sakurai H. Clinical results of proton beam
therapy for advanced neuroblastoma. Radiat Oncol 8(1):142, 2013
46. Oshiro Y, Okumura T, Mizumoto M, Fukushima T, Ishikawa H, Hashimoto T, Tsuboi K,
Kaneko M, Sakurai H. Proton beam therapy for unresectable hepatoblastoma in children:
survival in one case. Acta Oncol 52(3):600-603, 2013
47. Oshiro Y, Sakurai H. The use of proton-beam therapy in the treatment of non-small-cell lungcancer. Expert Rev Med Devices 10(2):239-245, 2013
48. Osuka S, Sampetrean O, Shimizu T, Saga I, Onishi N, Sugihara E, Okubo J, Fujita S,
Takano S, Matsumura A, Saya H. IGF1 receptor signaling regulates adaptive radioprotection
in glioma stem cells. Stem Cells 31(4):627-640, 201349. Pua ML, Yoshitomi T, Chonpathompikunlert P, Hirayama A, Nagasaki Y. Redox-active
injectable gel using thermo-responsive nanoscale polyion complex flower micelle fornoninvasive treatment of local inflammation. J Control Release 172(3):914-920, 2013
50. Rodriguez-Araujo G, Nakagami H, Hayashi H, Mori M, Shiuchi T, Minokoshi Y, Nakaoka
Y, Takami Y, Komuro I, Morishita R, Kaneda Y. Alpha-synuclein elicits glucose uptake andutilization in adipocytes through the Gab1/PI3K/Akt transduction pathway. Cell Mol Life Sci
70(6):1123-1133, 2013
51. Saga K, Kaneda Y. Virosome presents multimodel cancer therapy without viral replication.
28

Biomed Res Int 2013:764706, 2013
52. Saga K, Tamai K, Yamazaki T, Kaneda Y. Systemic administration of a novel
immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionallyenhancing IFN-γ production. Clin Cancer Res 19(3):668-679, 2013
53. Saito Y, Matsuzaki Y, Honda A, Iwamoto J, Ikegami T, Chiba T, Sugahara S, Okumura T,
Tsujii H, Doy M, Tokuuye K. Post-therapeutic needle biopsy in patients with hepatocellular
carcinoma is a useful tool to evaluate response to proton irradiation. Hepatol Res doi:
10.1111/hepr.12133, 2013 	
 54. Saito Y, Nakagami H, Kaneda Y, Morishita R. Lymphedema and therapeutic
lymphangiogenesis. Biomed Res Int 2013:804675, 2013
55. Sakakura K, Akutsu H, Yamamoto T, Masuda Y, Ishikawa E, Matsumura A. Trigeminal
Neuralgia in a Patient with Marfan Syndrome: Case Report. Neurol Med Chir (Tokyo)
doi:10.2176/nmc.cr.2013-0072, 2013	
 56. Sakamoto N, Akutsu H, Takano S, Yamamoto T, Matsumura A. Useful 'sliding-lock-knot'
technique for suturing dural patch to prevent cerebrospinal fluid leakage after extended
transsphenoidal surgery. Surg Neurol Int 4:19, 2013
57. Sakamoto N, Ishikawa E, Aoki K, Uemae Y, Komatsu Y, Matsumura A. Clinical OutcomesofIntracerebral

HemorrhageinHemodialysis

Patients.

World

Neurosurgdoi:

10.1016/j.wneu.2013.10.033, 2013
58. Sato E, Yamamoto T, Shikano N, Ogura M, Nakai K, Yoshida F, Uemae Y, Takada T, Isobe
T, Matsumura A. Intracellular boron accumulation in CHO-K1 cells using amino acidtransport control. Appl Radiat Isot doi: 10.1016/j.apradiso.2013.12.015, 2013
59. Sato M, Nakai Y, Tsurushima H, Shiigai M, Masumoto T, Matsumura A. Risk factors ofischemic lesions related to cerebral angiography and neuro-interventional procedures. Neurol
Med Chir (Tokyo) 53(6):381-387, 2013
60. Sato M, Takigawa T, Shiigai M, Tamura G, Masumoto T, Nakai Y, Zaboronok A,
Tsurushima H, Matsumura A. Spinal dural arteriovenous fistula with lipomyelodysplasia.
Neurol Med Chir (Tokyo) 53(2):107-109, 2013
61. Sato S, Nakamura H. Ligand-directed selective protein modification based on local
single-electron-transfer catalysis. Angew Chem Int Ed Engl 52(33):8681-8684, 2013
62. Satoh T, Matsumoto K, Tanaka YO, Akiyama A, Nakao S, Sakurai M, Ochi H, Onuki M,
Minaguchi T, Sakurai H, Yoshikawa H. Incidence of venous thromboembolism before
treatment in cervical cancer and the impact of management on venous thromboembolism
29after commencement of treatment. Thromb Res 131(4):e127-132, 2013
63. Sha S, Vong LB, Chonpathompikunlert P, Yoshitomi T, Matsui H, Nagasaki Y. Suppressionof NSAID-induced small intestinal inflammation by orally administered redox nanoparticles.
Biomaterials 34(33):8393-8400, 2013
64. Shashni B, Sakharkar KR, Nagasaki Y, Sakharkar MK. Glycolytic enzymes PGK1 andPKM2 as novel transcriptional targets of PPARgamma in breast cancer pathophysiology. J
Drug Target 21(2):161-174, 2013
65. Shashni B, Sharma K, Singh R, Sakharkar KR, Dhillon SK, Nagasaki Y, Sakharkar MK.
Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma andimplications in breast cancer. BMC Genomics 14 Suppl 5:S6, 2013
66. Shirai K, Tamaki Y, Kitamoto Y, Murata K, Satoh Y, Higuchi K, Ishikawa H, Nonaka T,
Takahashi T, Nakano T. Prognosis was not deteriorated by multiple primary cancers inesophageal cancer patients treated by radiotherapy. J Radiat Res 54(4):706-711, 2013	
 67. Sun L, Moritake T, Zheng YW, Suzuki K, Gerelchuluun A, Hong Z, Zenkoh J, Taniguchi H,
Tsuboi K. In vitro stemness characterization of radio-resistant clones isolated from a
medulloblastoma cell line ONS-76. J Radiat Res 54(1):61-69, 2013
68. Takada T, Tamura M, Yamamoto T, Matsui H, Matsumura A. Selective accumulation ofhematoporphyrin derivative in glioma through proton-coupled folate transporter SLC46A1. J
Clin Biochem Nutr doi: 10.3164/jcbn.13-87, 2013
69. Takano S, Kimu H, Tsuda K, Osuka S, Nakai K, Yamamoto T, Ishikawa E, Akutsu H,
Matsuda M, Matsumura A. Decrease in the apparent diffusion coefficient in peritumoral
edema for the assessment of recurrent glioblastoma treated by bevacizumab. Acta Neurochir
Suppl 118:185-189, 2013
70. Takehara Y, Satoh T, Nishizawa A, Saeki K, Nakamura M, Masuzawa M, Kaneda Y,
Katayama I, Yokozeki H. Anti-tumor effects of inactivated Sendai virus particles with an IL-2
gene on angiosarcoma. Clin Immunol 149(1):1-10, 2013
71. Takeichi M, Nimura K, Mori M, Nakagami H, Kaneda Y. The transcription factors Tbx18
and Wt1 control the epicardial epithelial-mesenchymal transition through bi-directional
regulation of Slug in murine primary epicardial cells. PLoS One 8(2):e57829, 2013
72. Takizawa D, Oshiro Y, Okumura T, Mizumoto M, Fukushima T, Ishikawa H, Tsuboi K,
Kaneko M, Sakurai H. Proton beam therapy for a patient with large rhabdomyosarcoma of
the body trunk. Pediatr Blood Cancer 60(3):93, 2013
73. Tsuda K, Akutsu H, Yamamoto T, Ishikawa E, Saito A, Nakai K, Takano S, Matsumura A.
30

Benign spinal meningioma without dural attachment presenting delayed CSF disseminationand malignant transformation. Brain Tumor Pathol 30(3):185-191, 2013
74. Yabu M, Korekane H, Hatano K, Kaneda Y, Nonomura N, Sato C, Kitajima K, Miyamoto Y.
Occurrence of free deaminoneuraminic acid (KDN)-containing complex-type N-glycans inhuman prostate cancers. Glycobiology 23(6):634-642, 2013
75. Yamaoka M, Akiyama M, Yokokawa Y, Terao Y, Yokoi K, Kato T, Fukushima T, Sakurai H,
Ida H. Multidisciplinary therapy including proton beam radiotherapy for a Ewing sarcoma
family tumor of maxillary sinus in a 4-year-old girl. Head Neck 35(12):E386-390, 2013
76. Yamazaki T, Sonobe M, Kato N, Kasuya H, Ikeda G, Nakamura K, Ito Y, Tsuruta W, Nakai
Y, Matsumura A. Endovascular coiling as the first treatment strategy for ruptured pericallosalartery aneurysms: results, complications, and follow up. Neurol Med Chir (Tokyo)
53(6):409-417, 2013
77. Yoshitomi T, Ozaki Y, Thangavel S, Nagasaki Y. Redox nanoparticle therapeutics tocancer--increase in therapeutic effect of doxorubicin, suppressing its adverse effect. J
Control Release 172(1):137-143, 2013
78. Zaboronok A, Isobe T, Yamamoto T, Sato E, Takada K, Sakae T, Tsurushima H, Matsumura
A. Proton beam irradiation stimulates migration and invasion of human U87 malignant
glioma cells. J Radiat Res doi: 10.1093/jrr/rrt119, 2013	 2) 英文以外の論文
1. Ito Y, Kato N, Matsumura A, Sonobe M. Internal coil trapping for a doughnut-shaped giant
intracranial aneurysm: a case report. No Shinkei Geka 41(5):415-420, 2013
2. Kawamura H, Shinoda K, Miyamoto K, Sakae T, Monma M, Matsumura A. Investigation ofpolymer gel dosimetry for small circular irradiated fields. Nihon Hoshasen Gijutsu Gakkai
Zasshi 69(9):933-943, 2013
3. Nakamura H. Development of high boron content liposomes and their promising antitumor
effect for neutron capture therapy. Yakugaku Zasshi 133(12):1297-1306, 2013
4. Nishimura S. Positron emission tomography as a research tool for translational science.
Nihon Yakurigaku Zasshi 141(3):136-140, 2013
5. Suzuki R., Nakamura H. Toward development of innovative diagnostic/therapeutic system(theranostics) using nanotechnologies. Yakugaku Zasshi 133(12):1261-1262, 2013
6. 阿部孝憲, 江原威, 原田耕作, 白井克幸, 塩谷真里子, 鈴木義行, 櫻井英幸, 中野隆史. A
Case of Recurrent Pleomorphic Liposarcoma that Exhibited a Remarkable Response to31

Hyperthermoradiotherapy. Thermal Medicine 29(3):63-67, 2013
7. 磯辺智範, 榮武二, 高田健太, 森祐太郎, 山本哲哉. 環境中における放射性物質の簡易型
リ ア ル タ イ ム モ ニ タ リ ン グ シ ス テ ム の 開 発. 大 和 証 券 ヘ ル ス 財 団 研 究 業 績 集
36:185-193, 2013
8. 大久保英樹, 中山雅博, 廣瀬由紀, 田中秀峰, 西村文吾, 星野朝文, 上前泊功, 飛田忠道,
辻茂希, 田渕経司, 和田哲郎, 原晃, 橋井晴子, 石川仁, 水本斉志, 奥村敏之, 櫻井英幸. 過去 10 年間に当科で陽子線治療を行った頭頸部癌に関する検討. 耳鼻咽喉科展望 56(補冊 1):118-122, 2013
9. 大城佳子, 水本斉志, 石川仁, 奥村敏之, 坪井康次, 榮武二, 福島敬, 須磨崎亮, 増本幸二,
金子道夫, 櫻井英幸. 固形腫瘍の治療の進歩 小児固形がんに対する陽子線治療. 日本
小児血液・がん学会雑誌 50(3):331-334, 2013
10. 川村拓, 篠田和哉, 宮本勝美, 榮武二, 門間正彦, 松村明. ポリマーゲル線量計を用いた
球状小照射野線量測定に関する検討. 日本放射線技術学会雑誌 69(9):933-943, 2013
11. 熊田博明. 加速器中性子源の研究開発による BNCT の確立に向けて. 医学物理
32(3):104-110, 201312. 竹内秀輔, 鈴木涼子, 福島敬, 福島紘子, 岩淵敦, 中尾朋平, 山口玲子, 工藤寿子, 杉田真太朗, 稲留征典, 佐藤豊実, 櫻井英幸, 金子道夫, 須磨崎亮. 進行期卵巣小細胞癌に対して集学的治療を施行した女児例. 日本小児血液・がん学会雑誌 50(2):269-273, 2013
13. 田中浩喜, 兵行義, 與田茂利, 宇野雅子, 粟飯原輝人, 原田保. 降下性壊死性縦隔炎 2 例.
耳鼻咽喉科臨床 106(8):739-746, 2013
14. 長崎幸夫. 【光線力学診断・治療の最新動向】 がん光線力学療法を目指した光 NO
発生ナノ粒子の設計. 日本レーザー医学会誌 34(2):138-140, 2013	 3) 英文著書
1. Tamura A, Nagasaki Y. Chapter 10. Environmentally-Responsive Nanogels for siRNA
Delivery; in "Advanced Delivery and Therapeutic Applications of RNAi (1st edition)" (editedby Cheng K, Mahato RI), Wiley (Hoboken) 2013; pp207-224

4) 英文以外の著書
1. 井垣浩, 櫻井英幸. 【肝胆膵領域への放射線療法 as of 2013】 肝臓領域の放射線療法	
 肝細胞癌治療アルゴリズムからみた放射線治療; "肝・胆・膵 67(2)” 2013; pp211-219
2. 石川仁. 9 章. 管腔臓器	
  Ａ食道; "密封小線源治療	
  診療・物理 QA マニュアル (第 1版)” (編集 小線源治療部会), 金原出版 (東京) 2013; pp141-146
32

3. 石川仁, 橋本孝之, 牧島弘和, 水本斉志, 奥村敏之, 櫻井英幸. 高精度放射線治療の現状と Adaptive Therapy の展望	
 前立腺がんに対する放射線治療を中心に; "医学物理 32(3)”2013; pp138-147
4. 石川仁, 牧島弘和, 加藤弘之, 櫻井英幸. 【アップデートシリーズ	
  前立腺がんの治療】
放射線療法; "泌尿器ケア 18(6)” 2013; pp653-658
5. 磯辺智範, 藤原恵子, 鎌田知子, 安藤浩樹, 富田哲也, 山田真子, 森祐太郎, 高田健太, 佐藤英介, 小見正太郎, 吉村洋祐. 1. 新機能検査; "若葉マーク	
  臨床検査学エッセンス・ノート	  １臨床生理機能検査 (第 1 版)” (編集 磯辺智範), メディカルビュー社 (東京)2013; pp2-13
6. 磯辺智範, 藤原恵子, 鎌田知子, 安藤浩樹, 富田哲也, 山田真子, 森祐太郎, 高田健太, 佐藤英介, 小見正太郎, 吉村洋祐. 2. 呼吸機能検査; "若葉マーク	
  臨床検査学エッセン
ス・ノート	
  ２臨床生理機能検査 (第 1 版)” (編集 磯辺智範), メディカルビュー社 (東京) 2013; pp48-63
7. 磯辺智範, 藤原恵子, 鎌田知子, 安藤浩樹, 富田哲也, 山田真子, 森祐太郎, 高田健太, 佐藤英介, 小見正太郎, 吉村洋祐. 5. 感覚器検査; "若葉マーク 臨床検査学エッセンス・ノート ３ 臨床生理機能検査 (第 1 版)” (編集 磯辺智範), メジカルビュー社 (東京) 2013;
pp117-134
8. 磯辺智範, 藤原恵子, 鎌田知子, 安藤浩樹, 富田哲也, 山田真子, 森祐太郎, 高田健太, 佐藤英介, 小見正太郎, 吉村洋祐. 6. 超音波検査; "若葉マーク	
  臨床検査学エッセンス・ノート	
 ４臨床生理機能検査 (第 1 版)” (編集 磯辺智範), メジカルビュー社 (東京) 2013;
pp136-161
9. 磯辺智範, 藤原恵子, 鎌田知子, 安藤浩樹, 富田哲也, 山田真子, 森祐太郎, 高田健太, 佐藤英介, 小見正太郎, 吉村洋祐. 7. 眼底検査; "若葉マーク	
  臨床検査学エッセンス・ノート	
  ５臨床生理機能検査 (第 1 版)” (編集 磯辺智範), メジカルビュー社 (東京) 2013;
pp164-169
10. 磯辺智範, 藤原恵子, 鎌田知子, 安藤浩樹, 富田哲也, 山田真子, 森祐太郎, 高田健太, 佐藤英介, 小見正太郎, 吉村洋祐. 9. 熱画像検査; "若葉マーク	
  臨床検査学エッセンス・ノート	
 ６臨床生理機能検査 (第 1 版)” (編集 磯辺智範), メジカルビュー社 (東京) 2013;
pp222-231
11. 奥村敏之, 水本斉志, 福光延吉, 大西かよ子, 沼尻晴子, 石川仁, 粟飯原輝人, 坪井康次,
榮武二, 櫻井英幸. 【肝胆膵領域への放射線療法 as of 2013】 肝臓領域の放射線療法	
 肝腫瘍に対する陽子線療法の現状と成績; "肝・胆・膵 67(2)” 2013; pp271-278
12. 川端信司, 粟飯原輝人.【放射線治療の進歩】硼素中性子捕捉療法の現状と今後; "PET33

Journal (22)” 2013; pp16-19
13. 熊田博明. つくば国際戦略総合特区における次世代がん治療(BNCT)の開発実用化プ
ロジェクトについて; "バイオサイエンスとインダストリー 71(1)” 2013; pp63-66
14. 櫻井英幸. 【婦人科腫瘍に対する三次元画像誘導小線源治療】 小線源治療と粒子線治療に関する事例と考察; "臨床放射線 58(3)” 2013; pp425-431
15. 櫻井英幸, 大川綾子, 沼尻晴子, 菅原香織, 瀧澤大地, 牧島弘和, 大野豊然貴, 石川仁, 奥村敏之. 【婦人科がん放射線治療の最新知見】 放射線治療の最新技術	
  陽子線治療の概要と婦人科腫瘍への応用について; "産婦人科の実際 62(7)” 2013; pp943-949
16. 櫻井英幸, 奥村敏之, 石川仁, 福光延吉, 粟飯原輝人, 大西かよ子, 水本斉志, 大城佳子,
沼尻晴子, 盛武敬, 高田健太, 照沼利之, 安岡聖, 磯辺智範, 熊田博明, 坪井康次, 榮武二.
【Radiotherapy Today 2013	
 粒子線治療最前線-進化する粒子線治療の現況と展望-】 粒
子線治療の現状と展望	
  粒子線治療実施施設からの報告	
  筑波大学陽子線医学利用研究センター	
  PMRC; "INNERVISION 28(7)” 2013; pp19-21
17. 坪井康次, 水本斉志. 【悪性脳腫瘍の治療-最新のトピックス】 放射線治療のトピックス	  陽子線・重粒子線治療; "Clinical Neuroscience 31(10)” 2013; pp1169-1172
18. 長崎幸夫. 第 12 章 2. 大腸粘膜に対する経口型レドックスナノ粒子の集積と潰瘍性大腸炎治療効果の増強; "非経口投与製剤の開発と応用―次世代型医薬品の新規投与形
態 の 開 拓 を 目 指 し て― (第 1 版)” (編 集 山 本 昌), シ ー エ ム シ ー 出 版 (東 京)2013;pp147-151
19. 中村浩之, 柳衛宏宣. 第 7 章 7.1 中性子捕捉療法にける薬剤送達システム; "医学物理の理工学（下巻） (第 1 版)” (編集 上坂充, 中川恵一, 金井達明, 西尾禎治), 養賢堂 (東京) 2013; pp153-164
20. 水本斉志. 第 7 章. 放射線治療; "肝癌診療ガイドライン 2013 年版 (第 3 版)” (編集 日本
肝臓学会), 金原出版 (東京) 2013; pp160-17134ゲノム医科学	 1) 英文論文
1. Ano S, Morishima Y, Ishii Y, Yoh K, Yageta Y, Ohtsuka S, Matsuyama M, Kawaguchi M,
Takahashi S, Hizawa N. Transcription factors GATA-3 and RORgammat are important for
determining the phenotype of allergic airway inflammation in a murine model of asthma. J
Immunol 190(3):1056-1065, 2013
2. Bodhak S, Kikuchi M, Sogo Y, Tsurushima H, Ito A, Oyane A. Calcium phosphate coating on
a bioresorbable hudroxyapatite/collagen nanocomposite for surface functionalization. Chem
Lett 42:1029-1031, 2013
3. Doki K, Homma M, Kuga K, Aonuma K, Kohda Y. SCN5A promoter haplotype affects thetherapeutic range for serum flecainide concentration in Asian patients. Pharmacogenet
Genomics 23(7):349-354, 2013
4. Fukushima H, Fukushima T, Sakai A, Suzuki R, Nakajima-Yamaguchi R, Kobayashi C,
Iwabuchi A, Saito M, Yoshimi A, Nakao T, Kato K, Tsuchida M, Takahashi H, Koike K,
Kiyokawa N, Noguchi E, Sumazaki R. Polymorphisms of MTHFR Associated with Higher
Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid
Malignancies. Leuk Res Treatment 2013:238528, 2013
5. Furukawa H, Kawasaki A, Oka S, Shimada K, Matsui T, Ikenaka T, Hashimoto A, Okazaki Y,
Takaoka H, Futami H, Komiya A, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M,
Takasaki Y, Nagai T, Hirohata S, Setoguchi K, Suda A, Nagaoka S, Kono H, Okamoto A,
Chiba N, Suematsu E, Fukui N, Hashimoto H, Sumida T, Ono M, Tsuchiya N, Tohma S.
Association of a single nucleotide polymorphism in the SH2D1A intronic region withsystemic lupus erythematosus. Lupus 22(5):497-503, 2013
6. Furukawa H, Oka S, Matsui T, Hashimoto A, Arinuma Y, Komiya A, Fukui N, Tsuchiya N,
Tohma S. Genome, epigenome and transcriptome analyses of a pair of monozygotic twins
discordant for systemic lupus erythematosus. Hum Immunol 74(2):170-175, 2013
7. Furukawa H, Oka S, Shimada K, Rheumatoid Arthritis-Interstitial Lung Disease Study C,
Tsuchiya N, Tohma S. HLA-A*31:01 and methotrexate-induced interstitial lung disease inJapanese rheumatoid arthritis patients: a multidrug hypersensitivity marker? Ann Rheum Dis
72(1):153-155, 2013
8. Furukawa H, Oka S, Shimada K, Sugii S, Hashimoto A, Komiya A, Fukui N, Nagai T,
Hirohata S, Setoguchi K, Okamoto A, Chiba N, Suematsu E, Miyashita T, Migita K, Suda A,
Nagaoka S, Tsuchiya N, Tohma S. Association of increased frequencies of HLA-DPB1*05:01
35

with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in Japanese rheumatoid
arthritis and systemic lupus erythematosus patients. PLoS One 8(1):e53910, 2013
9. Furukawa H, Oka S, Takehana K, Muramatsu T, Shimada K, Komiya A, Fukui N, Tsuchiya
N, Tohma S. Plasma amino acid profiles in collagen disease patients with interstitial lungdisease. Immunome Research 9:64, 2013
10. Furukawa M, Tochigi M, Otowa T, Arinami T, Inada T, Ujike H, Watanabe Y, Iwata N,
Itokawa M, Kunugi H, Hashimoto R, Ozaki N, Kakiuchi C, Kasai K, Sasaki T. An
association analysis of the cardiomyopathy-associated 5 (CMYA5) gene with schizophrenia
in a Japanese population. Psychiatr Genet 23(4):179-180, 2013
11. Furusawa T, Naka I, Yamauchi T, Natsuhara K, Eddie R, Kimura R, Nakazawa M, Ishida T,
Inaoka T, Matsumura Y, Ataka Y, Ohtsuka R, Ohashi J. Hypertension-susceptibility geneprevalence in the Pacific Islands and associations with hypertension in Melanesia. J Hum
Genet 58(3):142-149, 2013
12. Genin E, Coustet B, Allanore Y, Ito I, Teruel M, Constantin A, Schaeverbeke T,
Ruyssen-Witrand A, Tohma S, Cantagrel A, Vittecoq O, Barnetche T, Le Loet X, Fardellone
P, Furukawa H, Meyer O, Fernandez-Gutierrez B, Balsa A, Gonzalez-Gay MA, Chiocchia G,
Tsuchiya N, Martin J, Dieude P. Epistatic interaction between BANK1 and BLK inrheumatoid arthritis: results from a large trans-ethnic meta-analysis. PLoS One 8(4):e61044,
2013
13. Hayashi M, Hirota T, Saeki H, Nakagawa H, Ishiuji Y, Matsuzaki H, Tsunemi Y, Kato T,
Shibata S, Sugaya M, Sato S, Tada Y, Doi S, Miyatake A, Ebe K, Noguchi E, Ebihara T,
Amagai M, Esaki H, Takeuchi S, Furue M, Tamari M. Genetic polymorphism in the
TRAF3IP2 gene is associated with psoriasis vulgaris in a Japanese population. J DermatolSci doi: 10.1016/j.jdermsci.2013.11.012, 201314.

HizawaN.

Pharmacogenetics

ofchronic

obstructive

pulmonarydisease.

Pharmacogenomics 14(10):1215-1225, 2013
15. Honda K. The Ashikaga case of Japan--Y-STR testing used as the exculpatory evidence tofree a convicted felon after 17.5 years in prison. Forensic Sci Int Genet 7(1):e1-2, 2013
16. Honda K, Yano S, Nishi T, Iwabuchi Y, Kurosu A, Sugano Y. Selective blood-DNA
extraction from mixed stain using ABO antibody for short tandem repeat typing. FSIGSS
4(1):e326-e327, 2013
17. Horiuchi Y, Ishikawa M, Kaito N, Iijima Y, Tanabe Y, Ishiguro H, Arinami T. Experimental
evidence for the involvement of PDLIM5 in mood disorders in hetero knockout mice. PLoS
36

One 8(4):e59320, 2013
18. Iijima H, Kaneko Y, Yamada H, Yatagai Y, Masuko H, Sakamoto T, Naito T, Hirota T,
Tamari M, Konno S, Nishimura M, Noguchi E, Hizawa N. A distinct sensitization patternassociated with asthma and the thymic stromal lymphopoietin (TSLP) genotype. Allergol Int
62(1):123-130, 2013
19. Ikeda T, Ishii KA, Saito Y, Miura M, Otagiri A, Kawakami Y, Shimano H, Hara H,
Takekoshi K. Inhibition of autophagy enhances sunitinib-induced cytotoxicity in rat
pheochromocytoma PC12 cells. J Pharmacol Sci 121(1):67-73, 2013
20. Imoto Y, Tokunaga T, Matsumoto Y, Hamada Y, Ono M, Yamada T, Ito Y, Arinami T, Okano
M, Noguchi E, Fujieda S. Cystatin SN upregulation in patients with seasonal allergic rhinitis.
PLoS One 8(8):e67057, 2013
21. Inoue Y, Nakagawara R, Kambara T, Tanaka K, Seki K, Enomoto H, Noguchi E, Aihara M,
Ikezawa Z. Prevalence of atopic dermatitis in Japanese infants treated with moisturizer sincebirth and its relation to FLG mutations. Eur J Dermatol 23(2):288-289, 2013
22. Ito Y, Tsurushima H, Sato M, Ito A, Oyane A, Sogo Y, Matsumura A. Angiogenesis therapy
for brain infarction using a slow-releasing drug delivery system for fibroblast growth factor
2. Biochem Biophys Res Commun 432(1):182-187, 2013
23. Jimbo T, Masumoto K, Urita Y, Takayasu H, Shinkai T, Uesugi T, Gotoh C, Sakamoto N,
Sasaki T, Oto T, Fukushima T, Noguchi E, Nakano Y. Nevoid basal cell carcinoma syndrome
with a unilateral giant ovarian fibroma in a Japanese 6-year-old girl. Eur J Pediatr 1 doi:
10.1007/s00431-013-2200-7, 2013
24. Kaminiwa J, Honda K, Kurosu A, Nishi T, Sugano Y, Yano S. Application of trace element
measurement for diagnosis of metabolic disorders. Rom J Leg Med 21(2):259-262, 2013
25. Kaminiwa J, Honda K, Sugano Y, Yano S, Nishi T, Sekine Y. Vanadium accelerates
polymerase chain reaction and expands the applicability of forensic DNA testing. J Forensic
Leg Med 20(4):326-333, 2013
26. Kaneko Y, Masuko H, Sakamoto T, Iijima H, Naito T, Yatagai Y, Yamada H, Konno S,
Nishimura M, Noguchi E, Hizawa N. Asthma phenotypes in Japanese adults - theirassociations with the CCL5 and ADRB2 genotypes. Allergol Int 62(1):113-121, 2013
27. Kaneko Y, Yatagai Y, Yamada H, Iijima H, Masuko H, Sakamoto T, Hizawa N. The searchfor common pathways underlying asthma and COPD. Int J Chron Obstruct Pulmon Dis
8:65-78, 2013
28. Kawaku S, Sato R, Song H, Bando Y, Arinami T, Noguchi E. Functional analysis of BRCA1
37

missense variants of uncertain significance in Japanese breast cancer families. J Hum Genet
58(9):618-621, 2013
29. Kawasaki A, Inoue N, Ajimi C, Sada KE, Kobayashi S, Yamada H, Furukawa H, Sumida T,
Tohma S, Miyasaka N, Matsuo S, Ozaki S, Hashimoto H, Makino H, Harigai M, Tsuchiya N.
Association of IRF5 polymorphism with MPO-ANCA-positive vasculitis in a Japanese
population. Genes Immun 14(8):527-529, 2013
30. Kurihara Y, Hitomi S, Oishi T, Kondo T, Ebihara T, Funayama Y, Kawakami Y.
Characteristics of bacteremia caused by extended-spectrum beta-lactamase-producing
Proteus mirabilis. J Infect Chemother 19(5):799-805, 2013
31. Maie K, Okoshi Y, Takaiwa N, Kurita N, Hasegawa Y, Homma M, Ishii K, Kohda Y, Chiba
S. Aprepitant does not alter prednisolone pharmacokinetics in patients treated with R-CHOP.
Ann Oncol doi: 10.1093/annonc/mdt477, 2013
32. Momo K, Homma M, Kohda Y. Lower metabolic clearance of tizanidine in Japanese
subjects. Int J Clin Pharmacol Ther 51(12):986-988, 2013
33. Nagai K, Tahara-Hanaoka S, Morishima Y, Tokunaga T, Imoto Y, Noguchi E, Kanemaru K,
Imai M, Shibayama S, Hizawa N, Fujieda S, Yamagata K, Shibuya A. Expression andfunction of Allergin-1 on human primary mast cells. PLoS One 8(10):e76160, 2013
34. Naka I, Hikami K, Nakayama K, Koga M, Nishida N, Kimura R, Furusawa T, Natsuhara K,
Yamauchi T, Nakazawa M, Ataka Y, Ishida T, Inaoka T, Iwamoto S, Matsumura Y, Ohtsuka
R, Tsuchiya N, Ohashi J. A functional SNP upstream of the beta-2 adrenergic receptor gene
(ADRB2) is associated with obesity in Oceanic populations. Int J Obes (Lond)
37(9):1204-1210, 2013
35. Naka I, Ohashi J, Kimura R, Inaoka T, Matsumura Y. Association of ADRB2 polymorphismwith triglyceride levels in Tongans. Lipids Health Dis 12(1):110, 2013
36. Nishi T, Kurosu A, Sugano Y, Kaminiwa J, Sekine Y, Yano S, Honda K. Application of anovel multiplex polymerase chain reaction system for 12 X-chromosomal short tandem
repeats to a Japanese population study. Leg Med (Tokyo) 15(1):43-46, 2013
37. Noguchi S, Hijikata M, Hamano E, Matsushita I, Ito H, Ohashi J, Nagase T, Keicho N. MxAtranscripts with distinct first exons and modulation of gene expression levels bysingle-nucleotide polymorphisms in human bronchial epithelial cells. Immunogenetics
65(2):107-114, 2013
38. Oka S, Furukawa H, Kashiwase K, Tsuchiya N, Tohma S. A novel HLA-DQB1*04 allele,
DQB1*04:10, identified in a Japanese individual. Tissue Antigens 82(2):148-149, 201338

39. Oka S, Furukawa H, Shimada K, Hayakawa H, Fukui N, Tsuchiya N, Tohma S. Serumbiomarker analysis of collagen disease patients with acute-onset diffuse interstitial lungdisease. BMC Immunol 14:9, 2013
40. Onuma H, Tabara Y, Kawamura R, Ohashi J, Nishida W, Takata Y, Ochi M, Nishimiya T,
Kawamoto R, Kohara K, Miki T, Osawa H. Plasma resistin is associated with single
nucleotide polymorphisms of a possible resistin receptor, the decorin gene, in the general
Japanese population. Diabetes 62(2):649-652, 2013
41. Oyane A, Araki H, Sogo Y, Ito A, Tsurushima H. Spontaneous assembly of DNA-amorphous
calcium phosphate nanocomposite spheres for surface-mediated genetransfer. Cryst Eng
Comm 15(25):4994-4997, 2013
42. Saeki H, Hirota T, Nakagawa H, Tsunemi Y, Kato T, Shibata S, Sugaya M, Sato S, Doi S,
Miyatake A, Ebe K, Noguchi E, Ebihara T, Amagai M, Esaki H, Takeuchi S, Furue M,
Nakamura Y, Tamari M. Genetic polymorphisms in the IL22 gene are associated withpsoriasis vulgaris in a Japanese population. J Dermatol Sci 71(2):148-150, 2013
43. Saito R, Suzuki H, Yamada T, Endo S, Moriwaki T, Ueno T, Hirose M, Hirai S, Yamato K,
Mizokami Y, Hyodo I. Predicting skin toxicity according to EGFR polymorphisms in patientswith colorectal cancer receiving antibody against EGFR. Anticancer Res 33(11):4995-4998,
2013
44. Shibata H, Yamamoto K, Sun Z, Oka A, Inoko H, Arinami T, Inada T, Ujike H, Itokawa M,
Tochigi M, Watanabe Y, Someya T, Kunugi H, Suzuki T, Iwata N, Ozaki N, Fukumaki Y.
Genome-wide association study of schizophrenia using microsatellite markers in the Japanese
population. Psychiatr Genet 23(3):117-123, 2013
45. Suzuki Y, Homma M, Abei M, Hyodo I, Kohda Y. Impact of solute carrier family 29
member 1 (SLC29A1) single nucleotide polymorphisms on mRNA expression in peripheral
blood mononuclear cells. Biol Pharm Bull 36(1):144-146, 2013
46. Suzuki Y, Homma M, Abei M, Hyodo I, Kohda Y. Effects of dipyridamole coadministrationon the pharmacokinetics of ribavirin in healthy volunteers. Drug Metab Pharmacokinet
28(5):406-410, 2013
47. Taniguchi N, Konno S, Hattori T, Isada A, Shimizu K, Shimizu K, Shijubo N, Huang SK,
Hizawa N, Nishimura M. The CC16 A38G polymorphism is associated with asymptomatic
airway hyper-responsiveness and development of late-onset asthma. Ann Allergy Asthma
Immunol 111(5):376-381 e371, 2013
48. Terao C, Ohmura K, Kawaguchi Y, Nishimoto T, Kawasaki A, Takehara K, Furukawa H,
39

Kochi Y, Ota Y, Ikari K, Sato S, Tohma S, Yamada R, Yamamoto K, Kubo M, Yamanaka H,
Kuwana M, Tsuchiya N, Matsuda F, Mimori T. PLD4 as a novel susceptibility gene forsystemic sclerosis in a Japanese population. Arthritis Rheum 65(2):472-480, 2013
49. Tomita K, Sakashita M, Hirota T, Tanaka S, Masuyama K, Yamada T, Fujieda S, Miyatake
A, Hizawa N, Kubo M, Nakamura Y, Tamari M. Variants in the 17q21 asthma susceptibility
locus are associated with allergic rhinitis in the Japanese population. Allergy 68(1):92-100,
2013
50. Tsuchiya N. Genetics of ANCA-associated vasculitis in Japan: a role for HLA-DRB1*09:01
haplotype. Clin Exp Nephrol 17(5):628-630, 2013
51. Umeda N, Matsumoto I, Ito I, Kawasaki A, Tanaka Y, Inoue A, Tsuboi H, Suzuki T, Hayashi
T, Ito S, Tsuchiya N, Sumida T. Anti-citrullinated glucose-6-phosphate isomerase peptide
antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 sharedepitope alleles and disease activity. Clin Exp Immunol 172(1):44-53, 2013
52. Wang X, Ito A, Sogo Y, Hirose M, Oyane A, Tsurushima H. DNA-lipid-apatitie composite
layers enhance gene expression of mesenchymal stem cells. Mat Sci Eng C 33:512-518,
2013
53. Watanabe Y, Iijima Y, Egawa J, Nunokawa A, Kaneko N, Arinami T, Ujike H, Inada T, Iwata
N, Kunugi H, Itokawa M, Sasaki T, Ozaki N, Hashimoto R, Shibuya M, Igeta H, Someya T.
Replication in a Japanese population that a MIR30E gene variation is associated withschizophrenia. Schizophr Res 150(2-3):596-597, 2013
54. Yatagai Y, Sakamoto T, Masuko H, Kaneko Y, Yamada H, Iijima H, Naito T, Noguchi E,
Hirota T, Tamari M, Imoto Y, Tokunaga T, Fujieda S, Konno S, Nishimura M, Hizawa N.
Genome-wide association study for levels of total serum IgE identifies HLA-C in a Japanese
population. PLoS One 8(12):e80941, 2013	 2) 英文以外の論文
1. 坂本透, 檜澤伸之.【変貌する肺の生活習慣病 COPD-早期診断で併存症にも好影響】疾
患理解の変遷	  COPD と遺伝素因. Modern Physician 33(11):1359-1361, 2013
2. 土屋尚之. 【血管炎-基礎と臨床のクロストーク-】 ANCA 関連血管炎の病因・病理、診断・治療	
  ANCA 関連血管炎(AAV)の基礎研究から臨床へのアプローチ	  ゲノミクスと遺伝子解析	
  ANCA 関連血管炎疾患感受性遺伝子. 日本臨床 71(増刊 1 血管炎):208-213, 2013
3. 土屋尚之. 【全身性エリテマトーデス-免疫異常と腎症の最近の知見】 全身性エリテマ
40トーデスの疾患感受性遺伝子. 腎と透析 74(1):15-20, 2013
4. 土屋尚之. GPA と MPA の遺伝学的相違. リウマチ科 49(5):611-615, 2013
5. 土屋尚之. 話題の疾患と治療	
  ANCA 関連血管炎の遺伝因子. 感染・炎症・免疫42(4):345-348, 2013
6. 土屋尚之.【全身性エリテマトーデスの up to date】SLE 疾患感受性遺伝子研究 2013. リウマチ科 50(5):517-524, 2013
7. 檜澤伸之. 【呼吸器疾患-state of arts	  Ver.6】	
  (第 1 章)病態生理に関する最新の基礎的 研 究 喘 息 ・COPD の phenotype. 医 学 の あ ゆ み 別 冊(呼 吸 器 疾 患-state of arts
Ver.6):11-13, 2013
8. 檜澤伸之. 【疾患感受性遺伝子解析による呼吸器疾患の病態解析】 ゲノム解析とCOPD. 呼吸と循環 61(10):914-918, 2013
9. 檜澤伸之. 【咳と痰のサイエンス】 慢性咳嗽に関わる遺伝子. THE LUNG-perspectives
21(4):348-350, 2013
10. 檜澤伸之. 【気管支喘息の研究	  アップデート】 気管支喘息のフェノタイプ・エン
ドタイプ. アレルギー・免疫 20(7):1036-1042, 2013
11. 檜澤伸之. 【喘息病態の修飾因子・難治化因子】 遺伝素因. 呼吸と循環 61(6):516-522,
2013
12. 檜澤伸之. 【気管支喘息:診断と治療の進歩】 病因と病態	
  喘息関連遺伝子. 日本内科学会雑誌 102(6):1365-1369, 201313. 檜澤伸之. ゲノム解析からみた喘息難治化要因. 呼吸器内科 23(2):223-227, 201314. 檜澤伸之. 【喘息・アレルギーと遺伝子 Up-To-Date】 β2 受容体変異と喘息病態との関連. 喘息 26(1):27-31, 201315. 檜 澤 伸 之. 診 断 の 進 歩 GWAS	
  ゲ ノ ム ワ イ ド 関 連 解 析. Annual Review 呼 吸 器
2013:200-205, 2013
16. 百賢二, 本間真人, 松本早矢香, 佐々木忠徳, 幸田幸直. チザニジンの副作用に関する
実 態 調 査 	  Cytochrome P450 1A2 に 影 響 す る 薬 剤 の 併 用 と の 関 連. 薬 学 雑 誌
133(2):275-281, 201317. 松本 和彦, 荒川 義弘, 小池 竜司, 中村 哲也, 花岡 英紀, 本間 真人, 吉澤 弘久, 大学病院臨床試験アライアンス共同 IRB 推進検討作業斑. 大学病院間の共同 IRB 等の体制	
 大学病院臨床試験アライアンスにおける検討. 臨床薬理 44(3):207-215, 2013	 4) 英文以外の著書
1. 本田克也. 特別企画. ＤＮＡ鑑定の有用性と課題; "刑事弁護” (編集 成澤壽信), 現代
41

人文社 (東京) 2013; pp109-12042分子スポトロジー	 1) 英文論文
1. Baba O, Yamagata K, Tomidokoro Y, Tamaoka A, Itoh H, Yanagawa T, Onizawa K, Bukawa
H. Neuroleptic malignant syndrome in a patient with tongue cancer: a report of a rare case.
Case Rep Dent 2013:542130, 2013
2. Doi H, Adachi H, Katsuno M, Minamiyama M, Matsumoto S, Kondo N, Miyazaki Y, Iida M,
Tohnai G, Qiang Q, Tanaka F, Yanagawa T, Warabi E, Ishii T, Sobue G. p62/SQSTM1
differentially removes the toxic mutant androgen receptor via autophagy and inclusion
formation in a spinal and bulbar muscular atrophy mouse model. J Neurosci
33(18):7710-7727, 2013
3. Harada H, Warabi E, Matsuki T, Yanagawa T, Okada K, Uwayama J, Ikeda A, Nakaso K,
Kirii K, Noguchi N, Bukawa H, Siow RC, Mann GE, Shoda J, Ishii T, Sakurai T. Deficiencyof p62/Sequestosome 1 causes hyperphagia due to leptin resistance in the brain. J Neurosci
33(37):14767-14777, 2013
4. Higashino R, Miyaki A, Kumagai H, Choi Y, Akazawa N, Ra SG, Tanabe Y, Eto M, So R,
Tanaka K, Ajisaka R, Maeda S. Effects of lifestyle modification on central blood pressure in
overweight and obese men. Blood Press Monit 18(6):311-315, 2013
5. Hotta K, Kitamoto A, Kitamoto T, Mizusawa S, Teranishi H, So R, Matsuo T, Nakata Y,
Hyogo H, Ochi H, Nakamura T, Kamohara S, Miyatake N, Kotani K, Itoh N, Mineo I, WadaJ, Yoneda M, Nakajima A, Funahashi T, Miyazaki S, Tokunaga K, Masuzaki H, Ueno T,
Chayama K, Hamaguchi K, Yamada K, Hanafusa T, Oikawa S, Sakata T, Tanaka K,
Matsuzawa Y, Nakao K, Sekine A. Replication study of 15 recently published Loci for bodyfat distribution in the Japanese population. J Atheroscler Thromb 20(4):336-350, 2013
6. Ishii T, Warabi E, Siow RC, Mann GE. Sequestosome1/p62: a regulator of redox-sensitive
voltage-activated potassium channels, arterial remodeling, inflammation, and neurite
outgrowth. Free Radic Biol Med 65:102-116, 2013
7. Kitamoto A, Kitamoto T, Mizusawa S, Teranishi H, So R, Matsuo T, Nakata Y, Hyogo H,
Ochi H, Nakamura T, Kamohara S, Miyatake N, Kotani K, Komatsu R, Itoh N, Mineo I,
Wada J, Yoneda M, Nakajima A, Funahashi T, Miyazaki S, Tokunaga K, Masuzaki H, Ueno
T, Chayama K, Hamaguchi K, Yamada K, Hanafusa T, Oikawa S, Sakata T, Tanaka K,
Matsuzawa Y, Nakao K, Sekine A, Hotta K. NUDT3 rs206936 is associated with body massindex in obese Japanese women. Endocr J 60(8):991-1000, 2013
8. Maeda S, Miyaki A, Kumagai H, Eto M, So R, Tanaka K, Ajisaka R. Lifestyle modification
43

decreases arterial stiffness and plasma asymmetric dimethylarginine level in overweight andobese men. Coron Artery Dis 24(7):583-588, 2013
9. Miyaki A, Maeda S, Choi Y, Akazawa N, Eto M, Tanaka K, Ajisaka R. Association of plasma
pentraxin 3 with arterial stiffness in overweight and obese individuals. Am J Hypertens
26(10):1250-1255, 2013
10. Oh S, Tanaka K, Warabi E, Shoda J. Exercise reduces inflammation and oxidative stress in
obesity-related liver diseases. Med Sci Sports Exerc 45(12):2214-2222, 2013
11. Okubo Y, Sairenchi T, Irie F, Yamagishi K, Iso H, Watanabe H, Muto T, Tanaka K, Ota H.
Association of alcohol consumption with incident hypertension among middle-aged and older
Japanese population: the Ibarakai Prefectural Health Study (IPHS). Hypertension doi:
10.1161/HYPERTENSIONAHA.113.01585, 2013
12. Onuki K, Sugiyama H, Ishige K, Kawamoto T, Ota T, Ariizumi S, Yamato M, Kadota S,
Takeuchi K, Ishikawa A, Onodera M, Onizawa K, Yamamoto M, Miyoshi E, Shoda J.
Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates withpostsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder. J
Gastroenterol doi: 10.1007/s00535-013-0813-2, 2013
13. Seino S, Yabushita N, Kim MJ, Nemoto M, Jung S, Osuka Y, Okubo Y, Figueroa R, Matsuo
T, Tanaka K. Physical performance measures as a useful indicator of multiple geriatricsyndromes in women aged 75 years and older. Geriatr Gerontol Int 13(4):901-10, 2013
14. Seto K, Shoda J, Horibe T, Warabi E, Ishige K, Yamagata K, Kohno M, Yanagawa T,
Bukawa H, Kawakami K. Interleukin-4 receptor α-based hybrid peptide effectively induces
antitumor activity in head and neck squamous cell carcinoma. Oncol Rep 29(6):2147-2153,
2013
15. Seto K, Uchida F, Baba O, Yamatoji M, Karube R, Warabi E, Sakai S, Hasegawa S,
Yamagata K, Yanagawa T, Onizawa K, Miyoshi E, Shoda J, Bukawa H. Negative expressionof N-acetylglucosaminyltransferase V in oral squamous cell carcinoma correlates with poor
prognosis. Springerplus 2:657, 2013
16. Seto K, Yamagata K, Uchida F, Yanagawa T, Onizawa K, Bukawa H. Radiation-induced
carotid artery stenosis in a patient with carcinoma of the oral floor. Case Rep Oncol Med
2013:379039, 2013
17. Yamagata K, Ito H, Onizawa K, Yamatoji M, Yanagawa T, Bukawa H. Prognosis forgingival carcinomas with a delayed diagnosis after dental extraction. J Oral Maxillofac Surg
71(12):2189-2194, 2013444)英文以外の著書
1. 正田純一. I 基礎編 2. 胆道の炎症; "内科学書第 8 版	  Vol.4 肝・胆道・膵疾患 (第 8 版)”(編集 小川聡), 中山書店 (東京) pp349−351
2. 正田純一. 第 2 章. トピックス：胆石形成の分子機序; "専門医のための消化器病学 (第2 版)” (編集	  下瀬川徹, 渡辺守, 木下芳一, 金子周一, 樫田博史), 医学書院 (東京) 2013;
pp494-496

45

脂質エネルギー代謝	
 1) 英文論文
1. Ali WH, Chen Q, Delgiorno KE, Su W, Hall JC, Hongu T, Tian H, Kanaho Y, Di Paolo G,
Crawford HC, Frohman MA. Deficiencies of the lipid-signaling enzymes phospholipase D1
and D2 alter cytoskeletal organization, macrophage phagocytosis, and cytokine-stimulated
neutrophil recruitment. PLoS One 8(1):e55325, 2013
2. Amano H, Ito Y, Ogawa F, Eshima K, Suzuki T, Oba K, Matsui Y, Kato S, Fukui T, Nakamura
M, Kitasato H, Fukamizu A, Majima M. Angiotensin II type 1A receptor signaling facilitatestumor metastasis formation through P-selectin-mediated interaction of tumor cells withplatelets and endothelial cells. Am J Pathol 182(2):553-564, 2013
3. Ano S, Morishima Y, Ishii Y, Yoh K, Yageta Y, Ohtsuka S, Matsuyama M, Kawaguchi M,
Takahashi S, Hizawa N. Transcription factors GATA-3 and RORgammat are important for
determining the phenotype of allergic airway inflammation in a murine model of asthma. J
Immunol 190(3):1056-1065, 2013
4. Arase Y, Kawamura Y, Seko Y, Kobayashi M, Suzuki F, Suzuki Y, Akuta N, Kobayashi M,
Sezaki H, Saito S, Hosaka T, Ikeda K, Kumada H, Ohmoto-Sekine Y, Hsieh SD, Amakawa K,
Ogawa K, Matsumoto N, Iwao A, Tsuji H, Hara S, Mori Y, Okubo M, Sone H, Kobayashi T.
Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liverdisease. Hepatol Res 43(11):1163-1168, 2013
5. Asano L, Ito I, Kuwabara N, Waku T, Yanagisawa J, Miyachi H, Shimizu T. Structural basis
for vitamin D receptor agonism by novel non-secosteroidal ligands. FEBS Lett
587(7):957-963, 2013
6. Chang I, Bramall AN, Baynash AG, Rattner A, Rakheja D, Post M, Joza S, McKerlie C,
Stewart DJ, McInnes RR, Yanagisawa M. Endothelin-2 deficiency causes growth retardation,
hypothermia, and emphysema in mice. J Clin Invest 123(6):2643-2653, 2013
7. Chujo Y, Fujii N, Okita N, Konishi T, Narita T, Yamada A, Haruyama Y, Tashiro K, Chiba T,
Shimokawa I, Higami Y. Caloric restriction-associated remodeling of rat white adipose
tissue: effects on the growth hormone/insulin-like growth factor-1 axis, sterol regulatory
element binding protein-1, and macrophage infiltration. Age (Dordr) 35(4):1143-1156, 2013
8. Fujihara K, Kodama S, Horikawa C, Yoshizawa S, Sugawara A, Hirasawa R, Shimano H,
Yachi Y, Suzuki A, Hanyu O, Sone H. The Relationship between Diabetic Neuropathy and
Sleep Apnea Syndrome: A Meta-Analysis. Sleep Disord 2013:150371, 2013
9. Fujihara K, Suzuki H, Sato A, Kodama S, Heianza Y, Saito K, Iwasaki H, Kobayashi K,
46

Yatoh S, Takahashi A, Yamada N, Sone H, Shimano H. Carotid artery plaque and
LDL-to-HDL cholesterol ratio predict atherosclerotic status in coronary arteries inasymptomatic patients with type 2 diabetes mellitus. J Atheroscler Thromb 20(5):452-464,
2013
10. Fujimoto Y, Nakagawa Y, Satoh A, Okuda K, Shingyouchi A, Naka A, Matsuzaka T, Iwasaki
H, Kobayashi K, Yahagi N, Shimada M, Yatoh S, Suzuki H, Yogosawa S, Izumi T, Sone H,
Urayama O, Yamada N, Shimano H. TFE3 controls lipid metabolism in adipose tissue ofmale mice by suppressing lipolysis and thermogenesis. Endocrinology 154(10):3577-3588,
2013
11. Fukuzawa T, Ishida J, Kato A, Ichinose T, Ariestanti DM, Takahashi T, Ito K, Abe J, Suzuki
T, Wakana S, Fukamizu A, Nakamura N, Hirose S. Lung surfactant levels are regulated by
Ig-Hepta/GPR116 by monitoring surfactant protein D. PLoS One 8(7):e69451, 2013
12. Furutani N, Hondo M, Kageyama H, Tsujino N, Mieda M, Yanagisawa M, Shioda S, Sakurai
T. Neurotensin co-expressed in orexin-producing neurons in the lateral hypothalamus plays
an important role in regulation of sleep/wakefulness states. PLoS One 8(4):e62391, 2013
13. Hamanaka S, Ooehara J, Morita Y, Ema H, Takahashi S, Miyawaki A, Otsu M, Yamaguchi
T, Onodera M, Nakauchi H. Generation of transgenic mouse line expressing Kusabira Orange
throughout body, including erythrocytes, by random segregation of provirus method.
Biochem Biophys Res Commun 435(4):586-591, 2013
14. Harada H, Warabi E, Matsuki T, Yanagawa T, Okada K, Uwayama J, Ikeda A, Nakaso K,
Kirii K, Noguchi N, Bukawa H, Siow RC, Mann GE, Shoda J, Ishii T, Sakurai T. Deficiencyof p62/Sequestosome 1 causes hyperphagia due to leptin resistance in the brain. J Neurosci
33(37):14767-14777, 2013
15. Hasegawa Y, Daitoku Y, Sekiguchi K, Tanimoto Y, Mizuno-Iijima S, Mizuno S, Kajiwara N,
Ema M, Miwa Y, Mekada K, Yoshiki A, Takahashi S, Sugiyama F, Yagami K. NovelROSA26 Cre-reporter knock-in C57BL/6N mice exhibiting green emission before and red
emission after Cre-mediated recombination. Exp Anim 62(4):295-304, 2013
16. Hayashi T, Araki A, Kawashima S, Sone H, Watanabe H, Ohrui T, Yokote K, Takemoto M,
Kubota K, Noda M, Noto H, Ina K, Nomura H. Metabolic predictors of ischemic heartdisease and cerebrovascular attack in elderly diabetic individuals: difference in risk by age.
Cardiovasc Diabetol 12:10, 2013
17. Heianza Y, Arase Y, Kodama S, Hsieh SD, Tsuji H, Saito K, Shimano H, Hara S, Sone H.
Effect of postmenopausal status and age at menopause on type 2 diabetes and prediabetes in47

Japanese individuals: Toranomon Hospital Health Management Center Study 17 (TOPICS
17). Diabetes Care 36(12):4007-4014, 2013
18. Heianza Y, Arase Y, Kodama S, Hsieh SD, Tsuji H, Saito K, Shimano H, Hara S, Sone H.
Association of living alone with the presence of undiagnosed diabetes in Japanese men: therole of modifiable risk factors for diabetes: Toranomon Hospital Health Management Center
Study 13 (TOPICS 13). Diabet Med 30(11):1355-1359, 2013
19. Heianza Y, Arase Y, Saito K, Hsieh SD, Tsuji H, Kodama S, Tanaka S, Ohashi Y, Shimano
H, Yamada N, Hara S, Sone H. Development of a screening score for undiagnosed diabetes
and its application in estimating absolute risk of future type 2 diabetes in Japan: Toranomon
Hospital Health Management Center Study 10 (TOPICS 10). J Clin Endocrinol Metab
98(3):1051-1060, 2013
20. Heianza Y, Arase Y, Saito K, Tsuji H, Fujihara K, Hsieh SD, Kodama S, Shimano H,
Yamada N, Hara S, Sone H. Role of alcohol drinking pattern in type 2 diabetes in Japanesemen: the Toranomon Hospital Health Management Center Study 11 (TOPICS 11). Am J Clin
Nutr 97(3):561-568, 2013
21. Hirasawa R, Yachi Y, Yoshizawa S, Horikawa C, Heianza Y, Sugawara A, Sone Y, Kondo K,
Shimano H, Saito K, Kodama S, Sone H. Quality and accuracy of Internet information
concerning a healthy diet. Int J Food Sci Nutr 64(8):1007-1013, 2013
22. Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Sowa
N, Yahagi N, Shimano H, Matsumura S, Inoue K, Marusawa H, Nakamura T, Hasegawa K,
Kume N, Yokode M, Kita T, Kimura T, Ono K. MicroRNA-33 regulates sterol regulatory
element-binding protein 1 expression in mice. Nat Commun 4:2883, 2013
23. Horiguchi Y, Miyachi S, Nagasaki Y. High-performance surface acoustic wave
immunosensing system on a PEG/aptamer hybridized surface. Langmuir 29(24):7369-7376,
2013
24. Horikawa C, Kodama S, Tanaka S, Fujihara K, Hirasawa R, Yachi Y, Shimano H, Yamada
N, Saito K, Sone H. Diabetes and risk of hearing impairment in adults: a meta-analysis. J
Clin Endocrinol Metab 98(1):51-58, 2013
25. Hossain MA, Ikeda Y, Hara T, Nagasaki Y. Novel biocompatible nanoreactor for silica/gold
hybrid nanoparticles preparation. Colloids Surf B Biointerfaces 102:778-782, 2013
26. Ikeda T, Ishii KA, Saito Y, Miura M, Otagiri A, Kawakami Y, Shimano H, Hara H,
Takekoshi K. Inhibition of autophagy enhances sunitinib-induced cytotoxicity in rat
pheochromocytoma PC12 cells. J Pharmacol Sci 121(1):67-73, 201348

27. Ikeda Y, Katamachi J, Kawasaki H, Nagasaki Y. Novel protein PEGylation chemistry via
glutalaldehyde-functionalized PEG. Bioconjug Chem 24(11):1824-1827, 2013
28. Ikeda Y, Kawasaki H, Ichinohe S, Nagasaki Y. Facile solid-phase synthesis of a highly stablepoly(ethylene glycol)-oligonucleotide conjugate. Journal of Materials Chemistry B
1:529-535, 2013
29. Ikeda Y, Kubota D, Nagasaki Y. Design of sugar-oligonucleotide conjugates installed gold
nanoparticle for effective delivery to hepatic parenchymal cells. Colloid and Polymer
Science 291(12):2959-2964, 2013
30. Ikeda Y, Kumagai H, Skach A, Sato M, Yanagisawa M. Modulation of circadian
glucocorticoid oscillation via adrenal opioid-CXCR7 signaling alters emotional behavior.
Cell 155(6):1323-1336, 2013
31. Ishida T, Ohta M, Nakakuki M, Kami H, Uchiyama R, Kawano H, Notsu T, Imada K,
Shimano H. Distinct regulation of plasma LDL cholesterol by eicosapentaenoic acid anddocosahexaenoic acid in high fat diet-fed hamsters: participation of cholesterol ester transfer
protein and LDL receptor. Prostaglandins Leukot Essent Fatty Acids 88(4):281-288, 2013
32. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Yoh Kido I, Yokoyama K,
Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. A
nonclassical vitamin D receptor pathway suppresses renal fibrosis. J Clin Invest
123(11):4579-4594, 2013
33. Iwai M, Sone H, Kanno H, Moritani T, Horiuchi M. Reciprocal regulation of cholesterol
excretion in apolipoprotein E-null mice by angiotensin II type 1 and type 2 receptor
deficiency. Life Sci 92(4-5):276-281, 2013
34. Izumida Y, Yahagi N, Takeuchi Y, Nishi M, Shikama A, Takarada A, Masuda Y, Kubota M,
Matsuzaka T, Nakagawa Y, Iizuka Y, Itaka K, Kataoka K, Shioda S, Niijima A, Yamada T,
Katagiri H, Nagai R, Yamada N, Kadowaki T, Shimano H. Glycogen shortage during fasting
triggers liver-brain-adipose neurocircuitry to facilitate fat utilization. Nat Commun 4:2316,
2013
35. Kamimura M, Furukawa T, Akiyama S, Nagasaki Y. pH-sensitive doxorubicin/poly(ethylene
glycol)-block-poly(4-vinylbenzylphosphonate) nanoparticles in multi-drug resistant humanepidermoid KB carcinoma cells. Biomaterials Science 1(4):361-367, 2013
36. Kanaho Y, Sato T, Hongu T, Funakoshi Y. Molecular mechanisms of fMLP-induced
superoxide generation and degranulation in mouse neutrophils. Adv Biol Regul
53(1):128-134, 201349

37. Katsumata T, Oishi H, Sekiguchi Y, Nagasaki H, Daassi D, Tai PH, Ema M, Kudo T,
Takahashi S. Bioluminescence imaging of beta cells and intrahepatic insulin gene activity
under normal and pathological conditions. PLoS One 8(4):e60411, 2013
38. Kawasaki R, Tanaka S, Tanaka S, Abe S, Sone H, Yokote K, Ishibashi S, Katayama S,
Ohashi Y, Akanuma Y, Yamada N, Yamashita H. Risk of cardiovascular diseases is increased
even with mild diabetic retinopathy: the Japan Diabetes Complications Study.
Ophthalmology 120(3):574-582, 2013
39. Kodama S, Horikawa C, Fujihara K, Hirasawa R, Yachi Y, Yoshizawa S, Tanaka S, Sone Y,
Shimano H, Iida KT, Saito K, Sone H. Use of high-normal levels of haemoglobin A(1C) andfasting plasma glucose for diabetes screening and for prediction: a meta-analysis. Diabetes
Metab Res Rev 29(8):680-692, 2013
40. Kodama S, Horikawa C, Yoshizawa S, Fujihara K, Yachi Y, Tanaka S, Suzuki A, Hanyu O,
Yagyu H, Sone H. Body weight change and type 2 diabetes. Epidemiology 24(5):778-779,
2013
41. Kodama S, Tanaka S, Heianza Y, Fujihara K, Horikawa C, Shimano H, Saito K, Yamada N,
Ohashi Y, Sone H. Association between physical activity and risk of all-cause mortality andcardiovascular disease in patients with diabetes: a meta-analysis. Diabetes Care
36(2):471-479, 2013
42. Kohlmeier KA, Tyler CJ, Kalogiannis M, Ishibashi M, Kristensen MP, Gumenchuk I,
Chemelli RM, Kisanuki Y, Yanagisawa M, Leonard CS. Differential actions of orexin
receptors in brainstem cholinergic and monoaminergic neurons revealed by receptor
knockouts: implications for orexinergic signaling in arousal and narcolepsy. Front Neurosci
7:246, 2013
43. Kudo T, Sato T, Hagiwara K, Kozuma Y, Yamaguchi T, Ikehara Y, Hamada M, Matsumoto
K, Ema M, Murata S, Ohkohchi N, Narimatsu H, Takahashi S. C1galt1-deficient mice exhibit
thrombocytopenia due to abnormal terminal differentiation of megakaryocytes. Blood
122(9):1649-1657, 2013
44. Lakshmipriya T, Fujimaki M, Gopinath SC, Awazu K, Horiguchi Y, Nagasaki Y. A
high-performance waveguide-mode biosensor for detection of factor IX using PEG-based
blocking agents to suppress non-specific binding and improve sensitivity. Analyst
138(10):2863-2870, 2013
45. Matsuo T, Miyata Y, Sagara Y, Higami Y, Tobu S, Matsuo M, Noguchi M, Shimokawa I,
Kanetake H, Sakai H. Renoprotective effects of telmisartan after unilateral renal ablation in50

rats. Int J Nephrol Renovasc Dis 6:207-214, 2013
46. Mizuno S, Tra DT, Mizobuchi A, Iseki H, Mizuno-Iijima S, Kim JD, Ishida J, Matsuda Y,
Kunita S, Fukamizu A, Sugiyama F, Yagami K. Truncated Cables1 causes agenesis of the
corpus callosum in mice. Lab Invest doi: 10.1038/labinvest.2013.146, 2013
47. Moriya T, Tanaka S, Kawasaki R, Ohashi Y, Akanuma Y, Yamada N, Sone H, Yamashita H,
Katayama S. Diabetic retinopathy and microalbuminuria can predict macroalbuminuria andrenal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications
Study. Diabetes Care 36(9):2803-2809, 2013
48. Murata K, Saito C, Ishida J, Hamada J, Sugiyama F, Yagami K, Fukamizu A. Effect of
lactation on postpartum cardiac function of pregnancy-associated hypertensive mice.
Endocrinology 154(2):597-602, 2013
49. Nagano K, Ishida J, Unno M, Matsukura T, Fukamizu A. Apelin elevates blood pressure in
ICR mice with LNAMEinduced endothelial dysfunction. Mol Med Rep 7(5):1371-1375,
2013
50. Naka A, Iida KT, Nakagawa Y, Iwasaki H, Takeuchi Y, Satoh A, Matsuzaka T, Ishii KA,
Kobayashi K, Yatoh S, Shimada M, Yahagi N, Suzuki H, Sone H, Yamada N, Shimano H.
TFE3 inhibits myoblast differentiation in C2C12 cells via down-regulating gene expressionof myogenin. Biochem Biophys Res Commun 430(2):664-669, 2013
51. Nguyen TT, Kim YM, Kim TD, Le OT, Kim JJ, Kang HC, Hasegawa H, Kanaho Y, Jou I,
Lee SY. Phosphatidylinositol 4-phosphate 5-kinase α facilitates Toll-like receptor 4-mediatedmicroglial

inflammation

throughregulation

of

the

Toll/interleukin-1

receptordomain-containing adaptor protein (TIRAP) location. J Biol Chem 288(8):5645-5659, 2013
52. Nishimoto M, Katano M, Yamagishi T, Hishida T, Kamon M, Suzuki A, Hirasaki M,
Nabeshima Y, Nabeshima Y, Katsura Y, Satta Y, Deakin JE, Graves JA, Kuroki Y, Ono R,
Ishino F, Ema M, Takahashi S, Kato H, Okuda A. In vivo function and evolution of theeutherian-specific pluripotency marker UTF1. PLoS One 8(7):e68119, 2013
53. Nishimura R, Sone H, Nakagami T, Tajima N. Importance of high-density lipoproteincholesterol control during pravastatin treatment in hypercholesterolemic Japanese with type 2
diabetes mellitus: a post hoc analysis of MEGA study. Diabetes Res Clin Pract
100(2):e31-33, 2013
54. Oh S, Kim M, Eto M, Kim B, Shoda J, Tanaka K. New approach for obesity treatment
incorporating individual self- management education. J Obesity & Weight Loss Therapy
3(2): 1000164, 2013	
 51

55. Oh S, Tanaka K, Warabi E, Shoda J. Exercise training decreases elevated serum ferritin andlipid peroxidation marker levels in middle-aged obese men with non-alcoholic fatty liverdisease. Medicine & Science in Sports & Exercise 45:2214-2222, 2013
56. Ohara N, Hanyu O, Hirayama S, Nakagawa O, Aizawa Y, Ito S, Sone H. Hypertension
increases urinary excretion of immunoglobulin G, ceruloplasmin and transferrin innormoalbuminuric

patients

with

type

2

diabetes

mellitus.

J

Hypertensdoi:

10.1097/HJH.0000000000000019, 2013
57. Oishi H, Tsubaki T, Miyazaki T, Ono M, Nose M, Takahashi S. A bacterial artificial
chromosometransgenewithpolymorphic

Cd72

inhibits

thedevelopmentof

glomerulonephritis and vasculitis in MRL-Faslpr lupus mice. J Immunol 190(5):2129-2137,
2013
58. Okamura E, Matsuzaki H, Fukamizu A, Tanimoto K. The chicken HS4 insulator element
does not protect the H19 ICR from differential DNA methylation in yeast artificial
chromosome transgenic mouse. PLoS One 8(9):e73925, 2013
59. Okamura E, Matsuzaki H, Sakaguchi R, Takahashi T, Fukamizu A, Tanimoto K. The H19
imprinting control region mediates preimplantation imprinted methylation of nearby
sequences in yeast artificial chromosome transgenic mice. Mol Cell Biol 33(4):858-871,
2013
60. Okita N, Yoshimura M, Watanabe K, Minato S, Kudo Y, Higami Y, Tanuma S. CHK1
cleavage in programmed cell death is intricately regulated by both caspase and non-caspasefamily proteases. Biochim Biophys Acta 1830(1):2204-2213, 2013
61. Ono W, Akaogi K, Waku T, Kuroda T, Yokoyama W, Hayashi Y, Kimura K, Kishimoto H,
Yanagisawa J. Nucleolar protein, Myb-binding protein 1A, specifically binds tononacetylated p53 and efficiently promotes transcriptional activation. Biochem Biophys Res
Commun 434(3):659-663, 2013
62. Ono W, Hayashi Y, Yokoyama W, Kuroda T, Kishimoto H, Ito I, Kimura K, Akaogi K, Waku
T, Yanagisawa J. The nucleolar protein Myb-binding protein 1A (MYBBP1A) enhances p53
tetramerization and acetylation in response to nucleolar disruption. J Biol Chem doi:
10.1074/jbc.M113.474049, 2013
63. Onuki K, Sugiyama H, Ishige K, Kawamoto T, Ota T, Ariizumi S, Yamato M, Kadota S,
Takeuchi K, Ishikawa A, Onodera M, Onizawa K, Yamamoto M, Miyoshi E, Shoda J.
Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates withpostsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder. J
52

Gastroenterol doi: 10.1007/s00535-013-0813-2, 2013
64. Orimo H, Ueno T, Yoshida H, Sone H, Tanaka A, Itakura H. Nutrition education in Japanese
medical schools: a follow-up survey. Asia Pac J Clin Nutr 22(1):144-149, 2013
65. Pua ML, Yoshitomi T, Chonpathompikunlert P, Hirayama A, Nagasaki Y. Redox-active
injectable gel using thermo-responsive nanoscale polyion complex flower micelle fornoninvasive treatment of local inflammation. J Control Release 172(3):914-920, 2013
66. Sakaguchi R, Okamura E, Matsuzaki H, Fukamizu A, Tanimoto K. Sox-Oct motifs
contribute to maintenance of the unmethylated H19 ICR in YAC transgenic mice. Hum Mol
Genet 22(22):4627-4637, 2013
67. Sanematsu F, Nishikimi A, Watanabe M, Hongu T, Tanaka Y, Kanaho Y, Cote JF, Fukui Y.
Phosphatidic acid-dependent recruitment and function of the Rac activator DOCK1 during
dorsal ruffle formation. J Biol Chem 288(12):8092-8100, 2013
68. Sato T, Hongu T, Sakamoto M, Funakoshi Y, Kanaho Y. Molecular mechanisms of
N-formyl-methionyl-leucyl-phenylalanine-induced superoxide generation and degranulationin mouse neutrophils: phospholipase D is dispensable. Mol Cell Biol 33(1):136-145, 2013
69. Sato T, Suzuki T, Watanabe H, Kadowaki A, Fukamizu A, Liu PP, Kimura A, Ito H,
Penninger JM, Imai Y, Kuba K. Apelin is a positive regulator of ACE2 in failing hearts. J
Clin Invest 123(12):5203-5211, 2013
70. Seto K, Shoda J, Horibe T, Warabi E, Ishige K, Yamagata K, Kohno M, Yanagawa T,
Bukawa H, Kawakami K. Interleukin-4 receptor alpha-based hybrid peptide effectively
induces antitumor activity in head and neck squamous cell carcinoma. Oncol Rep
29(6):2147-2153, 2013
71. Seto K, Uchida F, Baba O, Yamatoji M, Karube R, Warabi E, Sakai S, Hasegawa S,
Yamagata K, Yanagawa T, Onizawa K, Miyoshi E, Shoda J, Bukawa H. Negative expressionof N-acetylglucosaminyltransferase V in oral squamous cell carcinoma correlates with poor
prognosis. Springerplus 2:657, 2013
72. Sha S, Vong LB, Chonpathompikunlert P, Yoshitomi T, Matsui H, Nagasaki Y. Suppressionof NSAID-induced small intestinal inflammation by orally administered redox nanoparticles.
Biomaterials 34(33):8393-8400, 2013
73. Shashni B, Sakharkar KR, Nagasaki Y, Sakharkar MK. Glycolytic enzymes PGK1 andPKM2 as novel transcriptional targets of PPARgamma in breast cancer pathophysiology. J
Drug Target 21(2):161-174, 201374. Shashni B, Sharma K, Singh R, Sakharkar KR, Dhillon SK, Nagasaki Y, Sakharkar MK.
53

Coffee component Hydroxyl Hydro Quinone (HHQ) as a novel ligand for PPAR gamma andimplications for breast cancer. BMC (BioMedCentral) Genomics 14(Suppl 5):S6, 201375. Shimada M. Overview of calpain-mediated regulation of bone and fat mass in osteoblasts.
Cell Biochem Biophys 66(1):23-28, 201376. Shinkai Y, Yamanaka I, Duong HH, Quynh NT, Kanaho Y, Kumagai Y. Garcinia vilersiana
bark extract activates the Nrf2/HO-1 signaling pathway in RAW264.7 cells. J Toxicol Sci
38(6):875-878, 2013
77. Soetikno V, Suzuki K, Veeraveedu PT, Arumugam S, Lakshmanan AP, Sone H, Watanabe K.
Molecular understanding of curcumin in diabetic nephropathy. Drug Discov Today
18(15-16):756-763, 2013
78. Sone H, Tanaka S, Tanaka S, Suzuki S, Seino H, Hanyu O, Sato A, Toyonaga T, Okita K,
Ishibashi S, Kodama S, Akanuma Y, Yamada N. Leisure-time physical activity is a significant
predictor of stroke and total mortality in Japanese patients with type 2 diabetes: analysis fromthe Japan Diabetes Complications Study (JDCS). Diabetologia 56(5):1021-1030, 2013
79. Sone Y, Kido T, Ainuki T, Sonoda M, Ichi I, Kodama S, Sone H, Kondo K, Morita Y, Egawa
S, Kawahara K, Otsuka Y, Fujiwara Y. Genetic variants of the fatty acid desaturase genecluster are associated with plasma LDL cholesterol levels in Japanese males. J Nutr Sci
Vitaminol (Tokyo) 59(4):325-335, 2013
80. Soya S, Shoji H, Hasegawa E, Hondo M, Miyakawa T, Yanagisawa M, Mieda M, Sakurai T.
Orexin receptor-1 in the locus coeruleus plays an important role in cue-dependent fear
memory consolidation. J Neurosci 33(36):14549-14557, 2013
81. Sunaga H, Matsui H, Ueno M, Maeno T, Iso T, Syamsunarno MR, Anjo S, Matsuzaka T,
Shimano H, Yokoyama T, Kurabayashi M. Deranged fatty acid composition causes
pulmonary fibrosis in Elovl6-deficient mice. Nat Commun 4:2563, 2013
82. Suzuki A, Sinton CM, Greene RW, Yanagisawa M. Behavioral and biochemical dissociationof arousal and homeostatic sleep need influenced by prior wakeful experience in mice. Proc
Natl Acad Sci U S A 110(25):10288-10293, 2013
83. Takase S, Osuga J, Fujita H, Hara K, Sekiya M, Igarashi M, Takanashi M, Takeuchi Y,
Izumida Y, Ohta K, Kumagai M, Nishi M, Kubota M, Masuda Y, Taira Y, Okazaki S, Iizuka
Y, Yahagi N, Ohashi K, Yoshida H, Yanai H, Tada N, Gotoda T, Ishibashi S, Kadowaki T,
Okazaki H. Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene. J
Atheroscler Thromb 20(5):481-493, 2013
84. Tamiya H, Hirota K, Takahashi Y, Daitoku H, Kaneko Y, Sakuta G, Iizuka K, Watanabe S,
54

Ishii N, Fukamizu A. Conserved SAMS function in regulating egg-laying in C. elegans. J
Recept Signal Transduct Res 33(1):56-62, 2013
85. Tanaka S, Tanaka S, Iimuro S, Yamashita H, Katayama S, Akanuma Y, Yamada N, Araki A,
Ito H, Sone H, Ohashi Y. Predicting macro- and microvascular complications in type 2
diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention
Trial risk engine. Diabetes Care 36(5):1193-1199, 2013
86. Tanaka S, Yoshimura Y, Kamada C, Tanaka S, Horikawa C, Okumura R, Ito H, Ohashi Y,
Akanuma Y, Yamada N, Sone H. Intakes of dietary fiber, vegetables, and fruits and incidenceof cardiovascular disease in Japanese patients with type 2 diabetes. Diabetes Care
36(12):3916-3922, 2013
87. Tanaka S, Yoshimura Y, Kawasaki R, Kamada C, Tanaka S, Horikawa C, Ohashi Y, Araki A,
Ito H, Akanuma Y, Yamada N, Yamashita H, Sone H. Fruit intake and incident diabetic
retinopathy with type 2 diabetes. Epidemiology 24(2):204-211, 2013
88. Terawaki K, Sawada Y, Kashiwase Y, Hashimoto H, Yoshimura M, Suzuki M, Miyano K,
Sudo Y, Shiraishi S, Higami Y, Yanagihara K, Kase Y, Ueta Y, Uezono Y. New cancer
cachexia rat model generated by implantation of a peritoneal dissemination-derived humanstomach cancer cell line. Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00116.2013,
2013
89. Wada T, Miyashita Y, Sasaki M, Aruga Y, Nakamura Y, Ishii Y, Sasahara M, Kanasaki K,
Kitada M, Koya D, Shimano H, Tsuneki H, Sasaoka T. Eplerenone ameliorates thephenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed
high-fat and high-fructose diet. Am J Physiol Endocrinol Metab 305(11):E1415-1425, 2013
90. Yamazaki M, Yamauchi Y, Goshima Y, Kanaho Y. Phosphatidylinositol 4-phosphate
5-kinase β regulates growth cone morphology and semaphorin 3A-triggered growth cone
collapse in mouse dorsal root ganglion neurons. Neurosci Lett 547:59-64, 2013
91. Yokoyama H, Araki S, Honjo J, Okizaki S, Yamada D, Shudo R, Shimizu H, Sone H,
Moriya T, Haneda M. Association between remission of macroalbuminuria and preservationof renal function in patients with type 2 diabetes with overt proteinuria. Diabetes Care
36(10):3227-3233, 2013
92. Yoshitomi T, Ozaki Y, Thangavel S, Nagasaki Y. Redox nanoparticle therapeutics tocancer--increase in therapeutic effect of doxorubicin, suppressing its adverse effect. J
Control Release 172(1):137-143, 2013

55

	
 
2) 英文以外の論文
1. 正田純一. 肝内結石症の胆道発癌-分子生物学の立場から-. 胆と膵 34:1153−1158, 2013
2. 正田純一. 胆道癌，肝内胆管癌のリスクファクターとその発癌・進展の分子メカニズ
ム. 胆と膵 34:455−460, 2013
3. 正田純一. Science of Kampo View インチンコウ湯. 漢方医学 37(3):194−197, 2013
4. 正田純一. 日本胆道学会認定指導医養成講座	
  胆石の種類と成因	
  	
  胆道	
  第 48 回日本胆道学会学術集会記録 27:672-679, 2013
5. 須藤結香, 沖田直之, 樋上賀一. カロリー制限による抗老化・寿命延伸効果のメカニズ
ム	  〜脂肪組織のリモデリングと脂質代謝の活性化〜. 自律神経 50:192-195, 2013
6. 田中喜代次, 蘇リナ, 宮木亜沙子, 小野塚太郎, 正田純一. 加速度トレーニングを含む減量介入が肥満者の健康・体力に及ぼす影響. 臨床スポーツ医学 30:565-569, 2013
7. 土屋拓郎, 沖田直之, 須藤結香, 樋上賀一. カロリー制限が白色脂肪組織における脂肪酸合成に及ぼす影響の経時的解析. 基礎老化研究 37:29-31, 2013
8. 長谷川潤, 金保安則. 哺乳動物個体から見るホスファチジルイノシトール 4-リン酸 5キナーゼの生理機能. 生化学 85(5):362-367, 2013	 3) 英文著書
1. Arumungam S, Karuppagounder V, Thandavarayan RA, Pitchaimani V, Sone H, Watanabe K.
Chapter 2 Diabetic cardiomyopathy and oxidative stress; in "Diabetes: Oxidative Stress andDietary Antioxidant (1st edition)" (edited by Preedy V), Elsevier (Amsterdam) 2013; pp25-32
2. Tamura A, Nagasaki Y. Capter 10. Environmentally-Responsive Nanogels for siRNA
Delivery; in "Advanced Delivery and Therapeutic Applications of RNAi (1st edition)" (editedby Cheng K,Mahato R I), Wiley (Hoboken) 2013; pp207-220

4) 英文以外の著書
1. 泉田欣彦, 矢作直也. 第 8 章. リパーゼ; "糖尿病の分子標的と治療薬事典 (第 1 版)” (編集 春日雅人, 綿田裕孝, 松本道宏), 羊土社 (東京) 2013; pp232-233
2. 岩崎仁, 島野仁. 2 章-2. 脂肪酸の主な働き; "そうだったんだ！脂肪酸−循環器疾患との深い関係− (第 1 版)” (編集 伊藤浩), 文光堂 (東京) 2013; pp17-21
3. 岩崎仁, 島野仁. IV 章. トピックス	
  肝臓における脂質代謝研究の進歩（IV 章. 肝臓代謝性疾患）; "専門医のための消化器病学 (第 2 版)” (監修 小俣政男, 千葉勉, 編集 下
瀬川徹, 渡辺守, 木下芳一, 金子周一, 樫田博史), 医学書院 (東京) 2013; pp386-387
56

4. 植村靖行, 曽根博仁. 食後脂質異常症と大血管合併症; "月刊糖尿病 (第 5 巻 9 号)” (編集島野仁), 医学出版 (東京) 2013; pp66-72
5. 大崎芳典, 矢作直也. 第 8 章. URAT1; "糖尿病の分子標的と治療薬事典 (第 1 版)” (編集春日雅人, 綿田裕孝, 松本道宏), 羊土社 (東京) 2013; pp230-231
6. 岡崎啓明. 8. リパーゼと糖尿病; "月刊糖尿病第５巻９号 (第 1 版)” (編集 島野仁), 医学出版 (東京) 2013; pp56-65
7. 岡崎啓明. II-4. 細胞内のリパーゼ（HSL・ATGL・NCEH など）; "The Lipid 第２４巻第４号 (第 1 版)” (編集 平田健一), メディカルレビュー社 (東京) 2013; pp51-64
8. 煙山紀子, 矢作直也. 第 8 章. GPR120; "糖尿病の分子標的と治療薬事典 (第 1 版)” (編集春日雅人, 綿田裕孝, 松本道宏), 羊土社 (東京) 2013; pp234-235
9. 煙山（鈴木）紀子, 松坂賢, 島野仁. 第 18 章. 慢性炎症と栄養; "「慢性炎症と生活習慣病」循環器・代謝・呼吸器・消化器疾患の基盤病態へのアプローチ (第 1 版)” (編集 小川佳宏, 眞鍋一郎), 南山堂 (東京) 2013; pp161-168
10. 齋藤和美, 曽根博仁. 第 2 章. 喫煙と糖尿病・代謝疾患; "日本臨牀 (第 73 巻 3 号)”, 日本臨牀社 (東京) 2013; pp443-448
11. 志鎌明人, 矢作直也. 第 8 章. SGLT2; "糖尿病の分子標的と治療薬事典 (第 1 版)” (編集春日雅人, 綿田裕孝, 松本道宏), 羊土社 (東京) 2013; pp228-229
12. 島野仁. 第 6 章. 内分泌・代謝疾患; "ガイドラインに基づく臨床指針 (第 10 版)” (監修	 福井次矢), 2013; pp274-296
13. 島野仁. III 章 1〜4. 療養指導各論（III 章 1〜4、1 診断と治療に関する知識、2 食事療法、3 運動療法、4 薬物療法）; "日本糖尿病療養指導士受験ガイドブック	
 2013 (第 1版)” (編集 日本糖尿病療養指導士認定機構), メディカルレビュー社 (大阪) 2013;
pp33-68
14. 島野仁. 第 6 章-B. 脂肪酸の生合成とその酸化; "人体の構造と機能及び疾病の成り立
ち (第 2 版)” (編集 香川靖雄, 近藤和雄, 石田均, 門脇孝), 南江堂 (東京) 2013; pp151-154
15. 正田純一. 第 5 章. トピックス：胆石形成の分子機序; "専門医のための消化器病学	
 (第2 版)” (編集 下瀬川徹, 渡辺守, 木下芳一, 金子周一, 樫田博史), 医学書院 (東京) 2013;
pp494-496
16. 正田純一. Vol.4. 肝・胆道・膵疾患胆道の炎症; "内科学書	
 (第 8 版)” (編集 小川聡), 中
山書店 (東京) 2013; pp349−351
17. 正田純一. Vol.4. 肝・胆道・膵疾患	  原発性硬化性胆管炎; "内科学書	  (第 8 版)” (編集 小川聡), 中山書店 (東京) 2013; pp352−353
18. 菅野洋子, 島野仁. 第 2 部. リポ蛋白とその分画; "臨床検査ガイド 2013〜2014 (第 157

版)” (編集 MedicalPractice 編集委員会), 文光堂 (東京) 2013; pp272-276
19. 曽根博仁. ? 総論	  糖尿病運動療法のエビデンス; "臨床スポーツ医学 (第 30 巻 10 号)”(編集 小熊祐子), 文光堂 (東京) 2013; pp939-46
20. 曽根博仁. 日本人 2 型糖尿病の臨床疫学; "日本疫学会ニュースレター No. 42”, 日本疫学会 (東京) 2013; pp4-6
21. 曽根博仁. 糖尿病治療における運動のエビデンスと今後の課題; "PRACTICE (第 30 巻
5 号)”, 医歯薬出版 (東京) 2013; pp269-576
22. 曽根博仁. 身体運動と糖尿病：疫学的研究成績; "月刊糖尿病 (第 5 巻 8 号)” (編集 片山茂裕), 医学出版 (東京) 2013; pp102-108
23. 曽根博仁. 糖尿病の死亡リスクを半減させる方法/Q&A; "現代の 5 大病	  がん・脳卒
中・心臓病・糖尿病・うつ病” (編集 MMJ 編集部), 毎日新聞社 (東京) 2013; pp110-123
24. 曽根博仁. 10. 生活習慣病と食生活 Ⅰ 肥満とやせ・メタボリックシンドローム; "改訂	 食と健康” (編集 小城勝相, 清水誠), NHK 出版 (東京) 2013; pp168-184
25. 曽根博仁. 11. 生活習慣病と食生活 Ⅱ	  糖尿病; "改訂	  食と健康” (編集 小城勝相, 清水誠), NHK 出版 (東京) 2013; pp185-205
26. 曽根博仁. 12. 生活習慣病と食生活 Ⅲ	  動脈硬化とその他の生活習慣病; "改訂	  食と健康” (編集 小城勝相, 清水誠), NHK 出版 (東京) 2013; pp206-230
27. 曽根博仁. 11. 糖尿病の職による予防と是正; "食健康科学” (編集 中谷延二, 小城勝相), NHK 出版 (東京) 2013; pp180-200
28. 曽根博仁. 12. 動脈硬化の職による予防と是正; "食健康科学” (編集 中谷延二, 小城勝相), NHK 出版 (東京) 2013; pp201-220
29. 曽根博仁. 13. 肥満、メタボリックシンドロームとその他の生活習慣病の食による予防と是正; "食健康科学” (編集 中谷延二, 小城勝相), NHK 出版 (東京) 2013; pp221-236
30. 曽根博仁. 8. 内分泌系; "人体の構造と機能および疾病の成り立ち	
  疾病の成因・病態・診断・治療 (第 2 版)” (編集 竹中優), 医歯薬出版 (東京) 2013; pp193-204
31. 曽根博仁, 赤沼安夫, 山田信博. 日本人 2 型糖尿病患者の特徴と病態についての臨床
疫学; "日本内科学会雑誌 (第 102 巻 10 号)”, 日本内科学会 (東京) 2013; pp2714-2722
32. 曽根博仁, 田中司朗, 片山茂裕, 山下英俊, 赤沼安夫, 山田信博. 15. Japan Diabetes
Complications Study (JDCS)が教えてくれるもの; "糖尿病学 2013(第 1 版)” (編集 門脇考), 診断と治療社 (東京) 2013; pp118-125
33. 谷内洋子, 曽根博仁. 健常妊婦における栄養と妊娠経過に関する中間解析; "栄養学雑誌 (第 71 巻 5 号短報), 日本栄養改善学会 (東京) 2013; pp242-252
34. 羽入修, 曽根博仁. 第 4 章. 糖尿病患者における脂質管理はどこまで厳格であるべき
58

か	  異論/争論、私の意見; "糖尿病診療マスター (第 11 巻 4 号)” 医学書院 (東京) 2013;
pp391-396
35. 久芳素子, 矢作直也. 第 8 章. CETP; "糖尿病の分子標的と治療薬事典 (第 1 版)” (編集春日雅人, 綿田裕孝, 松本道宏), 羊土社 (東京) 2013; pp236-238
36. 藤原和哉, 曽根博仁. 特集 3. α グルコシダーゼ阻害薬と治療成績; "医薬ジャーナル(第 49 巻 10 号)” 医薬ジャーナル社 (大阪) 2013; pp65-71
37. 皆川真一, 曽根博仁. 糖尿病における脂質異常症治療とその成績; "医薬ジャーナル(第 49 巻 10 号)” 医薬ジャーナル社 (大阪) 2013; pp113-118
38. 皆川真一, 曽根博仁. 一次予防におけるスタチンでの心血管ベネフィットと糖尿病発症リスク：JUPITER 試験より; "DIABETES UPDATE (第 2 巻 2 号)” メディカルレビュ
ー社 (大阪) 2013; pp30-31
39. 皆川真一, 羽入修, 曽根博仁. 脳卒中; "日本臨牀 (第 71 巻 11 号)” 日 本 臨牀社 (東京)2013; pp1948-1953
40. 矢藤繁, 島野仁. 16-1.1. 生活習慣病（生活・社会・環境要因）; "内科学 (第 10 版)” (総編集 矢崎義雄), 朝倉書店 (東京) 2013; pp2348-2352
41. 矢藤繁, 島野仁. I-10 章-A. NAFLD と糖代謝異常（NASH 編	
 I.基本編〜NASH を診る
前の基礎知識〜）; "NASH・アルコール性肝障害の診療を極める	  基本から最前線まで（Hepatology Practice 第 2 巻）(第 1 版)” (編集 竹井謙之（ゲスト編集）, 竹原徹郎, 持田智（常任編集）, 文光堂 (東京) 2013; pp71-74
42. 矢作直也. 筑波大学附属病院とクックパッドのおいしく治す「糖尿病食」 講談社
2013 年 (全 200 ページ)59

ヘルスサービス	 1) 英文論文	
 1. Abe T, Ishimatsu S, Tokuda Y. Descriptive analysis of patients' EMS use related to severity inTokyo: a population-based observational study. PLoS One 8(3):e59738, 2013
2.

Abe

T,

TokudaY.

Bilateralcarotidarteries

occlusion.

BMJ

Case

Rep

doi:10.1136/bcr-2012-008048, 2013
3. Abe T, Tokuda Y. The Triage in a Mild and Mini Disaster. General Medicine 34:79-94, 2013
4. Akamatsu M, Takuma H, Yamashita T, Okada T, Keino-Masu K, Ishii K, Kwak S, Masu M,
Tamaoka A. A unique mouse model for investigating the properties of amyotrophic lateralsclerosis-associatedproteinTDP-43,

by

in

utero

electroporation.

NeurosciRes

77(4):234-241, 2013
5. Baba O, Yamagata K, Tomidokoro Y, Tamaoka A, Itoh H, Yanagawa T, Onizawa K, Bukawa
H. Neuroleptic malignant syndrome in a patient with tongue cancer: a report of a rare case.
Case Rep Dent 2013:542130, 2013
6. Chei CL, Yamagishi K, Kitamura A, Kiyama M, Imano H, Ohira T, Cui R, Tanigawa T,
Sankai T, Ishikawa Y, Sato S, Hitsumoto S, Iso H. High-density lipoprotein subclasses andrisk of stroke and its subtypes in Japanese population: the Circulatory Risk in Communities
Study. Stroke 44(2):327-333, 2013
7. Cui R, Li YY, Gero K, Yamagishi K, Umesawa M, Imano H, Ohira T, Kiyama M, Okada T,
Kitamura A, Hitsumoto S, Tanigawa T, Iso H. An association between central aortic pressure
and subclinical organ damage of the heart among a general Japanese cohort: Circulatory Risk
in Communities Study (CIRCS). Atherosclerosis 232(1):94-98, 2013
8. Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T,
Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H,
Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K,
Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A,
Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, Inoue H.
Response to comment on "Drug screening for ALS using patient-specific induced pluripotent
stem cells". Sci Transl Med 5(188):188lr182, 2013
9. Fujisue K, Sugiyama S, Ono T, Matsuzawa Y, Akiyama E, Sugamura K, Matsubara J,
Kurokawa H, Kaikita K, Iwashita S, Sumida H, Hokimoto S, Oniki K, Nakagawa K, Matsui
K, Ogawa H. Response to letter regarding article, "Effects of endothelial dysfunction on
residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in60

patients with stable coronary artery disease". Circ Cardiovasc Interv 6(5):e66, 2013
10. Fujisue K, Sugiyama S, Ono T, Matsuzawa Y, Akiyama E, Sugamura K, Matsubara J,
Kurokawa H, Kaikita K, Iwashita S, Sumida H, Hokimoto S, Oniki K, Nakagawa K, Matsui
K, Ogawa H. Effects of endothelial dysfunction on residual platelet aggregability after dual
antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary arterydisease. Circ Cardiovasc Interv 6(4):452-459, 2013
11. Fukushima H, Fukushima T, Sakai A, Suzuki R, Nakajima-Yamaguchi R, Kobayashi C,
Iwabuchi A, Saito M, Yoshimi A, Nakao T, Kato K, Tsuchida M, Takahashi H, Koike K,
Kiyokawa N, Noguchi E, Sumazaki R. Polymorphisms of MTHFR Associated with Higher
Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid
Malignancies. Leuk Res Treatment 2013:238528, 2013
12. Fukushima H, Fukushima T, Suzuki R, Enokizono T, Matsunaga M, Nakao T, Koike K,
Mori K, Matsueda K, Sumazaki R. Continuous regional arterial infusion effective forchildren with acute necrotizing pancreatitis even under neutropenia. Pediatr Int
55(2):e11-13, 2013
13. Hara T, Akutsu H, Yamamoto T, Ishikawa E, Matsuda M, Matsumura A. Cushing’s disease
presenting with gastrointestinal perforation: a case report. Endocrinology, diabetes andmetabolism. Case reports Nov:1-4, 2013
14. Hara T, Matsuda M, Watanabe S, Nakai K, Yamamoto T, Matsumura A. Remote cerebellar
hemorrhage after removal of a supratentorial glioma without perioperative CSF loss: A casereport. Case Rep Surg 2013:305039, 2013
15. Honda K. The Ashikaga case of Japan--Y-STR testing used as the exculpatory evidence tofree a convicted felon after 17.5 years in prison. Forensic Sci Int Genet 7(1):e1-2, 2013
16. Honda K, Yano S, Nishi T, Iwabuchi Y, Kurosu A, Sugano Y. Selective blood-DNA
extraction from mixed stain using ABO antibody for short tandem repeat typing. Forensic
Sci Int Genet 4(1):e326–e327, 2013
17. Hosaka A, Araki W, Oda A, Tomidokoro Y, Tamaoka A. Statins reduce amyloid β-peptide
production by modulating amyloid precursor protein maturation and phosphorylation througha cholesterol-independent mechanism in cultured neurons. Neurochem Res 38(3):589-600,
2013
18. Hoshino S, Sakamoto K, Vassilopoulos S, Camus SM, Griffin CA, Esk C, Torres JA,
Ohkoshi N, Ishii A, Tamaoka A, Funke BH, Kucherlapati R, Margeta M, Rando TA, Brodsky
FM. The CHC22 clathrin-GLUT4 transport pathway contributes to skeletal muscle
61regeneration. PLoS One 8(10):e77787, 2013
19. Hosokawa M, Arai T, Yamashita M, Tsuji H, Nonaka T, Masuda-Suzukake M, Tamaoka A,
Hasegawa M, Akiyama H. Differential diagnosis of amyotrophic lateral sclerosis from
Guillain-Barre syndrome by quantitative determination of TDP-43 in cerebrospinal fluid. Int
J Neurosci doi: 10.3109/00207454.2013.848440, 2013
20. Ikehara S, Iso H, Yamagishi K, Kokubo Y, Saito I, Yatsuya H, Inoue M, Tsugane S. Alcohol
consumption and risk of stroke and coronary heart disease among Japanese women: the Japan
Public Health Center-based prospective study. Prev Med 57(5):505-510, 2013
21. Ishii A, Ohkoshi N, Yoshida M, Tamaoka A. The effect of water-soluble fullerene withdifferentnumber of hydroxyl groups in muscle regeneration process of experimantal murine
skeletal muscle. Neuromuscular Disorders 23(9-10):838, 2013
22. Ito Y, Kato N, Matsumura A, Sonobe M. Hemodynamic instability increases new ischemic
brain lesions on diffusion-weighted imaging after carotid artery stenting. Neurol Med Chir
(Tokyo) 53(6):375-380, 2013
23. Ito Y, Tsurushima H, Sato M, Ito A, Oyane A, Sogo Y, Matsumura A. Angiogenesis therapy
for brain infarction using a slow-releasing drug delivery system for fibroblast growth factor
2. Biochem Biophys Res Commun 432(1):182-187, 2013
24. Iwata A, Nagata K, Hatsuta H, Takuma H, Bundo M, Iwamoto K, Tamaoka A, Murayama S,
Saido T, Tsuji S. Altered CpG methylation in sporadic Alzheimer's disease is associated with
APP and MAPT dysregulation. Hum Mol Genet doi: 10.1093/hmg/ddt451, 2013
25. Jimbo T, Masumoto K, Urita Y, Takayasu H, Shinkai T, Uesugi T, Gotoh C, Sakamoto N,
Sasaki T, Oto T, Fukushima T, Noguchi E, Nakano Y. Nevoid basal cell carcinoma syndrome
with a unilateral giant ovarian fibroma in a Japanese 6-year-old girl. Eur J Pediatr doi:
10.1007/s00431-013-2200-7, 2013
26. Kaminiwa J, Honda K, Kurosu A, Nishi T, Sugano Y, Yano S. Application of trace element
measurement for diagnosis of metabolic disorders. Rom J Leg Med 21(2):259-262, 2013
27. Kaminiwa J, Honda K, Sugano Y, Yano S, Nishi T, Sekine Y. Vanadium accelerates
polymerase chain reaction and expands the applicability of forensic DNA testing. J Forensic
Leg Med 20(4):326-333, 2013
28. Kaneko S, Kaneko M, Fukushima T. Enhanced antitumor effect of lower-dose andlonger-term

CPT-11

treatmentincombination

withlow-dosecelecoxibagainstneuroblastoma xenografts. Int J Clin Oncol 18(1):116-125, 2013
29. Kashiwagi M, Tamiya N, Sato M, Yano E. Factors associated with the use of home-visit
62

nursing services covered by the long-term care insurance in rural Japan: a cross-sectional
study. BMC Geriatr 13:1, 2013
30. Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K. The authors
reply. Kidney Int 84(5):1047-1048, 2013
31. Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K. The authors
reply. Kidney Int 84(1):215-216, 2013
32. Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K. An
angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular
events in elderly high-risk hypertensive patients with chronic kidney disease better thanhigh-dose angiotensin II receptor blockade alone. Kidney Int 83(1):167-176, 2013
33. Kin H, Ishikawa E, Takano S, Ayuzawa S, Matsushita A, Muragaki Y, Aiyama H, Sakamoto
N, Yamamoto T, Matsumura A. Language areas involving the inferior temporal cortex on
intraoperative mapping in a bilingual patient with glioblastoma. Neurol Med Chir (Tokyo)
53(4):256-258, 2013
34. Kobayashi M, Tamiya N, Kashiwagi M, Ito T, Yamaoka Y, Matsuzawa A. Factors related topositive feelings of caregivers who provide home-based long-term care for their family
members in Japan. Journal of Research on Humanities and Social Sciences 3(16):27-36,
2013
35. Kojima S, Matsui K, Ogawa H. Temporal trends in hospitalization for acute myocardial
infarction between 2004 and 2011 in Kumamoto, Japan. Circ J 77(11):2841-2843, 2013
36. Kokubo Y, Iso H, Saito I, Yamagishi K, Yatsuya H, Ishihara J, Inoue M, Tsugane S. The
impact of green tea and coffee consumption on the reduced risk of stroke incidence inJapanese population: the Japan public health center-based study cohort. Stroke
44(5):1369-1374, 2013
37. Kurogi K, Sugiyama S, Sakamoto K, Tayama S, Nakamura S, Biwa T, Matsui K, Ogawa H.
Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectinin patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study. J
Cardiol 62(2):87-94, 2013
38. Li YY, Yatsuya H, Yamagishi K, Wakai K, Tamakoshi A, Iso H. Body mass index andweight change during adulthood are associated with increased mortality from liver cancer:
the JACC Study. J Epidemiol 23(3):219-226, 2013
39. Li-mei C, Tamiya N, Kato G, Yamaoka Y, Ito T, Matsuzawa A, Yamamoto H. Predictors ofvolunteerism: A study of older adults in Japan. Journal of Public Policy and Administration
63

Research 3(6):71-19, 2013
40. Mahmoud SS, Fukushima T, Shimizu T, Nakao T, Yamaguchi R, Fukushima H, Wada H,
Nanmoku T, Sumazaki R. Persistent low level Epstein-Barr virus DNAemia in childhood
cancer survivors. Pediatr Hematol Oncol 30(3):216-225, 2013
41. Matsubara T, Ayuzawa S, Aoki T, Fujimoto A, Osuka S, Matsumura A. The patient had anormal magnetic resonance imaging and temporal lobe epilepsy secondaru to a porencephaliccyst but showed structural lesions (hippocampal sclerosis). Epilepsy & Behavior Case
Reports 1:153-156, 2013
42. Matsubara T, Ayuzawa S, Aoki T, Ikeda G, Shiigai M, Matsumura A. Cerebral Venous
Thrombosis after Ventriculoperitoneal Shunting: A Case Report. Neurol Med Chir (Tokyo)
doi:10.2176/nmc.cr.2012-0312, 2013 	
 43. Matsubara T, Ishikawa E, Hirata K, Matsuda M, Akutsu H, Masumoto T, Zaboronok A,
Matsumura A. A New Mechanism of Cerebrospinal Fluid Leakage after Lumboperitoneal
Shunt: A Theory of Shunt Side Hole-Case Report. Neurol Med Chir (Tokyo)
doi:10.2176/nmc.cr.2013-0067, 2013 	
 44. Matsuzawa A, Yamaoka Y, Tamiya N, Taniguchi K, Yamazaki

K. Family caregiving

problems of suspected elderly neglect. Journal of Research on Humanities and Social
Sciences 3(9):117-124, 2013
45. Matsuzawa Y, Sugiyama S, Sumida H, Sugamura K, Nozaki T, Ohba K, Matsubara J,
Kurokawa H, Fujisue K, Konishi M, Akiyama E, Suzuki H, Nagayoshi Y, Yamamuro M,
Sakamoto K, Iwashita S, Jinnouchi H, Taguri M, Morita S, Matsui K, Kimura K, Umemura
S, Ogawa H. Peripheral endothelial function and cardiovascular events in high-risk patients.
J Am Heart Assoc 2(6):e000426, 2013
46. Minakuchi E, Ohnishi E, Ohnishi J, Sakamoto S, Hori M, Motomura M, Hoshino J,
Murakami K, Kawaguchi T. Evaluation of mental stress by physiological indices derived
from finger plethysmography. J Physiol Anthropol 32:17, 2013
47. Mizumoto M, Okumura T, Ishikawa E, Yamamoto T, Takano S, Matsumura A, Oshiro Y,
Ishikawa H, Sakurai H, Tsuboi K. Reirradiation for recurrent malignant brain tumor withradiotherapy or proton beam therapy. Technical considerations based on experience at asingle institution. Strahlenther Onkol 189(8):656-663, 2013
48. Mizuno T, Tokuda K. Influence of a great disaster in toddlers from the perspective ofnursery terchers : Subjecting the nursery teachers who work in the area with strong shakes.
The Asian Journal of Child Care 3:53-60, 201364

49. Morita N, Nomoto Y, Ukeda E, Sufu K. How does trauma caused by violence influence therisk of relapse in and effects of cognitive behavioral therapy for drug addicts in prison? Acta
Criminologiae et Medicinae Legalis Japonica 179(1):3-15, 2013
50. Muragaki Y, Akimoto J, Maruyama T, Iseki H, Ikuta S, Nitta M, Maebayashi K, Saito T,
Okada Y, Kaneko S, Matsumura A, Kuroiwa T, Karasawa K, Nakazato Y, Kayama T. Phase II
clinical study on intraoperative photodynamic therapy with talaporfin sodium andsemiconductor laser in patients with malignant brain tumors. J Neurosurg 119(4):845-852,
2013
51. Mizuno T. Installation Condition of Tactile Ground Surface Indicators and Problems inCentral and Eastern Europe. The Asian Journal of Disable Sociology 13:49-63, 2013
52. Nakahara S, Tomio J, Takahashi H, Ichikawa M, Nishida M, Morimura N, Sakamoto T.
Evaluation of pre-hospital administration of adrenaline (epinephrine) by emergency medical
services for patients with out of hospital cardiac arrest in Japan: controlled propensity
matched retrospective cohort study. BMJ 347:f6829, 2013
53. Nakamagoe K, Fujizuka N, Koganezawa T, Shimizu K, Takiguchi S, Horaguchi T, Ishii K,
Tamaoka A. Residual central nervous system damage due to organoarsenic poisoning.
Neurotoxicol Teratol 37:33-38, 2013
54. Nakamagoe K, Fujizuka N, Koganezawa T, Yamaguchi T, Tamaoka A. Downbeat nystagmus
associated with damage to the medial longitudinal fasciculus of the pons: a vestibular balance
control mechanism via the lower brainstem paramedian tract neurons. J Neurol Sci
328(1-2):98-101, 2013
55. Nguyen TNH, Akutsu H, Nouguch iS, Tsunoda T, Sasak iM, Tsurushima H, Matsumura A.
Reversible focal radiological changes due to non-convulsive status epilepticus of the rightparietooccipital lobe. Turk Neurosurg 23(2):278-281, 2013
56. Nishi T, Kurosu A, Sugano Y, Kaminiwa J, Sekine Y, Yano S, Honda K. Application of anovel multiplex polymerase chain reaction system for 12 X-chromosomal short tandem
repeats to a Japanese population study. Leg Med (Tokyo) 15(1):43-6, 2013
57. Nishidate A, NIishimura M, Ajimi A, Mizuno T, Tokuda K. Effect of evacuetion due to theGreat East Japan Earthquake on young children and parents. The Asian Journal of Child
Care 3:15-24, 2013
58. Ono A, Mizuno T. A Child-Care Provider's Cooperation about Children with Developmental
Disorder 2 : Focused on Sending Guidebook and Doing Handover. The Asian Journal of
Disable Sociology 13:17-30, 201365

59. Onuma K, Ishikawa E, Matsuda M, Hirata K, Osuka S, Yamamoto T, Masumoto T,
Zaboronok A, Matsumura A. Clinical characteristics and neuroimaging findings in 12 casesof recurrent glioblastoma with communicating hydrocephalus. Neurol Med Chir (Tokyo)
53(7):474-481, 2013
60. Oshiro Y, Mizumoto M, Okumura T, Sugahara S, Fukushima T, Ishikawa H, Nakao T,
Hashimoto T, Tsuboi K, Ohkawa H, Kaneko M, Sakurai H. Clinical results of proton beam
therapy for advanced neuroblastoma. Radiat Oncol 8(1):142, 2013
61. Oshiro Y, Okumura T, Mizumoto M, Fukushima T, Ishikawa H, Hashimoto T, Tsuboi K,
Kaneko M, Sakurai H. Proton beam therapy for unresectable hepatoblastoma in children:
survival in one case. Acta Oncol 52(3):600-603, 2013
62. Osuka S, Sampetrean O, Shimizu T, Saga I, Onishi N, Sugihara E, Okubo J, Fujita S,
Takano S, Matsumura A, Saya H. IGF1 receptor signaling regulates adaptive radioprotection
in glioma stem cells. Stem Cells 31(4):627-640, 2013
63. Saito I, Yamagishi K, Chei CL, Cui R, Ohira T, Kitamura A, Kiyama M, Imano H, Okada T,
Kato T, Hitsumoto S, Ishikawa Y, Tanigawa T, Iso H. Total and high molecular weightadiponectin levels and risk of cardiovascular disease in individuals with high blood glucose
levels. Atherosclerosis 229(1):222-227, 2013
64. Sakamoto N, Akutsu H, Takano S, Yamamoto T, Matsumura A. Useful 'sliding-lock-knot'
technique for suturing dural patch to prevent cerebrospinal fluid leakage after extended
transsphenoidal surgery. Surg Neurol Int 4:19, 2013
65. Sakamoto N, Ishikawa E, Aoki K, Uemae Y, Komatsu Y, Matsumura A. Clinical OutcomesofIntracerebral

HemorrhageinHemodialysis

Patients.

World

Neurosurgdoi:

10.1016/j.wneu.2013.10.033, 2013
66. Sakamoto T, Ogawa H, Nakao K, Koide S, Yamamoto N, Shimomura H, Matsumura T,
Oshima S, Kikuta K, Oka H, Kimura K, Matsui K. Rationale, design and baselinecharacteristics of a study to evaluate effects of candesartan on cardiovascular events afterdrug-eluting stent implantation in patients with ischemic heart disease. J Atheroscler
Thromb 20(5):472-480, 2013
67. Sandoval Garrido FA, Tamiya N, Kashiwagi M, Miyata S, Okochi J, Moriyama Y, Yamaoka
Y, Takamuku K. Relationship between structural characteristics and outcome quality
indicators at health care facilities for the elderly requiring long-term care in Japan from anationwide survey. Geriatr Gerontol Int doi: 10.1111/ggi.12098, 2013
68. Sato K, Kaikita K, Nakayama N, Horio E, Yoshimura H, Ono T, Ohba K, Tsujita K, Kojima
66

S, Tayama S, Hokimoto S, Matsui K, Sugiyama S, Yamabe H, Ogawa H. Coronary
vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term
prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study
over 20 years. J Am Heart Assoc 2(4):e000227, 2013
69. Sato M, Nakai Y, Tsurushima H, Shiigai M, Masumoto T, Matsumura A. Risk factors ofischemic lesions related to cerebral angiography and neuro-interventional procedures. Neurol
Med Chir (Tokyo) 53(6):381-387, 2013
70. Sato M, Takigawa T, Shiigai M, Tamura G, Masumoto T, Nakai Y, Zaboronok A,
Tsurushima H, Matsumura A. Spinal dural arteriovenous fistula with lipomyelodysplasia.
Neurol Med Chir (Tokyo) 53(2):107-109, 2013
71. Satoh M, Masuhara K, Goldhahn S, Kawaguchi T. Cross-cultural adaptation and validation
reliability, validity of the Japanese version of the Hip disability and Osteoarthritis Outcome
Score (HOOS) in patients with hip osteoarthritis. Osteoarthritis Cartilage 21(4):570-573,
2013
72. Sawa A, Abe T, Omoto M, Fujihara K, Kobayashi H, Tokuda Y. Lactic acidosis with
metformin use in a patient with type 1 diabetes mellitus. General Medicine 14(1):72-75 2013
73. Shimizu Y, Imano H, Ohira T, Kitamura A, Kiyama M, Okada T, Ishikawa Y, Shimamoto T,
Yamagishi K, Tanigawa T, Iso H. Alkaline phosphatase and risk of stroke among Japanese:
the Circulatory Risk in Communities Study (CIRCS). J Stroke Cerebrovasc Dis
22(7):1046-1055, 201374. Sueta D, Kataoka K, Koibuchi N, Toyama K, Uekawa K, Katayama T, Mingjie M,
Nakagawa T, Waki H, Maeda M, Yasuda O, Matsui K, Ogawa H, Kim-Mitsuyama S. Novelmechanism for disrupted circadian blood pressure rhythm in a rat model of metabolic
syndrome--the critical role of angiotensin II. J Am Heart Assoc 2(3):e000035, 2013
75. Takano S, Kimu H, Tsuda K, Osuka S, Nakai K, Yamamoto T, Ishikawa E, Akutsu H,
Matsuda M, Matsumura A. Decrease in the apparent diffusion coefficient in peritumoral
edema for the assessment of recurrent glioblastoma treated by bevacizumab. Acta Neurochir
Suppl 118:185-189, 2013
76. Tokuda K. Childcare provider's and child care researchers' evaluation on the DVD thatvisualized a picture book. The Asian Journal of Child Care 3:1-6, 2013
77. Tokuda K. Vitality in Children who are Sick or have Disabilities. The Asian Journal of
Disable Sociology 13:101-103, 2013
78. Tsuda K, Akutsu H, Yamamoto T, Ishikawa E, Saito A, Nakai K, Takano S, Matsumura A.
67

Benign spinal meningioma without dural attachment presenting delayed CSF disseminationand malignant transformation. Brain Tumor Pathol 30(3):185-191, 2013
79. Tsuda K, Tsurushima H, Takano S, Tsuboi K, Matsumura A. Brain metastasis from papillary
thyroid carcinomas. Molecular and clinical oncology 1(5):817-819, 2013
80. Yamagishi K, Folsom AR, Steffen LM. Plasma fatty acid composition and incident ischemic
stroke in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study.
Cerebrovasc Dis 36(1):38-46, 2013
81. Yamagishi K, Iso H, Kokubo Y, Saito I, Yatsuya H, Ishihara J, Inoue M, Tsugane S. Dietaryintake of saturated fatty acids and incident stroke and coronary heart disease in Japanesecommunities: the JPHC Study. Eur Heart J 34(16):1225-1232, 2013
82. Yamamoto T, Tsuboi K, Nakai K, Kumada H, Sakurai H, Matsumura A. Boron neutron
capture therapy for brain tumors. Transl Cancer Res 2(2):80-86, 2013
83. Yamazaki T, Sonobe M, Kato N, Kasuya H, Ikeda G, Nakamura K, Ito Y, Tsuruta W, Nakai
Y, Matsumura A. Endovascular coiling as the first treatment strategy for ruptured pericallosalartery aneurysms: results, complications, and follow up. Neurol Med Chir (Tokyo)
53(6):409-417, 2013
84. Yatsuya H, Iso H, Yamagishi K, Kokubo Y, Saito I, Suzuki K, Sawada N, Inoue M, Tsugane
S. Development of a point-based prediction model for the incidence of total stroke: Japan
public health center study. Stroke 44(5):1295-1302, 2013
85. Yoshimatsu S, Hossain MI, Islam MM, Chisti MJ, Okada M, Kamoda T, Fukushima T,
Wagatsuma Y, Sumazaki R, Ahmed T. Hypophosphatemia among severely malnourishedchildren with sepsis in Bangladesh. Pediatr Int 55(1):79-84, 2013
86. Zaboronok A, Isobe T, Yamamoto T, Sato E, Takada K, Sakae T, Tsurushima H, Matsumura
A. Proton beam irradiation stimulates migration and invasion of human U87 malignant
glioma cells. J Radiat Res doi: 10.1093/jrr/rrt119, 2013
87. Zaboronok A, Tsurushima H, Yamamoto T, Isobe T, Takada K, Sakae T, Yoshida F,
Matsumura A. Size-dependent radiosensitization effects of gold nanoparticles on humanU251 malignant glioma cells. Nanosci nanotech lett 5(9):9904, 2013	 2) 英文以外の論文
1. 阿久津博義, 高野晋吾, 田中秀峰, 山本哲哉, 村下秀和, 石川栄一, 松村明. Four-hand
technique を 用 い た 内 視 鏡 下 経 鼻 頭 蓋 底 手 術 の 現 状 と 未 来. 日 本 内 分 泌 学 会 雑 誌
89(Suppl.HPT):13-14, 201368

2. 阿久津博義, 増田洋亮, 松村明. ビジウス	
  サージカルシアター	
  脳外科領域で用いられる機器最前線. 脳神経外科速報 23(11):1240-1245, 2013
3. 浅沼徹, 武田文, 朴峠周子, 門間貴史, 香田泰子, 藤原愛子, 木田春代, 増地克之, 岡田弘隆, 酒井利信, 香田郡秀. 大学生武道部員におけるストレス対処力(SOC)とその関連要因. 健康支援 15(2):7-14, 2013
4. 阿部智一. 呼吸管理：神経集中治療に応用可能なエビデンスからの検討. Intensivist
5(3):579-585, 2013
5. 新井清美, 森田展彰, 韮澤博一. プレアルコホリックの認識における変化のプロセス	
 アルコール依存症患者とその家族の語りからの分析. 日本アルコール・薬物医学会雑誌 48(3):198-215, 2013
6. 池田剛, 園部眞, 加藤徳之, 山崎友郷, 粕谷泰道, 中居康展, 松村明. 脳動脈瘤コイル塞栓術 後 の 破 裂 ・ 再 治 療 と Volume Embolization Ratio(VER)の 関 連 性. 脳 卒 中 の 外 科
41(6):440-446, 2013
7. 伊藤嘉朗, 加藤徳之, 中居康展, 松村明, 園部眞. Closed-cell stent を用いた頸動脈ステン
ト 留 置 術 に お け る 頸 動 脈 の 屈 曲 度 と 微 小 脳 塞 栓 の 関 係. JNET: Journal of
Neuroendovascular Therapy 7(2):75-80, 2013
8. 伊藤嘉朗, 加藤徳之, 松村明, 園部眞. ドーナツ型巨大脳動脈瘤に対してコイルとラッ
ピング術を施行した 1 例. 脳神経外科 41(5):415-420, 2013
9. 大脇由紀子, 森田展彰, 大谷保和, 梁京賢, 松山紀子, 藤田教子, 川畠弘子. 消化器内科入院患者におけるアルコール依存症と有害使用の実態および支援に関する研究. 日本ア
ルコール・薬物医学会雑誌 48(2):126-144, 2013
10. 木田春代, 武田文, 荒川義人. 幼稚園における野菜栽培活動の状況とその食育効果	  北
海道某市での調査. 天使大学紀要 13(2):1-11, 2013
11. 塩谷彩子, 詫間浩, 石井亜紀子, 山口清次, 玉岡晃. 緩徐進行性の筋力低下を主訴とし、
ETFDH 遺伝子に変異を認めた成人発症グルタル酸尿症 2 型の 31 歳男性例. 臨床神経学 53(2):167, 201312. 須賀朋子, 森田展彰, 斎藤環. 中学生のための DV 予防教育プログラム開発と効果研
究. 思春期学 31(4):384-393, 201313. 菅原田鶴子, 森田展彰, 中谷陽二. アルコール依存症異性愛評価尺度の開発. 日本アルコール・薬物医学会雑誌 48(5):261-281, 201314. 菅原田鶴子, 森田展彰, 中谷陽二. アルコール依存症者の異性愛と回復について−施設
スタッフの認識調査−. 日本アルコール・薬物医学会雑誌 48(6):389-406	
  2013
15. 菅原田鶴子, 森田展彰, 中谷陽二. 依存症者本人が認識するアルコール依存症に対す
69

るパートナーの態度尺度の作成. 日本アルコール・薬物医学会雑誌 48(6):373-388	
 2013
16. 竹内秀輔, 鈴木涼子, 福島敬, 福島紘子, 岩淵敦, 中尾朋平, 山口玲子, 工藤寿子, 杉田真太朗, 稲留征典, 佐藤豊実, 櫻井英幸, 金子道夫, 須磨崎亮. 進行期卵巣小細胞癌に対して集学的治療を施行した女児例. 日本小児血液・がん学会雑誌 50(2):269-273, 201317. 種田綾乃, 宮城純子, 森田展彰, 中谷陽二. 当事者団体との継続的関わりをもつ住民における精神障害者との関係性構築の過程	
  "臨機応変な対応"の獲得過程に着目して.
日本社会精神医学会雑誌 22(3):381, 2013
18. 玉井紀子, 森田展彰, 大谷保和. 児童養護施設におけるリービングケアに関する研究	
 生活担当職員を対象とした中高生のケアに関する調査. 子どもの虐待とネグレクト
15(1):66-77, 2013
19. 千綿かおる, 武田文, 金久弥生, 高橋由希子. 歯科診療補助内容についての既卒者と 4年制歯科衛生士学生の理解度の比較検討	
 歯科衛生士国家試験出題基準を用いた質問
紙調査. 日本歯科衛生学会雑誌 7(2):49-57, 2013
20. 津田恭治, 阿久津博義, 山本哲哉, 中井啓, 井原哲, 石川栄一, 安田貢, 高野晋吾, 松村
明. 当院で経験した脊髄髄膜腫の治療成績と手術戦略. 脊髄外科 27(1):61-63, 2013
21. 鶴田和太郎, 松丸祐司, 上坂義和, 松村明. 神経放射線診断	
  進行する脊髄症状を呈し、MRI にて上部頸髄に異常を認めた症例. 脳神経外科ジャーナル 22(11):873-877, 2013
22. 乗峯絵理, 石澤不二雄, 本田克也, 関義元, 村松輝夫. 有機リン系農薬スクリーニング用検知管の考案. 中毒研究 26(2):113-114, 2013
23. 原拓真, 阿久津博義, 高野晋吾, 山本哲哉, 鈴木浩明, 松村明. Cushing 病に対する手術
および放射線照射例の長期予後. 日本内分泌学会雑誌 89(Suppl.HPT):63-64, 201324. 福島紘子, 福島敬, 後藤悠大, 田宮裕太郎, 中尾朋平, 吉見愛, 山口玲子, 五味詩絵奈, 鈴木涼子, 清水崇史, 林立申, 長谷川誠, 福島富士子, 中原智子, 須磨崎亮. 血友病児の生活支援における診療連携の役割と課題. 日本小児血液・がん学会雑誌 50(2):227-231, 201325. 藤代準, 小野健太郎, 星野論子, 新開統子, 瓜田泰久, 五藤周, 福島紘子, 福島敬, 金子道夫, 増本幸二. 小児進行副腎皮質癌の 1 例. 日本小児外科学会雑誌 49(2):246-250, 2013
26. 益子良太, 中居康展, 原拓真, 今井資, 松原鉄平, 松田真秀, 上村和也, 小松洋治, 松村明. 錐体骨部特発性内頸動脈解離に対するステント留置術の 1 例. 脳神経外科ジャー
ナル 22(7):557-561, 201327. 松澤明美, 田宮菜奈子, 柏木聖代, 田中竜太, 竹谷俊樹, 野村芳子. 障害者自立支援法導入による在宅障害児・者の母親の養育負担感の変化とその関連要因. 小児保健研究
72(1):54-64, 201328. 松田智行, 田宮菜奈子, 柏木聖代, 森山葉子. 介護保険制度導入前後における在宅サー
70

ビス利用の変化. 日本公衆衛生雑誌 60(9):586-595, 201329. 松原鉄平, 松田真秀, 益子良太, 上村和也, 小松洋治, 松村明. 多発性未破裂脳動脈瘤の経過観察中に生じた新生動脈瘤破裂によるくも膜下出血の 1 例. 脳卒中の外科
41(1):56-59, 201330. 松丸祐司, 原貴行, 松村明. 【血管奇形の基礎と臨床】 脊髄動静脈シャント	
  何が治
せて何が治療困難か. 脳神経外科ジャーナル 22(1):44-51, 201331. 松本俊彦, 松下幸生, 奥平謙一, 成瀬暢也, 長徹二, 武藤岳夫, 芦沢健, 小沼杏坪, 森田展
彰, 猪野亜朗. 物質使用障害患者における自殺の危険因子とその性差	
 年齢、乱用物質の種類、およびうつ病との関連. 精神神経学雑誌 115(7):703-710, 201332. 松山眞知子, 森田展彰, 大谷保和. 精神障害者を持つ親の精神的健康およびこれに関
わ る 要 因 	  精 神 障 害 者 に よ る 親 へ の 虐 待 に 注 目 し て. ア デ ィ ク シ ョ ン と 家 族
29(1):50-59, 2013
33. 三木俊一郎, 山崎友郷, 加藤徳之, 池田剛, 粕谷泰道, 園部眞, 中居康展, 松村明. Double
catheter technique を応用した coil-assist technique で治療を行ったブレブをネック近傍に伴う破裂脳動脈瘤の 1 例. JNET: Journal of Neuroendovascular Therapy 7(3):186-191,
2013
34. 本村美和, 川口孝泰. 中規模病院の看護管理者におけるコンピテンシー評価尺度の開発. 日本看護研究学会雑誌 36(1):61-70, 201335. 門間貴史, 武田文, 角田憲治, 朴峠周子, 浅沼徹, 大藏倫博. 地域高齢者における運動・
ス ポ ー ツ の 実 施 量 と ス ト レ ス 対 処 力(Sense of Coherence)と の 関 連. 厚 生 の 指 標
60(4):14-19, 201336. 門間貴史, 武田文, 香田泰子. 身体障害者施設職員の精神健康に関わる職業要因	  高齢化 の 進 行 す る 身 体 障 害 者 入 所 施 設 に お け る 検 討. 高 齢 者 ケ ア リ ン グ 学 研 究 会 誌
4(1):11-19, 2013
37. 山口哲人, 石井一弘, 河野豊, 玉岡晃. 歩行開始困難を認めた Orthostatic tremor の 75 歳
男性例. 運動障害 23(1):15-19, 2013
38. 山本詞子, 山口哲人, 玉岡晃. 多彩な自己抗体陽性を示した抗グルタミン酸受容体抗体陽性辺縁系脳炎の 1 例. 日本内科学会雑誌 102(8):2057-2059, 20133) 英文の著書
1. Olivares-Tirado P, Tamiya N. Trends and Factors in Japan's Long-Term Care Insurance
System: Japan's 10-year Experience. Springer (New York), 2013 (138 pages)
2. Tsuruta W, Yamamoto T, Matsumura A. 30. Prevention of vascular restenosis after vascular71

angioplasty; in "Neutron Capture Therapy" (edited by Sauerwein W, Wittig A, Moss R,
Nakagawa Y), Springer Berlin Heidelberg (Berlin) 2013; pp377-388

4) 英文以外の著書
1. "ユニバーサルデザインとバリアフリーの図鑑 (第 1 版)” (監修	  徳田克己), ポプラ社
(東京) 2013
2. "気になる子の保育のための絵カードセット (第 1 版)” (監修	  徳田克己, 水野智美, 大越和美), チャイルド本社 (東京) 2013
3. "気になる子の保育のためのスケジュールカードセット (第 1 版)” (監修	  徳田克己, 水野智美, 大越和美), チャイルド本社 (東京) 2013
4. "運動あそび・感覚あそび	  その具体的な指導法 (第 1 版)” (監修	  徳田克己, 西館有沙,澤江幸則), チャイルド本社 (東京) 2013
5.「自己抗体陽性女性の妊娠管理指針の作成及び新生児ループスの発症リスクの軽減に関する研究」研究班. "抗 SS-A 抗体陽性女性の妊娠に関する診療の手引き (第 1 版)” (編集 村島温子, 福嶋恒太郎, 穴見愛, 堀米仁志, 前野泰樹, 山岸良匡, 坪井洋人, 岸本暢将),
国立成育医療研究センター母性医療診療部 (東京) 2013; pp1-16
6. 筑西市健康副読本編集委員. "筑西市健康副読本：めざせ！ず〜っとけんこう！！ (第7 版)” (編集 磯博康, 山岸良匡), 筑西市 (筑西) 2013; pp1-30
7. 川口孝泰, 佐藤政枝, 小西美和子. 1、2-2、2-5、3-1、3-3、4-1. 看護援助の基礎のキソ、
コミュニケーション、安全安楽、食べる、活動する・運動する、実践の学としての看
護; "看護援助の基礎のキソ (第 1 版)” (編著), 医学書院 (東京) 2013; pp1-12、25-34、58-66、89-98、134-145
8. 武田文, 茨木尚子, 門間貴史. 第 3 章. 身体障害者ケアワーカーのウェルビーイングと労動; "ヒューマン・セキュリティー／ヒューマン・ケアの視点から (第 1 版)” (編集 松田ひとみ, 大久保一郎, 柏木志保), 医学評論社 (東京) 2013; pp41-52
9. 玉岡晃. PART 4. アルツハイマー病の症状、検査、診断. アルツハイマー病による認知症の診断; "からだの科学 (2013 SUMMAR)” (編集 山田正仁), 日本評論社 (東京) 2013;
pp27878-27883
10. 玉岡晃. J. 神経・精神・運動器疾患. Alzheimer 病; "イヤーノート TOPICS	  2013-2014	
 内科・外科疾患 (第 3 版)” (編集 岡庭豊, 荒瀬康司, 三角和雄), MEDICMEDIA (東京)2013; pp296-298
11. 玉岡晃. II. 本年の動向. 新しいアルツハイマー病の診断基準; "Annual Review 2013	
 神経” (編集 鈴木則宏, 祖父江元, 荒木信夫, 宇川義一, 川原信隆), 中外医学社 (東京)722013; pp81-91
12. 玉岡晃. 第 14 章. 代謝性疾患. 葉酸欠乏; "今日の神経疾患治療指針 (第 2 版)” (編集 水澤英洋, 鈴木則宏, 梶龍兒, 吉良潤一, 神田隆, 斉藤延人), 医学書院 (東京) 2103
pp761-763
13. 田宮菜奈子, 松澤明美. 第 3 部. 13. 要介護者の状況改善と介護家族の負担軽減に向けたインフラ整備−日本初の全国レベルの実証的取り組みの結果から―; "家族のための総合政策―家族と職業の両立― (第 1 版)” (編集 本澤巳代子, ウタ・マイヤー＝グレーヴェ), 信山社 (東京) 2013; pp235-246
14. 田宮菜奈子, 宮下裕美子. 第 7 章. グローバルエイジング : アジアの一員として; "ヒューマン・セキュリティ : ヒューマン・ケアの視点から (第 1 版)” (編集 松田ひとみ, 大久保一郎, 岩浅昌幸, 柏木志保), 医学評論社 (東京) 2013; pp122-136
15. 徳田克己, 水野智美. 世界の物乞い障害者と子どもの物乞い. 子ども支援研究所(茨城) 2013 年 (全 32 ページ)
16. 本澤巳代子. 第 3 部 10. 家族関係における暴力・虐待に対する日本の立法と対策の特徴	
  -秒力・虐待防止法制に関する比較法的研究; "家族のための総合政策 Ⅲ-家族と職業の両立 (第 1 版)” (編集 本澤巳代子, ウタ・マイヤー=グレーヴェ), 信山社 (東京)2013; pp185-202
17. 本澤巳代子. 2.11. 介護保障、社会保障; "トピック社会保障法 (第 7 版)” (編集 本澤巳代子, 新田秀樹), 不磨書房 (東京) 2013; pp25-47、241-255
18. 本田克也. 特別企画. ＤＮＡ鑑定の有用性と課題; "刑事弁護” (編集 成澤壽信), 現代人
文社 (東京) 2013; pp109-120
19. 松村明, 松田真秀. 脳神経外科分野における陽子線治療の適用; "定位放射線治療 17(編集 好本裕平), 定位放射線学会 (東京) 2013; pp11-19
20. 松村明, 山本哲哉. 小児脳腫瘍に対する放射線治療; " 小児脳神経外科診療ガイドブ
ック (第 1 版)” (編集 新井一, 伊達裕昭, 西本博) メジカルビュー社 (東京) 2013;
pp14-21
21. 水野智美. 第 1 章 4. うまく遊べない理由と遊び支援のコツ; "運動あそび・感覚あそび	  その具体的な指導法 (第 1 版)” (編監修	  徳田克己, 西館有沙, 澤江幸則), チャイル
ド本社 (東京) 2013; pp18-32
22. 水野智美, 徳田克己. 12. 教育. 特別支援教育; "最新	  心理学事典(第 1 版)” (監修	  藤永保), 平凡社 (東京) 2013; pp563-564
23. 森田展彰. 第 28 章. 親が暴力をふるう; "中高生のためのメンタル系サバイバルガイ
ト (第 1 版)” (編集 松本俊彦), 日本評論社 (東京) 2013; pp179-183
7324. 森田展彰. 第 6 章４. 暴力などのトラウマ問題を抱えた薬物依存症者に対する治療; "依存と嗜癖: どう理解し,どう対処するか (第 1 版)” (編集 和田清), 医学書院 (東京)2013; pp35-40
25. 森田展彰. 第 5 章. 家庭内の暴力に関する安全保障-ドメスティックバイオレンスに対する包括的対応; "ヒューマン・セキュリティ-ヒューマン・ケアの視点から (第 1 版)”(編集 松田ひとみ, 大久保一郎, 岩浅昌幸, 柏木志保), 医学評論社 (東京) 2013; pp65-82
26. 森田展彰. 【物質使用障害とアディクション	
  臨床ハンドブック】 (第 V 部) 物質使
用障害とアディクションをめぐる様々な問題	
 地域支援に際して無視できない問題	
 ア
ルコール・薬物依存症と子育て支援・児童虐待防止; "精神科治療学 28(増刊) ” 2013;
pp407-411
27. 森田展彰. 【精神保健・医療・福祉の今がわかる	 キーワード 126】 (第 2 章) 当事者・
家 族 の 力 	  ア ノ ニ マ ス グ ル ー プ/AA/NA/SA; "精 神 科 臨 床 サ ー ビ ス 13(2)”2013;pp172-173
28. 山岸良匡, 磯博康. 3-1. 魚をたべると心筋梗塞が減る？：疫学的根拠; "そうだったんだ！脂肪酸：循環器疾患との深い関係 (第 1 版)” (編集 伊藤浩), 文光堂 (東京) 2013;
pp34-3929. 山本詞子, 石井亜紀子, 玉岡晃. 小児-9. 骨格筋画像検査が診断に有用であった小児型
ポンぺ病の 1 例; "ポンぺ病症例集	
  早期診断・早期治療のために (第 1 版)” (編集 埜中征哉), Medical Tribune (東京) 2013; pp60-6474生体機能制御・再生研究グループ	 1) 英文論文
1. Akimoto K, Kimura K, Nagano M, Takano S, To'a Salazar G, Yamashita T, Ohneda O.
Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived
mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells Dev
22(9):1370-1386, 2013
2. Aoki T, Nishikawa R, Sugiyama K, Nonoguchi N, Kawabata N, Mishima K, Adachi JI,
Kurisu K, Yamasaki F, Tominaga T, Kumabe T, Ueki K, Higuchi F, Yamamoto T, Ishikawa E,
Takeshima H, Yamashita S, Arita K, Hirano H, Yamada S, Matsutani M. A Multicenter Phase
I/II Study of the BCNU Implant (Gliadel Wafer) for Japanese Patients with Malignant
Gliomas. Neurol Med Chir (Tokyo) doi:10.2176/nmc.oa2013-0112, 2013	  	 3. Bodhak S, Kikuchi M, Sogo Y, Tsurushima H, Ito A, Oyane A. Calcium phosphate coating on
a bioresorbable hudroxyapatite/collagen nanocomposite for surface functionalization. Chem
Lett 42:1029-1031, 2013
4. Hara T, Akutsu H, Yamamoto T, Ishikawa E, Matsuda M, Matsumura A. Cushing’s disease
presenting with gastrointestinal perforation: a case report. Endocrinology, diabetes andmetabolism. Case reports Nov:1-4, 2013
5. Hara T, Matsuda M, Watanabe S, Nakai K, Yamamoto T, Matsumura A. Remote cerebellar
hemorrhage after removal of a supratentorial glioma without perioperative CSF loss: A casereport. Case Rep Surg 2013:305039, 2013
6. Horiguchi Y, Miyachi S, Nagasaki Y. High-performance surface acoustic wave
immunosensing system on a PEG/aptamer hybridized surface. Langmuir 29(24):7369-7376,
2013
7. Hossain MA, Ikeda Y, Hara T, Nagasaki Y. Novel biocompatible nanoreactor for silica/gold
hybrid nanoparticles preparation. Colloids Surf B Biointerfaces 102:778-782, 2013
8. Ikeda Y, Katamachi J, Kawasaki H, Nagasaki Y. Novel protein PEGylation chemistry via
glutalaldehyde-functionalized PEG. Bioconjug Chem 24(11):1824-1827, 2013
9. Ikeda Y, Kawasaki H, Ichinohe S, Nagasaki Y. Facile solid-phase synthesis of a highly stablepoly(ethylene glycol)-oligonucleotide conjugate. Journal of Materials Chemistry B
1:529-535, 2013
10. Ikeda Y, Kubota D, Nagasaki Y. Design of sugar-oligonucleotide conjugates installed gold
nanoparticle for effective delivery to hepatic parenchymal cells. Colloid and Polymer
Science 291(12):2959-2964, 201375

11. Ito Y, Kato N, Matsumura A, Sonobe M. Hemodynamic instability increases new ischemic
brain lesions on diffusion-weighted imaging after carotid artery stenting. Neurol Med Chir
(Tokyo) 53(6):375-380, 2013
12. Ito Y, Tsurushima H, Sato M, Ito A, Oyane A, Sogo Y, Matsumura A. Angiogenesis therapy
for brain infarction using a slow-releasing drug delivery system for fibroblast growth factor
2. Biochem Biophys Res Commun 432(1):182-187, 2013
13. Kamimura M, Furukawa T, Akiyama S, Nagasaki Y. pH-sensitive doxorubicin/poly(ethylene
glycol)-block-poly(4-vinylbenzylphosphonate) nanoparticles in multi-drug resistant humanepidermoid KB carcinoma cells. Biomaterials Science 1(4):361-367, 2013
14. Kin H, Ishikawa E, Takano S, Ayuzawa S, Matsushita A, Muragaki Y, Aiyama H, Sakamoto
N, Yamamoto T, Matsumura A. Language areas involving the inferior temporal cortex on
intraoperative mapping in a bilingual patient with glioblastoma. Neurol Med Chir (Tokyo)
53(4):256-258, 2013
15. Lakshmipriya T, Fujimaki M, Gopinath SC, Awazu K, Horiguchi Y, Nagasaki Y. A
high-performance waveguide-mode biosensor for detection of factor IX using PEG-based
blocking agents to suppress non-specific binding and improve sensitivity. Analyst
138(10):2863-2870, 2013
16. Matsubara T, Ayuzawa S, Aoki T, Fujimoto A, Osuka S, Matsumura A. The patient had anormal magnetic resonance imaging and temporal lobe epilepsy secondaru to a porencephaliccyst but showed structural lesions (hippocampal sclerosis). Epilepsy & Behavior Case
Reports 1:153-156, 2013
17. Matsubara T, Ayuzawa S, Aoki T, Ikeda G, Shiigai M, Matsumura A. Cerebral Venous
Thrombosis after Ventriculoperitoneal Shunting: A Case Report. Neurol Med Chir (Tokyo)
doi:10.2176/nmc.cr.2012-0312, 2013
18. Matsubara T, Ishikawa E, Hirata K, Matsuda M, Akutsu H, Masumoto T, Zaboronok A,
Matsumura A. A New Mechanism of Cerebrospinal Fluid Leakage after Lumboperitoneal
Shunt: A Theory of Shunt Side Hole-Case Report. Neurol Med Chir (Tokyo)
doi:10.2176/nmc.cr.2013-0067, 2013
19. Mizumoto M, Okumura T, Ishikawa E, Yamamoto T, Takano S, Matsumura A, Oshiro Y,
Ishikawa H, Sakurai H, Tsuboi K. Reirradiation for recurrent malignant brain tumor withradiotherapy or proton beam therapy. Technical considerations based on experience at asingle institution. Strahlenther Onkol 189(8):656-663, 2013
20. Muragaki Y, Akimoto J, Maruyama T, Iseki H, Ikuta S, Nitta M, Maebayashi K, Saito T,76

Okada Y, Kaneko S, Matsumura A, Kuroiwa T, Karasawa K, Nakazato Y, Kayama T. Phase II
clinical study on intraoperative photodynamic therapy with talaporfin sodium andsemiconductor laser in patients with malignant brain tumors. J Neurosurg 119(4):845-852,
2013
21. Nakajima J, Hitomi S, Koganemaru H, Nakai Y. Isolation of Staphylococcus epidermidis
intermediately resistant to vancomycin in a case of central venous catheter-associatedbloodstream infection. J Infect Chemother 19(5):983-986, 2013
22. Nguyen TNH, Akutsu H, Nouguch iS, Tsunoda T, Sasak iM, Tsurushima H, Matsumura A.
Reversible focal radiological changes due to non-convulsive status epilepticus of the rightparietooccipital lobe. Turk Neurosurg 23(2):278-281, 2013
23. Onuma K, Ishikawa E, Matsuda M, Hirata K, Osuka S, Yamamoto T, Masumoto T,
Zaboronok A, Matsumura A. Clinical characteristics and neuroimaging findings in 12 casesof recurrent glioblastoma with communicating hydrocephalus. Neurol Med Chir (Tokyo)
53(7):474-481, 2013
24. Osuka S, Sampetrean O, Shimizu T, Saga I, Onishi N, Sugihara E, Okubo J, Fujita S, Takano
S, Matsumura A, Saya H. IGF1 receptor signaling regulates adaptive radioprotection inglioma stem cells. Stem Cells 31(4):627-640, 2013
25. Oyane A, Araki H, Sogo Y, Ito A, Tsurushima H. Spontaneous assembly of DNA-amorphous
calcium phosphate nanocomposite spheres for surface-mediated genetransfer. Cryst Eng
Comm 15(25):4994-4997, 2013
26. Pua ML, Yoshitomi T, Chonpathompikunlert P, Hirayama A, Nagasaki Y. Redox-active
injectable gel using thermo-responsive nanoscale polyion complex flower micelle fornoninvasive treatment of local inflammation. J Control Release 172(3):914-920, 2013
27. Sakamoto N, Akutsu H, Takano S, Yamamoto T, Matsumura A. Useful 'sliding-lock-knot'
technique for suturing dural patch to prevent cerebrospinal fluid leakage after extended
transsphenoidal surgery. Surg Neurol Int 4:19, 2013
28. Sakamoto N, Ishikawa E, Aoki K, Uemae Y, Komatsu Y, Matsumura A. Clinical OutcomesofIntracerebral

HemorrhageinHemodialysis

Patients.

World

Neurosurgdoi:

10.1016/j.wneu.2013.10.033, 2013
29. Sato M, Nakai Y, Tsurushima H, Shiigai M, Masumoto T, Matsumura A. Risk factors ofischemic lesions related to cerebral angiography and neuro-interventional procedures. Neurol
Med Chir (Tokyo) 53(6):381-387, 2013
30. Sato M, Takigawa T, Shiigai M, Tamura G, Masumoto T, Nakai Y, Zaboronok A,
77

Tsurushima H, Matsumura A. Spinal dural arteriovenous fistula with lipomyelodysplasia.
Neurol Med Chir (Tokyo) 53(2):107-109, 201331. Sha S, Vong LB, Chonpathompikunlert P, Yoshitomi T, Matsui H, Nagasaki Y. Suppressionof NSAID-induced small intestinal inflammation by orally administered redox nanoparticles.
Biomaterials 34(33):8393-8400, 2013
32. Shashni B, Sakharkar KR, Nagasaki Y, Sakharkar MK. Glycolytic enzymes PGK1 andPKM2 as novel transcriptional targets of PPARgamma in breast cancer pathophysiology. J
Drug Target 21(2):161-174, 2013
33. Shashni B, Sharma K, Singh R, Sakharkar KR, Dhillon SK, Nagasaki Y, Sakharkar MK.
Coffee component Hydroxyl Hydro Quinone (HHQ) as a novel ligand for PPAR gamma andimplications for breast cancer. BMC (BioMedCentral) Genomics 14(Suppl 5):S6, 2013
34. Takano S, Kimu H, Tsuda K, Osuka S, Nakai K, Yamamoto T, Ishikawa E, Akutsu H,
Matsuda M, Matsumura A. Decrease in the apparent diffusion coefficient in peritumoral
edema for the assessment of recurrent glioblastoma treated by bevacizumab. Acta Neurochir
Suppl 118:185-189, 2013
35. Tsuda K, Akutsu H, Yamamoto T, Ishikawa E, Saito A, Nakai K, Takano S, Matsumura A.
Benign spinal meningioma without dural attachment presenting delayed CSF disseminationand malignant transformation. Brain Tumor Pathol 30(3):185-191, 2013
36. Tsuda K, Tsurushima H, Takano S, Tsuboi K, Matsumura A. Brain metastasis from papillary
thyroid carcinomas. Molecular and clinical oncology 1:817-819, 2013
37. Wang X, Ito A, Sogo Y, Hirose M, Oyane A, Tsurushima H. DNA-lipid-apatitie composite
layers enhance gene expression of mesenchymal stem cells. Mat Sci Eng C 33:512-518,
2013
38. Yamamoto T, Tsuboi K, Nakai K, Kumada H, Sakurai H, Matsumura A. Boron neutron
capture therapy for brain tumors. Transl Cancer Res 2:80-86, 2013
39. Yamazaki T, Sonobe M, Kato N, Kasuya H, Ikeda G, Nakamura K, Ito Y, Tsuruta W, Nakai
Y, Matsumura A. Endovascular coiling as the first treatment strategy for ruptured pericallosalartery aneurysms: results, complications, and follow up. Neurol Med Chir (Tokyo)
53(6):409-417, 2013
40. Yoshitomi T, Ozaki Y, Thangavel S, Nagasaki Y. Redox nanoparticle therapeutics tocancer--increase in therapeutic effect of doxorubicin, suppressing its adverse effect. J
Control Release 172(1):137-143, 2013
41. Zaboronok A, Isobe T, Yamamoto T, Sato E, Takada K, Sakae T, Tsurushima H, Matsumura
78

A. Proton beam irradiation stimulates migration and invasion of human U87 malignant
glioma cells. J Radiat Res doi: 10.1093/jrr/rrt119, 2013
42. Zaboronok A, Tsurushima H, Yamamoto T, Isobe T, Takada K, Sakae T, Yoshida F,
Matsumura A. Size-dependent radiosensitization effects of gold nanoparticles on humanU251 malignant glioma cells. Nanosci nanotech lett 5(9):9904, 2013	 2) 英文以外の論文
1. 阿久津博義. 【手術室で、今、有用な画像診断装置】 臨床効果を具体的に示す	
  術中MRI 手術システムの現況・有用性と機器上の要件. 新医療 40(10):106-109, 2013
2. 阿久津博義. 【先端医療技術に対応する病院建築】 術中 MRI 統合システム. 医療福祉
建築 180:12, 2013
3. 阿久津博義, 高野晋吾, 田中秀峰, 山本哲哉, 村下秀和, 石川栄一, 松村明. Four-hand
technique を 用 い た 内 視 鏡 下 経 鼻 頭 蓋 底 手 術 の 現 状 と 未 来. 日 本 内 分 泌 学 会 雑 誌
89(Suppl.HPT):13-14, 2013
4. 阿久津博義, 増田洋亮, 松村明. ビジウス	
  サージカルシアター	
  脳外科領域で用いられる機器最前線. 脳神経外科速報 23(11):1240-1245, 2013
5. 池田剛, 園部眞, 加藤徳之, 山崎友郷, 粕谷泰道, 中居康展, 松村明. 脳動脈瘤コイル塞栓術 後 の 破 裂 ・ 再 治 療 と Volume Embolization Ratio(VER)の 関 連 性. 脳 卒 中 の 外 科
41(6):440-446, 2013
6. 伊藤嘉朗, 加藤徳之, 中居康展, 松村明, 園部眞. Closed-cell stent を用いた頸動脈ステン
ト 留 置 術 に お け る 頸 動 脈 の 屈 曲 度 と 微 小 脳 塞 栓 の 関 係. JNET: Journal of
Neuroendovascular Therapy 7(2):75-80, 2013
7. 伊藤嘉朗, 加藤徳之, 松村明, 園部眞. ドーナツ型巨大脳動脈瘤に対してコイルとラッ
ピング術を施行した 1 例. 脳神経外科 41(5):415-420, 2013
8. 小松洋治. 目で見るシリーズ	
  頭部 CT	  早すぎる搬送は観察が必要. 日立医学会誌
52(1):47-48, 2013
9. 小松洋治, 中村和弘, 伊藤嘉朗, 益子良太, 上村和也, 松村明. 【光線力学診断・治療の最新動向】 脳神経外科手術におけるインドシアニングリーン術中蛍光血管撮影の有用性と課題. 日本レーザー医学会誌 34(2):141-147, 2013
10. 津田恭治, 阿久津博義, 山本哲哉, 中井啓, 井原哲, 石川栄一, 安田貢, 高野晋吾, 松村
明. 当院で経験した脊髄髄膜腫の治療成績と手術戦略. 脊髄外科 27(1):61-63, 201311. 鶴田和太郎, 松丸祐司, 上坂義和, 松村明. 神経放射線診断	
  進行する脊髄症状を呈し、MRI にて上部頸髄に異常を認めた症例. 脳神経外科ジャーナル 22(11):873-877, 201379

12. 原拓真, 阿久津博義, 高野晋吾, 山本哲哉, 鈴木浩明, 松村明. Cushing 病に対する手術
および放射線照射例の長期予後. 日本内分泌学会雑誌 89(Suppl.HPT):63-64, 2013
13. 益子良太, 中居康展, 原拓真, 今井資, 松原鉄平, 松田真秀, 上村和也, 小松洋治, 松村明. 錐体骨部特発性内頸動脈解離に対するステント留置術の 1 例. 脳神経外科ジャー
ナル 22(7):557-561, 2013
14. 増本智彦, 椎貝真成, 檜山貴志. 【神経集中治療】 神経学的所見と画像診断	
  撮像法と脳解剖の知識をベースとした画像診断に向けて. Intensivist 5(3):493-506, 201315. 松原鉄平, 松田真秀, 益子良太, 上村和也, 小松洋治, 松村明. 多発性未破裂脳動脈瘤の経過観察中に生じた新生動脈瘤破裂によるくも膜下出血の 1 例. 脳卒中の外科
41(1):56-59, 201316. 松丸祐司, 原貴行, 松村明. 【血管奇形の基礎と臨床】 脊髄動静脈シャント	
  何が治
せて何が治療困難か. 脳神経外科ジャーナル 22(1):44-51, 2013
17. 三木俊一郎, 山崎友郷, 加藤徳之, 池田剛, 粕谷泰道, 園部眞, 中居康展, 松村明. Double
catheter technique を応用した coil-assist technique で治療を行ったブレブをネック近傍に伴う破裂脳動脈瘤の 1 例. JNET: Journal of Neuroendovascular Therapy 7(3):186-191,
2013

	
 
4) 英文以外の著書
1. 松村明, 松田真秀. 第 1 章. 脳神経外科分野における陽子線治療の適用; "定位的放射線治療 17 (第１版)” (編集	  新井一、伊達裕昭、西本博), メジカルビュー社 (東京) 2013;
pp11-19
2. 松村明, 山本哲哉. 第 1 章. 小児脳腫瘍に対する放射線治療; " 小児脳神経外科診療ガイドブック (第 1 版)” (編集	  新井一、伊達裕昭、西本博) メジカルビュー社 (東京) 2013;
pp14-2180

筑波発ナノ粒子の包括的臨床応用	 1) 英文論文
1. Akashi Y, Oda T, Ohara Y, Miyamoto R, Hashimoto S, Enomoto T, Yamada K, Kobayashi A,
Fukunaga K, Ohkochi N. Histological advantages of the tumor graft: a murine model
involving transplantation of human pancreatic cancer tissue fragments. Pancreas
42(8):1275-1282, 2013
2. Bodhak S, Kikuchi M, Sogo Y, Tsurushima H, Ito A, Oyane A. Calcium phosphate coating on
a bioresorbable hudroxyapatite/collagen nanocomposite for surface functionalization. Chem
Lett 42:1029-1031, 2013
3 Hara T, Akutsu H, Yamamoto T, Ishikawa E, Matsuda M, Matsumura A. Cushing’s disease
presenting with gastrointestinal perforation: a case report. Endocrinology, diabetes andmetabolism. Case reports Nov:1-4, 2013
4. Hara T, Matsuda M, Watanabe S, Nakai K, Yamamoto T, Matsumura A. Remote cerebellar
hemorrhage after removal of a supratentorial glioma without perioperative CSF loss: A casereport. Case Rep Surg 2013:305039, 2013
5. Horiguchi Y, Miyachi S, Nagasaki Y. High-performance surface acoustic wave
immunosensing system on a PEG/aptamer hybridized surface. Langmuir 29(24):7369-7376,
2013
6. Hossain MA, Ikeda Y, Hara T, Nagasaki Y. Novel biocompatible nanoreactor for silica/gold
hybrid nanoparticles preparation. Colloids Surf B Biointerfaces 102:778-782, 2013
7. Ikeda Y, Katamachi J, Kawasaki H, Nagasaki Y. Novel protein PEGylation chemistry via
glutalaldehyde-functionalized PEG. Bioconjug Chem 24(11):1824-1827, 2013
8. Ikeda Y, Kawasaki H, Ichinohe S, Nagasaki Y. Facile solid-phase synthesis of a highly stablepoly(ethylene glycol)-oligonucleotide conjugate. Journal of Materials Chemistry B
1:529-535, 2013
9. Ikeda Y, Kubota D, Nagasaki Y. Design of sugar-oligonucleotide conjugates installed gold
nanoparticle for effective delivery to hepatic parenchymal cells. Colloid and Polymer
Science 291(12):2959-2964, 2013
10. Indo HP, Nakanishi I, Yen HC, Nyui M, Manda S, Matsumoto K, Anzai K, Ikota N, Matsui
H, Minamiyama Y, Nakajima A, Ichikawa I, Ozawa T, Mukai C, Majima HJ. Comparison of
in Vivo and in Vitro Antioxidative Parameters for Eleven Food Factors.,. RSC Adv
3:4535-4538, 2013
11. Ito Y, Kato N, Matsumura A, Sonobe M. Hemodynamic instability increases new ischemic81

brain lesions on diffusion-weighted imaging after carotid artery stenting. Neurol Med Chir
(Tokyo) 53(6):375-380, 2013
12. Ito Y, Tsurushima H, Sato M, Ito A, Oyane A, Sogo Y, Matsumura A. Angiogenesis therapy
for brain infarction using a slow-releasing drug delivery system for fibroblast growth factor
2. Biochem Biophys Res Commun 432(1):182-187, 2013
13. Kamimura M, Furukawa T, Akiyama S, Nagasaki Y. pH-sensitive doxorubicin/poly(ethylene
glycol)-block-poly(4-vinylbenzylphosphonate) nanoparticles in multi-drug resistant humanepidermoid KB carcinoma cells. Biomaterials Science 1(4):361-367, 2013
14. Kin H, Ishikawa E, Takano S, Ayuzawa S, Matsushita A, Muragaki Y, Aiyama H, Sakamoto
N, Yamamoto T, Matsumura A. Language areas involving the inferior temporal cortex on
intraoperative mapping in a bilingual patient with glioblastoma. Neurol Med Chir (Tokyo)
53(4):256-258, 2013
15. Lakshmipriya T, Fujimaki M, Gopinath SC, Awazu K, Horiguchi Y, Nagasaki Y. A
high-performance waveguide-mode biosensor for detection of factor IX using PEG-based
blocking agents to suppress non-specific binding and improve sensitivity. Analyst
138(10):2863-2870, 2013
16. Maruyama T, Murata S, Takahashi K, Tamura T, Nozaki R, Ikeda N, Fukunaga K, Oda T,
Sasaki R, Ohkohchi N. Platelet transfusion improves liver function in patients with chronic
liver disease and cirrhosis. Tohoku J Exp Med 229(3):213-220, 2013
17. Matsubara T, Ayuzawa S, Aoki T, Fujimoto A, Osuka S, Matsumura A. The patient had anormal magnetic resonance imaging and temporal lobe epilepsy secondaru to a porencephaliccyst but showed structural lesions (hippocampal sclerosis). Epilepsy & Behavior Case
Reports 1:153-156, 2013
18. Matsubara T, Ayuzawa S, Aoki T, Ikeda G, Shiigai M, Matsumura A. Cerebral Venous
Thrombosis after Ventriculoperitoneal Shunting: A Case Report. Neurol Med Chir (Tokyo)
doi:10.2176/nmc.cr.2012-0312, 2013	 19. Matsubara T, Ishikawa E, Hirata K, Matsuda M, Akutsu H, Masumoto T, Zaboronok A,
Matsumura A. A New Mechanism of Cerebrospinal Fluid Leakage after Lumboperitoneal
Shunt: A Theory of Shunt Side Hole-Case Report. Neurol Med Chir (Tokyo)
doi:10.2176/nmc.cr.2013-0067, 2013
20. Mizumoto M, Okumura T, Ishikawa E, Yamamoto T, Takano S, Matsumura A, Oshiro Y,
Ishikawa H, Sakurai H, Tsuboi K. Reirradiation for recurrent malignant brain tumor withradiotherapy or proton beam therapy. Technical considerations based on experience at a82

single institution. Strahlenther Onkol 189(8):656-663, 2013
21. Muragaki Y, Akimoto J, Maruyama T, Iseki H, Ikuta S, Nitta M, Maebayashi K, Saito T,
Okada Y, Kaneko S, Matsumura A, Kuroiwa T, Karasawa K, Nakazato Y, Kayama T. Phase II
clinical study on intraoperative photodynamic therapy with talaporfin sodium andsemiconductor laser in patients with malignant brain tumors. J Neurosurg 119(4):845-852,
2013
22. Nguyen TNH, Akutsu H, Nouguch iS, Tsunoda T, Sasak iM, Tsurushima H, Matsumura A.
Reversible focal radiological changes due to non-convulsive status epilepticus of the rightparietooccipital lobe. Turk Neurosurg 23(2):278-281, 2013
23. Ogawa K, Kondo T, Tamura T, Matsumura H, Fukunaga K, Oda T, Ohkohchi N. Influenceof Kupffer cells and platelets on ischemia-reperfusion injury in mild steatotic liver. World J
Gastroenterol 19(9):1396-1404, 2013
24. Ohara Y, Oda T, Sugano M, Hashimoto S, Enomoto T, Yamada K, Akashi Y, Miyamoto R,
Kobayashi A, Fukunaga K, Morishita Y, Ohkohchi N. Histological and prognostic importanceof CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer. Cancer Sci
104(8):1127-1134, 2013
25. Onuma K, Ishikawa E, Matsuda M, Hirata K, Osuka S, Yamamoto T, Masumoto T,
Zaboronok A, Matsumura A. Clinical characteristics and neuroimaging findings in 12 casesof recurrent glioblastoma with communicating hydrocephalus. Neurol Med Chir (Tokyo)
53(7):474-481, 2013
26. Oshiro Y, Sasaki R, Fukunaga K, Kondo T, Oda T, Takahashi H, Ohkohchi N.
Inflammation-based prognostic score is a useful predictor of postoperative outcome inpatients with extrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 20(3):389-395,
2013
27. Osuka S, Sampetrean O, Shimizu T, Saga I, Onishi N, Sugihara E, Okubo J, Fujita S, Takano
S, Matsumura A, Saya H. IGF1 receptor signaling regulates adaptive radioprotection inglioma stem cells. Stem Cells 31(4):627-640, 2013
28. Oyane A, Araki H, Sogo Y, Ito A, Tsurushima H. Spontaneous assembly of DNA-amorphous
calcium phosphate nanocomposite spheres for surface-mediated genetransfer. Cryst Eng
Comm 15(25):4994-4997, 2013
29. Pua ML, Yoshitomi T, Chonpathompikunlert P, Hirayama A, Nagasaki Y. Redox-active
injectable gel using thermo-responsive nanoscale polyion complex flower micelle fornoninvasive treatment of local inflammation. J Control Release 172(3):914-920, 201383

30. Saito R, Suzuki H, Yamada T, Endo S, Moriwaki T, Ueno T, Hirose M, Hirai S, Yamato K,
Mizokami Y, Hyodo I. Predicting skin toxicity according to EGFR polymorphisms inpatients with colorectal cancer receiving antibody against EGFR. Anticancer Res
33(11):4995-4998, 201331. Sakamoto N, Akutsu H, Takano S, Yamamoto T, Matsumura A. Useful 'sliding-lock-knot'
technique for suturing dural patch to prevent cerebrospinal fluid leakage after extended
transsphenoidal surgery. Surg Neurol Int doi: 10.4103/2152-7806.107546, 2013
32. Sakamoto N, Ishikawa E, Aoki K, Uemae Y, Komatsu Y, Matsumura A. Clinical OutcomesofIntracerebral

HemorrhageinHemodialysis

Patients.

World

Neurosurgdoi:

10.1016/j.wneu.2013.10.033, 2013
33. Sato M, Nakai Y, Tsurushima H, Shiigai M, Masumoto T, Matsumura A. Risk factors ofischemic lesions related to cerebral angiography and neuro-interventional procedures. Neurol
Med Chir (Tokyo) 53(6):381-387, 201334. Sato M, Takigawa T, Shiigai M, Tamura G, Masumoto T, Nakai Y, Zaboronok A,
Tsurushima H, Matsumura A. Spinal dural arteriovenous fistula with lipomyelodysplasia.
Neurol Med Chir (Tokyo) 53(2):107-109, 201335. Sha S, Vong LB, Chonpathompikunlert P, Yoshitomi T, Matsui H, Nagasaki Y. Suppressionof NSAID-induced small intestinal inflammation by orally administered redox nanoparticles.
Biomaterials 34(33):8393-8400, 2013
36. Shashni B, Sakharkar KR, Nagasaki Y, Sakharkar MK. Glycolytic enzymes PGK1 andPKM2 as novel transcriptional targets of PPARgamma in breast cancer pathophysiology. J
Drug Target 21(2):161-174, 201337. Shashni B, Sharma K, Singh R, Sakharkar KR, Dhillon SK, Nagasaki Y, Sakharkar MK.
Coffee component Hydroxyl Hydro Quinone (HHQ) as a novel ligand for PPAR gamma andimplications for breast cancer. BMC (BioMedCentral) Genomics 14(Suppl 5):S6, 2013
38. Suzuki H, Kaneko T, Mizokami Y, Narasaka T, Endo S, Matsui H, Yanaka A, Hirayama A,
Hyodo I. Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis.
World J Gastroenterol 19(17):2718-2722, 2013
39. Takano S, Kimu H, Tsuda K, Osuka S, Nakai K, Yamamoto T, Ishikawa E, Akutsu H,
Matsuda M, Matsumura A. Decrease in the apparent diffusion coefficient in peritumoral
edema for the assessment of recurrent glioblastoma treated by bevacizumab. Acta Neurochir
Suppl 118:185-189, 2013
40. Tamura M, Matsui H, Kaneko T, Hyodo I. Alcohol is an oxidative stressor for gastric84

epithelial cells: detection of superoxide in living cells. J Clin Biochem Nutr 53(2):75-80,
2013
41. Tamura M, Matsui H, Nagano YN, Kaneko T, Indo HP, Majima HJ, Hyodo I. Salt is anoxidative stressor for gastric epithelial cells. J Physiol Pharmacol 64(1):89-94, 2013	
 42. Tamura M, Matsui H, Tomita T, Sadakata H, Indo HP, Majima HJ, Kaneko T, Hyodo I.
Mitochondrial reactive oxygen species accelerate gastric cancer cell invasion. J Clin
Biochem Nutr doi: 10.3164/jcbn.13-36, 2013
43. Tamura M, Yanagawa F, Sugiura S, T T, Sumaru K, Matsui H, Kanamori T. Optical cell
picking in photodegrable hydrogels based on cellular morphology in 3D culture environment.
Proc mTAS:1929–1931, 2013
44. Tsuda K, Akutsu H, Yamamoto T, Ishikawa E, Saito A, Nakai K, Takano S, Matsumura A.
Benign spinal meningioma without dural attachment presenting delayed CSF disseminationand malignant transformation. Brain Tumor Pathol 30(3):185-191, 2013
45. Tsuda K, Tsurushima H, Takano S, Tsuboi K, Matsumura A. Brain metastasis from papillary
thyroid carcinomas. Molecular and clinical oncology 1:817-819, 2013
46. Vong LB, Yoshitomi T, Morikawa K, Saito S, Matsui H, Nagasaki Y. Oral nanotherapeutics:
effect of redox nanoparticle on microflora in mice with dextran sodium sulfate-induced
colitis. J Gastroenterol doi: 10.1007/s00535-013-0836-8, 2013
47. Wang X, Ito A, Sogo Y, Hirose M, Oyane A, Tsurushima H. DNA-lipid-apatitie composite
layers enhance gene expression of mesenchymal stem cells. Mat Sci Eng C 33:512-518,
2013
48. Yamamoto T, Tsuboi K, Nakai K, Kumada H, Sakurai H, Matsumura A. Boron neutron
capture therapy for brain tumors. Transl Cancer Res 2:80-86, 2013
49. Yamazaki T, Sonobe M, Kato N, Kasuya H, Ikeda G, Nakamura K, Ito Y, Tsuruta W, Nakai
Y, Matsumura A. Endovascular coiling as the first treatment strategy for ruptured pericallosalartery aneurysms: results, complications, and follow up. Neurol Med Chir (Tokyo)
53(6):409-417, 2013
50. Yoshitomi T, Ozaki Y, Thangavel S, Nagasaki Y. Redox nanoparticle therapeutics tocancer--increase in therapeutic effect of doxorubicin, suppressing its adverse effect. J
Control Release 172(1):137-143, 2013
51. Zaboronok A, Isobe T, Yamamoto T, Sato E, Takada K, Sakae T, Tsurushima H, Matsumura
A. Proton beam irradiation stimulates migration and invasion of human U87 malignant
glioma cells. J Radiat Res doi: 10.1093/jrr/rrt119, 201385

52. Zaboronok A, Tsurushima H, Yamamoto T, Isobe T, Takada K, Sakae T, Yoshida F,
Matsumura A. Size-dependent radiosensitization effects of gold nanoparticles on humanU251 malignant glioma cells. Nanosci nanotech lett 5(9):9904, 20132) 英文以外の論文
1. 阿久津博義. 【先端医療技術に対応する病院建築】 術中 MRI 統合システム. 医療福祉
建築 180:12, 2013
2. 阿久津博義. 【手術室で、今、有用な画像診断装置】 臨床効果を具体的に示す	
  術中MRI 手術システムの現況・有用性と機器上の要件. 新医療 40(10):106-109, 2013
3. 阿久津博義, 高野晋吾, 田中秀峰, 山本哲哉, 村下秀和, 石川栄一, 松村明. Four-hand
technique を 用 い た 内 視 鏡 下 経 鼻 頭 蓋 底 手 術 の 現 状 と 未 来. 日 本 内 分 泌 学 会 雑 誌
89(Suppl.HPT):13-14, 2013
4. 阿久津博義, 増田洋亮, 松村明. ビジウス	
  サージカルシアター	
  脳外科領域で用いられる機器最前線. 脳神経外科速報 23(11):1240-1245, 2013
5. 池田剛, 園部眞, 加藤徳之, 山崎友郷, 粕谷泰道, 中居康展, 松村明. 脳動脈瘤コイル塞栓術 後 の 破 裂 ・ 再 治 療 と Volume Embolization Ratio(VER)の 関 連 性. 脳 卒 中 の 外 科
41(6):440-446, 2013
6. 伊藤嘉朗, 加藤徳之, 中居康展, 松村明, 園部眞. Closed-cell stent を用いた頸動脈ステン
ト 留 置 術 に お け る 頸 動 脈 の 屈 曲 度 と 微 小 脳 塞 栓 の 関 係. JNET: Journal of
Neuroendovascular Therapy 7(2):75-80, 2013
7. 伊藤嘉朗, 加藤徳之, 松村明, 園部眞. ドーナツ型巨大脳動脈瘤に対してコイルとラッ
ピング術を施行した 1 例. 脳神経外科 41(5):415-420, 2013
8. 岡部進, 松井裕史. 低濃度酢酸のヒトおよびラット由来胃がん細胞株に対する効果	  潰瘍	
  40(2):17-19, 2013
9. 小松洋治, 中村和弘, 伊藤嘉朗, 益子良太, 上村和也, 松村明. 【光線力学診断・治療の最新動向】 脳神経外科手術におけるインドシアニングリーン術中蛍光血管撮影の有用性と課題. 日本レーザー医学会誌 34(2):141-147, 2013
10. 鈴木英雄, 奈良坂俊明, 溝上裕士, 金子剛, 森脇俊和, 遠藤慎治, 松井裕史, 谷中昭典, 兵頭一之介, 大森敏秀, 船山夏子, 杉谷武彦, 新澤岳. 下痢型過敏性腸症候群患者におけるラモセトロンの服用状況調査. 日本消化器病学会雑誌 110(臨増大会):A949, 2013
11. 津田恭治, 阿久津博義, 山本哲哉, 中井啓, 井原哲, 石川栄一, 安田貢, 高野晋吾, 松村
明. 当院で経験した脊髄髄膜腫の治療成績と手術戦略. 脊髄外科 27(1):61-63, 201312. 鶴田和太郎, 松丸祐司, 上坂義和, 松村明. 神経放射線診断	
  進行する脊髄症状を呈し、
86

MRI にて上部頸髄に異常を認めた症例. 脳神経外科ジャーナル 22(11):873-877, 2013
13. 原拓真, 阿久津博義, 高野晋吾, 山本哲哉, 鈴木浩明, 松村明. Cushing 病に対する手術
および放射線照射例の長期予後. 日本内分泌学会雑誌 89(Suppl.HPT):63-64, 201314. 益子良太, 中居康展, 原拓真, 今井資, 松原鉄平, 松田真秀, 上村和也, 小松洋治, 松村明. 錐体骨部特発性内頸動脈解離に対するステント留置術の 1 例. 脳神経外科ジャー
ナル 22(7):557-561, 201315. 松原鉄平, 松田真秀, 益子良太, 上村和也, 小松洋治, 松村明. 多発性未破裂脳動脈瘤の経過観察中に生じた新生動脈瘤破裂によるくも膜下出血の 1 例. 脳卒中の外科
41(1):56-59, 201316. 松丸祐司, 原貴行, 松村明. 【血管奇形の基礎と臨床】 脊髄動静脈シャント	
  何が治
せて何が治療困難か. 脳神経外科ジャーナル 22(1):44-51, 2013
17. 三木俊一郎, 山崎友郷, 加藤徳之, 池田剛, 粕谷泰道, 園部眞, 中居康展, 松村明. Double
catheter technique を応用した coil-assist technique で治療を行ったブレブをネック近傍に伴う破裂脳動脈瘤の 1 例. JNET: Journal of Neuroendovascular Therapy 7(3):186-191,
2013

	
 
4) 英文以外の著書
1. 松村明, 松田真秀. 第 1 章. 脳神経外科分野における陽子線治療の適用; "定位的放射線治療 17 (第 1 版)” (編集	  新井一、伊達裕昭、西本博), メジカルビュー社 (東京) 2013;
pp11-19
2. 松村明, 山本哲哉. 第 1 章. 小児脳腫瘍に対する放射線治療; "小児脳神経外科診療ガイドブック (第 1 版)” (編集	
 新井一、伊達裕昭、西本博), メジカルビュー社 (東京) 2013;
pp14-2187

先端医療技術・生体材料・医療機器臨床応用	 1) 英文論文
1. Bodhak S, Kikuchi M, Sogo Y, Tsurushima H, Ito A, Oyane A. Calcium phosphate coating on
a bioresorbable hudroxyapatite/collagen nanocomposite for surface functionalization. Chem
Lett 42(1029-1031, 2013
2. Fujie K, Nakata Y, Yasuda S, Mizutani T, Hashimoto K. Do dispatcher instructions facilitate
bystander-initiated cardiopulmonary resuscitation and improve outcomes in patients with
out-of-hospital cardiac arrest? A comparison of family and non-family bystanders.
Resuscitation doi: 10.1016/j.resuscitation.2013.11.013, 2013
3. Funayama T, Sakane M, Yoshizawa T, Takeuchi Y, Ochiai N. Tanycytic ependymoma of thefilum terminale associated with multiple endocrine neoplasia type 1: first reported case.
Spine J 13(8):e49-54, 2013
4. Funayama T, Tsukanishi T, Hara I, Ozeki E, Sakane M. Tumor-selective near-infrared
photodynamic therapy with novel indocyanine green-loaded nanocarrier delays paralysis inrats with spinal metastasis. Photodiagnosis Photodyn Ther 10(4):374-378, 2013
5. Ito Y, Tsurushima H, Sato M, Ito A, Oyane A, Sogo Y, Matsumura A. Angiogenesis therapy
for brain infarction using a slow-releasing drug delivery system for fibroblast growth factor
2. Biochem Biophys Res Commun 432(1):182-187, 2013
6. Kawamoto H, Kamibayashi K, Nakata Y, Yamawaki K, Ariyasu R, Sankai Y, Sakane M,
Eguchi K, Ochiai N. Pilot study of locomotion improvement using hybrid assistive limb inchronic stroke patients. BMC Neurol 13:141, 2013
7. Kubota S, Nakata Y, Eguchi K, Kawamoto H, Kamibayashi K, Sakane M, Sankai Y, Ochiai
N. Feasibility of rehabilitation training with a newly developed wearable robot for patientswith limited mobility. Arch Phys Med Rehabil 94(6):1080-1087, 2013
8. Oyane A, Araki H, Sogo Y, Ito A, Tsurushima H. Spontaneous assembly of DNA-amorphous
calcium phosphate nanocomposite spheres for surface-mediated genetransfer. Cryst Eng
Comm 15(25):4994-4997, 2013
9. Sato M, Nakai Y, Tsurushima H, Shiigai M, Masumoto T, Matsumura A. Risk factors ofischemic lesions related to cerebral angiography and neuro-interventional procedures. Neurol
Med Chir (Tokyo) 53(6):381-387, 2013
10. Sato M, Takigawa T, Shiigai M, Tamura G, Masumoto T, Nakai Y, Zaboronok A,
Tsurushima H, Matsumura A. Spinal dural arteriovenous fistula with lipomyelodysplasia.
Neurol Med Chir (Tokyo) 53(2):107-109, 201388

11. Tsuda K, Tsurushima H, Takano S, Tsuboi K, Matsumura A. Brain metastasis from papillary
thyroid carcinomas. Mol Clin Oncol 1(5):817-819, 2013
12. Wang X, Ito A, Sogo Y, Hirose M, Oyane A, Tsurushima H. DNA-lipid-apatitie composite
layers enhance gene expression of mesenchymal stem cells. Mat Sci Eng C 33:512-518,
2013
13. Zaboronok A, Isobe T, Yamamoto T, Sato E, Takada K, Sakae T, Tsurushima H, Matsumura
A. Proton beam irradiation stimulates migration and invasion of human U87 malignant
glioma cells. J Radiat Res doi: 10.1093/jrr/rrt119, 2013
14. Zaboronok A, Tsurushima H, Yamamoto T, Isobe T, Takada K, Sakae T, Yoshida F,
Matsumura A. Size-dependent radiosensitization effects of gold nanoparticles on humanU251 malignant glioma cells. Nanosci nanotech lett 5(9):9904, 2013	 2) 英文以外の論文
1. 安部哲哉, 坂根正孝, 船山徹, 俣木優輝, 竹内陽介, 兵頭康次郎, 神山翔, 日置繁, 山崎正志. 全身麻酔下の経椎間孔アプローチの PELD の手術成績. Journal of Spine Research
4(8):1264-1269, 2013
2. 鎌田浩史, 竹内亮子, 中川将吾, 三島初, 坂根正孝, 山崎正志, 落合直之, 岡本嘉一.【小児整形外科疾患	
  診断・治療の進歩】 診断・評価の進歩	
  MRI	
  発育性股関節形成不全における三次元 MRI を用いた三次元的評価. 別冊整形外科 64:11-17, 2013
3. 絹笠友則, 小松崎徹也, 金森章浩, 青戸克哉, 長谷川隆司, 塚越祐太, 辰村正紀, 福島真,矢田部佳久, 池田耕太郎. TKA 術後疼痛コントロール	  人工膝関節術後疼痛に対する
術中大腿骨後方骨膜上ロピバカイン注入の試み. 日本人工関節学会誌 43:293-294,
2013
4. 絹笠友則, 六崎裕高, 青戸克哉, 金森章浩, 池田耕太郎. AI ドリル使用による Outside-in
法 と ToggleLoc Femoral Fixation Device を 併 用 し た 大 腿 骨 側 骨 孔 作 成. JOSKAS
38(1):58-59, 2013
5. 鈴木恒, 馬見塚尚孝, 芋生祥之, 大瀧保明, 奈良隆章, 藤江敬子, 橋本幸一, 中田由夫, 原田義則, 坂根正孝, 平野篤, 落合直之. 腰部脊柱管狭窄症患者に対する日本語版チューリッヒ跛行質問票と 6 分間歩行試験の試用評価と基準関連妥当性検証. Journal of
Spine Research 4(1):63-67, 2013
6. 中田研, 橋本祐介, 米谷泰一, 奥平修三, 三谷玄弥, 金森章浩. 平成 24 年度日本体育協会
スポーツ医・科学研究報告	
 日本におけるスポーツ外傷サーベイランスシステムの構
築(第 3 報) 各競技におけるスポーツ外傷発生調査	
 テニス. 日本体育協会スポーツ医・
89

科学研究報告集 2012 年度:72-75, 2013
7. 西田雄亮, 西野衆文, 金森章浩, 坂根正孝. 腱部分切除術とラジオ波焼灼術を併用した
膝蓋腱炎の 1 例. 日本整形外科スポーツ医学会雑誌 33(3):327-331, 2013
8. 藤江敬子, 橋本幸一. 都道府県別データから見た市民による AED 使用除細動実施に関連する因子. 日本農村医学会雑誌 62(3):416, 2013
9. 牧原武史, 坂根正孝, 藤井賢吾, 大西信三. 後頭下減圧術後に関節窩の骨リモデリングを生じた Charcot 肩の一例. 肩関節 37(2):893-896, 201310. 俣木健太朗, 野澤大輔, 三島初, 牧原武史, 岡野英里子, 和田大志, 坂根正孝. 外反母趾に対する DLMO 法の経験. 関東整形災害外科学会雑誌 44(2):48-51, 2013
11. 馬見塚尚孝, 藤江敬子, 椎名逸雄, 平野篤, 万本健生, 橋本幸一, 中田由夫, 大瀧保明, 坂根正孝. 腰部脊柱管狭窄症のを対象としたチューリッヒ跛行質問票および JOABPEQの内部一貫性. Journal of Spine Research 4(3):370, 201312. 吉岡友和, 金森章浩. 【アスリートの関節軟骨損傷-スポーツ復帰のために-】 多血小板 血 漿(PRP)に よ る 関 節 軟 骨 損 傷 治 療 の 今 後 の 可 能 性. 臨 床 ス ポ ー ツ 医 学
30(4):367-372, 20134) 英文以外の著書
1. 坂根正孝. 6 章 脊椎（頸椎、胸椎、腰椎）. 脊椎・脊髄損傷; "新版 スポーツ整形外科
マニュアル (第 1 版)” (監修 福林徹, 編集 篠塚昌述), 株式会社中外医学者 (東京) 2013;
pp104-107
2. 坂根正孝. 6 章 脊椎（頸椎、胸椎、腰椎）. 胸腰椎の外傷（圧迫骨折、破裂骨折、横突起骨折）; "新版 スポーツ整形外科マニュアル (第 1 版)” (監修 福林徹, 編集 篠塚昌述),
株式会社中外医学者 (東京) 2013; pp111-114
3. 坂根正孝, 安部哲哉. II．脊椎内視鏡下手術のための基本手技 [PED] 手術器具（特殊器具を含む）; "［スキル関節鏡下手術アトラス］シリーズ	
 「脊椎内視鏡下手術」(第 1版)” (編集 吉田宗人, 監修 越智光夫), 株式会社文光堂 (東京) 2013; pp48-51
4. 坂根正孝, 安部哲哉. V．脊椎内視鏡下手術とそのスキル. ［PED］2. 頚椎間孔的ヘルニ
ア摘出; "［スキル関節鏡下手術アトラス］シリーズ	
 「脊椎内視鏡下手術」(第 1 版)”(編集 吉田宗人, 監修 越智光夫), 株式会社文光堂 (東京) 2013; pp140-14490絆社会継続発展モデルとしての小児難病総合	 1) 英文論文
1. Abei M, Okumura T, Fukuda K, Hashimoto T, Araki M, Ishige K, Hyodo I, Kanemoto A,
Numajiri H, Mizumoto M, Sakae T, Sakurai H, Zenkoh J, Ariungerel G, Sogo Y, Ito A, Ohno
T, Tsuboi K. A phase I study on combined therapy with proton-beam radiotherapy and in situ
tumor vaccination for locally advanced recurrent hepatocellular carcinoma. Radiat Oncol
8:239, 2013
2. Akimoto K, Kimura K, Nagano M, Takano S, To'a Salazar G, Yamashita T, Ohneda O.
Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived
mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells Dev
22(9):1370-1386, 2013
3. Aoki T, Nishikawa R, Sugiyama K, Nonoguchi N, Kawabata N, Mishima K, Adachi JI,
Kurisu K, Yamasaki F, Tominaga T, Kumabe T, Ueki K, Higuchi F, Yamamoto T, Ishikawa E,
Takeshima H, Yamashita S, Arita K, Hirano H, Yamada S, Matsutani M. A Multicenter Phase
I/II Study of the BCNU Implant (Gliadel Wafer) for Japanese Patients with Malignant
Gliomas. Neurol Med Chir (Tokyo) 54(4)290-301, doi:10.2176/nmc.oa2013-0112, 2013	  	 4. Bodhak S, Kikuchi M, Sogo Y, Tsurushima H, Ito A, Oyane A. Calcium phosphate coating on
a bioresorbable hudroxyapatite/collagen nanocomposite for surface functionalization. Chem
Lett 42(1029-1031, 2013
5. Fujishiro J, Masumoto K, Urita Y, Shinkai T, Gotoh C. Pancreatic complications in pediatriccholedochal cysts. J Pediatr Surg 48(9):1897-1902, 2013
6. Fukushima H, Fukushima T, Sakai A, Suzuki R, Nakajima-Yamaguchi R, Kobayashi C,
Iwabuchi A, Saito M, Yoshimi A, Nakao T, Kato K, Tsuchida M, Takahashi H, Koike K,
Kiyokawa N, Noguchi E, Sumazaki R. Polymorphisms of MTHFR Associated with Higher
Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid
Malignancies. Leuk Res Treatment 2013(?):238528, 2013
7. Fukushima H, Fukushima T, Suzuki R, Enokizono T, Matsunaga M, Nakao T, Koike K, MoriK, Matsueda K, Sumazaki R. Continuous regional arterial infusion effective for children withacute necrotizing pancreatitis even under neutropenia. Pediatr Int 55(2):e11-13, 2013
8. Hara T, Akutsu H, Yamamoto T, Ishikawa E, Matsuda M, Matsumura A. Cushing’s disease
presenting with gastrointestinal perforation: a case report. Endocrinology, diabetes andmetabolism. Case reports Nov:1-4, 2013
9. Hara T, Matsuda M, Watanabe S, Nakai K, Yamamoto T, Matsumura A. Remote cerebellar
91hemorrhage after removal of a supratentorial glioma without perioperative CSF loss: A casereport. Case Rep Surg 2013:305039, 2013
10. Hashii H, Hashimoto T, Okawa A, Shida K, Isobe T, Hanmura M, Nishimura T, Aonuma K,
Sakae T, Sakurai H. Comparison of the effects of high-energy photon beam irradiation (10and 18 MV) on 2 types of implantable cardioverter-defibrillators. Int J Radiat Oncol Biol
Phys 85(3):840-845, 2013
11. Hayashi M, Hirota T, Saeki H, Nakagawa H, Ishiuji Y, Matsuzaki H, Tsunemi Y, Kato T,
Shibata S, Sugaya M, Sato S, Tada Y, Doi S, Miyatake A, Ebe K, Noguchi E, Ebihara T,
Amagai M, Esaki H, Takeuchi S, Furue M, Tamari M. Genetic polymorphism in the
TRAF3IP2 gene is associated with psoriasis vulgaris in a Japanese population. J DermatolSci doi: 10.1016/j.jdermsci.2013.11.012, 2013
12. Hirohata T, Asano K, Ogawa Y, Takano S, Amano K, Isozaki O, Iwai Y, Sakata K, Fukuhara
N, Nishioka H, Yamada S, Fujio S, Arita K, Takano K, Tominaga A, Hizuka N, Ikeda H,
Osamura RY, Tahara S, Ishii Y, Kawamata T, Shimatsu A, Teramoto A, Matsuno A. DNA
mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas
and pituitary carcinomas to temozolomide: the national cooperative study by the Japan
Society for Hypothalamic and Pituitary Tumors. J Clin Endocrinol Metab 98(3):1130-1136,
2013
13. Hong Z, Kase Y, Moritake T, Gerelchuluun A, Sun L, Suzuki K, Terunuma T, Yasuoka K,
Kumada H, Anzai K, Sakurai H, Sakae T, Tsuboi K. Lineal energy-based evaluation ofoxidative DNA damage induced by proton beams and X-rays. Int J Radiat Biol 89(1):36-43,
2013
14. Iijima H, Kaneko Y, Yamada H, Yatagai Y, Masuko H, Sakamoto T, Naito T, Hirota T,
Tamari M, Konno S, Nishimura M, Noguchi E, Hizawa N. A distinct sensitization patternassociated with asthma and the thymic stromal lymphopoietin (TSLP) genotype. Allergol Int
62(1):123-130, 2013
15. Imoto Y, Tokunaga T, Matsumoto Y, Hamada Y, Ono M, Yamada T, Ito Y, Arinami T, Okano
M, Noguchi E, Fujieda S. Cystatin SN upregulation in patients with seasonal allergic rhinitis.
PLoS One 8(8):e67057, 2013
16. Inoue Y, Nakagawara R, Kambara T, Tanaka K, Seki K, Enomoto H, Noguchi E, Aihara M,
Ikezawa Z. Prevalence of atopic dermatitis in Japanese infants treated with moisturizer sincebirth and its relation to FLG mutations. Eur J Dermatol 23(2):288-289, 2013
17. Isobe T, Mori Y, Takada K, Sato E, Sakurai H, Sakae T. Robust technique using an imaging
92

plate to detect environmental radioactivity. Health Phys 104(4):362-365, 2013
18. Isobe T, Mori Y, Takada K, Sato E, Takahashi H, Sekiguchi T, Yoshimura Y, Sakurai H,
Sakae T. Evaluation of vegetables in Tsukuba for contamination with radioactive materials
from the accident at Fukushima Daiichi nuclear power plant. Health Phys 105(4):311-317,
2013
19. Ito Y, Kato N, Matsumura A, Sonobe M. Hemodynamic instability increases new ischemic
brain lesions on diffusion-weighted imaging after carotid artery stenting. Neurol Med Chir
(Tokyo) 53(6):375-380, 2013
20. Ito Y, Tsurushima H, Sato M, Ito A, Oyane A, Sogo Y, Matsumura A. Angiogenesis therapy
for brain infarction using a slow-releasing drug delivery system for fibroblast growth factor
2. Biochem Biophys Res Commun 432(1):182-187, 2013
21. Iwabuchi A, Kamoda T, Saito M, Nozue H, Izumi I, Hirano T, Sumazaki R. Serum
dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus. J Pediatr Endocrinol
Metab 26(11-12):1093-1097, 2013
22. Iwabuchi A, Kamoda T, Shinohara H, Sumazaki R. Japanese boy with maturity-onset
diabetes of the young type 3 who developed diabetes at 19 months old. Pediatr Int
55(2):e32-34, 2013
23. Iwakawa R, Takenaka M, Kohno T, Shimada Y, Totoki Y, Shibata T, Tsuta K, Nishikawa R,
Noguchi M, Sato-Otsubo A, Ogawa S, Yokota J. Genome-wide identification of genes withamplification and/or fusion in small cell lung cancer. Genes Chromosomes Cancer
52(9):802-816, 2013
24. Iwasawa M, Miyahara J, Noriaki T, Nozue H, Sumazaki R. Behavioral support to parents
through a cellular-phone website that provides the degree of urgency for medical attention ofa child. Stud Health Technol Inform 192:1115, 2013
25. Jimbo T, Masumoto K, Urita Y, Takayasu H, Shinkai T, Uesugi T, Gotoh C, Sakamoto N,
Sasaki T, Oto T, Fukushima T, Noguchi E, Nakano Y. Nevoid basal cell carcinoma syndrome
with a unilateral giant ovarian fibroma in a Japanese 6-year-old girl. Eur J Pediatr doi:
10.1007/s00431-013-2200-7, 2013
26. Kaneko MK, Morita S, Tsujimoto Y, Yanagiya R, Nasu K, Sasaki H, Hozumi Y, Goto K,
Natsume A, Watanabe M, Kumabe T, Takano S, Kato Y. Establishment of novel monoclonal
antibodies KMab-1 and MMab-1 specific for IDH2 mutations. Biol Biophys Res Commun
432:40-45, 2013
27. Kaneko Y, Masuko H, Sakamoto T, Iijima H, Naito T, Yatagai Y, Yamada H, Konno S,
93

Nishimura M, Noguchi E, Hizawa N. Asthma phenotypes in Japanese adults - theirassociations with the CCL5 and ADRB2 genotypes. Allergol Int 62(1):113-121, 2013
28. Kanemoto A, Mizumoto M, Okumura T, Takahashi H, Hashimoto T, Oshiro Y, Fukumitsu N,
Moritake T, Tsuboi K, Sakae T, Sakurai H. Dose-volume histogram analysis for risk factorsof radiation-induced rib fracture after hypofractionated proton beam therapy forhepatocellular carcinoma. Acta Oncol 52(3):538-544, 2013
29. Kanemoto A, Okumura T, Ishikawa H, Mizumoto M, Oshiro Y, Kurishima K, Homma S,
Hashimoto T, Ohkawa A, Numajiri H, Ohno T, Moritake T, Tsuboi K, Sakae T, Sakurai H.
Outcomes and prognostic factors for recurrence after high-dose proton beam therapy forcentrally and peripherally located stage I non--small-cell lung cancer. Clin Lung Cancer doi:
10.1016/j.cllc.2013.11.002, 2013
30. Kashiwagi M, Tamiya N, Sato M, Yano E. Factors associated with the use of home-visit
nursing services covered by the long-term care insurance in rural Japan: a cross-sectional
study. BMC Geriatr 13:1, 2013
31. Kawamura T, Usui J, Kaseda K, Takada K, Ebihara I, Ishizu T, Iitsuka T, Sakai K, Takemura
K, Kobayashi M, Koyama A, Kanemoto K, Sumazaki R, Uesugi N, Noguchi M, Nagata M,
Suka M, Yamagata K. Primary membranoproliferative glomerulonephritis on the decline:
decreased rate from the 1970s to the 2000s in Japan. Clin Exp Nephrol 17(2):248-254, 2013
32. Kin H, Ishikawa E, Takano S, Ayuzawa S, Matsushita A, Muragaki Y, Aiyama H, Sakamoto
N, Yamamoto T, Matsumura A. Language areas involving the inferior temporal cortex on
intraoperative mapping in a bilingual patient with glioblastoma. Neurol Med Chir (Tokyo)
53(4):256-258, 2013
33. Kiyokawa N, Iijima K, Tomita O, Miharu M, Hasegawa D, Kobayashi K, Okita H, Kajiwara
M, Shimada H, Inukai T, Makimoto A, Fukushima T, Nanmoku T, Koh K, Manabe A,
Kikuchi A, Sugita K, Fujimoto J, Hayashi Y, Ohara A. Significance of CD66c expression inchildhood acute lymphoblastic leukemia. Leuk Res doi: 10.1016/j.leukres.2013.10.008, 2013
34. Kobayashi M, Tamiya N, Kashiwagi M, Ito T, Yamaoka Y, Matsuzawa A. Factors related topositive feelings of caregivers who provide home-based long-term care for their family
members in Japan. Journal of Research on Humanities and Social Sciences 3(16):27-36,
2013
35. Kojima M, Nishikii H, Takizawa J, Aoki S, Noguchi M, Chiba S, Ando K, Nakamura N.
MYC rearrangements are useful for predicting outcomes following rituximab andchemotherapy: multicenter analysis of Japanese patients with diffuse large B-cell lymphoma.
94

Leuk Lymphoma 54(10):2149-2154, 2013
36. Lee SY, Kurita N, Yokoyama Y, Seki M, Hasegawa Y, Okoshi Y, Chiba S.
Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP
chemotherapy. Support Care Cancer doi: 10.1007/s00520-013-2097-8, 2013
37. Li-mei C, Tamiya N, Kato G, Yamaoka Y, Ito T, Matsuzawa A, Yamamoto H. Predictors ofvolunteerism: A study of older adults in Japan. Journal of Public Policy and Administration
Research 3(6):71-19, 2013
38. Mahmoud SS, Fukushima T, Shimizu T, Nakao T, Yamaguchi R, Fukushima H, Wada H,
Nanmoku T, Sumazaki R. Persistent low level Epstein-Barr virus DNAemia in childhood
cancer survivors. Pediatr Hematol Oncol 30(3):216-225, 2013
39. Maie K, Okoshi Y, Takaiwa N, Kurita N, Hasegawa Y, Homma M, Ishii K, Kohda Y, Chiba
S. Aprepitant does not alter prednisolone pharmacokinetics in patients treated with R-CHOP.
Ann Oncol doi: 10.1093/annonc/mdt477, 2013
40. Matsubara T, Ayuzawa S, Aoki T, Fujimoto A, Osuka S, Matsumura A. The patient had anormal magnetic resonance imaging and temporal lobe epilepsy secondaru to a porencephaliccyst but showed structural lesions (hippocampal sclerosis). Epilepsy & Behavior Case
Reports 1:153-156, 2013
41. Matsubara T, Ayuzawa S, Aoki T, Ikeda G, Shiigai M, Matsumura A. Cerebral Venous
Thrombosis after Ventriculoperitoneal Shunting: A Case Report. Neurol Med Chir (Tokyo)
doi:10.2176/nmc.cr.2012-0312, 2013
42. Matsubara T, Ishikawa E, Hirata K, Matsuda M, Akutsu H, Masumoto T, Zaboronok A,
Matsumura A. A New Mechanism of Cerebrospinal Fluid Leakage after Lumboperitoneal
Shunt: A Theory of Shunt Side Hole-Case Report. Neurol Med Chir (Tokyo)
doi:10.2176/nmc.cr.2013-0067, 2013
43. Matsunari H, Nagashima H, Watanabe M, Umeyama K, Nakano K, Nagaya M, Kobayashi
T, Yamaguchi T, Sumazaki R, Herzenberg LA, Nakauchi H. Blastocyst complementation
generates exogenic pancreas in vivo in apancreatic cloned pigs. Proc Natl Acad Sci U S A
110(12):4557-4562, 2013
44. Matsuzawa A, Yamaoka Y, Tamiya N, Taniguchi K, Yamazaki

K. Family caregiving

problems of suspected elderly neglect. Journal of Research on Humanities and Social
Sciences 3(9):117-124, 2013
45. Mizumoto M, Hashii H, Senarita M, Sakai S, Wada T, Okumura T, Tsuboi K, Sakurai H.
Proton beam therapy for malignancy in Bloom syndrome. Strahlenther Onkol
95

189(4):335-338, 2013
46. Mizumoto M, Okumura T, Ishikawa E, Yamamoto T, Takano S, Matsumura A, Oshiro Y,
Ishikawa H, Sakurai H, Tsuboi K. Reirradiation for recurrent malignant brain tumor withradiotherapy or proton beam therapy. Technical considerations based on experience at asingle institution. Strahlenther Onkol 189(8):656-663, 2013
47. Muragaki Y, Akimoto J, Maruyama T, Iseki H, Ikuta S, Nitta M, Maebayashi K, Saito T,
Okada Y, Kaneko S, Matsumura A, Kuroiwa T, Karasawa K, Nakazato Y, Kayama T. Phase II
clinical study on intraoperative photodynamic therapy with talaporfin sodium andsemiconductor laser in patients with malignant brain tumors. J Neurosurg 119(4):845-852,
2013
48. Nakahara S, Tomio J, Takahashi H, Ichikawa M, Nishida M, Morimura N, Sakamoto T.
Evaluation of pre-hospital administration of adrenaline (epinephrine) by emergency medical
services for patients with out of hospital cardiac arrest in Japan: controlled propensity
matched retrospective cohort study. BMJ 347:f6829, 2013
49. Nakajima J, Hitomi S, Koganemaru H, Nakai Y. Isolation of Staphylococcus epidermidis
intermediately resistant to vancomycin in a case of central venous catheter-associatedbloodstream infection. J Infect Chemother 19(5):983-986, 2013
50. Nakayama H, Kanemoto A, Kikuchi K, Matsuki K, Tomobe M, Tsukamoto S, Takeshima H,
Oshiro Y, Sugahara S, Tokuuye K. Delayed radiotherapy for patients with localized prostatecancer: validation by propensity score matching. Anticancer Res 33(4):1629-1633, 2013
51. Nakazato Y, Maeshima AM, Ishikawa Y, Yatabe Y, Fukuoka J, Yokose T, Tomita Y, Minami
Y, Asamura H, Tachibana K, Goya T, Noguchi M. Interobserver agreement in the nuclear
grading of primary pulmonary adenocarcinoma. J Thorac Oncol 8(6):736-743, 2013
52. Nguyen TNH, Akutsu H, Nouguch iS, Tsunoda T, Sasak iM, Tsurushima H, Matsumura A.
Reversible focal radiological changes due to non-convulsive status epilepticus of the rightparietooccipital lobe. Turk Neurosurg 23(2):278-281, 2013
53. Niho S, Kenmotsu H, Sekine I, Ishii G, Ishikawa Y, Noguchi M, Oshita F, Watanabe S,
Nakajima R, Tada H, Nagai K. Combination chemotherapy with irinotecan and cisplatin forlarge-cell neuroendocrine carcinoma of the lung: a multicenter phase II study. J Thorac
Oncol 8(7):980-984, 2013
54. Nitta S, Kawai K, Onozawa M, Ando S, Miyazaki J, Nagata C, Noguchi M, Yamasaki K,
Uchida K, Iwamoto T, Nishiyama H. Intratubular trophoblasts in the contralateral testis
caused elevation of serum human chorionic gonadotropin following complete remission of96

stage II testicular tumor: a case report. Jpn J Clin Oncol 43(1):83-86, 2013
55. Onuma K, Ishikawa E, Matsuda M, Hirata K, Osuka S, Yamamoto T, Masumoto T,
Zaboronok A, Matsumura A. Clinical characteristics and neuroimaging findings in 12 casesof recurrent glioblastoma with communicating hydrocephalus. Neurol Med Chir (Tokyo)
53(7):474-481, 2013
56. Oshiro Y, Mizumoto M, Okumura T, Sugahara S, Fukushima T, Ishikawa H, Nakao T,
Hashimoto T, Tsuboi K, Ohkawa H, Kaneko M, Sakurai H. Clinical results of proton beam
therapy for advanced neuroblastoma. Radiat Oncol 8(1):142, 2013
57. Oshiro Y, Okumura T, Mizumoto M, Fukushima T, Ishikawa H, Hashimoto T, Tsuboi K,
Kaneko M, Sakurai H. Proton beam therapy for unresectable hepatoblastoma in children:
survival in one case. Acta Oncol 52(3):600-603, 2013
58. Oshiro Y, Sakurai H. The use of proton-beam therapy in the treatment of non-small-celllung cancer. Expert Rev Med Devices 10(2):239-245, 2013
59. Oshiro Y, Sasaki R, Fukunaga K, Kondo T, Oda T, Takahashi H, Ohkohchi N.
Inflammation-based prognostic score is a useful predictor of postoperative outcome inpatients with extrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 20(3):389-395,
2013
60. Osuka S, Sampetrean O, Shimizu T, Saga I, Onishi N, Sugihara E, Okubo J, Fujita S, Takano
S, Matsumura A, Saya H. IGF1 receptor signaling regulates adaptive radioprotection inglioma stem cells. Stem Cells 31(4):627-640, 2013
61. Oyane A, Araki H, Sogo Y, Ito A, Tsurushima H. Spontaneous assembly of DNA-amorphous
calcium phosphate nanocomposite spheres for surface-mediated genetransfer. Cryst Eng
Comm 15(25):4994-4997, 2013
62. Saida T, Mori K, Yabe H, Shindo M, Nasu K, Shiigai M, Takahashi H, Minami M.
Noninvasive visualization of endoleaks after endovascular aortic aneurysm repair throughunenhanced MRI with motion-sensitized driven equilibrium preparation: Phantom
experiments. J Magn Reson Imaging 38(3):714-721, 2013
63. Saito T, Takahashi H, Kaneda H, Binnie M, Azad S, Sato M, Waddell TK, Cypel M, Liu M,
Keshavjee S. Impact of cytokine expression in the pre-implanted donor lung on thedevelopment of chronic lung allograft dysfunction subtypes. Am J Transplant
13(12):3192-3201, 2013
64. Sakamoto N, Akutsu H, Takano S, Yamamoto T, Matsumura A. Useful 'sliding-lock-knot'
technique for suturing dural patch to prevent cerebrospinal fluid leakage after extended97transsphenoidal surgery. Surg Neurol Int 4:19, 2013
65. Sakamoto N, Ishikawa E, Aoki K, Uemae Y, Komatsu Y, Matsumura A. Clinical OutcomesofIntracerebral

HemorrhageinHemodialysis

Patients.

World

Neurosurgdoi:

10.1016/j.wneu.2013.10.033., 2013
66. Sakamoto T, Obara N, Kurita N, Sakata-Yanagimoto M, Nishikii H, Yokoyama Y, Suzukawa
K, Hasegawa Y, Chiba S. Effectiveness and safety of rabbit anti-thymocyte globulin in
Japanese patients with aplastic anemia. Int J Hematol 98(3):319-322, 2013
67. Sakurai H, Morishima Y, Itoguchi N, Ohtsuka S, Yamadori I, Oto T, Ishii Y, Sakamoto T,
Noguchi M, Hizawa N. Broncho-bronchiolitis obliterans after living-donor lungtransplantation: a unique manifestation of chronic allograft rejection. Transplantation
96(4):e29-30, 2013
68. Sandoval Garrido FA, Tamiya N, Kashiwagi M, Miyata S, Okochi J, Moriyama Y, Yamaoka
Y, Takamuku K. Relationship between structural characteristics and outcome quality
indicators at health care facilities for the elderly requiring long-term care in Japan from anationwide survey. Geriatr Gerontol Int doi: 10.1111/ggi.12098, 2013
69. Sato M, Nakai Y, Tsurushima H, Shiigai M, Masumoto T, Matsumura A. Risk factors ofischemic lesions related to cerebral angiography and neuro-interventional procedures. Neurol
Med Chir (Tokyo) 53(6):381-387, 2013
70. Sato M, Takigawa T, Shiigai M, Tamura G, Masumoto T, Nakai Y, Zaboronok A,
Tsurushima H, Matsumura A. Spinal dural arteriovenous fistula with lipomyelodysplasia.
Neurol Med Chir (Tokyo) 53(2):107-109, 2013
71. Satoh T, Matsumoto K, Tanaka YO, Akiyama A, Nakao S, Sakurai M, Ochi H, Onuki M,
Minaguchi T, Sakurai H, Yoshikawa H. Incidence of venous thromboembolism before
treatment in cervical cancer and the impact of management on venous thromboembolism
after commencement of treatment. Thromb Res 131(4):e127-132, 2013
72. Satomi K, Morishita Y, Murata Y, Shiba-Ishii A, Sugano M, Noguchi M. Epidermal growth
factor receptor abnormalities in atypical teratoid/rhabdoid tumors and an unusual case withgene amplification. Pathol Res Pract 209(8):521-526, 2013
73. Shibui S, Narita Y, Mizusawa J, Beppu T, Ogasawara K, Sawamura Y, Kobayashi H,
Nishikawa R, Mishima K, Muragaki Y, Maruyama T, Kuratsu J, Nakamura H, Kochi M,
Minamida Y, Yamaki T, Kumabe T, Tominaga T, Kayama T, Sakurada K, Nagane M,
Kobayashi K, Nakamura H, Ito T, Yazaki T, Sasaki H, Tanaka K, Takahashi H, Asai A, Todo
T, Wakabayashi T, Takahashi J, Takano S, Fujimaki T, Sumi M, Miyakita Y, Nakazato Y, Sato98

A, Fukuda H, Nomura K. Randomized trial of chemoradiotherapy and adjuvant
chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly
diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305). Cancer ChemotherPharmacol 71(2):511-521, 2013
74. Takagi M, Piao J, Lin L, Kawaguchi H, Imai C, Ogawa A, Watanabe A, Akiyama K,
Kobayashi C, Mori M, Ko K, Sugimoto M, Mizutani S. Autoimmunity and persistent
RAS-mutated clones long after the spontaneous regression of JMML. Leukemia
27(9):1926-1928, 2013
75. Takano S, Kimu H, Tsuda K, Osuka S, Nakai K, Yamamoto T, Ishikawa E, Akutsu H,
Matsuda M, Matsumura A. Decrease in the apparent diffusion coefficient in peritumoral
edema for the assessment of recurrent glioblastoma treated by bevacizumab. Acta Neurochir
Suppl 118:185-189, 2013
76. Tasaka N, Matsumoto K, Satoh T, Minaguchi T, Onuki M, Ochi H, Tanaka YO, Sakata A,
Noguchi M, Yoshikawa H. Therapeutic effect of dienogest on adenosarcoma arising fromendometriosis: a case report. Springerplus 2:618, 2013
77. Teshiba R, Tajiri T, Sumitomo K, Masumoto K, Taguchi T, Yamamoto K. Identification of a
KEAP1 germline mutation in a family with multinodular goitre. PLoS One 8(5):e65141,
2013
78. Thunnissen E, Belien JA, Kerr KM, Chung JH, Flieder DB, Noguchi M, Yatabe Y, Hwang
DM, Lely RJ, Hartemink KJ, Meijer-Jorna LB, Tsao MS. In compressed lung tissue
microscopic sections of adenocarcinoma in situ may mimic papillary adenocarcinoma. Arch
Pathol Lab Med 137(12):1792-1797, 2013
79. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, Ishikawa Y,
Wistuba I, Flieder DB, Franklin W, Gazdar A, Hasleton PS, Henderson DW, Kerr KM,
Nakatani Y, Petersen I, Roggli V, Thunnissen E, Tsao M. Diagnosis of lung adenocarcinoma
in resected specimens: implications of the 2011 International Association for the Study ofLung Cancer/American Thoracic Society/European Respiratory Society classification. Arch
Pathol Lab Med 137(5):685-705, 2013	
 80. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, Ishikawa Y,
Wistuba I, Flieder DB, Franklin W, Gazdar A, Hasleton PS, Henderson DW, Kerr KM,
Petersen I, Roggli V, Thunnissen E, Tsao M. Diagnosis of lung cancer in small biopsies andcytology: implications of the 2011 International Association for the Study of Lung
Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol
99

Lab Med 137(5):668-684, 2013
81. Tsuda K, Akutsu H, Yamamoto T, Ishikawa E, Saito A, Nakai K, Takano S, Matsumura A.
Benign spinal meningioma without dural attachment presenting delayed CSF disseminationand malignant transformation. Brain Tumor Pathol 30(3):185-191, 2013
82. Tsuda K, Tsurushima H, Takano S, Tsuboi K, Matsumura A. Brain metastasis from papillary
thyroid carcinomas. Molecular and clinical oncology 1:817-819, 2013
83. Tsukada T, Hiramatsu Y, Kanemoto S, Lin L, Takahashi-Igari M, Horigome H, Matsushita S,
Sakakibara Y. Nontraditional placement of an implantable cardioverter-defibrillator in aheterotaxy patient after the completion of total cavopulmonary connection. J Artif Organs
16(4):495-497, 2013
84. Tsuruta W, Matsumaru Y, Hamada Y, Hayakawa M, Kamiya Y. Analysis of closed-cell
intracranial stent characteristics using cone-beam computed tomography with contrast
material. Neurol Med Chir (Tokyo) 53(6):403-408, 2013
85. Usui S, Minami Y, Shiozawa T, Iyama S, Satomi K, Sakashita S, Sato Y, Noguchi M.
Differences in the prognostic implications of vascular invasion between lung adenocarcinoma
and squamous cell carcinoma. Lung Cancer 82(3):407-412, 2013
86. Wang X, Ito A, Sogo Y, Hirose M, Oyane A, Tsurushima H. DNA-lipid-apatitie composite
layers enhance gene expression of mesenchymal stem cells. Mat Sci Eng C 33:512-518,
2013
87. Yamamoto T, Tsuboi K, Nakai K, Kumada H, Sakurai H, Matsumura A. Boron neutron
capture therapy for brain tumors. Transl Cancer Res 2:80-86, 2013
88. Yamaoka M, Akiyama M, Yokokawa Y, Terao Y, Yokoi K, Kato T, Fukushima T, Sakurai H,
Ida H. Multidisciplinary therapy including proton beam radiotherapy for a Ewing sarcoma
family tumor of maxillary sinus in a 4-year-old girl. Head Neck 35(12):E386-390, 2013
89. Yamazaki T, Sonobe M, Kato N, Kasuya H, Ikeda G, Nakamura K, Ito Y, Tsuruta W, Nakai
Y, Matsumura A. Endovascular coiling as the first treatment strategy for ruptured pericallosalartery aneurysms: results, complications, and follow up. Neurol Med Chir (Tokyo)
53(6):409-417, 2013
90. Yoshimatsu S, Hossain MI, Islam MM, Chisti MJ, Okada M, Kamoda T, Fukushima T,
Wagatsuma Y, Sumazaki R, Ahmed T. Hypophosphatemia among severely malnourishedchildren with sepsis in Bangladesh. Pediatr Int 55(1):79-84, 2013
91. Yoshimi A, Kamachi Y, Imai K, Watanabe N, Nakadate H, Kanazawa T, Ozono S,
Kobayashi R, Yoshida M, Kobayashi C, Hama A, Muramatsu H, Sasahara Y, Jakob M, Morio100

T, Ehl S, Manabe A, Niemeyer C, Kojima S. Wiskott-Aldrich syndrome presenting with aclinical picture mimicking juvenile myelomonocytic leukaemia. Pediatr Blood Cancer
60(5):836-841, 2013
92. Yoshinaga M, Ushinohama H, Sato S, Tauchi N, Horigome H, Takahashi H, Sumitomo N,
Kucho Y, Shiraishi H, Nomura Y, Shimizu W, Nagashima M. Electrocardiographic screeningof 1-month-old infants for identifying prolonged QT intervals. Circ Arrhythm Electrophysiol
6(5):932-938, 2013
93. Zaboronok A, Isobe T, Yamamoto T, Sato E, Takada K, Sakae T, Tsurushima H, Matsumura
A. Proton beam irradiation stimulates migration and invasion of human U87 malignant
glioma cells. J Radiat Res doi: 10.1093/jrr/rrt119, 2013
94. Zaboronok A, Tsurushima H, Yamamoto T, Isobe T, Takada K, Sakae T, Yoshida F,
Matsumura A. Size-dependent radiosensitization effects of gold nanoparticles on humanU251 malignant glioma cells. Nanosci nanotech lett 5(9):9904, 2013	 2) 英文以外の論文
1. Fukushima Hiroko, Fukushima Takashi, Hosaka Syo, Sakai Aiko, Suzuki Ryoko, Kobayashi
Chie, Iwabuchi Atsushi, Kamoda Tomohiro, Kato Keisuke, Koike Kazutoshi, Yamazaki Kai,
Fujisaki Hiroyuki, Hara Junichi, Ihara Satoshi, Yamamoto Tetsuya, Takano Shingo,
Masumoto Tomohiko, Mizumoto Masashi, Sakurai Hideyuki, Sumazaki Ryo. Brain Tumor
Suprasellar GCT and endocrinopathy: duration of symptoms and outcome. 日本小児血液・がん学会学術集会・日本小児がん看護学会・公益財団法人がんの子どもを守る会公開
シンポジウムプログラム総会号 55 回・11 回・18 回:145, 2013
2. Suzuki Ryoko, Fukushima Takashi, Kobayashi Chie, Fukushima Hiroko, Sakai Aiko, IshidaToshiaki, Ohsumi Tomoki, Ochiai Hidemasa, Kishimoto Seiji, Chin Motoaki, Hosogai
Ryosuke, Hosoya Yousuke, Watanabe Atsuko, Goto Chikashi, Masumoto Kouji, Mizumoto
Masashi, Sakurai Hideyuki, Sumazaki Ryo. Radiation Therapy Multidisciplinary therapy
including proton beam therapy for Ewing's sarcoma family of tumors. 日本小児血液・がん学会学術集会・日本小児がん看護学会・公益財団法人がんの子どもを守る会公開シンポジウムプログラム総会号 55 回・11 回・18 回:136, 2013
3. 今川和生, 福島敬, 鈴木涼子, 福島紘子, 小林千恵, 遠藤幹也, 前田美穂, 岩井艶子, 櫻井英幸, 須磨崎亮. 難治 Ewing 肉腫ファミリー腫瘍例への医療連携による陽子線併用療法は効果的である. 日本小児科学会雑誌 117(2):288, 2013
4. 大城佳子, 水本斉志, 石川仁, 奥村敏之, 坪井康次, 榮武二, 福島敬, 須磨崎亮, 増本幸二,
101金子道夫, 櫻井英幸. 固形腫瘍の治療の進歩 小児固形がんに対する陽子線治療. 日本
小児血液・がん学会雑誌 50(3):331-334, 2013
5. 酒井愛子, 小林千恵, 加藤啓輔, 鈴木涼子, 福島紘子, 福島敬, 神保教広, 増本幸二, 里見介史, 野口雅之, 大喜多肇, 森健作, 南学, 石川仁, 櫻井英幸, 須磨崎亮. 学校検尿を契機に診断され分子標的治療を施行中の Xp11 転座腎癌の 12 歳女児例. 日本小児血液・がん学会学術集会・日本小児がん看護学会・公益財団法人がんの子どもを守る会公開シンポジウムプログラム総会号 55 回・11 回・18 回:219, 2013
6. 竹内秀輔, 鈴木涼子, 福島敬, 福島紘子, 岩淵敦, 中尾朋平, 山口玲子, 工藤寿子, 杉田真太朗, 稲留征典, 佐藤豊実, 櫻井英幸, 金子道夫, 須磨崎亮. 進行期卵巣小細胞癌に対して集学的治療を施行した女児例. 日本小児血液・がん学会雑誌 50(2):269-273, 2013
7. 福島紘子, 福島敬, 後藤悠大, 田宮裕太郎, 中尾朋平, 吉見愛, 山口玲子, 五味詩絵奈, 鈴木涼子, 清水崇史, 林立申, 長谷川誠, 福島富士子, 中原智子, 須磨崎亮. 血友病児の生活支援における診療連携の役割と課題. 日本小児血液・がん学会雑誌 50(2):227-231, 2013
8. 藤代準, 小野健太郎, 星野論子, 新開統子, 瓜田泰久, 五藤周, 福島紘子, 福島敬, 金子道夫, 増本幸二. 小児進行副腎皮質癌の 1 例. 日本小児外科学会雑誌 49(2):246-250, 2013
9. 穂坂翔, 福島紘子, 福島敬, 酒井愛子, 鈴木涼子, 小林千恵, 井原哲, 山本哲哉, 高野晋吾,
増本	
 智彦, 水本斉志, 櫻井英幸, 須磨崎亮. 高度の視覚障害が治療介入により回復した
鞍上部 germ cell tumor の 2 例. 日本小児血液・がん学会学術集会・日本小児がん看護学会・公益財団法人がんの子どもを守る会公開シンポジウムプログラム総会号 55
回・11 回・18 回:293, 2013
10. 三春晶嗣, 清河信敬, 小林健一郎, 大喜多肇, 飯島一智, 森鉄也, 斎藤正博, 福島敬, 康勝
好, 真部淳, 菊地陽, 林泰秀, 小原明.【FCM によるリンパ系腫瘍への新たなアプローチ】
小児白血病 MRD 検出における 10 カラーフローサイトメトリーの有用性. Cytometry
Research 23(2):7-14, 2013	 3) 英文著書
1. Fujimori M, Hara H, Tsutsui H. CQ49. Does TSH Suppression Therapy After Surgery for
Differentiated Thyroid Carcinoma Improve Survival?; in "Treatment of Thyroid Tumor (1stedition)", Springer (Tokyo) 2013; pp289
2. Fujimori M, Hara H, Tsutsui H. CQ50. Is Serum Thyroglobulin Measurement Useful as aMarker of Carcinoma Recurrence After Surgery?; in "Treatment of Thyroid Tumor (1stedition)", Springer (Tokyo) 2013; pp291
3. Fujimori M, Hara H, Tsutsui H. CQ51. Are Measurements of Calcitonin and CEA Useful as
102

Markers of Recurrence After Surgery for Medullary	  Carcinoma?; in "Treatment of Thyroid
Tumor (1st edition)", Springer (Tokyo) 2013; pp293
4. Fujimori M, Hara H, Tsutsui H. CQ52. What Are Useful Imaging Studies to Detect Lesions of
Recurrence for Medullary Carcinoma with Elevation of Postoperative Calcitonin Level?; in"Treatment of Thyroid Tumor (1st edition)", Springer (Tokyo) 2013; pp295
5. Fujimori M, Hara H, Tsutsui H. CQ53. Is Chemotherapy for Advanced Thyroid Carcinoma
Effective?; in "Treatment of Thyroid Tumor (1st edition)", Springer (Tokyo) 2013; pp299
6. Fujimori M, Hara H, Tsutsui H. CQ54. Is Percutaneous Ethanol Injection Therapy Effective
for Local or Lymph Node Recurrence and Bone Metastasis?; in "Treatment of Thyroid Tumor(1st edition)", Springer (Tokyo) 2013; pp301
7. Fujimori M, Hara H, Tsutsui H. CQ55. Are Alternate Therapies Effective for Thyroid
Carcinoma?; in "Treatment of Thyroid Tumor (1st edition)", Springer (Tokyo) 2013; pp303
8. Fujimori M, Hara H, Tsutsui H. Column 19. How Long Should Patients with DifferentiatedThyroid Carcinoma Be Followed After Surgery?; in "Treatment of Thyroid Tumor (1stedition)", Springer (Tokyo) 2013; pp305
9. Olivares-Tirado P, Tamiya N. Trends and Factors in Japan's Long-Term Care Insurance
System: Japan's 10-year Experience. Springer (New York), 2013 (138 pages)4) 英文以外の著書
1. 阿久津博義. 神経内視鏡における止血・凝固機器; "先端医療シリーズ 45	
  臨床医のための最新脳神経外科” (編集 橋本信夫, 寺本明, 小川彰, 嘉山孝正), 2013
2. 上杉達, 増本幸二. 【一般外科医が知っておくべき小児患者への対応】代表的な症候の鑑別診断と初期対応	
  脱水; "臨床外科 68 巻 5 号”, 医学書院 (東京) 2013; pp526-529
3. 大城佳子, 水本斉志, 石川仁, 奥村敏之, 坪井康次, 榮武二, 福島敬, 須磨崎亮, 増本幸二,
金子道夫, 櫻井英幸. 固形腫瘍の治療の進歩 小児固形がんに対する陽子線治療; "日本
小児血液・がん学会雑誌 50 巻 3 号” (編集 学会誌編集委員会 嶋緑倫 他), 日本小児血液･がん学会 (東京) 2103; pp331-334
4. 大戸達之, 宮本信也.【子ども虐待予防	
  周産期から助産師ができること】 虐待発症のメカニズムと乳児虐待死亡例; "Birth2 巻 2 号”, 医学出版 (東京) 2013; pp25-31
5. 大戸達之, 宮本信也. 【クローズアップ	  子どもの心の発達】 子どもの年齢からみた心	  青年期における心の発達の特徴と問題への対応; "小児内科 45 巻 8 号”, 東京医学社 (東京) 2013; pp1461-1463
6. 五藤周, 増本幸二.【クローズアップ	  図説	
  最新の小児科処置】腸重積症に対する非103

観血的整復術; "小児内科 45 巻 4 号”, 東京医学社 (東京) 2013; pp731-735
7. 新開統子, 増本幸二. I 総論. 合併症対策と予防. カテーテル関連合併症; "小児の静脈栄
養マニュアル (第 1 版)” (編集 土岐彰, 増本幸二), メジカルビュー社 (東京) 2013;
pp84-97
8. 須磨崎亮, 長谷川誠, 和田宏来, 田川学.【前腸系ステム細胞】 非腫瘍性疾患の疾患理解	
 嚢胞性線維症(Cystic fibrosis)とその肝病変; "肝・胆・膵 66 巻 4 号”, 株式会社アークメ
ディア (東京) 2013; pp661-670
9. 田川学, 須磨崎亮.【変貌を遂げつつあるわが国の予防接種体制】 A 型肝炎ウイルスワ
クチン・B 型肝炎ウイルスワクチン; "日本医師会雑誌 142 巻 8 号”, 日本医師会 (東京)2013; pp1773-1775
10. 田川学, 須磨崎亮.【予防接種 Q&A】 予防接種全般	
 医療従事者へのワクチン接種	
 医
学生・看護学生	
 医学生・看護学生の予防接種について、どのように対処するのが望ましいでしょうか; "小児内科 45 巻増刊”, 東京医学社 (東京) 2013; pp193-194
11. 田川学, 須磨崎亮.【予防接種 Q&A】 予防接種全般	
 医療従事者へのワクチン接種	
 医
師以外の病院職員	
 病院の管理体制のなかに、職員の予防接種に関する決まりをつくっ ているところはありますか; "小児内科 45 巻増刊”, 東京医学社 (東京) 2013;
pp195-196
12. 田宮菜奈子, 松澤明美. 要介護者の状況改善と介護家族の負担軽減に向けたインフラ整備−日本初の全国レベルの実証的取り組みの結果から―; "家族のための総合政策―
家族と職業の両立―” (編集 本澤巳代子, ウタ・マイヤー＝グレーヴェ), 信山社 (東京)2013; pp235-246
13. 田宮菜奈子, 宮下裕美子. グローバルエイジング : アジアの一員として; "ヒューマン・セキュリティ : ヒューマン・ケアの視点から” (編集 松田ひとみ, 大久保一郎, 岩浅昌幸, 柏木志保), 医学評論社 (東京) 2013; pp122-136
14. 中居康展. ②セットアップ	
  "特集	  よくわかる脳血管内治療. BRAIN 3(5)”, 2013; pp366-370
15. 濱田吉則, 増本幸二. Hirschsprung 病類縁疾患：Segmental dilatation of intestine; "厚生労働科学研究費補助金	
 難治性疾患克服研究事業，小児期からの消化器系希少難治性疾
患群の包括的調査研究とシームレスなガイドライン作成，平成 24 年度総括･分担研究
報告書” (編集 田口智章), 厚生労働省 (東京) 2013; pp38-43
16. 福島紘子, 長谷川雄一.【理解して出そう	  小児の検査-オーダー・手技・解釈】 血液	
 Coombs 試験; "小児科診療 76 巻増刊”, 診断と治療社 (東京) 2013; pp146-151
17. 藤代準, 増本幸二. Ⅰ. 基本手技. CAPD; "スタンダード小児外科手術	
  押さえておきた104

い手技のポイント (第 1 版)” (監修 田口智章, 岩中督, 編集 猪股裕紀洋, 黒田達夫, 奥山宏臣), メジカルビュー社 (東京) 2013; pp22-25
18. 増本幸二. 小児 NST 病態栄養シリーズ：在宅栄養のすべて	
  経腸栄養剤のトラブルと 対 策‐微 量 栄 養 素 欠 乏 症; "小 児 外 科 45 巻 12 号”, 東 京 医 学 社 (東 京) 2013;
pp1339-1345
19. 増本幸二. 臨床栄養と亜鉛	  栄養管理において注意すべき微量元素; "亜鉛栄養治療 4
巻 1 号”, 近畿亜鉛栄養治療研究会 (京都) 2013; pp28-36
20. 増本幸二. Ⅲ. 小児の栄養管理. 小児の栄養アセスメント; "静脈経腸栄養ガイドライン：静脈・経腸栄養を適正に実施するためのガイドライン (第 3 版)” (編集 日本静脈経腸栄養学会), 照林社 (東京) 2013; pp178-179
21. 増本幸二. Ⅲ. 小児の栄養管理. 新生児の栄養管理の原則; "静脈経腸栄養ガイドライン：静脈・経腸栄養を適正に実施するためのガイドライン (第 3 版)” (編集 日本静脈経腸栄養学会), 照林社 (東京) 2013; pp199-200
22. 増本幸二. Ⅲ. 小児の栄養管理. 新生児の静脈栄養; "静脈経腸栄養ガイドライン：静脈・経腸栄養を適正に実施するためのガイドライン (第 3 版)” (編集 日本静脈経腸栄養学会), 照林社 (東京) 2013; pp201-210
23. 増本幸二. Ⅲ. 小児の栄養管理. 新生児の結腸栄養; "静脈経腸栄養ガイドライン：静脈・経腸栄養を適正に実施するためのガイドライン (第 3 版)” (編集 日本静脈経腸栄養学会), 照林社 (東京) 2013; pp211-214
24. 増本幸二. Ⅴ. 小児の病態別栄養管理. 慢性肺疾患; "静脈経腸栄養ガイドライン：静脈・経腸栄養を適正に実施するためのガイドライン (第 3 版)” (編集 日本静脈経腸栄養学会), 照林社 (東京) 2013; pp407-409
25. 増本幸二. Ⅴ. 小児の病態別栄養管理. 慢性腎臓病; "静脈経腸栄養ガイドライン：静脈・経腸栄養を適正に実施するためのガイドライン (第 3 版)” (編集 日本静脈経腸栄養学会), 照林社 (東京) 2013; pp410-414
26. 増本幸二. Ⅰ. 基本手技. 中心静脈路の確保，; "スタンダード小児外科手術	
  押さえておきたい手技のポイント (第 1 版)” (監修 田口智章, 岩中督, 編集 猪股裕紀洋, 黒田達夫, 奥山宏臣), メジカルビュー社 (東京) 2013; pp12-19
27. 増本幸二. Ⅰ. 基本手技. ECMO; "スタンダード小児外科手術	
 押さえておきたい手技のポイント (第 1 版)” (監修 田口智章, 岩中督, 編集 猪股裕紀洋, 黒田達夫, 奥山宏臣), メ
ジカルビュー社 (東京) 2013; pp20-21
28. 増本幸二. Ⅴ. 腹部. 腸管延長術(STEP 法); "スタンダード小児外科手術	
  押さえておき
たい手技のポイント (第 1 版)” (監修 田口智章, 岩中督, 編集 猪股裕紀洋, 黒田達夫, 奥105山宏臣), メジカルビュー社 (東京) 2013; pp181-183
29. 松村明, 松田真秀. 脳神経外科分野における陽子線治療の適用; "定位的放射線治療
17”, 2013; pp11-19
30. 松村明, 山本哲哉.小児脳腫瘍に対する放射線治療; " 小児脳神経外科診療ガイドブック”メジカルビュー社 2013; pp14-21
31. 水本斉志. 第 7 章. 放射線治療; "肝癌診療ガイドライン 2013 年版 (第 3 版)” (編集 日本
肝臓学会), 金原出版 (東京) 2013
32. 室井愛. 頭部外傷（偶発性）; "小児科学レクチャー	  読影の極意を学ぶ	  小児の画像診断—頭部・頭頸部編—Q&A 3(4)” (編集 河野達夫), 2013; pp 822-828
33. 和田宏来, 須磨崎亮. 【小児用ワクチン Update】 予防接種各論	
  A 型肝炎ウイルスワ
クチン	
  最近の知見; "医学のあゆみ 244 巻 1 号”, 医歯薬出版株式会社 (東京) 2013;
pp112-118106

血小板による新規肝疾患治療法開発	 1) 英文論文
1. Akashi Y, Oda T, Ohara Y, Miyamoto R, Hashimoto S, Enomoto T, Yamada K, Kobayashi A,
Fukunaga K, Ohkochi N. Histological advantages of the tumor graft: a murine model
involving transplantation of human pancreatic cancer tissue fragments. Pancreas
42(8):1275-1282, 2013
2. Kudo T, Sato T, Hagiwara K, Kozuma Y, Yamaguchi T, Ikehara Y, Hamada M, Matsumoto K,
Ema M, Murata S, Ohkohchi N, Narimatsu H, Takahashi S. C1galt1-deficient mice exhibit
thrombocytopenia due to abnormal terminal differentiation of megakaryocytes. Blood
122(9):1649-1657, 2013
3. Kurokawa T, Yamamoto M, Ueda T, Enomoto T, Inoue K, Uchida A, Kikuchi K, Ohkohchi N.
Gastric bronchogenic cyst histologically diagnosed after laparoscopic excision: report of acase. Int Surg 98(4):455-460, 2013
4. Maruyama T, Murata S, Takahashi K, Tamura T, Nozaki R, Ikeda N, Fukunaga K, Oda T,
Sasaki R, Ohkohchi N. Platelet transfusion improves liver function in patients with chronic
liver disease and cirrhosis. Tohoku J Exp Med 229(3):213-220, 2013
5. Matsuda A, Kuno A, Matsuzaki H, Kawamoto T, Shikanai T, Nakanuma Y, Yamamoto M,
Ohkohchi N, Ikehara Y, Shoda J, Hirabayashi J, Narimatsu H. Glycoproteomics-based cancer
marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for highspecific glyco-diagnosis of cholangiocarcinoma. J Proteomics 85:1-11, 2013
6. Murata S, Shiragami R, Kosugi C, Tezuka T, Yamazaki M, Hirano A, Yoshimura Y, Suzuki
M, Shuto K, Ohkohchi N, Koda K. Antitumor effect of 1, 8-cineole against colon cancer.
Oncol Rep 30(6):2647-2652, 2013
7. Nowatari T, Murata S, Fukunaga K, Ohkohchi N. Role of platelets in chronic liver disease
and acute liver injury. Hepatol Res doi: 10.1111/hepr.12205, 2013
8. Nozaki R, Murata S, Nowatari T, Maruyama T, Ikeda N, Kawasaki T, Fukunaga K, Ohkohchi
N. Effects of thrombopoietin on growth of hepatocellular carcinoma: Is thrombopoietin
therapy for liver disease safe or not? Hepatol Res 43(6):610-620, 2013
9. Ogawa K, Kondo T, Tamura T, Matsumura H, Fukunaga K, Oda T, Ohkohchi N. Influence ofKupffer cells and platelets on ischemia-reperfusion injury in mild steatotic liver. World J
Gastroenterol 19(9):1396-1404, 2013
10. Oh S, Tanaka K, Warabi E, Shoda J. Exercise reduces inflammation and oxidative stress in
obesity-related liver diseases. Med Sci Sports Exerc 45(12):2214-2222, 2013107

11. Ohara Y, Oda T, Sugano M, Hashimoto S, Enomoto T, Yamada K, Akashi Y, Miyamoto R,
Kobayashi A, Fukunaga K, Morishita Y, Ohkohchi N. Histological and prognostic importanceof CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer. Cancer Sci
104(8):1127-1134, 2013
12. Okada K, Warabi E, Sugimoto H, Horie M, Gotoh N, Tokushige K, Hashimoto E,
Utsunomiya H, Takahashi H, Ishii T, Yamamoto M, Shoda J. Deletion of Nrf2 leads to rapid
progression of steatohepatitis in mice fed atherogenic plus high-fat diet. J Gastroenterol
48(5):620-632, 2013
13. Oshiro Y, Sasaki R, Fukunaga K, Kondo T, Oda T, Takahashi H, Ohkohchi N.
Inflammation-based prognostic score is a useful predictor of postoperative outcome inpatients with extrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 20(3):389-395,
2013
14. Oshiro Y, Sasaki R, Nasu K, Ohkohchi N. A novel preoperative fusion analysis using
three-dimensional MDCT combined with three-dimensional MRI for patients with hilar
cholangiocarcinoma. Clin Imaging 37(4):772-774, 2013
15. Oshiro Y, Sasaki R, Takeguchi T, Ibukuro K, Ohkohchi N. Analysis of the caudate arterywiththree-dimensional

imaging.

J

Hepatobiliary

PancreatSci

doi:10.1007/s00534-012-0589-4, 2013	  	 16. Oshiro Y, Takahashi K, Sasaki R, Kondo T, Sakashita S, Ohkohchi N. Adjuvant surgery foradvanced extrahepatic cholangiocarcinoma. World J Gastroenterol 19(40):6934-6938, 201317. Shiragami R, Murata S, Kosugi C, Tezuka T, Yamazaki M, Hirano A, Yoshimura Y, Suzuki
M, Shuto K, Koda K. Enhanced antitumor activity of cerulenin combined with oxaliplatin inhuman colon cancer cells. Int J Oncol 43(2):431-438, 2013
18. Takahashi A, Yamamoto Y, Yasunaga M, Koga Y, Kuroda J, Takigahira M, Harada M, Saito
H, Hayashi T, Kato Y, Kinoshita T, Ohkohchi N, Hyodo I, Matsumura Y. NC-6300, an
epirubicin-incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity
of epirubicin. Cancer Sci 104(7):920-925, 2013
19. Takahashi K, Kozuma Y, Suzuki H, Tamura T, Maruyama T, Fukunaga K, Murata S,
Ohkohchi N. Human platelets promote liver regeneration with Kupffer cells in SCID mice. J
Surg Res 180(1):62-72, 2013
20. Takahashi K, Murata S, Fukunaga K, Ohkohchi N. Human platelets inhibit liver fibrosis insevere combined immunodeficiency mice. World J Gastroenterol 19(32):5250-5260, 2013
21. Takahashi K, Murata S, Ohkohchi N. Novel therapy for liver regeneration by increasing the108number of platelets. Surg Today 43(10):1081-1087, 2013
22. Takahashi K, Murata S, Ohkohchi N. Platelet therapy:A novel strategy for liver
regeneration, anti-fibrosis,and anti-apoptosis. World J Surg Proced 3(3):29-36, 2013
23. Takahashi K, Terashima H, Kohno K, Ohkohchi N. A stand-alone synbiotic treatment for theprevention of d-lactic acidosis in short bowel syndrome. Int Surg 98(2):110-113, 2013
24. Takahashi K, Tsukamoto S, Saito K, Ohkohchi N, Hirayama K. Complete response tomultidisciplinary therapy in a patient with primary gastric choriocarcinoma. World J
Gastroenterol 19(31):5187-5194, 2013
25. Tamura T, Kondo T, Ogawa K, Fukunaga K, Ohkohchi N. Protective effect of heme
oxygenase-1 on hepatic ischemia-reperfusion injury through inhibition of platelet adhesion to
the sinusoids. J Gastroenterol Hepatol 28(4):700-706, 2013
26. Yoneyama S, Terashima H, Yamaguchi R, Tadano S, Ohkohchi N. The manner of theinflammation-boosting effect caused by acute hyperglycemia secondary to overfeeding andthe effects of insulin therapy in a rat model of sepsis. J Surg Res 185(1):380-387, 2013	 2) 英文以外の論文
1. 下村治, 福永潔, 中野順隆, 野渡剛之, 小林昭彦, 小田竜也, 佐々木亮孝, 山田健二, 野口
雅之, 大河内信弘. 肝切除後極めて急激な再発を認めた肉腫様変化を伴う G-CSF 産生
肝内胆管癌の 1 例. 日本消化器外科学会雑誌 46(1):41-49, 2013	 3) 英文著書
1. Maruyama T, Kawasaki T, Hisakura K, Murata S, Matsuo R, Ohkohchi N. in "New therapy
for liver disease by platelets (1st edition)", Nova Biomedical (Berlin) 2013; E-book109シグナル伝達と疾患	 1) 英文論文	
 1. Abiko Y, Kumagai Y. Interaction of Keap1 modified by 2-tert-butyl-1,4-benzoquinone with
GSH: evidence for S-transarylation. Chem Res Toxicol 26(7):1080-1087, 2013
2. Ali WH, Chen Q, Delgiorno KE, Su W, Hall JC, Hongu T, Tian H, Kanaho Y, Di Paolo G,
Crawford HC, Frohman MA. Deficiencies of the lipid-signaling enzymes phospholipase D1
and D2 alter cytoskeletal organization, macrophage phagocytosis, and cytokine-stimulated
neutrophil recruitment. PLoS One 8(1):e55325, 2013
3. Ano S, Morishima Y, Ishii Y, Yoh K, Yageta Y, Ohtsuka S, Matsuyama M, Kawaguchi M,
Takahashi S, Hizawa N. Transcription factors GATA-3 and RORgammat are important for
determining the phenotype of allergic airway inflammation in a murine model of asthma. J
Immunol 190(3):1056-1065, 2013
4. Arai S, Maehara N, Iwamura Y, Honda S, Nakashima K, Kai T, Ogishi M, Morita K,
Kurokawa J, Mori M, Motoi Y, Miyake K, Matsuhashi N, Yamamura K, Ohara O, Shibuya A,
Wakeland EK, Li QZ, Miyazaki T. Obesity-associated autoantibody production requires AIM
to retain the immunoglobulin M immune complex on follicular dendritic cells. Cell Rep
3(4):1187-1198, 2013
5. Beei C, Iwamoto N, Inaba T, Shinkai Y, Kumagai Y. Activation of EGFR/MEK/ERK/AP-1
signaling mediated by 1,2-naphthoquinone, an atmospheric electrophile, in human pulmonary
A549 cells. J Toxicol Sci 38(5):793-797, 2013
6. Danisch S, Qiu Q, Seth S, Ravens I, Dorsch M, Shibuya A, Shibuya K, Forster R, Bernhardt
G. CD226 interaction with CD155 impacts on retention and negative selection of CD8
positive thymocytes as well as T cell differentiation to follicular helper cells in Peyer's
Patches. Immunobiology 218(2):152-158, 2013
7. Georgiev H, Danisch S, Chambers BJ, Shibuya A, Forster R, Bernhardt G. To the editor:
TIGIT

versus

CD226:

hegemonyor

coexistence?

Eur

J

Immunoldoi:

10.1002/eji.201343925, 2013
8. Hamanaka S, Ooehara J, Morita Y, Ema H, Takahashi S, Miyawaki A, Otsu M, Yamaguchi T,
Onodera M, Nakauchi H. Generation of transgenic mouse line expressing Kusabira Orange
throughout body, including erythrocytes, by random segregation of provirus method.
Biochem Biophys Res Commun 435(4):586-591, 2013
9. Hasegawa Y, Daitoku Y, Sekiguchi K, Tanimoto Y, Mizuno-Iijima S, Mizuno S, Kajiwara N,
Ema M, Miwa Y, Mekada K, Yoshiki A, Takahashi S, Sugiyama F, Yagami K. Novel
110

ROSA26 Cre-reporter knock-in C57BL/6N mice exhibiting green emission before and red
emission after Cre-mediated recombination. Exp Anim 62(4):295-304, 2013
10. Ido K, Ohwada T, Yasutomi E, Yoshinaga T, Arai T, Kato M, Sawada K. Screening quality
for Ca2+-activated potassium channel in IonWorks Quattro is greatly improved by using
BAPTA-AM and ionomycin. J Pharmacol Toxicol Methods 67(1):16-24, 2013
11. Kanaho Y, Sato T, Hongu T, Funakoshi Y. Molecular mechanisms of fMLP-induced
superoxide generation and degranulation in mouse neutrophils. Adv Biol Regul
53(1):128-134, 2013
12. Katsumata T, Oishi H, Sekiguchi Y, Nagasaki H, Daassi D, Tai PH, Ema M, Kudo T,
Takahashi S. Bioluminescence imaging of β cells and intrahepatic insulin gene activity undernormal and pathological conditions. PLoS One 8(4):e60411, 2013
13. Kimura Y, Irie K, Irie K. Pbp1 is involved in Ccr4- and Khd1-mediated regulation of cell
growth through association with ribosomal proteins Rpl12a and Rpl12b. Eukaryot Cell
12(6):864-874, 2013
14. Koizumi R, Taguchi K, Hisamori M, Kumagai Y. Interaction of 9,10-phenanthraquinone
with dithiol causes oxidative modification of Cu,Zn-superoxide dismutase (SOD) throughredox cycling. J Toxicol Sci 38(3):317-324, 2013
15. Kudo T, Sato T, Hagiwara K, Kozuma Y, Yamaguchi T, Ikehara Y, Hamada M, Matsumoto
K, Ema M, Murata S, Ohkohchi N, Narimatsu H, Takahashi S. C1galt1-deficient mice exhibit
thrombocytopenia due to abnormal terminal differentiation of megakaryocytes. Blood
122(9):1649-1657, 2013
16. Kumagai Y, Kanda H, Shinkai Y, Toyama T. The role of the Keap1/Nrf2 pathway in thecellular response to methylmercury. Oxid Med Cell Longev 2013:848279, 2013
17. Nagai K, Tahara-Hanaoka S, Morishima Y, Tokunaga T, Imoto Y, Noguchi E, Kanemaru K,
Imai M, Shibayama S, Hizawa N, Fujieda S, Yamagata K, Shibuya A. Expression andfunction of Allergin-1 on human primary mast cells. PLoS One 8(10):e76160, 2013
18. Nguyen TT, Kim YM, Kim TD, Le OT, Kim JJ, Kang HC, Hasegawa H, Kanaho Y, Jou I,
Lee SY. Phosphatidylinositol 4-phosphate 5-kinase α facilitates Toll-like receptor 4-mediatedmicroglial

inflammation

throughregulation

of

the

Toll/interleukin-1

receptordomain-containing adaptor protein (TIRAP) location. J Biol Chem 288(8):5645-5659, 2013
19. Nishimoto M, Katano M, Yamagishi T, Hishida T, Kamon M, Suzuki A, Hirasaki M,
Nabeshima Y, Nabeshima Y, Katsura Y, Satta Y, Deakin JE, Graves JA, Kuroki Y, Ono R,
Ishino F, Ema M, Takahashi S, Kato H, Okuda A. In vivo function and evolution of the111

eutherian-specific pluripotency marker UTF1. PLoS One 8(7):e68119, 2013
20. Oishi H, Tsubaki T, Miyazaki T, Ono M, Nose M, Takahashi S. A bacterial artificial
chromosometransgenewithpolymorphic

Cd72

inhibits

thedevelopmentof

glomerulonephritis and vasculitis in MRL-Faslpr lupus mice. J Immunol 190(5):2129-2137,
2013
21. Okita Y, Kamoshida A, Suzuki H, Itoh K, Motohashi H, Igarashi K, Yamamoto M, Ogami T,
Koinuma D, Kato M. Transforming growth factor-beta induces transcription factors MafK
and Bach1 to suppress expression of the heme oxygenase-1 gene. J Biol Chem
288(28):20658-20667, 2013
22. Sanematsu F, Nishikimi A, Watanabe M, Hongu T, Tanaka Y, Kanaho Y, Cote JF, Fukui Y.
Phosphatidic acid-dependent recruitment and function of the Rac activator DOCK1 during
dorsal ruffle formation. J Biol Chem 288(12):8092-8100, 2013
23. Sato T, Hongu T, Sakamoto M, Funakoshi Y, Kanaho Y. Molecular mechanisms of
N-formyl-methionyl-leucyl-phenylalanine-induced superoxide generation and degranulationin mouse neutrophils: phospholipase D is dispensable. Mol Cell Biol 33(1):136-145, 201324. Shindo R, Kakehashi H, Okumura K, Kumagai Y, Nakano H. Critical contribution ofoxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation. Biochem
Biophys Res Commun 436(2):212-216, 2013
25. Shinkai Y, Nakajima S, Eiguren-Fernandez A, Stefano ED, Schmitz DA, Froines JR, Cho
AK, Kumagai Y. Ambient vapor samples activate the Nrf2-ARE pathway in human bronchial
epithelial BEAS-2B cells. Environ Toxicol doi:10.1002/tox.21860, 2013
26. Shinkai Y, Yamanaka I, Duong HH, Quynh NT, Kanaho Y, Kumagai Y. Garcinia vilersiana
bark extract activates the Nrf2/HO-1 signaling pathway in RAW264.7 cells. J Toxicol Sci
38(6):875-878, 2013
27. Takagaki K, Satoh K, Honda S, Shibuya A. Molecular characterization of the dimer
formation of Fcalpha/mu receptor (CD351). Mol Immunol 56(1-2):23-27, 2013
28. Takashima O, Tsuruta F, Kigoshi Y, Nakamura S, Kim J, Katoh MC, Fukuda T, Irie K, Chiba
T. Brap2 regulates temporal control of NF-κB localization mediated by inflammatory
response. PLoS One 8(3):e58911, 2013
29. Toyama T, Shinkai Y, Kaji T, Kumagai Y. Convenient method to assess chemical
modification of protein thiols by electrophilic metals. J Toxicol Sci 38(3):477-484, 2013
30. Yamashita Y, Abe F, Hirochika R, Tahara-Hanaoka S, Shibuya A, Shibuya K. Establishment
and characterization of a novel anti-DNAM-1 monoclonal antibody. Monoclon Antib
112

Immunodiagn Immunother 32(1):60-64, 2013
31. Yamazaki M, Yamauchi Y, Goshima Y, Kanaho Y. Phosphatidylinositol 4-phosphate
5-kinase β regulates growth cone morphology and semaphorin 3A-triggered growth cone
collapse in mouse dorsal root ganglion neurons. Neurosci Lett 547:59-64, 2013
32. Yoon JH, Jung SM, Park SH, Kato M, Yamashita T, Lee IK, Sudo K, Nakae S, Han JS, Kim
OH, Oh BC, Sumida T, Kuroda M, Ju JH, Jung KC, Park SH, Kim DK, Mamura M. Activin
receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of
Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes. EMBO Mol Med
5(11):1720-1739, 2013
33. Yoshizawa Y, Honda S, Shibuya A. Involvement of Fcα/µR (CD351) in autoantibody
production. Mol Immunol doi: 10.1016/j.molimm.2013.10.002, 2013	 2) 英文以外の論文
1. 長谷川潤, 金保安則. 哺乳動物個体から見るホスファチジルイノシトール 4-リン酸 5キナーゼの生理機能. 生化学 85(5):362-367, 2013
2. 本宮綱記, 船越祐司, 金保安則. リン脂質代謝酵素ホスホリパーゼ D2 は腫瘍形成を抑制する. 脂質生化学研究 55:64-66, 2013	 4) 英文以外の著書
1. 小田ちぐさ, 渋谷彰. 第 1 章	  敗血症の基礎研究の進め方	
  第 3 節[3]免疫学的にみた
敗血症の病態と研究動向; "敗血症の診断／治療の実状と病態・メガニズムをふまえた開発戦略 (第 1 版)” (編集 金原粲) (株)技術情報協会 (東京) 2013.08; pp96-100
2. 熊谷嘉人. 酸化ストレスと親電子シグナル制御; "医学のあゆみ「活性酸素 – 基礎から病態解明・制御まで」247 巻 9 号” (編集 医歯薬出版)	
 医歯薬出版 (東京) 2013; pp787-793

113前臨床がん研究	 1) 英文論文
1. Abe A, Minaguchi T, Ochi H, Onuki M, Okada S, Matsumoto K, Satoh T, Oki A, Yoshikawa
H. PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian
clear cell carcinoma. Hum Pathol 44(2):199-207, 2013
2. Akashi Y, Oda T, Ohara Y, Miyamoto R, Hashimoto S, Enomoto T, Yamada K, Kobayashi A,
Fukunaga K, Ohkochi N. Histological advantages of the tumor graft: a murine model
involving transplantation of human pancreatic cancer tissue fragments. Pancreas
42(8):1275-1282, 2013
3. Akiyama-Abe A, Minaguchi T, Nakamura Y, Michikami H, Shikama A, Nakao S, Sakurai M,
Ochi H, Onuki M, Matsumoto K, Satoh T, Oki A, Yoshikawa H. Loss of PTEN expression isan independent predictor of favourable survival in endometrial carcinomas. Br J Cancer
109(6):1703-1710, 2013
4. Donoyama N, Satoh T, Hamano T.	
  Effects of Anma massage therapy (Japanese massage) for
gynecological cancer survivors: study protocol for a randomized controlled trial. Trials
14:233, 2013
5. Eto T, Saito T, Shimokawa M, Hatae M, Takeshima N, Kobayashi H, Kasamatsu T,
Yoshikawa H, Kamura T, Konishi I. Status of treatment for the overall population of patientswith stage IVb endometrial cancer, and evaluation of the role of preoperative chemotherapy:
a retrospective multi-institutional study of 426 patients in Japan. Gynecol Oncol
131(3):574-580, 2013
6. Fujii T, Takatsuka N, Nagata C, Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi T, Kawana
K, Mitsuhashi A, Hirai Y, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T,
Yoshikawa H. Association between carotenoids and outcome of cervical intraepithelial
neoplasia: a prospective cohort study. Int J Clin Oncol 18(6):1091-1101, 2013
7. Fukuda K, Kurita N, Sakamoto T, Nishikii H, Okoshi Y, Sugano M, Chiba S. Post-transplant
gastric antral vascular ectasia after intra-venous busulfan regimen. Int J Hematol98(1):135-138, 2013
8. Goto Y, Hiramatsu Y, Ageyama N, Sato S, Kanemoto S, Sato Y, Sakakibara Y.
Cardiopulmonary bypass induces recruitment of bone marrow-derived leukocytes to thelungs in monkeys. Ann Thorac Surg doi: 10.1016/j.athoracsur.2013.10.072, 2013
9. Ichinose M, Fujimoto A, Osuga Y, Minaguchi T, Kawana K, Yano T, Kozuma S. The
influence of infertility treatment on the prognosis of endometrial cancer and atypical complex
114

endometrial hyperplasia. Int J Gynecol Cancer 23(2):288-293, 2013
10. Ikeda A, Miyagawa T, Kurobe M, Uchida M, Kojima T, Tsutsumi M, Ito S, Sugita S,
Nishiyama H. [A case of metastatic malignant melanoma of the urinary bladder]. Hinyokika
Kiyo 59(9):579-582, 2013
11. Inai H, Kawai K, Ikeda A, Ando S, Kimura T, Oikawa T, Onozawa M, Miyazaki J, Uchida
K, Nishiyama H. Risk factors for chronic kidney disease after chemotherapy for testicularcancer. Int J Urol 20(7):716-722, 2013
12. Inai H, Kawai K, Kojima T, Joraku A, Shimazui T, Yamauchi A, Miyagawa T, Endo T,
Fukuhara Y, Miyazaki J, Uchida K, Nishiyama H. Oncological outcomes of metastatic
testicular cancers under centralized management through regional medical network. Jpn J
Clin Oncol 43(12):1249-1254, 2013
13. Ito H, Matsushita S, Hyodo K, Sato Y, Sakakibara Y. Using synchrotron radiation
angiography with a highly sensitive detector to identify impaired peripheral perfusion in rat
pulmonary emphysema. J Synchrotron Radiat 20(Pt 2):376-382, 2013
14. Ito H, Matsushita S, Ishikawa S, Goto Y, Sakai M, Onizuka M, Sato Y, Sakakibara Y.
Significant correlation between endothelial nitric oxide synthase (eNOS) expression andalveolar repair in elastase-induced rat pulmonary emphysema. Surg Today 43(3):293-299,
2013
15. Iwakawa R, Takenaka M, Kohno T, Shimada Y, Totoki Y, Shibata T, Tsuta K, Nishikawa R,
Noguchi M, Sato-Otsubo A, Ogawa S, Yokota J. Genome-wide identification of genes withamplification and/or fusion in small cell lung cancer. Genes Chromosomes Cancer
52(9):802-816, 2013
16. Kajita Y, Kato T, Jr., Tamaki S, Furu M, Takahashi R, Nagayama S, Aoyama T, Nishiyama
H, Nakamura E, Katagiri T, Nakamura Y, Ogawa O, Toguchida J. The transcription factor
Sp3 regulates the expression of a metastasis-related marker of sarcoma, actin
filament-associated protein 1-like 1 (AFAP1L1). PLoS One 8(1):e49709, 2013
17. Kako S, Kanamori H, Kobayashi N, Shigematsu A, Nannya Y, Nakamae M, Shigeno K,
Suzukawa K, Takeuchi M, Tsuzuki M, Usuki K, Hatanaka K, Ogawa K, Mitani K, Nawa Y,
Hatta Y, Mizuno I, Kanda Y. Outcome after first relapse in adult patients with Philadelphia
chromosome-negative acute lymphoblastic leukaemia. Br J Haematol 161(1):95-103, 2013
18. Kanda Y, Oshima K, Kako S, Fukuda T, Uchida N, Miyamura K, Kondo Y, Nakao S,
Nagafuji K, Miyamoto T, Kurokawa M, Okoshi Y, Chiba S, Ohashi Y, Takaue Y, Taniguchi S.
In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell115

transplantation: Combined results of two studies on aplastic anemia and HLA-mismatchedhaploidentical transplantation. Am J Hematol 88(4):294-300, 2013
19. Katsumata N, Yoshikawa H, Kobayashi H, Saito T, Kuzuya K, Nakanishi T, Yasugi T,
Yaegashi N, Yokota H, Kodama S, Mizunoe T, Hiura M, Kasamatsu T, Shibata T, Kamura T.
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vsradical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology
Group trial (JCOG 0102). Br J Cancer 108(10):1957-1963, 2013
20. Katsutani S, Tomiyama Y, Kimura A, Miyakawa Y, Okamoto S, Okoshi Y, Ninomiya H,
Kosugi H, Ishii K, Ikeda Y, Hattori T, Katsura K, Kanakura Y. Oral eltrombopag for up to
three years is safe and well-tolerated in Japanese patients with previously treated chronic
immune thrombocytopenia: an open-label, extension study. Int J Hematol 98(3):323-330,
2013
21. Kawai K, Ichioka D, Inai H, Miyazaki J, Nishiyama H. Assessment and management of
renal

impairmentinchemotherapy

forurogenitalcancer.

Jpn

J

Clin

Oncol

43(11):1055-1063, 2013
22. Kawai K, Miyazaki J, Joraku A, Nishiyama H, Akaza H. Bacillus Calmette-Guerin (BCG)
immunotherapy for bladder cancer: current understanding and perspectives on engineered
BCG vaccine. Cancer Sci 104(1):22-27, 2013
23. Kawamura T, Usui J, Kaseda K, Takada K, Ebihara I, Ishizu T, Iitsuka T, Sakai K, Takemura
K, Kobayashi M, Koyama A, Kanemoto K, Sumazaki R, Uesugi N, Noguchi M, Nagata M,
Suka M, Yamagata K. Primary membranoproliferative glomerulonephritis on the decline:
decreased rate from the 1970s to the 2000s in Japan. Clin Exp Nephrol 17(2):248-254, 2013
24. Kikuchi M, Nakasone H, Mitani K, Gotoh M, Kobayashi A, Kurita N, Saito T, Sato K,
Kanda Y. Retrospective assessment of secondary prophylaxis for invasive aspergillosis inneutropenic hematology patients and identification of risk factors for relapse of fungal
disease. Scand J Infect Dis 45(7):531-536, 2013
25. Kimura T, Onozawa M, Miyazaki J, Kawai K, Nishiyama H, Hinotsu S, Akaza H. Validationof the prognostic grouping of the seventh edition of the tumor-nodes-metastasis classification
using a large-scale prospective cohort study database of prostate cancer treated with primary
androgen deprivation therapy. Int J Urol 20(9):880-888, 2013
26. Kojima M, Nishikii H, Takizawa J, Aoki S, Noguchi M, Chiba S, Ando K, Nakamura N.
MYC rearrangements are useful for predicting outcomes following rituximab andchemotherapy: multicenter analysis of Japanese patients with diffuse large B-cell lymphoma.
116

Leuk Lymphoma 54(10):2149-2154, 2013
27. Kon A, Shih LY, Minamino M, Sanada M, Shiraishi Y, Nagata Y, Yoshida K, Okuno Y,
Bando M, Nakato R, Ishikawa S, Sato-Otsubo A, Nagae G, Nishimoto A, Haferlach C,
Nowak D, Sato Y, Alpermann T, Nagasaki M, Shimamura T, Tanaka H, Chiba K, Yamamoto
R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Nakamaki T, Ishiyama K, Nolte F,
Hofmann WK, Miyawaki S, Chiba S, Mori H, Nakauchi H, Koeffler HP, Aburatani H,
Haferlach T, Shirahige K, Miyano S, Ogawa S. Recurrent mutations in multiple componentsof the cohesin complex in myeloid neoplasms. Nat Genet 45(10):1232-1237, 2013
28. Koyama D, Kikuchi J, Hiraoka N, Wada T, Kurosawa H, Chiba S, Furukawa Y. Proteasome
inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of
Notch1 in T-cell acute lymphoblastic leukemia. Leukemia doi: 10.1038/leu.2013.366, 2013
29. Kurita N, Obara N, Fukuda K, Nishikii H, Sato S, Inagawa S, Kurokawa T, Owada Y,
Ninomiya H, Chiba S. Perisurgical induction of eculizumab in a patient with paroxysmal
nocturnal hemoglobinuria: its inhibition of surgery-triggered hemolysis and the consequenceof subsequent discontinuation. Blood Coagul Fibrinolysis 24(6):658-662, 2013
30. Lee SY, Kurita N, Yokoyama Y, Seki M, Hasegawa Y, Okoshi Y, Chiba S.
Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP
chemotherapy. Support Care Cancer doi: 10.1007/s00520-013-2097-8, 2013
31. Maie K, Okoshi Y, Takaiwa N, Kurita N, Hasegawa Y, Homma M, Ishii K, Kohda Y, Chiba
S. Aprepitant does not alter prednisolone pharmacokinetics in patients treated with R-CHOP.
Ann Oncol doi: 10.1093/annonc/mdt477, 2013
32. Maruyama T, Murata S, Takahashi K, Tamura T, Nozaki R, Ikeda N, Fukunaga K, Oda T,
Sasaki R, Ohkohchi N. Platelet transfusion improves liver function in patients with chronic
liver disease and cirrhosis. Tohoku J Exp Med 229(3):213-220, 2013
33. Matsumoto K, Yoshikawa H. Human papillomavirus infection and the risk of cervicalcancer in Japan. J Obstet Gynaecol Res 39(1):7-17, 2013
34. Matsumoto T, Hiura M, Baba T, Ishiko O, Shiozawa T, Yaegashi N, Kobayashi H,
Yoshikawa H, Kawamura N, Kaku T. Clinical management of atypical polypoid
adenomyoma of the uterus. A clinicopathological review of 29 cases. Gynecol Oncol
129(1):54-57, 2013
35. Michikami H, Minaguchi T, Ochi H, Onuki M, Okada S, Matsumoto K, Satoh T, Oki A,
Yoshikawa H. Safety and efficacy of substituting nedaplatin after carboplatin hypersensitivity
reactions in gynecologic malignancies. J Obstet Gynaecol Res 39(1):330-335, 2013117

36. Miyazaki J, Hinotsu S, Ishizuka N, Naito S, Ozono S, Akaza H, Nishiyama H. Adverse
reactions related to treatment compliance during BCG maintenance therapy fornon-muscle-invasive bladder cancer. Jpn J Clin Oncol 43(8):827-834, 2013
37. Nagumo Y, Kimura T, Ichioka D, Uchida M, Oikawa T, Suetomi T, Miyazaki J, Kawai K,
Nagata C, Nishiyama H. [Long-term survival with gemcitabine and docetaxel for renal
leiomyosarcoma : a case report]. Hinyokika Kiyo 59(8):497-501, 2013
38. Nakazato Y, Maeshima AM, Ishikawa Y, Yatabe Y, Fukuoka J, Yokose T, Tomita Y, Minami
Y, Asamura H, Tachibana K, Goya T, Noguchi M. Interobserver agreement in the nuclear
grading of primary pulmonary adenocarcinoma. J Thorac Oncol 8(6):736-743, 2013
39. Nasu K, Satoh T, Nishio S, Nagai Y, Ito K, Otsuki T, Hongo A, Hirashima Y, Ogura T,
Shimada M. Clinicopathologic features of brain metastases from gynecologic malignancies: aretrospective study of 139 cases (KCOG-G1001s trial). Gynecol Oncol 128(2):198-203, 2013
40. Niho S, Kenmotsu H, Sekine I, Ishii G, Ishikawa Y, Noguchi M, Oshita F, Watanabe S,
Nakajima R, Tada H, Nagai K. Combination chemotherapy with irinotecan and cisplatin forlarge-cell neuroendocrine carcinoma of the lung: a multicenter phase II study. J Thorac
Oncol 8(7):980-984, 2013
41. Nitta S, Kawai K, Onozawa M, Ando S, Miyazaki J, Nagata C, Noguchi M, Yamasaki K,
Uchida K, Iwamoto T, Nishiyama H. Intratubular trophoblasts in the contralateral testis
caused elevation of serum human chorionic gonadotropin following complete remission ofstage II testicular tumor: a case report. Jpn J Clin Oncol 43(1):83-86, 2013
42. Ogawa K, Kondo T, Tamura T, Matsumura H, Fukunaga K, Oda T, Ohkohchi N. Influenceof Kupffer cells and platelets on ischemia-reperfusion injury in mild steatotic liver. World J
Gastroenterol 19(9):1396-1404, 2013
43. Ohara Y, Oda T, Sugano M, Hashimoto S, Enomoto T, Yamada K, Akashi Y, Miyamoto R,
Kobayashi A, Fukunaga K, Morishita Y, Ohkohchi N. Histological and prognostic importanceof CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer. Cancer Sci
104(8):1127-1134, 2013
44. Okita Y, Kamoshida A, Suzuki H, Itoh K, Motohashi H, Igarashi K, Yamamoto M, Ogami T,
Koinuma D, Kato M. Transforming growth factor-beta induces transcription factors MafK
and Bach1 to suppress expression of the heme oxygenase-1 gene. J Biol Chem
288(28):20658-20667, 2013
45. Oshiro Y, Sasaki R, Fukunaga K, Kondo T, Oda T, Takahashi H, Ohkohchi N.
Inflammation-based prognostic score is a useful predictor of postoperative outcome in118patients with extrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 20(3):389-395,
2013
46. Ota T, Komori H, Rii J, Ochi A, Suzuki K, Shiga N, Nishiyama H. Soft coagulation inpartial nephrectomy without renorrhaphy: feasibility of a new technique and early outcomes.
Int J Urol doi: 10.1111/iju.12276, 2013
47. Sakamoto K, Nakasone H, Tsurumi S, Sasaki K, Mitani K, Kida M, Hangaishi A, Usuki K,
Kobayashi A, Sato K, Karasawa-Yamaguchi M, Izutsu K, Okoshi Y, Chiba S, Kanda Y.
Prednisone

versushigh-dose

dexamethasone

foruntreatedprimaryimmunethrombocytopenia. A retrospective study of the Japan Hematology & Oncology ClinicalStudy Group. J Thromb Thrombolysis doi: 10.1007/s11239-013-0939-3, 2013
48. Sakamoto T, Obara N, Kurita N, Sakata-Yanagimoto M, Nishikii H, Yokoyama Y,
Suzukawa K, Hasegawa Y, Chiba S. Effectiveness and safety of rabbit anti-thymocyte
globulin in Japanese patients with aplastic anemia. Int J Hematol 98(3):319-322, 201349. Sakurai H, Morishima Y, Itoguchi N, Ohtsuka S, Yamadori I, Oto T, Ishii Y, Sakamoto T,
Noguchi M, Hizawa N. Broncho-bronchiolitis obliterans after living-donor lungtransplantation: a unique manifestation of chronic allograft rejection. Transplantation
96(4):e29-30, 2013
50. Satoh T, Matsumoto K, Fujii T, Sato O, Gemma N, Onuki M, Saito H, Aoki D, Hirai Y,
Yoshikawa H. Rapid genotyping of carcinogenic human papillomavirus by loop-mediatedisothermal amplification using a new automated DNA test (Clinichip HPV). J Virol Methods
188(1-2):83-93, 2013
51. Satoh T, Matsumoto K, Tanaka YO, Akiyama A, Nakao S, Sakurai M, Ochi H, Onuki M,
Minaguchi T, Sakurai H, Yoshikawa H. Incidence of venous thromboembolism before
treatment in cervical cancer and the impact of management on venous thromboembolism
after commencement of treatment. Thromb Res 131(4):e127-132, 2013
52. Satomi K, Morishita Y, Murata Y, Shiba-Ishii A, Sugano M, Noguchi M. Epidermal growth
factor receptor abnormalities in atypical teratoid/rhabdoid tumors and an unusual case withgene amplification. Pathol Res Pract 209(8):521-526, 2013
53. Shimazui T, Yoshikawa K, Miyazaki J, Kojima T, Inai H, Ando S, Uemura H, Uchida K,
Nishiyama H. Systemic transduction of p16INK4A antitumor peptide inhibits the growth of
MBT-2 mouse bladder tumor cell line grafts. Int J Oncol 42(2):543-548, 2013
54. Strehl S, Konig M, Boztug H, Cooper BW, Suzukawa K, Zhang SJ, Chen HY, Attarbaschi A,
Dworzak MN. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic
119leukemia with the variant STAT5B-RARA fusion gene. Leukemia 27(7):1606-1610, 2013
55. Takano M, Ochi H, Takei Y, Miyamoto M, Hasumi Y, Kaneta Y, Nakamura K, Kurosaki A,
Satoh T, Fujiwara H, Nagao S, Furuya K, Yokota H, Ito K, Minegishi T, Yoshikawa H,
Fujiwara K, Suzuki M. Surgery for endometrial cancers with suspected cervical involvement:is radical hysterectomy needed (a GOTIC study)? Br J Cancer 109(7):1760-1765, 2013
56. Takaoka E, Matsui Y, Inoue T, Miyazaki J, Nakashima M, Kimura T, Oikawa T, Kawai K,
Yoshimura K, Habuchi T, Ogawa O, Nishiyama H. Risk factors for intravesical recurrence inpatients with high-grade T1 bladder cancer in the second TUR era. Jpn J Clin Oncol
43(4):404-409, 2013
57. Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Saida T, Yoshikawa H, Minami M.
Diversity in size and signal intensity in multilocular cystic ovarian masses: new parameters
for distinguishing metastatic from primary mucinous ovarian neoplasms. J Magn Reson
Imaging 38(4):794-801, 2013
58. Tasaka N, Matsumoto K, Satoh T, Minaguchi T, Onuki M, Ochi H, Tanaka YO, Sakata A,
Noguchi M, Yoshikawa H. Therapeutic effect of dienogest on adenosarcoma arising fromendometriosis: a case report. Springerplus 2:618, 2013
59. Thunnissen E, Belien JA, Kerr KM, Chung JH, Flieder DB, Noguchi M, Yatabe Y, Hwang
DM, Lely RJ, Hartemink KJ, Meijer-Jorna LB, Tsao MS. In compressed lung tissue
microscopic sections of adenocarcinoma in situ may mimic papillary adenocarcinoma. Arch
Pathol Lab Med 137(12):1792-1797, 2013
60. Togo Y, Taoka R, Yamamoto S, Hiyama Y, Uehara T, Hashimoto J, Kurimura Y, Takahashi
S, Tsukamoto T, Miyazaki J, Nishiyama H, Kiyota H, Yazawa S, Oya M, Yasuda M, Deguchi
T, Ishikawa K, Hoshinaga K, Matsumoto M, Shigemura K, Tanaka K, Arakawa S, Fujisawa
M, Wada K, Uehara S, Watanabe T, Kumon H, Kobayashi K, Matsubara A, Matsumoto M,
Sho T, Hamasuna R, Matsumoto T, Hayami H, Yamane T, Nakagawa M. [A questionnaire
survey of antimicrobial prophylaxis to prevent perioperative infection in urological field inJapan]. Nihon Hinyokika Gakkai Zasshi 104(4):579-588, 2013
61. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, Ishikawa Y,
Wistuba I, Flieder DB, Franklin W, Gazdar A, Hasleton PS, Henderson DW, Kerr KM,
Nakatani Y, Petersen I, Roggli V, Thunnissen E, Tsao M. Diagnosis of lung adenocarcinoma
in resected specimens: implications of the 2011 International Association for the Study ofLung Cancer/American Thoracic Society/European Respiratory Society classification. Arch
Pathol Lab Med 137(5):685-705, 2013120

62. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, Ishikawa Y,
Wistuba I, Flieder DB, Franklin W, Gazdar A, Hasleton PS, Henderson DW, Kerr KM,
Petersen I, Roggli V, Thunnissen E, Tsao M. Diagnosis of lung cancer in small biopsies andcytology: implications of the 2011 International Association for the Study of Lung
Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol
Lab Med 137(5):668-684, 2013
63. Usui S, Minami Y, Shiozawa T, Iyama S, Satomi K, Sakashita S, Sato Y, Noguchi M.
Differences in the prognostic implications of vascular invasion between lung adenocarcinoma
and squamous cell carcinoma. Lung Cancer 82(3):407-412, 2013
64. Yoon JH, Jung SM, Park SH, Kato M, Yamashita T, Lee IK, Sudo K, Nakae S, Han JS, Kim
OH, Oh BC, Sumida T, Kuroda M, Ju JH, Jung KC, Park SH, Kim DK, Mamura M. Activin
receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of
Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes. EMBO Mol Med
5(11):1720-1739, 2013
65. Yoshikawa H, Ebihara K, Tanaka Y, Noda K. Efficacy of quadrivalent humanpapillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged
18-26 years. Cancer Sci 104(4):465-472, 2013	 2) 英文以外の論文
1. 岡崎有香, 岡田智志, 越智寛幸, 小貫麻美子, 水口剛雄, 松本光司, 佐藤豊実, 沖明典, 吉川裕之. 当院における高度肥満子宮体癌患者の治療経験. 関東連合産科婦人科学会誌50(1):51-55, 2013
2. 菊池慎二, 佐伯祐典, 北沢伸祐, 小林敬祐, 山本純, 薄井真悟, 井口けさ人, 後藤行延, 酒井光昭, 鬼塚正孝, 佐藤幸夫, 本間晋介, 南優子, 野口雅之. 術前導入ゲフィチニブ療法を施行した cStageI-IIA 肺腺癌の 1 例	  免疫組織化学的検討. 肺癌 53(5):600, 2013
3. 小宮春奈, 小倉剛, 八木洋也, 安部加奈子, 永井優子, 小畠真奈, 濱田洋実, 吉川裕之.
Interferon-α による周産期管理を行った妊娠中発症の本態性血小板血症合併妊娠の一例. 日本周産期・新生児医学会雑誌 49(3):1050-1054, 2013
4. 坂田麻実子, 千葉滋. Myeloid Malignancies in a New Era of Molecularly Targeted Therapy
造 血 器 腫 瘍 に お け る シ ト シ ン の ヒ ド ロ キ シ メ チ ル 化 修 飾 異 常. 臨 床 血 液
54(5):423-430, 2013
5. 周山拓也, 小原直, 河合弘二, 山田健二, 日下部学, 栗田尚樹, 錦井秀和, 横山泰久, 鈴川
和己, 長谷川雄一, 野口雅之, 千葉滋. 精巣胚細胞腫瘍由来の発症が示唆された急性骨121

髄性白血病. 臨床血液 54(8):764-768, 2013
6. 竹内 秀輔, 鈴木 涼子, 福島 敬, 福島 紘子, 岩淵 敦, 中尾 朋平, 山口 玲子, 工藤 寿子, 杉
田 真太朗, 稲留 征典, 佐藤	
 豊実, 櫻井 英幸, 金子 道夫, 須磨崎 亮. 進行期卵巣小細胞癌に対して集学的治療を施行した女児例. 日本小児血液・がん学会雑誌 50(2):269-273,
2013
7. 千葉滋. 骨髄異形成症候群のゲノム異常と病態. 臨床血液 54(10):1687-1696, 2013
8. 千葉滋. 【白血病:診断と治療の進歩】 病因と病態	
  最新の知見	  白血病の染色体異常と遺伝子異常. 日本内科学会雑誌 102(7):1661-1666, 2013
9. 水口剛雄, 吉川裕之. 【婦人科がんの予防戦略と早期診断】	
  子宮体がん リスク因子を考慮した子宮体がん予防. 臨床婦人科産科 67(8):798-804, 2013
10. 水口剛雄, 吉川裕之. 【プロメテウス	
  婦人科がん最新医療】 子宮頸がんの発がん機
構. 産婦人科の実際 62(12):1624-1631, 2013
11. 山本正樹, 西村純一, 細川晃平, 杉盛千春, 米村雄士, 小原直, 野地秀義, 中村嘉彦, 安藤潔, 七島勉, 二宮治彦, 千葉滋, 川口辰哉, 金倉譲, 中尾眞二. OPTIMA 試験	
  高精度フローサイトメトリー法による GPI アンカー膜蛋白欠損血球の検出. Cytometry Research23(1):23-28, 201312. 吉川裕之. 【婦人科がん手術の基本手技を学ぶ】 卵巣癌腫瘍減量手術の基本手技を学ぶ	  卵巣癌患者の予後と QOL 向上を目指して. 産婦人科手術 24:69-75, 2013
13. 吉川裕之. 子宮頸癌とヒトパピローマウイルス(HPV)感染 子宮頸癌以外の HPV 疾患と HPV ワクチン. 東京都医師会雑誌 66(7):724-728, 201314. 吉川裕之. 【臨床研究の成果を実地臨床へ生かそう-産科編】 産婦人科診療ガイドラ
イン産科編の理解にあたって. 周産期医学 43(10):1207-1210, 20134) 英文以外の著書
1. 石川雄一, 元井紀子, 野口雅之. 1. 肺癌の分類（病理と分子）1. 新しい IASLC/ATS/ERS
肺癌分類について教えてください 。14. 現在の組織分類にはどのような問題がありますか？; "肺癌診療 Q&A 一つ上をいく診療の実践 (第 2 版)” (編集 弦間昭彦), 中外医学社 (東京) 2013; pp2-5, pp39-43
2. 薄井真悟, 南優子, 野口雅之. 肺がん病理診断の問題点と新提案; "日本医師会雑誌”, 日
本医師会 2013; pp33-37
3. 佐藤豊実, 吉川裕之. 自律神経温存が推奨される広汎子宮全摘出術の適応と手技は？;"EBM 婦人科疾患の治療 2013-2014” 中外医学社 (東京) 2013; pp240-245
4. 千葉滋. 第 21 章. 血液系	  血漿蛋白質; "人体の構造と機能及び疾病の成り立ち (第 2122

版)” (編集 香川靖雄, 近藤和雄, 石田均, 門脇孝), 南江堂 (東京) 2013.09; pp433-434
5. 千葉滋. 第 21 章. 血液系	 白血球; "人体の構造と機能及び疾病の成り立ち (第 2 版)” (編集 香川靖雄, 近藤和雄, 石田均, 門脇孝), 南江堂 (東京) 2013.09; pp435-436
6. 千葉滋. 血液・造血器の構造と機能	
  白血球の形態と機能; "内科学書	
  血液・造血器疾患	
  神経疾患 (第 8 版)” (編集 小川聡, 小澤敬也, 祖父江元), 中山書店 (東京) 2013.10;
pp15-21
7. 野口雅之. 肺腺癌の病理診断で知っておくべき事; "診断病理”, 日本病理学会 (東京)2013; pp1-7
8. 吉川裕之. EBM とガイドライン; "産科婦人科疾患最新の治療 2013-2015” (編集 吉川史隆, 倉智博久, 平松祐司), 南江堂 (東京) 2013; pp1-4

123

３Ｄ‐ＣＧバーチャル手術シミュレーションシステム	 1) 英文論文
1. Akashi Y, Oda T, Ohara Y, Miyamoto R, Hashimoto S, Enomoto T, Yamada K, Kobayashi A,
Fukunaga K, Ohkochi N. Histological advantages of the tumor graft: a murine model
involving transplantation of human pancreatic cancer tissue fragments. Pancreas
42(8):1275-1282, 2013
2. Kudo T, Sato T, Hagiwara K, Kozuma Y, Yamaguchi T, Ikehara Y, Hamada M, Matsumoto
K, Ema M, Murata S, Ohkohchi N, Narimatsu H, Takahashi S. C1galt1-deficient mice exhibit
thrombocytopenia due to abnormal terminal differentiation of megakaryocytes. Blood
122(9):1649-1657, 2013
3. Kurokawa T, Yamamoto M, Ueda T, Enomoto T, Inoue K, Uchida A, Kikuchi K, Ohkohchi
N. Gastric bronchogenic cyst histologically diagnosed after laparoscopic excision: report of acase. Int Surg 98(4):455-460, 2013
4. Maruyama T, Murata S, Takahashi K, Tamura T, Nozaki R, Ikeda N, Fukunaga K, Oda T,
Sasaki R, Ohkohchi N. Platelet transfusion improves liver function in patients with chronic
liver disease and cirrhosis. Tohoku J Exp Med 229(3):213-220, 2013
5. Matsuda A, Kuno A, Matsuzaki H, Kawamoto T, Shikanai T, Nakanuma Y, Yamamoto M,
Ohkohchi N, Ikehara Y, Shoda J, Hirabayashi J, Narimatsu H. Glycoproteomics-based cancer
marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for highspecific glyco-diagnosis of cholangiocarcinoma. J Proteomics 85:1-11, 2013
6. Murata S, Shiragami R, Kosugi C, Tezuka T, Yamazaki M, Hirano A, Yoshimura Y, Suzuki
M, Shuto K, Ohkohchi N, Koda K. Antitumor effect of 1, 8-cineole against colon cancer.
Oncol Rep 30(6):2647-2652, 2013
7. Nowatari T, Murata S, Fukunaga K, Ohkohchi N. Role of platelets in chronic liver disease
and acute liver injury. Hepatol Res doi: 10.1111/hepr.12205, 2013
8. Nozaki R, Murata S, Nowatari T, Maruyama T, Ikeda N, Kawasaki T, Fukunaga K, Ohkohchi
N. Effects of thrombopoietin on growth of hepatocellular carcinoma: Is thrombopoietin
therapy for liver disease safe or not? Hepatol Res 43(6):610-620, 2013
9. Ogawa K, Kondo T, Tamura T, Matsumura H, Fukunaga K, Oda T, Ohkohchi N. Influence ofKupffer cells and platelets on ischemia-reperfusion injury in mild steatotic liver. World J
Gastroenterol 19(9):1396-1404, 2013
10. Ohara Y, Oda T, Sugano M, Hashimoto S, Enomoto T, Yamada K, Akashi Y, Miyamoto R,
Kobayashi A, Fukunaga K, Morishita Y, Ohkohchi N. Histological and prognostic
124

importance of CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer.
Cancer Sci 104(8):1127-1134, 2013
11. Oshiro Y, Sasaki R, Fukunaga K, Kondo T, Oda T, Takahashi H, Ohkohchi N.
Inflammation-based prognostic score is a useful predictor of postoperative outcome inpatients with extrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 20(3):389-395,
2013
12. Oshiro Y, Sasaki R, Nasu K, Ohkohchi N. A novel preoperative fusion analysis using
three-dimensional MDCT combined with three-dimensional MRI for patients with hilar
cholangiocarcinoma. Clin Imaging 37(4):772-774, 2013
13. Oshiro Y, Sasaki R, Takeguchi T, Ibukuro K, Ohkohchi N. Analysis of the caudate arterywith three-dimensional imaging. J Hepatobiliary Pancreat Sci 20:639-646, 2013
14. Oshiro Y, Takahashi K, Sasaki R, Kondo T, Sakashita S, Ohkohchi N. Adjuvant surgery foradvanced extrahepatic cholangiocarcinoma. World J Gastroenterol 19(40):6934-6938, 2013
15. Takahashi A, Yamamoto Y, Yasunaga M, Koga Y, Kuroda J, Takigahira M, Harada M, Saito
H, Hayashi T, Kato Y, Kinoshita T, Ohkohchi N, Hyodo I, Matsumura Y. NC-6300, an
epirubicin-incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity
of epirubicin. Cancer Sci 104(7):920-925, 2013
16. Takahashi K, Kozuma Y, Suzuki H, Tamura T, Maruyama T, Fukunaga K, Murata S,
Ohkohchi N. Human platelets promote liver regeneration with Kupffer cells in SCID mice. J
Surg Res 180(1):62-72, 2013
17. Takahashi K, Murata S, Fukunaga K, Ohkohchi N. Human platelets inhibit liver fibrosis insevere combined immunodeficiency mice. World J Gastroenterol 19(32):5250-5260, 2013
18. Takahashi K, Murata S, Ohkohchi N. Novel therapy for liver regeneration by increasing thenumber of platelets. Surg Today 43(10):1081-1087, 2013
19. Takahashi K, Murata S, Ohkohchi N. Platelet therapy: A novel strategy for liver
regeneration, anti-fibrosis,and anti-apoptosis. World J Surg Proced 3(3):29-36, 2013
20. Takahashi K, Terashima H, Kohno K, Ohkohchi N. A stand-alone synbiotic treatment for theprevention of d-lactic acidosis in short bowel syndrome. Int Surg 98(2):110-113, 2013
21. Takahashi K, Tsukamoto S, Saito K, Ohkohchi N, Hirayama K. Complete response tomultidisciplinary therapy in a patient with primary gastric choriocarcinoma. World J
Gastroenterol 19(31):5187-5194, 2013
22. Tamura T, Kondo T, Ogawa K, Fukunaga K, Ohkohchi N. Protective effect of heme
oxygenase-1 on hepatic ischemia-reperfusion injury through inhibition of platelet adhesion to125the sinusoids. J Gastroenterol Hepatol 28(4):700-706, 2013
23. Yoneyama S, Terashima H, Yamaguchi R, Tadano S, Ohkohchi N. The manner of theinflammation-boosting effect caused by acute hyperglycemia secondary to overfeeding andthe effects of insulin therapy in a rat model of sepsis. J Surg Res 185(1):380-387, 2013	 2) 英文以外の論文
1. 岩崎健一, 寺島秀夫, 久倉勝治, 佐野直樹, 宮本良一, 稲川智, 大河内信弘. 右側大動脈弓を伴う食道・胃同時性重複癌の 1 切除例. 日本消化器外科学会雑誌 46(8):564-572, 2013
2. 牛嶋良, 岡田晃穂, 田枝督教, 畠雅弘, 大河内信弘. 尿膜管-S 状結腸瘻の 1 例. 臨床外科
68(13):1484-1487, 2013
3. 榎本剛史, 田村孝史, 明石義正, 久倉勝治, 稲川智, 大河内信弘. 腹腔鏡下に切除した腸重積合併回腸脂肪腫の 1 例. The Kitakanto Medical Journal 63(3):243-247, 2013
4. 下村治, 福永潔, 中野順隆, 野渡剛之, 小林昭彦, 小田竜也, 佐々木亮孝, 山田健二, 野口
雅之, 大河内信弘. 肝切除後極めて急激な再発を認めた肉腫様変化を伴う G-CSF 産生
肝内胆管癌の 1 例. 日本消化器外科学会雑誌 46(1):41-49, 2013
5. 高橋一広, 塚本茂樹, 高橋さつき, 斎藤昌宏, 大河内信弘, 平山克. 腹直筋皮弁で再建した直腸癌による Fournier 壊疽の 1 例. 日本臨床外科学会雑誌 74(4):1086-1091, 2013
6. 宮崎貴寛, 高野恵輔, 久倉勝治, 榎本剛史, 稲川智, 大河内信弘. 陰圧閉鎖療法が奏効した難治性創離開の 3 例. 日本臨床外科学会雑誌 74(8):2337-2341, 2013
7. 宮崎貴寛, 田村孝史, 榎本剛史, 玄良三, 中山健, 久倉勝治, 稲川智, 大河内信弘. 破裂危
険のある内腸骨動脈瘤を合併した高度狭窄を伴う S 状結腸癌の 1 例. 日本臨床外科学会雑誌 74(3):750-755, 2013126

神経生理学	 1) 英文論文	 1. Inaba K, Mizuhiki T, Setogawa T, Toda K, Richmond BJ, Shidara M. Neurons in monkey
dorsal raphe nucleus code beginning and progress of step-by-step schedule, reward
expectation, and amount of reward outcome in the reward schedule task. J Neurosci
33(8):3477-3491, 2013
2. Matsumoto M, Takada M. Distinct representations of cognitive and motivational signals in
midbrain dopamine neurons. Neuron 79(5):1011-1024, 2013
3. Nakamagoe K, Fujizuka N, Koganezawa T, Shimizu K, Takiguchi S, Horaguchi T, Ishii K,
Tamaoka A. Residual central nervous system damage due to organoarsenic poisoning.
Neurotoxicol Teratol 37:33-38, 2013
4. Nakamagoe K, Fujizuka N, Koganezawa T, Yamaguchi T, Tamaoka A. Downbeat nystagmus
associated with damage to the medial longitudinal fasciculus of the pons: a vestibular balance
control mechanism via the lower brainstem paramedian tract neurons. J Neurol Sci
328(1-2):98-101, 2013
5. Toyoda Y, Shinohara R, Thumkeo D, Kamijo H, Nishimaru H, Hioki H, Kaneko T, Ishizaki T,
Furuyashiki T, Narumiya S. EphA4-dependent axon retraction and midline localization of
Ephrin-B3 are disrupted in the spinal cord of mice lacking mDia1 and mDia3 in combination.
Genes Cells 18(10):873-885, 2013
6. Yamada H, Inokawa H, Matsumoto N, Ueda Y, Enomoto K, Kimura M. Coding of thelong-term value of multiple future rewards in the primate striatum. J Neurophysiol
109(4):1140-1151, 2013
7. Yamada H, Tymula A, Louie K, Glimcher PW. Thirst-dependent risk preferences in monkeys
identify a primitive form of wealth. Proc Natl Acad Sci U S A 110(39):15788-15793, 2013
8. Yoshikawa M, Murakami Y, Senzaki K, Masuda T, Ozaki S, Ito Y, Shiga T. Coexpression of
Runx1 and Runx3 in mechanoreceptive dorsal root ganglion neurons. Dev Neurobiol
73(6):469-479, 2013	 4) 英文以外の著書
1. 尾崎繁. 第 3 章. 感じる脳（まえがき）; "感性認知脳科学への招待 (第 1 版)” (編集 久野
節二, 山田一夫, 尾崎繁, 内山俊朗), 筑波大学出版会 (つくば) 2013; pp47-48
2. 設楽宗孝. 第 6 章第 3 節. モチベーションと意欲の神経科学; "感性認知脳科学への招待(第 1 版)” (編集 久野節二, 山田一夫, 尾崎繁, 内山俊朗), 筑波大学出版会 (つくば) 2013;127pp182-196

128

行動決定の脳内情報処理機構	
 1) 英文論文
1. Akiyama E. Evolutionary Leader Game and Social Hierarchy. SICE Journal of Control,
Measurement, and System Integration 6(2):102-107, 2013
2. Furuie H, Yamada K, Ichitani Y. MK-801-induced and scopolamine-induced hyperactivity inrats neonatally treated chronically with MK-801. Behav Pharmacol 24(8):678-683, 2013
3. Hori M, Yamada K, Ohnishi J, Sakamoto S, Takimoto-Ohnishi E, Miyabe S, Murakami K,
Ichitani Y. Effects of repeated tickling on conditioned fear and hormonal responses insocially isolated rats. Neurosci Lett 536:85-89, 2013
4. Horie K, Suemitsu A, Morita M. Direct Estimation of Hand Motion Speed from Surface
EMG Using Selective Desensitization Neural Network. Proceedings of the 2014 RISPInternational

Workshopon

Nonlinear

Circuits,

Communications

andSignal

Processing:661-664, 2013
5. Inaba K, Mizuhiki T, Setogawa T, Toda K, Richmond BJ, Shidara M. Neurons in monkey
dorsal raphe nucleus code beginning and progress of step-by-step schedule, reward
expectation, and amount of reward outcome in the reward schedule task. J Neurosci
33(8):3477-3491, 2013
6. Kaku M, Yamada K, Ichitani Y. Can rats control previously acquired spatial information?
Evidence of "directed forgetting" phenomenon in delay-interposed radial maze behavior.
Behav Brain Res 248:1-6, 2013
7. Sugita M, Yamada K, Ichitani Y. Effects of number of items and interval length on theacquisition of temporal order discrimination in radial maze in rats. Learn Mem
20(3):125-129, 2013
8. Tanaka F, Takahashi T, Matsuzoe S, Tazawa N, Morita M. Child-Operated Telepresence
Robot: a Field Trial Connecting Classrooms between Australia and Japan. Proceedings ofIEEE/RSJ International Conference on Intelligent Robots and Systems:5896-5901, 2013
9. Tanaka F, Takahashi T, Matsuzoe S, Tazawa N, Morita M. Telepresence Robot Helps Children
in Communicating with Teachers who Speak a Different Language. Proceedings of the 2014
ACM/IEEE International Conference on Human-Robot Interaction:399-406, 2013
10. Tanaka F, Takahashi T, Morita M. Tricycle-style operation interface for children to control atelepresence robot. Advanced Robotics 27(17):1375-1384, 2013
11. Yoshikawa M, Murakami Y, Senzaki K, Masuda T, Ozaki S, Ito Y, Shiga T. Coexpression of
Runx1 and Runx3 in mechanoreceptive dorsal root ganglion neurons. Dev Neurobiol
129

73(6):469-479, 20133) 英文著書
1. Akiyama E, Ishikawa R, Kaneko M, Kline JJ. Chapter3. Inductive game theory: A simulation
study of learning a social situation.; in "Game Theory Relaunched (1st edition)" (edited by
Hanappi H), InTech (Rijeka) 2013 pp55-76

4) 英文以外の著書
1. 秋山英三. 第 10 章. 少数派ゲーム --- 参加者の能力の分布が社会全体の効率に与える
影響; "ゲーム理論：応用ガイドブック (第 1 版)” (編集 中山幹夫, 武藤滋夫, 船木由喜
彦), 東洋経済新報社 (東京) 2013; pp209-233
2. 秋山英三, 沼澤政信. 第 II 部第 4 章. シミュレーション学からの接近; "グローバルな危機の構造と日本の戦略 (第 1 版)” (編集 吉田和男, 藤本茂), 晃洋書房 (京都府) 2013;
pp230-251
3. 一谷幸男. 第 6 章第 2 節. 記憶と学習の神経科学; "感性認知脳科学への招待 (第 1 版)”(編 集 久 野 節 二, 山 田 一 夫, 尾 崎 繁, 内 山 俊 朗), 筑 波 大 学 出 版 会 (つ く ば) 2013;
pp171-181
4. "感性認知脳科学への招待 (第 1 版)” (編集 久野節二, 山田一夫, 尾崎繁, 内山俊朗), 筑
波大学出版会 (つくば) 2013; pp201
5. 設楽宗孝. 第 6 章 第 3 節. モチベーションと意欲の神経科学; "感性認知脳科学への招待 (第 1 版)” (編集 久野節二, 山田一夫, 尾崎繁, 内山俊朗), 筑波大学出版会 (つくば)2013; pp182-196

130

統合的神経回路	
 1) 英文論文
1. Akamatsu M, Takuma H, Yamashita T, Okada T, Keino-Masu K, Ishii K, Kwak S, Masu M,
Tamaoka A. A unique mouse model for investigating the properties of amyotrophic lateralsclerosis-associatedproteinTDP-43,

by

in

utero

electroporation.

NeurosciRes

77(4):234-241, 2013
2. Furukawa M, Tochigi M, Otowa T, Arinami T, Inada T, Ujike H, Watanabe Y, Iwata N,
Itokawa M, Kunugi H, Hashimoto R, Ozaki N, Kakiuchi C, Kasai K, Sasaki T. An
association analysis of the cardiomyopathy-associated 5 (CMYA5) gene with schizophrenia
in a Japanese population. Psychiatr Genet 23(4):179-180, 2013
3. Horiuchi Y, Ishikawa M, Kaito N, Iijima Y, Tanabe Y, Ishiguro H, Arinami T. Experimental
evidence for the involvement of PDLIM5 in mood disorders in hetero knockout mice. PLoS
One 8(4):e59320, 2013
4. Iwakura T, Sakoh M, Tsutiya A, Yamashita N, Ohtani A, Tsuda MC, Ogawa S, Tsukahara S,
Nishihara M, Shiga T, Goshima Y, Kato T, Ohtani-Kaneko R. Collapsin response mediator
protein 4 affects the number of tyrosine hydroxylase-immunoreactive neurons in the sexuallydimorphic nucleus in female mice. Dev Neurobiol 73(7):502-517, 2013
5. Li F, Ohtani A, Senzaki K, Shiga T. Receptor-dependent regulation of dendrite formation ofnoradrenaline and dopamine in non-GABAergic cerebral cortical neurons. Dev Neurobiol
73(5):370-383, 2013
6. Nakamagoe K, Fujizuka N, Koganezawa T, Shimizu K, Takiguchi S, Horaguchi T, Ishii K,
Tamaoka A. Residual central nervous system damage due to organoarsenic poisoning.
Neurotoxicol Teratol 37:33-38, 2013
7. Nakamagoe K, Fujizuka N, Koganezawa T, Yamaguchi T, Tamaoka A. Downbeat nystagmus
associated with damage to the medial longitudinal fasciculus of the pons: a vestibular balance
control mechanism via the lower brainstem paramedian tract neurons. J Neurol Sci
328(1-2):98-101, 2013
8. Shibata H, Yamamoto K, Sun Z, Oka A, Inoko H, Arinami T, Inada T, Ujike H, Itokawa M,
Tochigi M, Watanabe Y, Someya T, Kunugi H, Suzuki T, Iwata N, Ozaki N, Fukumaki Y.
Genome-wide association study of schizophrenia using microsatellite markers in the Japanese
population. Psychiatr Genet 23(3):117-123, 2013
9. Toyoda Y, Shinohara R, Thumkeo D, Kamijo H, Nishimaru H, Hioki H, Kaneko T, Ishizaki T,
Furuyashiki T, Narumiya S. EphA4-dependent axon retraction and midline localization of131

Ephrin-B3 are disrupted in the spinal cord of mice lacking mDia1 and mDia3 in combination.
Genes Cells 18(10):873-885, 2013
10. Wang R, Iwakura Y, Araki K, Keino-Masu K, Masu M, Wang XY, Takei N, Higashiyama S,
Nawa H. ErbB2 dephosphorylation and anti-proliferative effects of neuregulin-1 in
ErbB2-overexpressing cells; re-evaluation of their low-affinity interaction. Sci Rep 3:1402,
2013
11. Watanabe Y, Iijima Y, Egawa J, Nunokawa A, Kaneko N, Arinami T, Ujike H, Inada T, Iwata
N, Kunugi H, Itokawa M, Sasaki T, Ozaki N, Hashimoto R, Shibuya M, Igeta H, Someya T.
Replication in a Japanese population that a MIR30E gene variation is associated withschizophrenia. Schizophr Res 150(2-3):596-597, 2013
12. Yamamuro T, Hori M, Nakagawa Y, Hayashi T, Sakamoto S, Ohnishi J, Takeuchi S, Mihara
Y, Shiga T, Murakami K, Urayama O. Tickling stimulation causes the up-regulation of thekallikrein family in the submandibular gland of the rat. Behav Brain Res 236(1):236-243,
2013
13. Yoshikawa M, Murakami Y, Senzaki K, Masuda T, Ozaki S, Ito Y, Shiga T. Coexpression of
Runx1 and Runx3 in mechanoreceptive dorsal root ganglion neurons. Dev Neurobiol
73(6):469-479, 2013	 2) 英文以外の論文
1. 桝和子, 桝正幸. ヘパラン硫酸微細構造の組織特異性とその決定機構. 医学のあゆみ
245(7):600-602, 2013	 	 3) 英文著書
1. Masu M. Emerging roles of heparan sulfate in axon guidance; in "Cortical Development:
Neural Diversity and Neocortical Organization (1st edition)" (edited by Kageyama
R,Yamamori T), Springer-Verlag (Tokyo) 2013; pp203-214
2. Masu M, Koike S, Okada T, Keino-Masu K. Studies on autotaxin signaling in endocytic
vesicle biogenesis and embryonic development using whole embryo culture andelectroporation; in "Lysophospholipid Receptors: Signaling and Biochemistry (1st edition)"(edited by Chun J, Hla T, Spiegel S,Moolenaar W), John Wiley & Son Inc. (Hoboken, NJ,
USA) 2013; pp121-136

4) 英文以外の著書
132

1. 尾崎繁. 第 3 章. 感じる脳（まえがき）; "感性認知脳科学への招待 (第 1 版)” (編集 久野
節二, 山田一夫, 尾崎繁, 内山俊朗), 筑波大学出版会 (つくば) 2013; pp47-48
2. 志賀隆. 第５章 第１節. 個体発生の神経科学：脳はどのように作られるのか; "感性認
知脳科学への招待 (第 1 版)” (編集 筑波大学感性認知脳科学研究プロジェクト), 筑波
大学出版会 (つくば) 2013; pp116-129

133

基礎・社会・臨床医学の連携による健康長寿の実現	 1) 英文論文	
 1. Akamatsu M, Takuma H, Yamashita T, Okada T, Keino-Masu K, Ishii K, Kwak S, Masu M,
Tamaoka A. A unique mouse model for investigating the properties of amyotrophic lateralsclerosis-associatedproteinTDP-43,

by

in

utero

electroporation.

NeurosciRes

77(4):234-241, 2013
2. Ano S, Morishima Y, Ishii Y, Kawaguchi M, Matsuno Y, Hizawa N. Defecation-related
asthma. Intern Med 52(6):685-687, 2013
3. Ano S, Morishima Y, Ishii Y, Yoh K, Yageta Y, Ohtsuka S, Matsuyama M, Kawaguchi M,
Takahashi S, Hizawa N. Transcription factors GATA-3 and RORγt are important for
determining the phenotype of allergic airway inflammation in a murine model of asthma. J
Immunol 190(3):1056-1065, 2013
4. Arai S, Maehara N, Iwamura Y, Honda S, Nakashima K, Kai T, Ogishi M, Morita K,
Kurokawa J, Mori M, Motoi Y, Miyake K, Matsuhashi N, Yamamura K, Ohara O, Shibuya A,
Wakeland EK, Li QZ, Miyazaki T. Obesity-associated autoantibody production requires AIM
to retain the immunoglobulin M immune complex on follicular dendritic cells. Cell Rep
3(4):1187-1198, 2013
5. Danisch S, Qiu Q, Seth S, Ravens I, Dorsch M, Shibuya A, Shibuya K, Forster R, Bernhardt
G. CD226 interaction with CD155 impacts on retention and negative selection of CD8
positive thymocytes as well as T cell differentiation to follicular helper cells in Peyer's
Patches. Immunobiology 218(2):152-158, 2013
6. Enoki S, Shimizu A, Hayashi C, Imanishi H, Hashizume O, Mekada K, Suzuki H, Hashimoto
T, Nakada K, Hayashi J. Selection of rodent species appropriate for mtDNA transfer togenerate transmitochondrial mito-mice expressing mitochondrial respiration defects. Exp
Anim http://dx.doi.org/10.1538/expanim.63.21, 2013	 7. Fujihara K, Kodama S, Horikawa C, Yoshizawa S, Sugawara A, Hirasawa R, Shimano H,
Yachi Y, Suzuki A, Hanyu O, Sone H. The Relationship between Diabetic Neuropathy and
Sleep Apnea Syndrome: A Meta-Analysis. Sleep Disord 2013:150371, 2013
8. Fujihara K, Suzuki H, Sato A, Kodama S, Heianza Y, Saito K, Iwasaki H, Kobayashi K,
Yatoh S, Takahashi A, Yamada N, Sone H, Shimano H. Carotid artery plaque and
LDL-to-HDL cholesterol ratio predict atherosclerotic status in coronary arteries inasymptomatic patients with type 2 diabetes mellitus. J Atheroscler Thromb 20(5):452-464,
2013
134

9. Fujimoto Y, Nakagawa Y, Satoh A, Okuda K, Shingyouchi A, Naka A, Matsuzaka T, Iwasaki
H, Kobayashi K, Yahagi N, Shimada M, Yatoh S, Suzuki H, Yogosawa S, Izumi T, Sone H,
Urayama O, Yamada N, Shimano H. TFE3 controls lipid metabolism in adipose tissue ofmale mice by suppressing lipolysis and thermogenesis. Endocrinology 154(10):3577-3588,
2013
10. Fukushima H, Fukushima T, Sakai A, Suzuki R, Nakajima-Yamaguchi R, Kobayashi C,
Iwabuchi A, Saito M, Yoshimi A, Nakao T, Kato K, Tsuchida M, Takahashi H, Koike K,
Kiyokawa N, Noguchi E, Sumazaki R. Polymorphisms of MTHFR Associated with Higher
Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid
Malignancies. Leuk Res Treatment 2013:238528, 2013
11. Fukuzawa T, Ishida J, Kato A, Ichinose T, Ariestanti DM, Takahashi T, Ito K, Abe J, Suzuki
T, Wakana S, Fukamizu A, Nakamura N, Hirose S. Lung surfactant levels are regulated by
Ig-Hepta/GPR116 by monitoring surfactant protein D. PLoS One 8(7):e69451, 2013
12. Gejyo F, Amano I, Ando T, Ishida M, Obayashi S, Ogawa H, Ono T, Kanno Y, Kitaoka T,
Kukita K, Kurihara S, Sato M, Shin J, Suzuki M, Takahashi S, Taguma Y, Takemoto Y,
Nakazawa R, Nakanishi T, Nakamura H, Hara S, Hiramatsu M, Furuya R, Masakane I,
Tsuchida K, Motomiya Y, Morita H, Yamagata K, Yoshiya K, Yamakawa T. Survey of theeffects of a column for adsorption of β2-microglobulin in patients with dialysis-related
amyloidosis in Japan. Ther Apher Dial 17(1):40-47, 2013
13. Georgiev H, Danisch S, Chambers BJ, Shibuya A, Forster R, Bernhardt G. To the editor:
TIGIT

versus

CD226:

hegemonyor

coexistence?

Eur

J

Immunoldoi:

10.1002/eji.201343925, 2013
14. Hamanaka S, Ooehara J, Morita Y, Ema H, Takahashi S, Miyawaki A, Otsu M, Yamaguchi
T, Onodera M, Nakauchi H. Generation of transgenic mouse line expressing Kusabira Orange
throughout body, including erythrocytes, by random segregation of provirus method.
Biochem Biophys Res Commun 435(4):586-591, 2013
15. Hasegawa Y, Daitoku Y, Sekiguchi K, Tanimoto Y, Mizuno-Iijima S, Mizuno S, Kajiwara N,
Ema M, Miwa Y, Mekada K, Yoshiki A, Takahashi S, Sugiyama F, Yagami K. NovelROSA26 Cre-reporter knock-in C57BL/6N mice exhibiting green emission before and red
emission after Cre-mediated recombination. Exp Anim 62(4):295-304, 2013
16. Heianza Y, Arase Y, Kodama S, Hsieh SD, Tsuji H, Saito K, Shimano H, Hara S, Sone H.
Effect of postmenopausal status and age at menopause on type 2 diabetes and prediabetes inJapanese individuals: Toranomon Hospital Health Management Center Study 17 (TOPICS
135

17). Diabetes Care 36(12):4007-4014, 2013
17. Heianza Y, Arase Y, Kodama S, Hsieh SD, Tsuji H, Saito K, Shimano H, Hara S, Sone H.
Association of living alone with the presence of undiagnosed diabetes in Japanese men: therole of modifiable risk factors for diabetes: Toranomon Hospital Health Management Center
Study 13 (TOPICS 13). Diabet Med 30(11):1355-1359, 2013
18. Heianza Y, Arase Y, Saito K, Hsieh SD, Tsuji H, Kodama S, Tanaka S, Ohashi Y, Shimano
H, Yamada N, Hara S, Sone H. Development of a screening score for undiagnosed diabetes
and its application in estimating absolute risk of future type 2 diabetes in Japan: Toranomon
Hospital Health Management Center Study 10 (TOPICS 10). J Clin Endocrinol Metab
98(3):1051-1060, 2013
19. Heianza Y, Arase Y, Saito K, Tsuji H, Fujihara K, Hsieh SD, Kodama S, Shimano H,
Yamada N, Hara S, Sone H. Role of alcohol drinking pattern in type 2 diabetes in Japanesemen: the Toranomon Hospital Health Management Center Study 11 (TOPICS 11). Am J Clin
Nutr 97(3):561-568, 2013
20. Hirasawa R, Yachi Y, Yoshizawa S, Horikawa C, Heianza Y, Sugawara A, Sone Y, Kondo K,
Shimano H, Saito K, Kodama S, Sone H. Quality and accuracy of Internet information
concerning a healthy diet. Int J Food Sci Nutr 64(8):1007-1013, 2013
21. Hirayama K, Yamagata K. The antiglomerular abasement membrane disease: treatments andoutcomes. OA Nephrology 1(1):1, 2013
22. Hizawa N. [Bronchial asthma: progress in diagnosis and treatments. Topics: II. Pathogenesis
and pathophysiology; 2. Genes associated with asthma and asthma-related phenotypes].
Nihon Naika Gakkai Zasshi 102(6):1365-1369, 201323.

HizawaN.

Pharmacogenetics

ofchronic

obstructive

pulmonarydisease.

Pharmacogenomics 14(10):1215-1225, 2013
24. Honda Y, Kondo M, McGregor G, Kim H, Guo YL, Hijioka Y, Yoshikawa M, Oka K,
Takano S, Hales S, Kovats RS. Heat-related mortality risk model for climate change impact
projection. Environ Health Prev Med doi: 10.1007/s12199-013-0354-6, 2013
25. Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Sowa
N, Yahagi N, Shimano H, Matsumura S, Inoue K, Marusawa H, Nakamura T, Hasegawa K,
Kume N, Yokode M, Kita T, Kimura T, Ono K. MicroRNA-33 regulates sterol regulatory
element-binding protein 1 expression in mice. Nat Commun 4:2883, 2013
26. Hoshi SL, Kondo M, Okubo I. Economic evaluation of vaccination programme of 13-valentpneumococcal conjugate vaccine to the birth cohort in Japan. Vaccine 31(25):2762-2771,
136

2013
27. Hoshino J, Mehrotra R, Rhee CM, Yamagata K, Ubara Y, Takaichi K, Kovesdy CP, Molnar
MZ, Kalantar-Zadeh K. Using hemoglobin A1c to derive mean blood glucose in peritoneal
dialysis patients. Am J Nephrol 37(5):413-420, 2013
28. Hoshino J, Molnar MZ, Yamagata K, Ubara Y, Takaichi K, Kovesdy CP, Kalantar-Zadeh K.
Developing an HbA(1c)-based equation to estimate blood glucose in maintenancehemodialysis patients. Diabetes Care 36(4):922-927, 2013
29. Ikeda T, Ishii KA, Saito Y, Miura M, Otagiri A, Kawakami Y, Shimano H, Hara H,
Takekoshi K. Inhibition of autophagy enhances sunitinib-induced cytotoxicity in rat
pheochromocytoma PC12 cells. J Pharmacol Sci 121(1):67-73, 2013
30. Imanishi H, Takibuchi G, Kobayashi T, Ishikawa K, Nakada K, Mori M, Kikkawa Y,
Takenaga K, Toyama-Sorimachi N, Hayashi J. Specific mtDNA mutations in mouse
carcinoma cells suppress their tumor formation via activation of the host innate immune
system. PLoS One 8(9):e75981, 2013
31. Inui Y, Mochida H, Yamairi F, Okada M, Ishida J, Fukamizu A, Arakawa K. Effects of aging
and uninephrectomy on renal changes in Tsukuba hypertensive mice. Biomed Rep
1(3):359-364, 2013
32. Ishida T, Ohta M, Nakakuki M, Kami H, Uchiyama R, Kawano H, Notsu T, Imada K,
Shimano H. Distinct regulation of plasma LDL cholesterol by eicosapentaenoic acid anddocosahexaenoic acid in high fat diet-fed hamsters: participation of cholesterol ester transfer
protein and LDL receptor. Prostaglandins Leukot Essent Fatty Acids 88(4):281-288, 2013
33. Ishizu A, Tomaru U, Murai T, Yamamoto T, Atsumi T, Yoshiki T, Yumura W, Yamagata K,
Yamada H, Kumagai S, Kurokawa MS, Suka M, Makino H, Ozaki S. Prediction of responseto treatment by gene expression profiling of peripheral blood in patients with microscopic
polyangiitis. PLoS One 8(5):e63182, 2013
34. Izumida Y, Yahagi N, Takeuchi Y, Nishi M, Shikama A, Takarada A, Masuda Y, Kubota M,
Matsuzaka T, Nakagawa Y, Iizuka Y, Itaka K, Kataoka K, Shioda S, Niijima A, Yamada T,
Katagiri H, Nagai R, Yamada N, Kadowaki T, Shimano H. Glycogen shortage during fasting
triggers liver-brain-adipose neurocircuitry to facilitate fat utilization. Nat Commun 4:2316,
2013
35. Kaburagi T, Satoh H, Hayashihara K, Endo T, Hizawa N, Kurishima K, Nishimura Y,
Hashimoto T, Nakamura H, Kishi K, Inagaki M, Nawa T, Ichimura H, Ishikawa H,
Kagohashi K, Fukuoka T, Shinohara Y, Kamiyama K, Sato Y, Sakai M, Matsumura T,
137

Uchiumi K, Furukawa K. Observational study on the efficacy and safety of erlotinib inpatients with non-small cell lung cancer. Oncol Lett 5(2):435-439, 2013
36. Kaneko Y, Masuko H, Sakamoto T, Iijima H, Naito T, Yatagai Y, Yamada H, Konno S,
Nishimura M, Noguchi E, Hizawa N. Asthma phenotypes in Japanese adults - theirassociations with the CCL5 and ADRB2 genotypes. Allergol Int 62(1):113-121, 2013
37. Kaneko Y, Yatagai Y, Yamada H, Iijima H, Masuko H, Sakamoto T, Hizawa N. The searchfor common pathways underlying asthma and COPD. Int J Chron Obstruct Pulmon Dis
8:65-78, 2013
38. Kanemoto A, Mizumoto M, Okumura T, Takahashi H, Hashimoto T, Oshiro Y, Fukumitsu N,
Moritake T, Tsuboi K, Sakae T, Sakurai H. Dose-volume histogram analysis for risk factorsof radiation-induced rib fracture after hypofractionated proton beam therapy forhepatocellular carcinoma. Acta Oncol 52(3):538-544, 2013
39. Katada S, Mito T, Ogasawara E, Hayashi J, Nakada K. Mitochondrial DNA with alarge-scale deletion causes two distinct mitochondrial disease phenotypes in mice. G3(Bethesda) 3(9):1545-1552, 2013
40. Katsumata T, Oishi H, Sekiguchi Y, Nagasaki H, Daassi D, Tai PH, Ema M, Kudo T,
Takahashi S. Bioluminescence imaging of beta cells and intrahepatic insulin gene activity
under normal and pathological conditions. PLoS One 8(4):e60411, 2013
41. Kawamura T, Usui J, Kaseda K, Takada K, Ebihara I, Ishizu T, Iitsuka T, Sakai K, Takemura
K, Kobayashi M, Koyama A, Kanemoto K, Sumazaki R, Uesugi N, Noguchi M, Nagata M,
Suka M, Yamagata K. Primary membranoproliferative glomerulonephritis on the decline:
decreased rate from the 1970s to the 2000s in Japan. Clin Exp Nephrol 17(2):248-254, 2013
42. Kim J, Tanabe K, Yokoyama N, Zempo H, Kuno S. Objectively measured light-intensity
lifestyle activity and sedentary time are independently associated with metabolic syndrome: across-sectional study of Japanese adults. Int J Behav Nutr Phys Act 10:30, 2013
43. Kim J, Tanabe K, Yoshizawa Y, Yokoyama N, Suga Y, Kuno S. Lifestyle-Based Physical
Activity Intervention for One Year Improves Metabolic Syndrome in Overweight Male
Employees. Tohoku J Exp Med 229:11-17, 2013
44. Kodama S, Horikawa C, Fujihara K, Hirasawa R, Yachi Y, Yoshizawa S, Tanaka S, Sone Y,
Shimano H, Iida KT, Saito K, Sone H. Use of high-normal levels of haemoglobin A(1C) andfasting plasma glucose for diabetes screening and for prediction: a meta-analysis. Diabetes
Metab Res Rev 29(8):680-692, 2013
45. Kodama S, Tanaka S, Heianza Y, Fujihara K, Horikawa C, Shimano H, Saito K, Yamada N,
138

Ohashi Y, Sone H. Association between physical activity and risk of all-cause mortality andcardiovascular disease in patients with diabetes: a meta-analysis. Diabetes Care
36(2):471-479, 2013
46. Kondo K, Fujimori M, Shirai Y, Yamada Y, Ogawa A, Hizawa N, Uchitomi Y.
Characteristics associated with empathic behavior in Japanese oncologists. Patient EducCouns 93(2):350-353, 2013
47. Kondo M, Ono M, Nakazawa K, Kayaba M, Minakuchi E, Sugimoto K, Honda Y.
Population at high-risk of indoor heatstroke: the usage of cooling appliances among urban
elderlies in Japan. Environ Health Prev Med 18(3):251-257, 2013
48. Kudo T, Sato T, Hagiwara K, Kozuma Y, Yamaguchi T, Ikehara Y, Hamada M, Matsumoto
K, Ema M, Murata S, Ohkohchi N, Narimatsu H, Takahashi S. C1galt1-deficient mice exhibit
thrombocytopenia due to abnormal terminal differentiation of megakaryocytes. Blood
122(9):1649-1657, 2013
49. Kurishima K, Homma S, Kagohashi K, Miyazaki K, Kawaguchi M, Satoh H, Hizawa N.
Brain metastasis as an isolated late recurrence in small cell lung cancer. Mol Clin Oncol
2(2):305-307, 2013
50. Kurishima K, Satoh H, Kaburagi T, Nishimura Y, Shinohara Y, Inagaki M, Endo T, Saito T,
Hayashihara K, Hizawa N, Nakamura H, Nawa T, Kagohashi K, Kishi K, Ishikawa H,
Ichimura H, Hashimoto T, Sato Y, Sakai M, Kamiyama K, Matsumura T, Unoura K, Fukuoka
T, Uchiumi K, Nomura A, Furukawa K. Erlotinib for elderly patients with non-small-celllung cancer: Subset analysis from a population-based observational study by the Ibaraki
Thoracic Integrative (POSITIVE) Research Group. Mol Clin Oncol 1(5):828-832, 2013
51. Mito T, Kikkawa Y, Shimizu A, Hashizume O, Katada S, Imanishi H, Ota A, Kato Y, Nakada
K, Hayashi J. Mitochondrial DNA mutations in mutator mice confer respiration defects andB-cell lymphoma development. PLoS One 8(2):e55789, 2013
52. Mizuno S, Tra DT, Mizobuchi A, Iseki H, Mizuno-Iijima S, Kim JD, Ishida J, Matsuda Y,
Kunita S, Fukamizu A, Sugiyama F, Yagami K. Truncated Cables1 causes agenesis of the
corpus callosum in mice. Lab Invest doi: 10.1038/labinvest.2013, 2013
53. Morishima Y, Ano S, Ishii Y, Ohtsuka S, Matsuyama M, Kawaguchi M, Hizawa N.
Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma. Clin Dev
Immunol 2013:609395, 2013
54. Murata K, Saito C, Ishida J, Hamada J, Sugiyama F, Yagami K, Fukamizu A. Effect of
lactation on postpartum cardiac function of pregnancy-associated hypertensive mice.
139

Endocrinology 154(2):597-602, 2013
55. Nagai K, Saito C, Watanabe F, Ohkubo R, Sato C, Kawamura T, Uchida K, Hiwatashi A,
Kai H, Ishida K, Sairenchi T, Yamagata K. Annual incidence of persistent proteinuria in thegeneral population from Ibaraki annual urinalysis study. Clin Exp Nephrol 17(2):255-260,
2013
56. Nagai K, Tahara-Hanaoka S, Morishima Y, Tokunaga T, Imoto Y, Noguchi E, Kanemaru K,
Imai M, Shibayama S, Hizawa N, Fujieda S, Yamagata K, Shibuya A. Expression andfunction of Allergin-1 on human primary mast cells. PLoS One 8(10):e76160, 2013
57. Nagai K, Ueda A, Yamagata K. Successful Use of Tocilizumab in a Case of Multicentric
Castleman's

Diseaseand

End-Stage

Renal

Disease.

Ther

Apher

Dial

doi:

10.1111/1744-9987.12128, 2013
58. Nagano K, Ishida J, Unno M, Matsukura T, Fukamizu A. Apelin elevates blood pressure in
ICR mice with LNAMEinduced endothelial dysfunction. Mol Med Rep 7(5):1371-1375,
2013
59. Nagata M, Yamaguchi Y. Diabetic nephrotic syndrome 25 years after tumor-forming
pancreatitis surgery--reply. Hum Pathol 44(2):300, 2013
60. Nakahara S, Tomio J, Takahashi H, Ichikawa M, Nishida M, Morimura N, Sakamoto T.
Evaluation of pre-hospital administration of adrenaline (epinephrine) by emergency medical
services for patients with out of hospital cardiac arrest in Japan: controlled propensity
matched retrospective cohort study. BMJ 347:f6829, 2013
61. Nakai S, Watanabe Y, Masakane I, Wada A, Shoji T, Hasegawa T, Nakamoto H, Yamagata
K, Kazama JJ, Fujii N, Itami N, Shinoda T, Shigematsu T, Marubayashi S, Morita O,
Hashimoto S, Suzuki K, Kimata N, Hanafusa N, Wakai K, Hamano T, Ogata S, Tsuchida K,
Taniguchi M, Nishi H, Iseki K, Tsubakihara Y. Overview of regular dialysis treatment inJapan (as of 31 December 2011). Ther Apher Dial 17(6):567-611, 2013
62. Nakazawa K, Kurishima K, Tamura T, Ishikawa H, Satoh H, Hizawa N. Survival differencein NSCLC and SCLC patients with diabetes mellitus according to the first-line therapy. Med
Oncol 30(1):367, 2013
63. Nishimoto M, Katano M, Yamagishi T, Hishida T, Kamon M, Suzuki A, Hirasaki M,
Nabeshima Y, Nabeshima Y, Katsura Y, Satta Y, Deakin JE, Graves JA, Kuroki Y, Ono R,
Ishino F, Ema M, Takahashi S, Kato H, Okuda A. In vivo function and evolution of theeutherian-specific pluripotency marker UTF1. PLoS One 8(7):e68119, 2013
64. Oishi H, Tsubaki T, Miyazaki T, Ono M, Nose M, Takahashi S. A bacterial artificial
140

chromosometransgenewithpolymorphic

Cd72

inhibits

thedevelopmentof

glomerulonephritis and vasculitis in MRL-Faslpr lupus mice. J Immunol 190(5):2129-2137,
2013
65. Okubo R, Kai H, Kondo M, Saito C, Yoh K, Morito N, Usui J, Yamagata K. Health-related
quality of life and prognosis in patients with chronic kidney disease: a 3-year follow-up
study. Clin Exp Nephrol doi:10.1007/s10157-013-0901-x, 2013
66. Oshiro Y, Sasaki R, Fukunaga K, Kondo T, Oda T, Takahashi H, Ohkohchi N.
Inflammation-based prognostic score is a useful predictor of postoperative outcome inpatients with extrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 20(3):389-395,
2013
67. Saida T, Mori K, Yabe H, Shindo M, Nasu K, Shiigai M, Takahashi H, Minami M.
Noninvasive visualization of endoleaks after endovascular aortic aneurysm repair throughunenhanced MRI with motion-sensitized driven equilibrium preparation: Phantom
experiments. J Magn Reson Imaging 38(3):714-721, 2013
68. Saito T, Takahashi H, Kaneda H, Binnie M, Azad S, Sato M, Waddell TK, Cypel M, Liu M,
Keshavjee S. Impact of cytokine expression in the pre-implanted donor lung on thedevelopment of chronic lung allograft dysfunction subtypes. Am J Transplant
13(12):3192-3201, 2013
69. Sakurai H, Kurishima K, Homma S, Kagohashi K, Miyazaki K, Kawaguchi M, Satoh H,
Hizawa N. Isolated solitary brain metastasis as a relapse of small cell lung cancer. Oncol Lett
6(4):1108-1110, 2013
70. Sakurai H, Morishima Y, Itoguchi N, Ohtsuka S, Yamadori I, Oto T, Ishii Y, Sakamoto T,
Noguchi M, Hizawa N. Broncho-bronchiolitis obliterans after living-donor lungtransplantation: a unique manifestation of chronic allograft rejection. Transplantation
96(4):e29-30, 2013
71. Satoh H, Kagohashi K, Ohara G, Sato S, Miyazaki K, Nakazawa K, Tamura T, Kurishima K,
Kawaguchi M, Hizawa N. Use of tiotropium in patients with COPD aged 80 years and older.
Exp Ther Med 5(4):997-1000, 2013
72. Suga Y, Tanabe K, Kim J, Sato H, Iwashita S, Hamada K, Kuno S. A Comparison of the
Influences of Soy- vs. Wheat-based Supplements on Weight Loss in Middle-aged Subjects.
Int J Sports Health Sci 11:10-19, 2013
73. Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida
H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Kawamura T, Takeda T, Hataya H,
141

Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Shimizu A, Kitamura H, Yuzawa Y,
Matsuo S, Kiyohara Y, Joh K, Nagata M, Taguchi T, Makino H. Japan Renal Biopsy Registry
and Japan Kidney Disease Registry: Committee Report for 2009 and 2010. Clin Exp
Nephrol 17(2):155-173, 201374. Sunaga H, Matsui H, Ueno M, Maeno T, Iso T, Syamsunarno MR, Anjo S, Matsuzaka T,
Shimano H, Yokoyama T, Kurabayashi M. Deranged fatty acid composition causes
pulmonary fibrosis in Elovl6-deficient mice. Nat Commun 4:2563, 2013
75. Takagaki K, Satoh K, Honda S, Shibuya A. Molecular characterization of the dimer
formation of Fcalpha/mu receptor (CD351). Mol Immunol 56(1-2):23-27, 2013
76. Takahashi S, Hiromura K, Tsukida M, Ohishi Y, Hamatani H, Sakurai N, Sakairi T, Ikeuchi
H, Kaneko Y, Maeshima A, Kuroiwa T, Yokoo H, Aoki T, Nagata M, Nojima Y. Nephrotic
syndrome caused by immune-mediated acquired LCAT deficiency. J Am Soc Nephrol24(8):1305-1312, 2013
77. Takibuchi G, Imanishi H, Morimoto M, Ishikawa K, Nakada K, Toyama-Sorimachi N,
Kikkawa Y, Takenaga K, Hayashi J. Polymorphic mutations in mouse mitochondrial DNA
regulate a tumor phenotype. Mitochondrion 13(6):881-887, 2013
78. Taniguchi N, Konno S, Hattori T, Isada A, Shimizu K, Shimizu K, Shijubo N, Huang SK,
Hizawa N, Nishimura M. The CC16 A38G polymorphism is associated with asymptomatic
airway hyper-responsiveness and development of late-onset asthma. Ann Allergy Asthma
Immunol 111(5):376-381 e371, 2013
79. Teramoto S, Hida N, Ishikawa H, Hizawa N. Inverse U shape of the trachea during anasthma attack. Intern Med 52(19):2289-2290, 2013
80. Tomita K, Sakashita M, Hirota T, Tanaka S, Masuyama K, Yamada T, Fujieda S, Miyatake
A, Hizawa N, Kubo M, Nakamura Y, Tamari M. Variants in the 17q21 asthma susceptibility
locus are associated with allergic rhinitis in the Japanese population. Allergy 68(1):92-100,
2013
81. Tsuruoka S, Kai H, Usui J, Morito N, Saito C, Yoh K, Yamagata K. Effects of irbesartan on
inflammatory cytokine concentrations in patients with chronic glomerulonephritis. Intern
Med 52(3):303-308, 2013
82. Tsuruoka S, Yokota N, Hayasaka T, Saito T, Yamagata K. Dialyzability andpharmacokinetics of sitafloxacin following multiple oral dosing in infected hemodialysis
patients. Ther Apher Dial 17(3):319-324, 2013
83. Ueno T, Kobayashi N, Nakayama M, Takashima Y, Ohse T, Pastan I, Pippin JW, Shankland
142

SJ, Uesugi N, Matsusaka T, Nagata M. Aberrant Notch1-dependent effects on glomerularparietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with
progressive podocyte loss. Kidney Int 83(6):1065-1075, 2013
84. Wada T, Miyashita Y, Sasaki M, Aruga Y, Nakamura Y, Ishii Y, Sasahara M, Kanasaki K,
Kitada M, Koya D, Shimano H, Tsuneki H, Sasaoka T. Eplerenone ameliorates thephenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed
high-fat and high-fructose diet. Am J Physiol Endocrinol Metab 305(11):E1415-1425, 2013
85. Wang R, Iwakura Y, Araki K, Keino-Masu K, Masu M, Wang XY, Takei N, Higashiyama S,
Nawa H. ErbB2 dephosphorylation and anti-proliferative effects of neuregulin-1 in
ErbB2-overexpressing cells; re-evaluation of their low-affinity interaction. Sci Rep 3:1402,
2013
86. Yageta Y, Ishii Y, Morishima Y, Ano S, Ohtsuka S, Matsuyama M, Takeuchi K, Itoh K,
Yamamoto M, Hizawa N. Carbocisteine Reduces Viral-Induced Pulmonary Inflammation in
Mice

ExposedtoCigarette

Smoke.

AmJ

Respir

Cell

Mol

Biol

doi:

10.1165/rcmb.2012-0292OC, 2013
87. Yamagata K, Usui J, Sugiyama H, Nitta K, Wada T, Muso E, Arimura Y, Koyama A, Makino
H, Matsuo S. Clinical findings on ANCA-associated renal vasculitis from the Japan RPGN
registry obtained via a questionnaire survey. Clin Exp Nephrol 17(5):646-649, 2013
88. Yamashita Y, Abe F, Hirochika R, Tahara-Hanaoka S, Shibuya A, Shibuya K. Establishment
and characterization of a novel anti-DNAM-1 monoclonal antibody. Monoclon AntibImmunodiagn Immunother 32(1):60-64, 2013
89. Yatagai Y, Sakamoto T, Masuko H, Kaneko Y, Yamada H, Iijima H, Naito T, Noguchi E,
Hirota T, Tamari M, Imoto Y, Tokunaga T, Fujieda S, Konno S, Nishimura M, Hizawa N.
Genome-wide association study for levels of total serum IgE identifies HLA-C in a Japanese
population. PLoS One 8(12):e80941, 2013
90. Yoshinaga M, Ushinohama H, Sato S, Tauchi N, Horigome H, Takahashi H, Sumitomo N,
Kucho Y, Shiraishi H, Nomura Y, Shimizu W, Nagashima M. Electrocardiographic screeningof 1-month-old infants for identifying prolonged QT intervals. Circ Arrhythm Electrophysiol
6(5):932-938, 2013
91. Yoshizawa Y, Honda S, Shibuya A. Involvement of Fχα/υR (CD351) in autoantibody
production. Mol Immunol doi: 10.1016/j.molimm.2013.10.002, 20131432) 英文以外の論文
1. 加藤尚子, 近藤正英, 大久保一郎, 長谷川敏彦. 病院機能分化施策に応じた私的病院の変遷について	 福岡県私設病院を対象とした 1998 年・2012 年の繰り返し調査から. 日
本医療マネジメント学会雑誌 14(1):9-13, 2013
2. 萱場桃子, 中澤浩一, 近藤正英, 小野雅司, 水口恵美子, 杉本和俊, 本田靖. 夏期における高齢者の夜間のエアコン使用に関する研究. 民族衛生 79(2):47-53, 2013
3. 星淑玲, 近藤正英, 大久保一郎. 23 価肺炎球菌ワクチンの再接種およびインフルエンザ
ワクチンとの同時接種に関する実態	
 自治体の接種に対する助成の有無による相違について. 厚生の指標 60(8):23-29, 2013
4. 桝和子, 桝正幸. ヘパラン硫酸微細構造の組織特異性とその決定機構. 医学のあゆみ
245(7):600-602, 2013
5. 村田知弥, 石田純治, 深水昭吉. 【腎と妊娠】 遺伝子改変マウスを活用した産前産後の疾患発症メカニズムに関する研究. 腎と透析 75(5):725-729, 2013
6. 吉澤裕世, 横山典子, 菅洋子, 田辺解, 西尾チヅル, 久野譜也. 地域コミュニティの再構
築がソーシャルキャピタル及び身体活動量に及ぼす影響. 日本臨床スポーツ医学会誌
21(1):201-210, 2013	 3) 英文著書
1. Masu M. 9. Emerging roles of heparan sulfate in axon guidance; in "Cortical Development(1st edition)" (edited by Kageyama R,Yamamori T), Springer-Verlag (Tokyo) 2013;
pp203-214
2. Masu M, Koike S, Okada T, Keino-Masu K. 7. Studies on autotaxin signaling in endocytic
vesicle biogenesis and embryonic development using whole embryo culture andelectroporation; in "Lysophospholipid Receptors: Signaling and Biochemistry (1st edition)"(edited by Chun J, Hla T, Spiegel S,Moolenaar W), John Wiley & Son Inc. (Hoboken, NJ,
USA) 2013; pp121-136

4) 英文以外の著書
1. 相川健, 赤塚東司雄, 旭浩一, 伊藤稔, 上野誠司, 大友浩志, 大森聡, 折笠一彦, 風間順一
郎, 川口洋, 川崎忠行, 川名篤子, 木全直樹, 木村朋由, 熊川健二郎, 小島祥敬, 小林正人,
新村浩明, 鈴木一裕, 関野宏, 常盤峻士, 戸澤修平, 中山昌明, 橋本樹, 堀井秀夫, 槇昭弘,
政金生人, 松岡久光, 水口潤, 宮崎真理子, 柳田知彦, 山川智之, 山縣邦弘, 渡辺毅. "東日本大震災	  学術調査報告書	
  ー災害時透析医療展開への提言ー” (編集 一般社団法人
144

日本透析医学会東日本大震災学術ワーキンググループ), 医学図書出版 (東京) 2013 年（全 267 ページ）
2. 岩崎仁, 島野仁. IV 章. トピックス	
  肝臓における脂質代謝研究の進歩（IV 章. 肝臓代謝性疾患）; "専門医のための消化器病学 (第 2 版)” (監修 小俣政男, 千葉勉, 編集 下
瀬川徹, 渡辺守, 木下芳一, 金子周一, 樫田博史), 医学書院 (東京) 2013; pp386-387
3. 岩崎仁, 島野仁. 2 章-2. 脂肪酸の主な働き; "そうだったんだ！脂肪酸−循環器疾患との深い関係− (第 1 版)” (編集 伊藤浩), 文光堂 (東京) 2013; pp17-21
4. 臼井丈一. ANCA 関連腎炎の患者をどう治療するか; "Bunkodo Essential & Advanced
Mook シリーズ患者を末期腎不全にしないための CKD 診療のコツ” (編集 今井圓裕),
文光堂 (東京) 2013; pp206-212
5. 臼井丈一, 山縣邦弘. CASE08. 感冒を契機に急性腎不全と肺胞出血を呈した 53 歳男性;"New 専門医を目指すケースメソッドアプローチ	
 腎臓疾患 (第 2 版)” (編集 槇野博史),
日本医事新報社 (東京) 2013; pp68-74
6. 臼井俊明, 山縣邦弘. Q14	  わが国の末期腎不全患者数は増加し続けるのでしょうか？;"CKD 診療ガイド 2012	
  Q&A (第 1 版)” (編集 今井圓裕), 診断と治療社 (東京) 2013
pp31-33
7. 河村哲也, 山縣邦弘. Q22	  CKD のリスクは何でしょうか？; "CKD 診療ガイド 2012	
 Q&A (第 1 版)” (編集 今井圓裕), 診断と治療社	  (東京) 2013; pp48-49
8. 加瀬田幸司, 山縣邦弘. Q39	 CKD 患者の専門医への紹介の時期について教えて下さい;"CKD 診療ガイド 2012	
  Q&A (第 1 版)” (編集 今井圓裕), 診断と治療社 (東京) 2013;
pp91-93
9. 富樫周, 山縣邦弘. Q41. CKD 患者に対して透析導入はいつ、どのように説明すればいいでしょうか？; "CKD 診療ガイド 2012	
  Q&A (第 1 版)” (編集 今井圓裕), 診断と治療社 (東京) 2013; pp97-99
10. 久野譜也. 股関節の痛みをとると健康になる【台湾語版】. PHP 研究所 (東京) 2013
年 (全 151 ページ)
11. 煙山（鈴木）紀子, 松坂賢, 島野仁. 第 18 章. 慢性炎症と栄養; "「慢性炎症と生活習慣病」循環器・代謝・呼吸器・消化器疾患の基盤病態へのアプローチ (第 1 版)” (編集 小川佳宏, 眞鍋一郎), 南山堂 (東京) 2013; pp161-168
12. 近藤正英. 医療経済; "最新医学別冊新しい診断と治療の ABC11 CKD（慢性腎臓病）
慢性腎不全 (第 2 版)” (編集 佐々木成), 最新医学社 (大阪) 2013; pp227-234
13. 斎藤知栄, 山縣邦弘. 第 2 章 ３. 国の CKD 診療に対する取り組み; "あなたも名医！
jmedmook29 透析まで行かせない！CKD 診療” (編集 海津嘉蔵), 日本医事新報社 (東145京) 2013; pp6-11
14. 斎藤知栄, 山縣邦弘. I	  慢性腎臓病（CKD)	
  ３. CKD の治療全般・管理目標; "腎不全治療レシピ (第 1 版)” (編集 丹羽利允), 医学出版 (東京) 2013; pp26-37
15. 島野仁. 第 6 章-B. 脂肪酸の生合成とその酸化; "人体の構造と機能及び疾病の成り立
ち (第 2 版)” (編集 香川靖雄, 近藤和雄, 石田均, 門脇孝), 南江堂 (東京) 2013; pp151-154
16. 島野仁. III 章 1〜4. 療養指導各論（III 章 1〜4、1 診断と治療に関する知識、2 食事療法、3 運動療法、4 薬物療法）; "日本糖尿病療養指導士受験ガイドブック	
 2013 (第 1版)” (編集 日本糖尿病療養指導士認定機構), メディカルレビュー社 (大阪) 2013;
pp33-68
17. 島野仁. 内分泌・代謝疾患; "ガイドラインに基づく臨床指針 (第 10 版)” (監修	  福井次矢), 2013; pp274-296
18. 菅野洋子, 島野仁. 第 2 部. リポ蛋白とその分画; "臨床検査ガイド 2013〜2014 (第 1版)” (編集 MedicalPractice 編集委員会), 文光堂 (東京) 2013; pp272-276
19. 堀江重郎, 伊藤秀一, 岡田浩一, 菊池春人, 成田一衛, 西山勉, 長谷川友紀, 三上裕司, 山縣邦弘, 油野友二, 武藤智. 血尿診断ガイドライン. ライフサイエンス出版 (東京) 2013
年 (全 80 ページ)
20. 槇野博史, 木村健二郎, 山縣邦弘. "NHK きょうの健康	
 ここが聞きたい！名医に Q	 腎
臓病のベストアンサー (第 1 版)” (編集 槇野博史, 木村健二郎, 山縣邦弘), 主婦と生活社 (東京) 2013（全 128 ページ）
21. 松永恒明, 山縣邦弘. 3 巻. 尿細管間質性腎炎; "臨床病態学 3 (第２版)” (編集 北村聖),
ヌーヴェルヒロカワ (東京) 2013; pp463-464
22. 矢藤繁, 島野仁. I-10 章-A. NAFLD と糖代謝異常（NASH 編	
 I.基本編〜NASH を診る
前の基礎知識〜）; "NASH・アルコール性肝障害の診療を極める	  基本から最前線まで（Hepatology Practice 第 2 巻）(第 1 版)” (編集 竹井謙之（ゲスト編集）, 竹原徹郎, 持田智（常任編集）), 文光堂 (東京) 2013; pp71-74
23. 矢藤繁, 島野仁. 16-1.1. 生活習慣病（生活・社会・環境要因）; "内科学 (第 10 版)” (編集 矢崎義雄総編集), 朝倉書店 (東京) 2013; pp2348-2352
24. 山縣邦弘. 第 2 章	  病理・病態生理. 病因１．微小変化型ネフローゼ症候群; "最新医学	  別冊	  新しい診断と治療の ABC80/腎 8 	  ネフローゼ症候群” (編集 今井圓裕), 最新医学社 (大阪) 2013; pp46-53
25. 山縣邦弘. 2. 急速進行性糸球体腎炎症候群; "腎臓病薬物療法	
  実践ガイド (第 1 版)”(編集 丹羽利允), 中山書店 (東京) 2013; pp203-214
26. 山縣邦弘. 主な原発性糸球体腎炎. １．溶連菌感染後急性糸球体腎炎; "内科学書 (第 8146

版)” (編集 小川聡), 中山書店 (東京) 2013; pp453-455
27. 山縣邦弘. 主な原発性糸球体腎炎. ２．急速進行性糸球体腎炎; "内科学書 (第 8 版)” (編集 小川聡), 中山書店 (東京) 2013; pp455-459
28. 山縣邦弘. Part3. 慢性腎臓病の治療	
  —原因疾患とその対処法; "別冊 NHK 今日の健康	  慢性腎臓病（CKD）” (編集 富野康日己), NHK 出版 (東京) 2013; pp42-64
29. 山縣邦弘. 9.腎疾患. 急速進行性腎炎症候群（ANCA 関連腎炎を含む）; "今日の治療指針	  私はこう治療している	  2013 (第 1 版)” (編集 山口徹, 北原光夫, 福井次矢), 医学書院 (東京) 2013; pp538-540
30. 山縣邦弘. 第 6 章. 第 1 節、第 2 節	  「ネフローゼ症候群」、「腎炎」; "ナーシング・
グラフィカ	
  健康の回復と看護⑦	
  「疾病と治療」 (第 2 版)” (編集 林正健二, 山内豊明), メディカ出版 (大阪) 2013; pp150-159
31. 山縣邦弘. 第 10 章. CKD 患者を専門医に紹介するタイミング—腎臓専門医との連携;"CKD 診療ガイド 2012 ガイドブック (第 1 版)” (編集 今井圓裕), 医歯薬出版株式会社(東京) pp61-66
32. 山縣邦弘, 臼井丈一. VI.糸球体疾患. 7.半月体形成性糸球体腎炎と ANCA 関連腎炎; "臨床腎臓内科学 (第 1 版)” (編集 安田孝, 平和伸仁, 小山雄太), 南山堂 (東京) 2013;
pp386-393
33. 山縣邦弘, 臼井丈一. VI.糸球体疾患	  14.感染に伴う糸球体疾患（MRSA, 細菌感染, ウ
イルス：肝炎ウイルスや HIV, その他）; "臨床腎臓内科学	  (第 1 版)” (編集 安田孝, 平
和伸仁, 小山雄太), 南山堂 (東京) 2013; pp448-456

147心臓血管	
 1) 英文論文
1. Abe D, Sato A, Hoshi T, Kakefuda Y, Watabe H, Ojima E, Hiraya D, Harunari T, Takeyasu N,
Aonuma K. Clinical predictors of contrast-induced acute kidney injury in patients undergoing
emergency versus elective percutaneous coronary intervention. Circ J 78(1):85-91, 2013
2. Abe D, Sato A, Hoshi T, Takeyasu N, Misaki M, Hayashi M, Aonuma K. Initial culprit-only
versus initial multivessel percutaneous coronary intervention in patients with ST-segment
elevation myocardial infarction: results from the Ibaraki Cardiovascular Assessment Study
registry. Heart Vessels doi: 10.1007/s00380-013-0342-1, 2013
3. Adachi T, Sato A, Baba M, Hiraya D, Hasegawa T, Kuroki K, Hoshi T, Aonuma K. Noveluse of the ultra-short-acting intravenous beta1-selective blocker landiolol for supraventriculartachyarrhythmiasinpatients

withcongestiveheart

failure.

Heart

Vesselsdoi:

10.1007/s00380-013-0377-3, 2013
4. Atsumi A, Ishizu T, Kameda Y, Yamamoto M, Harimura Y, Machino-Ohtsuka T, Kawamura
R, Enomoto M, Seo Y, Aonuma K. Application of 3-dimensional speckle tracking imaging to
the assessment of right ventricular regional deformation. Circ J 77(7):1760-1768, 2013
5. Atsumi A, Ueda K, Irie F, Sairenchi T, Iimura K, Watanabe H, Iso H, Ota H, Aonuma K.
Relationship between cold temperature and cardiovascular mortality, with assessment ofeffect modification by individual characteristics: Ibaraki Prefectural Health Study. Circ J
77(7):1854-1861, 2013
6. Bezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Simonet F, Verkerk AO,
Schwartz PJ, Crotti L, Dagradi F, Guicheney P, Fressart V, Leenhardt A, Antzelevitch C,
Bartkowiak S, Borggrefe M, Schimpf R, Schulze-Bahr E, Zumhagen S, Behr ER, Bastiaenen
R, Tfelt-Hansen J, Olesen MS, Kaab S, Beckmann BM, Weeke P, Watanabe H, Endo N,
Minamino T, Horie M, Ohno S, Hasegawa K, Makita N, Nogami A, Shimizu W, Aiba T,
Froguel P, Balkau B, Lantieri O, Torchio M, Wiese C, Weber D, Wolswinkel R, Coronel R,
Boukens BJ, Bezieau S, Charpentier E, Chatel S, Despres A, Gros F, Kyndt F, Lecointe S,
Lindenbaum P, Portero V, Violleau J, Gessler M, Tan HL, Roden DM, Christoffels VM, Le
Marec H, Wilde AA, Probst V, Schott JJ, Dina C, Redon R. Common variants at
SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with highrisk of sudden cardiac death. Nat Genet 45(9):1044-1049, 2013
7. Birnie D, Lemke B, Aonuma K, Krum H, Lee KL, Gasparini M, Starling RC, Milasinovic G,
Gorcsan J, 3rd, Houmsse M, Abeyratne A, Sambelashvili A, Martin DO. Clinical outcomes148

with synchronized left ventricular pacing: analysis of the adaptive CRT trial. Heart Rhythm
10(9):1368-1374, 2013
8. D'Ascenzo F, Corleto A, Biondi-Zoccai G, Anselmino M, Ferraris F, di Biase L, Natale A,
Hunter RJ, Schilling RJ, Miyazaki S, Tada H, Aonuma K, Yenn-Jiang L, Tao H, Ma C,
Packer D, Hammill S, Gaita F. Which are the most reliable predictors of recurrence of atrial
fibrillation after transcatheter ablation?: a meta-analysis. Int J Cardiol 167(5):1984-1989,
2013
9. Doki K, Homma M, Kuga K, Aonuma K, Kohda Y. SCN5A promoter haplotype affects thetherapeutic range for serum flecainide concentration in Asian patients. Pharmacogenet
Genomics 23(7):349-354, 2013
10. Fujihara K, Suzuki H, Sato A, Kodama S, Heianza Y, Saito K, Iwasaki H, Kobayashi K,
Yatoh S, Takahashi A, Yamada N, Sone H, Shimano H. Carotid artery plaque and
LDL-to-HDL cholesterol ratio predict atherosclerotic status in coronary arteries inasymptomatic patients with type 2 diabetes mellitus. J Atheroscler Thromb 20(5):452-464,
2013
11. Hashii H, Hashimoto T, Okawa A, Shida K, Isobe T, Hanmura M, Nishimura T, Aonuma K,
Sakae T, Sakurai H. Comparison of the effects of high-energy photon beam irradiation (10and 18 MV) on 2 types of implantable cardioverter-defibrillators. Int J Radiat Oncol Biol
Phys 85(3):840-845, 2013
12. Hikita H, Kuroda S, Oosaka Y, Kawaguchi N, Nakashima E, Sugiyama T, Akiyama D,
Kamiishi T, Kimura S, Takahashi Y, Kuwahara T, Sato A, Takahashi A, Isobe M. Impact ofstatin use before the onset of acute myocardial infarction on coronary plaque morphology of
the culprit lesion. Angiology 64(5):375-378, 2013
13. Hikita H, Shigeta T, Kojima K, Oosaka Y, Hishikari K, Kawaguchi N, Nakashima E,
Sugiyama T, Akiyama D, Kamiishi T, Kimura S, Takahashi Y, Kuwahara T, Sato A,
Takahashi A, Isobe M. Lipoprotein(a) is an important factor to determine coronary artery
plaque morphology in patients with acute myocardial infarction. Coron Artery Dis
24(5):381-385, 2013
14. Hiraoka M, Takagi M, Yokoyama Y, Sekiguchi Y, Aihara N, Aonuma K. Prognosis and risk
stratification of young adults with Brugada syndrome. J Electrocardiol 46(4):279-283, 2013
15. Hirata Y, Nabekura T, Maruyama H, Aonuma K, Satoh M. Elevation of plasma basic
fibroblast growth factor after nocturnal hypoxic events in patients with obstructive sleep
apnea syndrome. Springerplus 2(1):260, 2013149

16. Hoshi T, Sato A, Hiraya D, Kimura T, Wang Z, Aonuma K. Multimodality intracoronary
imaging in spontaneous coronary artery dissection: impacts of intravascular ultrasound,
optical coherence tomography, and coronary angioscopy. Catheter Cardiovasc Interv
81(3):E151-154, 2013
17. Hoshi T, Sato A, Kakefuda Y, Harunari T, Watabe H, Ojima E, Hiraya D, Abe D, Nishina H,
Takeyasu N, Noguchi Y, Aonuma K. Preventive effect of statin pretreatment on
contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity
score analysis from a multicenter registry. Int J Cardiol doi: 10.1016/j.ijcard.2013.12.017,
2013
18. Ito H, Matsushita S, Hyodo K, Sato Y, Sakakibara Y. Using synchrotron radiation
angiography with a highly sensitive detector to identify impaired peripheral perfusion in rat
pulmonary emphysema. J Synchrotron Radiat 20(Pt 2):376-382, 2013
19. Ito H, Matsushita S, Ishikawa S, Goto Y, Sakai M, Onizuka M, Sato Y, Sakakibara Y.
Significant correlation between endothelial nitric oxide synthase (eNOS) expression andalveolar repair in elastase-induced rat pulmonary emphysema. Surg Today 43(3):293-299,
2013
20. Ito Y, Yamasaki H, Naruse Y, Yoshida K, Kaneshiro T, Murakoshi N, Igarashi M, Kuroki K,
Machino T, Xu D, Kunugita F, Sekiguchi Y, Sato A, Tada H, Aonuma K. Effect ofeplerenone on maintenance of sinus rhythm after catheter ablation in patients withlong-standing persistent atrial fibrillation. Am J Cardiol 111(7):1012-1018, 2013
21. Kaneko H, Suzuki S, Uejima T, Kano H, Matsuno S, Otsuka T, Takai H, Oikawa Y, Yajima
J, Koike A, Nagashima K, Kirigaya H, Sagara K, Tanabe H, Sawada H, Aizawa T, Yamashita
T. Prevalence and the long-term prognosis of functional mitral regurgitation in Japanesepatients with symptomatic heart failure. Heart Vessels doi: 10.1007/s00380-013-0448-5,
2013 	
 22. Kaneko H, Suzuki S, Yajima J, Oikawa Y, Sagara K, Otsuka T, Matsuno S, Kano H, Uejima
T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T. Clinicalcharacteristics and long-term clinical outcomes of Japanese heart failure patients withpreserved versus reduced left ventricular ejection fraction: a prospective cohort of Shinken
Database 2004-2011. J Cardiol 62(2):102-109, 2013
23. Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T,
Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H,
Aizawa T, Yamashita T. Recent characteristics and outcomes of Japanese stable angina
150

pectoris after percutaneous coronary intervention. An observational cohort study using the
Shinken Database. Int Heart J 54(6):335-340, 2013
24. Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T,
Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H,
Aizawa T, Yamashita T. Obesity paradox in Japanese patients after percutaneous coronary
intervention: an observation cohort study. J Cardiol 62(1):18-24, 2013
25. Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T,
Matsuno S, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T,
Yamashita T. Long-term incidence and prognostic factors of the progression of new coronary
lesions in Japanese coronary artery disease patients after percutaneous coronary intervention.
Heart Vessels doi: 10.1007/s00380-013-0382-6, 2013
26. Kaneshiro T, Aonuma K. [General therapeutic strategy for atrial fibrillation]. Nihon Rinsho
71(1):60-66, 2013
27. Kato J, Koike A, Hoshimoto-Iwamoto M, Nagayama O, Sakurada K, Sato A, Yamashita T,
Wasserman K, Aonuma K. Relation between oscillatory breathing and cardiopulmonary
function during exercise in cardiac patients. Circ J 77(3):661-666, 2013
28. Kawamura M, Ohno S, Naiki N, Nagaoka I, Dochi K, Wang Q, Hasegawa K, Kimura H,
Miyamoto A, Mizusawa Y, Itoh H, Makiyama T, Sumitomo N, Ushinohama H, Oyama K,
Murakoshi N, Aonuma K, Horigome H, Honda T, Yoshinaga M, Ito M, Horie M. Genetic
background of catecholaminergic polymorphic ventricular tachycardia in Japan. Circ J
77(7):1705-1713, 2013
29. Kawamura R, Seo Y, Ishizu T, Atsumi A, Yamamoto M, Machino-Ohtsuka T, Nakajima H,
Sakai S, Tanaka YO, Minami M, Aonuma K. Feasibility of left ventricular volume
measurements by three-dimensional speckle tracking echocardiography depends on image
quality and degree of left ventricular enlargement: Validation study with cardiac magnetic
resonance imaging. J Cardiol doi: 10.1016/j.jjcc.2013.08.010, 2013
30. Koshizuka R, Ishizu T, Kameda Y, Kawamura R, Seo Y, Aonuma K. Longitudinal strain
impairment as a marker of the progression of heart failure with preserved ejection fraction ina rat model. J Am Soc Echocardiogr 26(3):316-323, 2013
31. Kumagai K, Sakamoto T, Nakamura K, Nishiuchi S, Hayano M, Hayashi T, Sasaki T,
Aonuma K, Oshima S. Combined dominant frequency and complex fractionated atrial
electrogram ablation after circumferential pulmonary vein isolation of atrial fibrillation. J
Cardiovasc Electrophysiol 24(9):975-983, 2013151

32. Kurosaki K, Nogami A, Shirai Y, Kowase S. Positive QRS complex in lead i as a malignant
sign in right ventricular outflow tract tachycardia: comparison between polymorphic andmonomorphic ventricular tachycardia. Circ J 77(4):968-974, 2013
33. Kuwahara T, Takahashi A, Takahashi Y, Kobori A, Miyazaki S, Takei A, Fujino T, Okubo K,
Takagi K, Fujii A, Takigawa M, Watari Y, Hikita H, Sato A, Aonuma K. Prevention of
periprocedural ischemic stroke and management of hemorrhagic complications in atrial
fibrillation ablation under continuous warfarin administration. J Cardiovasc Electrophysiol
24(5):510-515, 2013
34. Kuwahara T, Takahashi A, Takahashi Y, Kobori A, Miyazaki S, Takei A, Fujino T, Okubo K,
Takagi K, Fujii A, Takigawa M, Watari Y, Hikita H, Sato A, Aonuma K. Clinicalcharacteristics and management of periesophageal vagal nerve injury complicating left atrial
ablation of atrial fibrillation: lessons from eleven cases. J Cardiovasc Electrophysiol
24(8):847-851, 2013
35. Machino T, Tada H, Sekiguchi Y, Aonuma K. Three-dimensional visualization of the entire
reentrant circuit of bundle branch reentrant tachycardia. Heart Rhythm 10(3):459-460, 2013
36. Machino-Ohtsuka T, Seo Y, Ishizu T, Sugano A, Atsumi A, Yamamoto M, Kawamura R,
Machino T, Kuroki K, Yamasaki H, Igarashi M, Sekiguchi Y, Aonuma K. Efficacy, safety,
and outcomes of catheter ablation of atrial fibrillation in patients with heart failure withpreserved ejection fraction. J Am Coll Cardiol 62(20):1857-1865, 2013
37. Machino-Ohtsuka T, Seo Y, Ishizu T, Yanaka S, Nakajima H, Atsumi A, Yamamoto M,
Kawamura R, Koshino Y, Machino T, Kuroki K, Yamasaki H, Igarashi M, Sekiguchi Y, Tada
H, Aonuma K. Significant improvement of left atrial and left atrial appendage function after
catheter ablation for persistent atrial fibrillation. Circ J 77(7):1695-1704, 2013
38. Morizumi S, Hiramatsu Y, Matsuzaki K, Goto Y, Sato S, Abe M, Kato H, Matsubara M,
Sakakibara Y. Early heparin administration attenuates tissue factor-mediated thrombin
generation during simulated cardiopulmonary bypass. J Card Surg doi: 10.1111/jocs.12254,
2013
39. Murakoshi N, Aonuma K. Epidemiology of arrhythmias and sudden cardiac death in Asia.
Circ J 77(10):2419-2431, 2013
40. Nakano Y, Chayama K, Ochi H, Toshishige M, Hayashida Y, Miki D, Hayes CN, Suzuki H,
Tokuyama T, Oda N, Suenari K, Uchimura-Makita Y, Kajihara K, Sairaku A, Motoda C,
Fujiwara M, Watanabe Y, Yoshida Y, Ohkubo K, Watanabe I, Nogami A, Hasegawa K,
Watanabe H, Endo N, Aiba T, Shimizu W, Ohno S, Horie M, Arihiro K, Tashiro S, Makita N,
152

Kihara Y. A nonsynonymous polymorphism in semaphorin 3A as a risk factor for humanunexplained cardiac arrest with documented ventricular fibrillation. PLoS Genet
9(4):e1003364, 2013
41. Naruse Y, Sato A, Hoshi T, Takeyasu N, Kakefuda Y, Ishibashi M, Misaki M, Abe D,
Aonuma K. Triple antithrombotic therapy is the independent predictor for the occurrence ofmajor bleeding complications: analysis of percent time in therapeutic range. Circ Cardiovasc
Interv 6(4):444-451, 2013
42. Naruse Y, Tada H, Satoh M, Yanagihara M, Tsuneoka H, Hirata Y, Ito Y, Kuroki K,
Machino T, Yamasaki H, Igarashi M, Sekiguchi Y, Sato A, Aonuma K. Concomitantobstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency
catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure
therapy. Heart Rhythm 10(3):331-337, 2013
43. Nishiuchi S, Nogami A, Naito S. A case with occurrence of antidromic tachycardia after
ablation of idiopathic left fascicular tachycardia: mechanism of left upper septal ventriculartachycardia. J Cardiovasc Electrophysiol 24(7):825-827, 2013
44. Nogami Y, Ishizu T, Atsumi A, Yamamoto M, Kawamura R, Seo Y, Aonuma K. Abnormal
early diastolic intraventricular flow 'kinetic energy index' assessed by vector flow mapping inpatients with elevated filling pressure. Eur Heart J Cardiovasc Imaging 14(3):253-260,
2013
45. Nozato T, Sato A, Hirose S, Hikita H, Takahashi A, Endo H, Imanaka-Yoshida K, Yoshida T,
Aonuma K, Hiroe M. Preliminary study of serum tenascin-C levels as a diagnostic or
prognostic biomarker of type B acute aortic dissection. Int J Cardiol 168(4):4267-4269, 2013
46. Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A,
Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Michishita
I. Effects of statins on serum n-3 to n-6 polyunsaturated fatty acid ratios in patients withcoronary artery disease. J Cardiovasc Pharmacol Ther 18(4):320-326, 2013
47. Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A,
Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima
M, Michishita I. Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary
atherosclerosis in statin-treated patients with coronary artery disease. Am J Cardiol
111(1):6-11, 2013
48. Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A,
Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima
153M, Michishita I. Comparison of change in coronary atherosclerosis in patients with stableversus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on
Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology[TRUTH] study). Am J Cardiol 111(7):923-929, 2013
49. Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A,
Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima
M, Michishita I. Comparison of effects of serum n-3 to n-6 polyunsaturated fatty acid ratios
on coronary atherosclerosis in patients treated with pitavastatin or pravastatin undergoing
percutaneous coronary intervention. Am J Cardiol 111(11):1570-1575, 2013
50. Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A,
Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima
M, Michishita I. Comparison of the effects of pitavastatin versus pravastatin on coronary
artery plaque phenotype assessed by tissue characterization using serial virtual histology
intravascular ultrasound. Heart Vessels doi: 10.1007/s00380-013-0453-8, 2013 	
 51. Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A,
Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hirano T, Hibi K,
Terashima M, Michishita I. Impacts of age on coronary atherosclerosis and vascular responseto statin therapy. Heart Vessels doi: 10.1007/s00380-013-0387-1, 2013
52. Ohno I, Hayashi H, Aonuma K, Horio M, Kashihara N, Okada H, Komatsu Y, Tamura S,
Awai K, Yamashita Y, Kuwatsuru R, Hirayama A, Saito Y, Murohara T, Tamaki N, Sato A,
Takayama T, Imai E, Yasuda Y, Koya D, Tsubakihara Y, Horie S, Korogi Y, Narumi Y,
Hayakawa K, Daida H, Node K, Kubota I. Guidelines on the use of iodinated contrast media
in patients with kidney disease 2012: digest version. Circ J 77(7):1883-1914, 2013
53. Ohno I, Hayashi H, Aonuma K, Horio M, Kashihara N, Okada H, Komatsu Y, Tamura S,
Awai K, Yamashita Y, Kuwatsuru R, Hirayama A, Saito Y, Murohara T, Tamaki N, Sato A,
Takayama T, Imai E, Yasuda Y, Koya D, Tsubakihara Y, Horie S, Korogi Y, Narumi Y,
Hayakawa K, Daida H, Node K, Kubota I. Guidelines on the use of iodinated contrast media
in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working
Group. Jpn J Radiol 31(8):546-584, 2013
54. Ohno I, Hayashi H, Aonuma K, Horio M, Kashihara N, Okada H, Komatsu Y, Tamura S,
Awai K, Yamashita Y, Kuwatsuru R, Hirayama A, Saito Y, Murohara T, Tamaki N, Sato A,
Takayama T, Imai E, Yasuda Y, Koya D, Tsubakihara Y, Horie S, Korogi Y, Narumi Y,
Hayakawa K, Daida H, Node K, Kubota I. Guidelines on the use of iodinated contrast media154

in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working
Group. Clin Exp Nephrol 17(4):441-479, 2013
55. Sacher F, Probst V, Maury P, Babuty D, Mansourati J, Komatsu Y, Marquie C, Rosa A,
Diallo A, Cassagneau R, Loizeau C, Martins R, Field ME, Derval N, Miyazaki S, Denis A,
Nogami A, Ritter P, Gourraud JB, Ploux S, Rollin A, Zemmoura A, Lamaison D, Bordachar
P, Pierre B, Jais P, Pasquie JL, Hocini M, Legal F, Defaye P, Boveda S, Iesaka Y, Mabo P,
Haissaguerre M. Outcome after implantation of a cardioverter-defibrillator in patients with
Brugada syndrome: a multicenter study-part 2. Circulation 128(16):1739-1747, 2013
56. Sakuramoto H, Shimojo N, Jesmin S, Unoki T, Kamiyama J, Oki M, Miya K, Kawano S,
Mizutani T. Repeated open endotracheal suctioning causes gradual desaturation but does notexacerbate lung injury compared to closed endotracheal suctioning in a rabbit model of
ARDS. BMC Anesthesiol 13(1):47, 2013
57. Sasaki K, Matsushita S, Sato F, Tokunaga C, Hyodo K, Sakakibara Y. Cardiac sympathetic
activity assessed by heart rate variability indicates myocardial ischemia on cold exposure indiabetes. Ann Vasc Dis 6(3):583-589, 2013
58. Schuetz GM, Schlattmann P, Achenbach S, Budoff M, Garcia MJ, Roehle R, Pontone G,
Meijboom WB, Andreini D, Alkadhi H, Honoris L, Bettencourt N, Hausleiter J, Leschka S,
Gerber BL, Meijs MF, Shabestari AA, Sato A, Zimmermann E, Schoepf UJ, Diederichsen A,
Halon DA, Mendoza-Rodriguez V, Hamdan A, Norgaard BL, Brodoefel H, Ovrehus KA,
Jenkins SM, Halvorsen BA, Rixe J, Sheikh M, Langer C, Martuscelli E, Romagnoli A,
Scholte AJ, Marcus RP, Ulimoen GR, Nieman K, Mickley H, Nikolaou K, Tardif JC, Johnson
TR, Muraglia S, Chow BJ, Maintz D, Laule M, Dewey M. Individual patient datameta-analysis for the clinical assessment of coronary computed tomography angiography:
protocol of the Collaborative Meta-Analysis of Cardiac CT (CoMe-CCT). Syst Rev 2:13,
2013
59. Sekiguchi Y, Aonuma K, Takagi M, Aihara N, Yokoyama Y, Hiraoka M. New clinical andelectrocardiographic classification in patients with idiopathic ventricular fibrillation. J
Cardiovasc Electrophysiol 24(8):902-908, 2013
60. Seo Y, Yamasaki H, Kawamura R, Ishizu T, Igarashi M, Sekiguchi Y, Tada H, Aonuma K.
Left ventricular activation imaging by 3-dimensional speckle-tracking echocardiography.
Comparison with electrical activation mapping. Circ J 77(10):2481-2489, 2013
61. Seto K, Uchida F, Baba O, Yamatoji M, Karube R, Warabi E, Sakai S, Hasegawa S,
Yamagata K, Yanagawa T, Onizawa K, Miyoshi E, Shoda J, Bukawa H. Negative expression155

of N-acetylglucosaminyltransferase V in oral squamous cell carcinoma correlates with poor
prognosis. Springerplus 2:657, 2013
62. Suzuki S, Sagara K, Otsuka T, Kano H, Matsuno S, Takai H, Uejima T, Oikawa Y, Koike A,
Nagashima K, Kirigaya H, Yajima J, Tanabe H, Sawada H, Aizawa T, Yamashita T. Effects ofsmoking habit on the prevalence of atrial fibrillation in Japanese patients with specialreference to sex differences. Circ J 77(12):2948-2953, 2013
63. Suzuki S, Sagara K, Otsuka T, Kano H, Matsuno S, Takai H, Uejima T, Oikawa Y, Koike A,
Nagashima K, Kirigaya H, Yajima J, Tanabe H, Sawada H, Aizawa T, Yamashita T. "Blueletter effects": Changes in physicians' attitudes toward dabigatran after a safety advisory in a
specialized hospital for cardiovascular care in Japan. J Cardiol 62(6):366-373, 2013
64. Suzuki S, Sagara K, Otsuka T, Kano H, Matsuno S, Takai H, Uejima T, Oikawa Y, Koike A,
Nagashima K, Kirigaya H, Yajima J, Tanabe H, Sawada H, Aizawa T, Yamashita T.
Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict
first-time appearance of atrial fibrillation. Am J Cardiol 111(11):1602-1607, 2013
65. Tajiri K, Shimojo N, Sakai S, Machino-Ohtsuka T, Imanaka-Yoshida K, Hiroe M, TsujimuraY, Kimura T, Sato A, Yasutomi Y, Aonuma K. Pitavastatin regulates helper T-celldifferentiation and ameliorates autoimmune myocarditis in mice. Cardiovasc Drugs Ther
27(5):413-424, 2013
66. Takagi M, Aonuma K, Sekiguchi Y, Yokoyama Y, Aihara N, Hiraoka M. The prognostic
value of early repolarization (J wave) and ST-segment morphology after J wave in Brugada
syndrome: multicenter study in Japan. Heart Rhythm 10(4):533-539, 2013
67. Tokunaga C, Hiramatsu Y, Kanemoto S, Takahashi-Igari M, Abe M, Horigome H,
Sakakibara Y. Effects of landiolol hydrochloride on intractable tachyarrhythmia after
pediatric cardiac surgery. Ann Thorac Surg 95(5):1685-1688, 2013
68. Wang Z, Sato A, Akiyama D, Kimura T, Tajiri K, Hoshi T, Sakai S, Koike A, Miyauchi T,
Aonuma K. Clinical value of plasma pentraxin 3 levels for predicting cardiac troponinelevation after percutaneous coronary intervention. Life Sci doi: 10.1016/j.lfs.2013.11.021,
2013
69. Watabe H, Sato A, Hoshi T, Obara K, Kawamura R, Aonuma K. Dislodged andmechanically distorted stent stuck within a previously implanted drug-eluting stent. Heart
Vessels 28(4):541-545, 2013
70. Watanabe H, Kawarazaki M, Yoshida K, Sato A. Wearable ECG monitoring and alerting
system associated with smartphone: iHeart. International Journal of E-Health and Medical
156

Communications 4(4):1-15, 2013	
 71. Yamasaki H, Kaneshiro T, Sekiguchi Y, Tada H, Aonuma K. Ischemic esophageal ulcerationthat developed after an early endoscopic surveillance in a patient receiving catheter ablation
for atrial fibrillation. Circulation 127(21):e635-636, 2013
72. Yamasaki H, Tada H, Arimoto T, Sekiguchi Y, Sato A, Aonuma K. Coronary venous lead
implantation after an evaluation by virtual histology intravascular ultrasound and stenting ofa stenosis. Pacing Clin Electrophysiol 36(2):e59-63, 2013	 2) 英文以外の論文
1. 青沼和隆. 心房細動カテーテルアブレーション治療. 心臓 45(6):735-737, 2013
2. 青山結希, 青沼和隆, 瀬尾由広, 石津智子, 川村龍, 町野智子, 山本昌良, 渥美安紀子, 榎
本 真 美, 佐 藤 誠. 心 不 全 患 者 に 対 す る 陽 圧 換 気 療 法 の 効 果. 日 本 心 臓 病 学 会 誌
8(Suppl.I):479, 2013
3. 浅川哲也, 中川和也, 望田哲司, 松村国佳, 山内康照, 山崎浩, 青沼和隆. 非持続性心室頻拍様心電図所見と Mobitz II 型の偽性第 2 度房室ブロック所見を呈した心室二重応答の 1 例. 臨床心臓電気生理 36:169-176, 2013
4. 安達亨, 吉田健太郎, 山崎浩, 五十嵐都, 関口幸夫, 石津智子, 瀬尾由広, 夛田浩, 久賀圭祐, 青沼和隆. 心室 3 点ペーシングの有効性が確認された拡張型心筋症による重症左心不全の 1 例. Therapeutic Research 34(1):85-87, 2013
5. 渥美安紀子, 石津智子, 瀬尾由広, 青沼和隆. 心臓再同期療法の効果予測における右室機能評価の付加的価値	
  START 研究からの検討. 超音波医学 40(Suppl.):S467, 2013
6. 五十嵐都, 青沼和隆. 不整脈 心房細動のカテーテルアブレーションの新しいエビデンス	
  適応と成績を中心に. Annual Review 循環器 2013:145-151, 2013
7. 五十嵐都, 村越伸行, 許東洙, 夛田浩, 関口幸夫, 山崎浩, 黒木健志, 町野毅, 井藤葉子, 石津智子, 瀬尾由広, 久賀圭祐, 青沼和隆. 高血圧ラットにおけるアミオダロンの心房細動 抑 制 の メ カ ニ ズ ム に つ い て 	  ベ プ リ ジ ル と の 比 較 検 討. Progress in Medicine
33(Suppl.1):698-703, 2013
8. 石津智子, 青沼和隆. 【進化した 3D イメージング(後編)-超音波検査の見かた・撮りか
た】 総論. CIRCULATION Up-to-Date 8(4):380-389, 2013
9. 石津智子, 瀬尾由広, 関口幸夫, 青沼和隆. WPW 症候群における心エコー3 次元スペッ
クルトラッキング法を用いた副伝導路の評価. 日本心臓病学会誌 8(Suppl.I):378, 201310. 井藤葉子, 野上昭彦, 山崎浩, 成瀬代士久, 黒木健志, 町野毅, 五十嵐都, 関口幸夫, 青沼
和隆. 長期持続型心房細動に対するカテーテルアブレーションにおけるレニン-アン
157

ジオテンシン-アルドステロン系阻害薬の併用効果について. 日本心臓病学会誌
8(Suppl.I):383, 2013
11. 今井章人, 渡邉寛, 佐藤藤夫, 平松祐司, 榊原謙. 肋間動脈瘤と脊髄神経症状を合併した成人型大動脈縮窄症の 1 手術例. 日本血管外科学会雑誌 22(4):747 201312. 岩瀧麻衣, 瀬尾由広, 永田泰史, 桑木恒, 大谷恭子, 芳谷英俊, 竹内正明, 尾辻豊, 青沼和隆. 心臓再同期療法による左室機能改善の局在	
  2 次元スペックルトラッキング法を用いた検討. 日本心臓病学会誌 8(Suppl.I):609, 201313. 榎本真美, 石津智子, 瀬尾由広, 酒井俊, 青沼和隆, 鈴木浩明, 川上康, 島野仁. 糖尿病における左房 stiffness と血清レプチンとの関連. 成人病と生活習慣病 43(5):635, 201314. 榎本真美, 石津智子, 瀬尾由広, 酒井俊, 鈴木浩明, 川上康, 島野仁, 青沼和隆. 糖尿病における左房 stiffness と血清レプチンとの関連. 日本成人病(生活習慣病)学会会誌 39:72,
2013
15. 大塚紗土美, 瀬尾由広, 根崎里美, 小林紘子, 中島英樹, 飯田典子, 酒巻文子, 上牧隆, 石津智子, 青沼和隆. 術後仮性心室瘤を生じた劇症型感染性心内膜炎の一例. 超音波医学
40(2):219, 201316. 奥村謙, 相澤義房, 相原直彦, 青沼和隆, 沖重薫, 熊谷浩一郎, 庄田守男, 住友直方, 高橋
淳, 内藤滋人, 中村好秀, 野上昭彦, 平尾見三, 松本万夫, 村川裕二, 山根禎一, 大和田真玄, 佐々木真吾, 里見和浩, 夛田浩, 池主雅臣, 蜂谷仁, 新博次, 家坂義人, 櫻田春水, 筒井
裕之, 三田村秀雄, 日本循環器学会. 循環器病の診断と治療に関するガイドライン(2010-2011 年度合同研究班報告)	
  カテーテルアブレーションの適応と手技に関するガイドライン. 循環器病の診断と治療に関するガイドライン 2012:3-67, 201317. 奥村謙, 相澤義房, 相原直彦, 青沼和隆, 沖重薫, 熊谷浩一郎, 庄田守男, 住友直方, 高橋
淳, 内藤滋人, 中村好秀, 野上昭彦, 平尾見三, 松本万夫, 村川裕二, 山根禎一, 大和田真玄, 佐々木真吾, 里見和浩, 夛田浩, 池主雅臣, 蜂谷仁, 新博次, 家坂義人, 櫻田春水, 筒井
裕之, 三田村秀雄, 日本循環器学会. 循環器病の診断と治療に関するガイドライン(2010-2011 年度合同研究班報告)【ダイジェスト版】	
  カテーテルアブレーションの適応と手技に関するガイドライン. 循環器病の診断と治療に関するガイドライン
2012:69-88, 201318. 柏 原 直 樹, 今 井 圓 裕, 青 沼 和 隆, 林 宏 光. 【 造 影 剤 腎 症 】. Nephrology Frontier12(3):244-252, 201319. 加藤愛章, 高橋実穂, 林立申, 中村昭宏, 石川伸行, 今川和生, 野崎良寛, 関口幸夫, 青沼
和隆, 堀米仁志. Chanelopathy の管理	
 そのエビデンス カテコラミン誘発多形性心室頻拍に対する非薬物治療. 日本小児循環器学会雑誌 29(Suppl.):s95, 2013158

20. 金城貴士, 青沼和隆. 【心房細動-診断・治療の最新動向-】 心房細動の治療	
  心房細動に対する治療総論. 日本臨床 71(1):60-66, 2013
21. 金城貴士, 青沼和隆. 【進歩する慢性心不全の治療-薬物治療と非薬物治療の最前線を学ぶ】 ここまで進化した非薬物治療	
  CD と CRT. Mebio 30(1):60-66, 2013
22. 川松直人, 石津智子, 玄哲樹, 会田敏, 木全啓, 酒井俊介, 佐藤希美, 菅野昭憲, 加藤穣,
川辺正之, 許東洙, 木村泰三, 原唯史, 榎本佳治, 瀬尾由広, 青沼和隆. 大動脈弁置換術後の弁不全において PET-CT が治療方針決定に有用であった自己免疫性血管炎. 日本心臓病学会誌 8(Suppl.I):676, 2013
23. 川松直人, 瀬尾由広, 中島英樹, 佐藤希美, 菅野昭憲, 渥美安紀子, 山本昌良, 町野智子,
井藤葉子, 黒木健志, 山崎浩, 川村龍, 五十嵐都, 関口幸夫, 石津智子, 青沼和隆. ペース
メーカリード起因性三尖弁逆流症の有病率及びリスクファクターについての検討. 日本心臓病学会誌 8(Suppl.I):289, 2013
24. 許東洙, 村越伸行, 青沼和隆. 【心腎貧血連関】 慢性腎臓病と心房細動発症のリスク.
循環器内科 74(5):479-483, 2013
25. 黒木健志, 青沼和隆. 【循環器医の腕の魅せどころ-進化するデバイスを使いこなす】
心機能低下例に対する ICD 治療	
  不適切作動回避のための ICD 設定と薬物療法の実際. Circulation 3(2):35-42, 2013
26. 酒井俊, 蕨栄次, 柳川徹, 青沼和隆, 宮内卓, 石井哲郎. p62 遺伝子欠損肥満モデルマウ
スにおける血圧動態の解析. 日本高血圧学会臨床高血圧フォーラムプログラム・抄録
集 2 回:159, 201327. 酒巻文子, 瀬尾由広, 山本昌良, 大塚聡美, 根崎里美, 小林紘子, 飯田典子, 中島英樹, 石津智子, 青沼和隆. CRT 後に残存する高度左室拡張障害と予後の関連について. 超音波検査技術 38(Suppl.):S166, 201328. 坂元雄介, 縮恭一, 鳥羽清志郎, 赤星博和, 川上康, 町野毅, 黒木健志, 山崎浩, 五十嵐
都, 関口幸夫, 青沼和隆. 当院のカテーテル・アブレーション業務における臨床工学技士の取り組みと現状. 日本臨床工学技士会会誌 48:147, 201329. 坂元雄介, 縮恭一, 鳥羽清志郎, 赤星博和, 山本純偉, 平谷太吾, 春成智彦, 秋山大樹, 星智也, 佐藤明, 青沼和隆. 低分子デキストランを使用したフラッシュ法による FD-OCTの 画 像 評 価 に つ い て の 検 討. 日 本 心 血 管 イ ン タ ー ベ ン シ ョ ン 治 療 学 会 誌
5(Suppl.I):720, 2013
30. 佐藤明, 青沼和隆. 【心筋症の画像診断】 たこつぼ心筋症の画像診断. 循環器内科
73(4):423-429, 2013
31. 佐藤明, 関口幸夫, 野上昭彦, 青沼和隆. 虚血と不整脈 急性冠症候群に伴う不整脈と159

その対処. 心電図 33(Suppl.4):S-4-74, 2013
32. 佐藤希美, 瀬尾由広, 石津智子, 竹内正明, 出雲昌樹, 鈴木健吾, 山下英治, 大島茂, 三宅良彦, 尾辻豊, 青沼和隆. 低流量低圧較差重症大動脈弁狭窄症の予後評価におけるLongitudinal strain の有用性. 日本心臓病学会誌 8(Suppl.I):371, 2013
33. 佐藤希美, 瀬尾由広, 竹内正明, 出雲昌樹, 山下英治, 大島茂, 三宅良彦, 尾辻豊, 青沼和隆. 重 症 大 動 脈 弁 狭 窄 症 の エ コ ー 指 標 に よ る 予 後 評 価 の 検 討. 超 音 波 医 学
40(Suppl.):S501, 201334. 白井康大, 野上昭彦, 荻ノ沢泰司, 小和瀬晋弥, 黒崎健司, 村瀬達彦, 篠田康俊, 佐々木
法常, 福澤朋幸, 西山大樹, 青木元, 柚本和彦, 玉木利幸, 加藤健一. 頻拍中のみ心室刺激による室房伝導を認め，機序として遅伝導路の順行性潜在伝導が考えられた Long RP’
頻拍の 1 例. 臨床心臓電気生理 36:117-126, 201335. 菅野昭憲, 瀬尾由広, 渥美安紀子, 山本昌良, 町野智子, 針村佳江, 川村龍, 石津智子, 青
沼和隆. QRS 幅の狭い左室収縮障害患者における心筋線維化と左室非同期の関連. 超音波医学 40(Suppl.):S641, 201336. 菅野昭憲, 瀬尾由広, 渥美安紀子, 山本昌良, 町野智子, 針村佳江, 川村龍, 榎本真美, 石津智子, 青沼和隆. 肥大型心筋症患者における不整脈イベントと 2 次元スペックルト
ラッキング法との関連. 日本内科学会雑誌 102(Suppl.):165, 201337. 菅野昭憲, 瀬尾由広, 佐藤希美, 渥美安紀子, 山本昌良, 町野智子, 針村佳江, 川村龍, 石津智子, 野口祐一, 青沼和隆. 肥大型心筋症における左室 longtudinal strain と不整脈イ
ベントとの関連. 日本心臓病学会誌 8(Suppl.I):561, 201338. 鈴木篤, 山内康照, 柳下敦彦, 佐藤弘典, 川初寛道, 臼井英祐, 宮崎亮一, 山口徹雄, 小西
裕二, 原信博, 梅本朋幸, 宮本貴庸, 尾林徹, 田尾進, 平尾見三, 青沼和隆. 高位右房中隔での焼灼により根治し得た peri-mitral atrial flutter の 1 例. 心臓 45(Suppl.3):61-67, 2013
39. 瀬尾由広, 青沼和隆. 心臓再同期療法のエビデンス 心エコーによるレスポンダー予測	  J-CRT、START 研究から. 日本心臓病学会誌 8(Suppl.I):184, 2013
40. 瀬尾由広, 青沼和隆. リバース・リモデリングへの挑戦 リバース・リモデリングへの挑戦	  CRT. 日本心臓病学会誌 8(Suppl.I):222, 201341. 関口幸夫, 野上昭彦, 黒木健志, 町野毅, 山崎浩, 五十嵐都, 青沼和隆. 3D マッピング・
イメージングを用いた不整脈の診断と治療 CARTO システムを用いた VT アブレーシ
ョン. 心電図 33(Suppl.4):S-4-84, 201342. 田尾進, 山内康照, 岡田寛之, 前田真吾, 鍵山暢之, 小西裕二, 原信博, 山口徹雄, 内藤貴基, 宮崎亮一, 梅本朋幸, 宮本貴庸, 尾林徹, 平尾見三, 青沼和隆. 肺静脈隔離中に肺静脈
左房間の偽性一方向性伝導の所見を認めた持続性心房細動の 1 例. 臨床心臓電気生理16036:1-8, 2013
43. 縮恭一, 佐藤明, 坂元雄介, 山本純偉, 酒井俊介, 平谷太吾, 田尻和子, 木村泰三, 星智也, 青沼和隆. Everolimus-Eluting stent 留置後のステント内新生内膜被膜状態をウサギ
モデル及び臨床症例での血管内視鏡所見と OCT の検討. 日本心血管インターベンシ
ョン治療学会誌 5(Suppl.I):730, 2013
44. 縮恭一, 関口幸夫, 坂元雄介, 赤星博和, 茂木芳賢, 古垣達也, 山本純偉, 油井慶晃, 石津智子, 瀬尾由広, 河野了, 青沼和隆, 吉川裕之, 宮園弥生, 榊原謙. 慢性心不全患者の出産時に補助循環およびスワンガンツ・カテーテル使用下での周産期治療の関わりについて. 日本臨床工学技士会会誌 48:192, 2013
45. 縮恭一, 関口幸夫, 福田隆徳, 鳥羽清志郎, 茂木芳賢, 坂元雄介, 赤星博和, 古垣達也, 山
本純偉, 安達亨, 黒木健志, 町野毅, 山崎浩, 五十嵐都, 青沼和隆. Non-ischemic VT-ABL
中に誘発された VT が DC にても改善せず補助循環と ABL によって治療した 1 例. 日本臨床工学技士会会誌 48:147, 201346. 土 岐 浩 介, 関 口 幸 夫, 久 賀 圭 祐, 青 沼 和 隆, 本 間 真 人. β1-ア ド レ ナ リ ン 受 容 体
Arg389Gly 遺 伝 子 多 型 が フ レ カ イ ニ ド の 治 療 効 果 に お よ ぼ す 影 響. 臨 床 薬 理
44(Suppl.):S236, 201347. 土岐浩介, 本間真人, 久賀圭祐, 青沼和隆, 幸田幸直. フレカイニド光学異性体濃度測定のための逆相 HPLC. TDM 研究 30(3):199, 2013
48. 徳永千穂. 【古くて新しい心臓病-成人先天性心疾患】 Eisenmenger 症候群. 成人病と生活習慣病 43(2):218-222, 201349. 中島英樹, 瀬尾由広, 佐藤希美, 菅野昭憲, 渥美安紀子, 山本昌良, 川村龍, 榎本真美, 石津智子, 青沼和隆. <教育に活かす>超音波検査士に望まれる画像調整とレポート作成
診 断 価 値 の あ る 画 像 と 臨 床 医 が 求 め る 検 査 レ ポ ー ト と は な に か. 超 音 波 医 学
40(Suppl.):S186, 2013
50. 成瀬代士久, 小和瀬晋弥, 黒崎健司, 安倍大輔, 吉田健太郎, 武安法之, 青沼和隆. 右室
心 尖 部 ペ ー シ ン グ が 左 室 一 回 拍 出 量 に 与 え る 悪 影 響. 日 本 心 臓 病 学 会 誌
8(Suppl.I):306, 2013
51. 成瀬代士久, 瀬尾由広, 青沼和隆. 【不整脈の非薬物療法】 治す	
  もう一歩進んだデバ イ ス の 植 え 込 み と 管 理 	
  CRT-P と CRT-D の 選 択 と 最 適 化 の 妙. Heart View
17(10):1142-1147, 2013
52. 西内英, 内藤滋人, 佐々木健人, 塚田直史, 早野護, 福家悦子, 三樹祐子, 坂本有, 中村啓二郎, 中村紘規, 絈野健一, 熊谷浩司, 大島茂, 野上昭彦. 多極電極カテーテルで記録された左室中中隔前収縮期電位を指標にとし，アブレーションに成功した上部中隔型特161

発性左側心室頻拍（ILVT）の 1 例. 臨床心臓電気生理 36:211-222, 2013
53. 野上昭彦. 基礎心疾患のない持続性心室頻拍の治療. Medicina 50(13):2216-2220, 2013
54. 野上昭彦. 侵襲的治療の現状と可能性. 最新医学 68:1552-1563, 2013
55. 野上佳恵, 瀬尾由広, 渥美安紀子, 山本昌良, 石津智子, 青沼和隆. 高齢者高血圧症例における Wave-Intensity の意義について. 超音波医学 40(Suppl.):S449, 2013
56. 野寺穣, 武田寛人, 渡邉俊介, 金澤晃子, 石田悟朗, 遠藤教子, 新妻健夫, 小松宣夫, 竹石
恭知, 関口幸夫, 青沼和隆. 如何なる方法にても停止困難な持続性心室頻拍に対し、緊急で心外膜アプローチにてアブレーションに成功した心サルコイドーシスの 1 例. 心電図 33(Suppl.4):S-4-192, 201357. 羽鳥光晴, 中西啓太, 酒井俊介, 小原健一, 前田裕史, 青沼和隆. 胸痛を主訴に来院した
局所心筋炎の 2 症例. 日本心臓病学会誌 8(Suppl.I):668, 2013
58. 古垣達也, 高橋宏, 茂木芳賢, 森谷忠生, 川上康, 榊原謙. 二度にわたる自然災害の被害(大震災・竜巻)と防災訓練の効果. 体外循環技術 40(1):67-71, 2013
59. 星智也, 青沼和隆. 【循環器疾患の診断と治療(II)】 不安定狭心症. 医学と薬学
69(5):751-760, 2013
60. 星智也, 青沼和隆. 【ACS の診断と治療】 ACS の不整脈. Circulation 3(5):92-102, 2013
61. 本田洵也, 渡辺重行, 外山昌弘, 五十野博基, 住谷智恵子, 黒田裕久, 仁科秀崇. V1 の T
波が陽性の右脚ブロックは何を意味するか. 茨城循環器研究会雑誌 20:71-74, 2013
62. 町野智子, 瀬尾由広, 石津智子, 五十嵐都, 関口幸夫, 青沼和隆. Elimination of Atrial
Fibrillation by Catheter Ablation Suppresses Adverse Cardiac Events in HFPEF. 日本心臓病学会誌 8(Suppl.I):172, 2013
63. 宮内裕美, 酒井俊, ジェスミン・サブリナ, 下條信威, 本間覚, 前田清司, 渡辺重行, 青沼
和隆, 宮内卓. エンドセリン A/B デュアル受容体遮断薬の心臓血管系と腎臓に対する効果	
  高血圧肥大心、糖尿病性心筋症、高血圧性血管障害のモデルにおいて. 日本高血圧学会臨床高血圧フォーラムプログラム・抄録集 2 回:179, 2013
64. 村越伸行, 青沼和隆. 【高血圧診療のすべて】	
  高血圧治療の実際 合併症を有する高血圧患者の薬物療法	
  心房細動の血圧管理. 日本医師会雑誌 142(特別 1):S244-S246,
2013
65. 安島良輝子, 梅津努, 助川みわこ, 五十嵐都, 山崎浩, 関口幸夫, 青沼和隆. アブレーシ
ョン治療におけるメディカルスタッフの連携 アブレーションにおける看護師の役割.
日本心臓病学会誌 8(Suppl.I):206, 2013
66. 柳下敦彦, 山内康照, 佐藤弘典, 山下周, 平尾龍彦, 川初寛道, 臼井英祐, 宮崎亮一, 山口
徹雄, 原信博, 梅本朋幸, 宮本貴庸, 尾林徹, 平尾見三, 青沼和隆. Termination without
162

global capture を認めた部位での通電により心室頻拍の停止が得られなかった陳旧性
心筋梗塞の 1 例. 心電図 33(Suppl.4):S-4-157, 2013
67. 山崎浩, 青沼和隆. 【循環器病学における臨床研究-いかに確実に臨床に還元するか】
循環器臨床研究の展望	  不整脈疾患に対する新規治療アプローチ	
  有効性と安全性の向上をめざして. 医学のあゆみ 244(13):1335-1338, 2013
68. 山崎浩, 青沼和隆. 【最新の心房細動の診療】 心房細動の治療	  カテーテルアブレー
ション治療. 臨牀と研究 90(9):1180-1185, 2013
69. 山崎浩, 関口幸夫, 夛田浩, 町野毅, 黒木健志, 成瀬代士久, 井藤葉子, 五十嵐都, 吉田健
太郎, 青沼和隆. "時計"および"反時計"方向に旋回する 2 種の Localized Reentry が認められた僧帽弁輪峡部焼灼術後の 1 例. 臨床心臓電気生理 36:55-63, 2013
70. 山本昌良, 瀬尾由広, 川松直人, 佐藤希美, 菅野昭憲, 渥美安紀子, 町野智子, 中島英樹,
石 津 智 子, 青 沼 和 隆. 左 房 圧 の 上 昇 は 左 心 耳 を 拡 大 さ せ る か. 超 音 波 医 学
40(Suppl.):S471, 2013	 3) 英文著書
1. Miyauchi T, Goto K. 190. Endothelins; in "Handbook of biologically active peptides (1stedition)" (edited by Kastin A J), Academic Press (Elsevier Inc.) (San Diego) 2013;
pp1402-1407
2. Nogami A, Olshansky B. Chapter 83. Bundle Branch Reentry Tachycardia; in "Cardiac
Electrophysiology: From Cell to Bedside (6th edition)" (edited by Zipes D P,Jalife J),
Elsevier (Piladelphia) 2013; pp835-847

4) 英文以外の著書
1. 青沼和隆. 第 6 章. カテーテル・アブレーション; "今日の治療指針	
  -私はこう治療している-(2013 年)” (編集 山口徹, 北原三夫, 福井次矢), 医学書院 (東京) 2013; pp331-332
2. 五十嵐都, 青沼和隆. 第 4 章. 心房細動のカテーテルアブレーションの新しいエビデンス	
  –適応と成績を中心に; "循環器 (Annual Review 2013)” (編集 小室一成, 佐地勉, 坂田隆造, 赤坂隆史), 中外医学社 (東京) 2013; pp145-151
3. 金城貴士, 青沼和隆. 第 4 章. 心房細動に対する治療総論; "日本臨牀 (第 71 版)” 日本臨牀社 (東京) 2013; pp60-66
4. 黒木健志, 青沼和隆. 第 4 章. 心機能低下例に対する ICD 治療; "月刊循環器 2013 年 2月号 (第 1 版)” (編集 島本和明, 小川聡, 松崎益徳, 竹中克, 小室一成, 山科章, 代田浩之,
三田村秀雄), 医学出版 (東京) 2013; pp35-42
163

5. 榊原謙. 筑波大学における新しい医学教育の祖.堀	  原一; "医学教育 (第 1 版)”, 篠原出
版新社 (東京) 2013; pp457
6. 榊原謙. 桐で生い立つ若者たち; "桐医会会報 (第 1 版)”, 桐医会 (茨城) 2013; pp26-38
7. 佐藤明, 青沼和隆. 特集. 急性冠症候群に併発する不整脈; "日本医師会雑誌 (第 141 巻
12 号)” (編集 跡見裕, 北川泰久, 足立満, 五十嵐隆, 磯部光章, 井廻道夫, 岩本安彦, 大曲
貴夫, 小川郁, 片山一朗, 木村理, 黒川峰夫, 児玉浩子, 杉浦真弓, 田中栄, 寺崎浩子, 寺本明, 花岡一雄, 廣澤信作, 福田国彦, 松尾清一, 丸茂健, 三村将, 弓倉整), 日本医師会 (東京) 2013; pp2665-2668
8. 関口幸夫, 青沼和隆. 第 2 章. 緊急を要する不整脈の処置; "今日の循環器疾患治療指針(第 3 版)” (編集 井上博, 許俊悦, 檜垣寛男, 代田浩之, 筒井裕之), 医学書院 (東京) 2013;
pp85-88
9. 星智也, 青沼和隆. 第 12 章. ACS の不整脈; "月刊循環器 Circulation” (編集 医学出版 (東京) 2013; pp92-102
10. 村越伸行, 青沼和隆. 第 6 章. 心房細動の血圧管理; "日本医師会雑誌	
  高血圧診療のすべて (第 142 巻 特別号)” (編集 刈尾七臣, 斎藤能彦, 長谷部直幸, 弓倉整), 日本医師会(東京) 2013; pp244-266

164女性の健康と母性看護学に関連する研究	 1) 英文論文
1. Kawano A, Emori Y. Changes in maternal secretory immunoglobulin a levels in human milk
during 12 weeks after parturition. Am J Hum Biol 25(3):399-403, 2013
2. Koizumi H, Hotta K. Processing the experience of midwives who have opened andmaintained a private practice. Medicine and Biology 157(6(3)):1284-1288, 2013
3. Koizumi H, Saeki Y, Kawano A, Sankai C. Demographic factors, resilience, and occupational
stress symptoms among female nurses in Japan. Medicine and Biology 157(2):191-200, 2013
4. Koizumi H, Takayama N. Career development of hospital midwives; The experience process
before reaching the mid-level. Medicine and Biology 157(6(3)):1278-1283, 2013
5. Takayama N, Emori Y, Takayama M, Koizumi H. Oral Environment of Pregnant Women andFactors Associated with the Presence of	  Streptcoccus Mutans. General Medicine
14(1):48-56, 2013	 2) 英文以外の論文
1. 大森美保, 江守陽子, 日高紀久江. 回復期リハビリ病棟における運動器系疾患患者の日
常 生 活 機 能 評 価 得 点 と 退 院 先 と の 関 連. 日 本 プ ラ イ マ リ ・ ケ ア 連 合 学 会 誌
36(3):186-190, 2013
2. 岡島梨花, 村井文江, 江守陽子. コンドーム使用教育がその後のコンドーム使用行動に与える有効性の検討	  高校生に対する調査から. 思春期学 31(1):57-58, 2013
3. 岡本佐智子, 江守陽子. 商業的マッサージと看護技術としてのマッサージについての考察. 看護実践の科学 38(13):59-64, 2013
4. 楠見由里子, 江守陽子. 妊娠女性の冷え症と周産期アウトカムとの関連. 日本助産学会
誌 27(1):40-47, 2013
5. 小泉仁子, 川野亜津子, 山海千保子, 佐伯由香. 女性看護師の職業性ストレス反応と個
人背景およびレジリエンスとの関連	
  Demographic factors, resilience, and occupational
stress symptoms among female nurses in Japan. 医学と生物学 157(2):191-200, 2013
6. 山海千保子, 江守陽子, 佐藤康江. 「育児ストレス絵画テスト」の作成	
  P-F スタディをモデルとして. Health Sciences 29(2):65-74, 2013
7. 鶴巻陽子, 江守陽子, 村井文江, 永井泰, 小笠原加代子, 石渡勇. 不妊治療の長期化が女性の日常生活と健康に与える影響について. 母性衛生 54(1):78-85, 2013
8. 中田久恵, 村井文江, 江守陽子. 初めて育児をする母親が離乳をとおして母親役割を獲得 し て い く プ ロ セ ス 	
  離 乳 後 期 に お け る 母 親 役 割 獲 得 の 質 的 研 究. 母 性 衛 生165

54(1):69-77, 2013
9. 南雲史代, 村井文江, 江守陽子. 低出生体重児を持つ母親の育児に対する自信に関連する要因の検討	  レジリエンスに焦点をあてて. 小児保健研究 72(4):500-507, 2013166

聴覚障害発症機序の解明に関する検討	 1) 英文論文
1. Ano S, Morishima Y, Ishii Y, Yoh K, Yageta Y, Ohtsuka S, Matsuyama M, Kawaguchi M,
Takahashi S, Hizawa N. Transcription factors GATA-3 and RORgammat are important for
determining the phenotype of allergic airway inflammation in a murine model of asthma. J
Immunol 190(3):1056-1065, 2013
2. Fujishiro SH, Nakano K, Mizukami Y, Azami T, Arai Y, Matsunari H, Ishino R, Nishimura T,
Watanabe M, Abe T, Furukawa Y, Umeyama K, Yamanaka S, Ema M, Nagashima H,
Hanazono Y. Generation of naive-like porcine-induced pluripotent stem cells capable ofcontributing to embryonic and fetal development. Stem Cells Dev 22(3):473-482, 2013
3. Hamanaka S, Ooehara J, Morita Y, Ema H, Takahashi S, Miyawaki A, Otsu M, Yamaguchi T,
Onodera M, Nakauchi H. Generation of transgenic mouse line expressing Kusabira Orange
throughout body, including erythrocytes, by random segregation of provirus method.
Biochem Biophys Res Commun 435(4):586-591, 2013
4. Hasegawa Y, Daitoku Y, Sekiguchi K, Tanimoto Y, Mizuno-Iijima S, Mizuno S, Kajiwara N,
Ema M, Miwa Y, Mekada K, Yoshiki A, Takahashi S, Sugiyama F, Yagami K. NovelROSA26 Cre-reporter knock-in C57BL/6N mice exhibiting green emission before and red
emission after Cre-mediated recombination. Exp Anim 62(4):295-304, 2013
5. Katsumata T, Oishi H, Sekiguchi Y, Nagasaki H, Daassi D, Tai PH, Ema M, Kudo T,
Takahashi S. Bioluminescence imaging of beta cells and intrahepatic insulin gene activity
under normal and pathological conditions. PLoS One 8(4):e60411, 2013
6. Kudo T, Sato T, Hagiwara K, Kozuma Y, Yamaguchi T, Ikehara Y, Hamada M, Matsumoto K,
Ema M, Murata S, Ohkohchi N, Narimatsu H, Takahashi S. C1galt1-deficient mice exhibit
thrombocytopenia due to abnormal terminal differentiation of megakaryocytes. Blood
122(9):1649-1657, 2013
7. Nishimoto M, Katano M, Yamagishi T, Hishida T, Kamon M, Suzuki A, Hirasaki M,
Nabeshima Y, Nabeshima Y, Katsura Y, Satta Y, Deakin JE, Graves JA, Kuroki Y, Ono R,
Ishino F, Ema M, Takahashi S, Kato H, Okuda A. In vivo function and evolution of theeutherian-specific pluripotency marker UTF1. PLoS One 8(7):e68119, 2013
8. Oishi H, Tsubaki T, Miyazaki T, Ono M, Nose M, Takahashi S. A bacterial artificial
chromosometransgenewithpolymorphic

Cd72

inhibits

thedevelopmentof

glomerulonephritis and vasculitis in MRL-Faslpr lupus mice. J Immunol 190(5):2129-2137,
2013
167

9. Shimbo M, Ando S, Sugiura N, Kimata K, Ichijo H. Moderate repulsive effects of
E-unit-containing chondroitin sulfate (CSE) on behavior of retinal growth cones. Brain Res
1491:34-43, 2013
10. Uemaetomari I, Wada T, Nishimura B, Tanaka S, Nakayama M, Ashizawa K, Tabuchi K,
Minami Y, Hara A. Vessel sealing device in parotid gland surgery: clinical and pathologicalstudy. Advances in Cancer Research & Treatment doi:10.5171/2013.992721, 20132) 英文以外の論文
1. 芦澤圭, 田渕経司, 田中秀峰, 廣瀬由紀, 原晃. 鼻腔に発生したグロムス血管周皮腫例.
耳鼻咽喉科臨床 106(8):705-710, 2013
2. 上前泊功, 芦澤圭, 中山雅博, 田中秀峰, 西村文吾, 田渕経司, 和田哲郎, 高橋邦明, 原晃.
喉頭摘出後の気管食道シャント発声者と食道発声者における QOL 評価	
  Voice
Handicap Index(VHI)日本語改定版および Voice-Related Quality of Life(V-RQOL)日本語版を用いて. 耳鼻咽喉科臨床 106(11):1033-1038, 2013	 3) 英文著書
1. Nakayama M, Tabuchi K, Hara A. 4. Neck pain induced by deep neck infections; in "Neckpain caused, diahnosis management (1st edition)" (edited by Lombardi G), Nova Science(New York) 2013; pp45-56

168

がん看護・緩和ケア	 4) 英文以外の著書
1. 笹原朋代. 1 章 8 節. チームアプローチ; "ナーシンググラフィカ	
 緩和ケア (第 1 版)” (編集 宮下光令), メディカ出版 (大阪) 2013; pp38-41
2. 笹原朋代. 3 章 1〜3 節. チームアプローチ、精神症状概論、不安の治療と看護、抑うつの治療と看護; "ナーシンググラフィカ	
  緩和ケア (第 1 版)” (編集 宮下光令), メディ
カ出版 (大阪) 2013; pp126-136
3. 佐藤正美. 第 5 章 2 節. 排便行動の障害と看護; "ナーシンググラフィカ	
  栄養代謝機能障害 (第 2 版)” (編集 明石惠子, 野口孝), メディカ出版 (大阪) 2013; pp180-187
4. 佐藤正美. 第 2 部 7 章. 排便行動の変更への支援; "ナーシンググラフィカ	
  健康危機状況 (第 2 版)” (編集 安酸史子, 鈴木純恵, 吉田澄恵), メディカ出版 (大阪) 2013;
pp106-120
5. 佐藤正美. 第 V 章. がん手術患者に対するリハビリテーション看護	
  直腸がんで前方切除術を受けた患者の看護; "がん看護増刊号	
  手術をめぐるがん看護” (編集 雄西智恵美, 秋元典子), 南江堂 (東京) 2013; pp251-254

169

レギュラトリーサイエンス	 1) 英文論文
1. Bang L, Tsuru K, Munar M, Ishikawa K, Othman R. Mechanical behavior and cell responseof PCL coated α-TCP foam for cancellous-type bone replacement. Ceramics International
39(5):5631-5637, 2013
2. Funayama T, Sakane M, Yoshizawa T, Takeuchi Y, Ochiai N. Tanycytic ependymoma of thefilum terminale associated with multiple endocrine neoplasia type 1: first reported case.
Spine J 13(8):e49-54, 2013
3. Funayama T, Tsukanishi T, Hara I, Ozeki E, Sakane M. Tumor-selective near-infrared
photodynamic therapy with novel indocyanine green-loaded nanocarrier delays paralysis inrats with spinal metastasis. Photodiagnosis Photodyn Ther 10(4):374-378, 2013
4. Funayama T, Tsukanishi T, Hara I, Ozeki E, Sakane M. Tumor-selective near-infrared
photodynamic therapy with novel indocyanine green-loaded nanocarrier delays paralysis inrats with spinal metastasis. Photodiagnosis Photodyn Ther 10(4):374-378, 2013
5. Kawamoto H, Kamibayashi K, Nakata Y, Yamawaki K, Ariyasu R, Sankai Y, Sakane M,
Eguchi K, Ochiai N. Pilot study of locomotion improvement using hybrid assistive limb inchronic stroke patients. BMC Neurol 13:141, 2013
6. Kubota S, Nakata Y, Eguchi K, Kawamoto H, Kamibayashi K, Sakane M, Sankai Y, Ochiai
N. Feasibility of rehabilitation training with a newly developed wearable robot for patientswith limited mobility. Arch Phys Med Rehabil 94(6):1080-1087, 2013
7. Munar GM, Munar ML, Tsuru K, Ishikawa K. Influence of PLGA concentrations on
structural and mechanical properties of carbonate apatite foam. Dent Mater J 32(4):608-614,
2013
8. Mutsuzaki H, Sogo Y, Oyane A, Ito A. Improved bonding of partially osteomyelitic bone totitanium pins owing to biomimetic coating of apatite. Int J Mol Sci 14(12):24366-24379,
2013
9. Mutsuzaki H, Yokoyama Y, Ito A, Oyane A. Formation of apatite coatings on an artificial
ligament using a plasma- and precursor-assisted biomimetic process. Int J Mol Sci
14(9):19155-19168, 2013
10. Shiozaki Y, Kitajima T, Mazaki T, Yoshida A, Tanaka M, Umezawa A, Nakamura M,
Yoshida Y, Ito Y, Ozaki T, Matsukawa A. Enhanced in vivo osteogenesis by nanocarrier-fusedbone morphogenetic protein-4. Int J Nanomedicine 8:1349-1360, 2013

170

	
 
2) 英文以外の論文
1. 安部哲哉, 坂根正孝, 船山徹, 俣木優輝, 竹内陽介, 兵頭康次郎, 神山翔, 日置繁, 山崎正志. 全身麻酔下の経椎間孔アプローチの PELD の手術成績. Journal of Spine Research
4(8):1264-1269, 2013
2. 鎌田浩史, 竹内亮子, 中川将吾, 三島初, 坂根正孝, 山崎正志, 落合直之, 岡本嘉一.【小児整形外科疾患	
  診断・治療の進歩】 診断・評価の進歩	
  MRI	
  発育性股関節形成不全における三次元 MRI を用いた三次元的評価. 別冊整形外科 64:11-17, 2013
3. 鈴木恒, 馬見塚尚孝, 芋生祥之, 大瀧保明, 奈良隆章, 藤江敬子, 橋本幸一, 中田由夫, 原田義則, 坂根正孝, 平野篤, 落合直之. 腰部脊柱管狭窄症患者に対する日本語版チューリッヒ跛行質問票と 6 分間歩行試験の試用評価と基準関連妥当性検証. Journal of
Spine Research 4(1):63-67, 2013
4. 西田雄亮, 西野衆文, 金森章浩, 坂根正孝. 腱部分切除術とラジオ波焼灼術を併用した
膝蓋腱炎の 1 例. 日本整形外科スポーツ医学会雑誌 33(3):327-331, 2013
5. 牧原武史, 坂根正孝, 藤井賢吾, 大西信三. 後頭下減圧術後に関節窩の骨リモデリングを生じた Charcot 肩の一例. 肩関節 37(2):893-896, 20136. 俣木健太朗, 野澤大輔, 三島初, 牧原武史, 岡野英里子, 和田大志, 坂根正孝. 外反母趾に対する DLMO 法の経験. 関東整形災害外科学会雑誌 44(2):48-51, 20134) 英文以外の著書
1. 伊藤敦夫. 第 1 章	  スキャホールド. 無機系材料; "再生医療技術の最前線	
  普及版 (編集 岡野光夫, 監修 大和雅之), シーエムシー出版 (東京) 2013; pp10-16
2. 大矢根綾子, 伊藤敦夫. 第２節	  足場材料の開発事例. リン酸カルシウム研究の骨組織再生への応用; "再生医療における臨床研究と製品開発 (第 1 版)” 技術情報協会 (東京)2013; pp287-292
3. 坂根正孝. 6 章脊椎（頸椎、胸椎、腰椎）. 脊椎・脊髄損傷; "新版 スポーツ整形外科マニュアル (第 1 版)” (監修 福林徹, 編集	  篠塚昌述), 株式会社中外医学者 (東京) 2013;
pp104-107
4. 坂根正孝. 6 章脊椎（頸椎、胸椎、腰椎）. 胸腰椎の外傷（圧迫骨折、破裂骨折、横突起骨折）; "新版 スポーツ整形外科マニュアル (第 1 版)” (監修	  福林徹, 編集	  篠塚昌述), 株式会社中外医学者 (東京) 2013; pp111-114
5. 坂根正孝, 安部哲哉. II．脊椎内視鏡下手術のための基本手技 [PED] 手術器具（特殊器具を含む）; "［スキル関節鏡下手術アトラス］シリーズ	
  「脊椎内視鏡下手術」 (第171

1 版)” (編集 吉田宗人, 監修	
  越智光夫), 株式会社文光堂 (東京) 2013; pp48-51
6. 坂根正孝, 安部哲哉. V．脊椎内視鏡下手術とそのスキル. ［PED］2. 頚椎間孔的ヘルニ
ア摘出; "［スキル関節鏡下手術アトラス］シリーズ	
 「脊椎内視鏡下手術」 (第 1 版)”(編集 吉田宗人, 監修 越智光夫), 株式会社文光堂 (東京) 2013; pp140-144
7. 六崎裕高, 伊藤敦夫, 坂根正孝, 十河友, 大矢根綾子, 山崎正志. 第４節 体内固定用ネ
ジ・ボルトなど. 挿入路感染を防止する創外固定用ピンの開発; "体内埋め込み医療材料の開発とその理想的な性能・デザインの要件 (第 1 版)” 技術情報協会 (東京) 2013;
pp42-46172

心肺脳蘇生	 1) 英文論文
1. Nakayama S, Vest R, Traystman RJ, Herson PS. Sexually dimorphic response of TRPM2
inhibition following cardiac arrest-induced global cerebral ischemia in mice. J Mol Neurosci
51(1):92-98, 2013
2. Satsumae T, Yamaguchi H, Inomata S, Tanaka M. Magnesium sulfate attenuates tourniquet
pain in healthy volunteers. J Anesth 27(2):231-235, 2013
3. Tokuwaka J, Takahashi S, Tanaka M. Anaphylaxis after sugammadex administration. Can J
Anesth 60(7):733-734, 2013	 2) 英文以外の論文
1. 加藤真也, 山下創一郎, 田中誠. 先天性高インスリン血症を合併した心室中隔欠損パッ
チ閉鎖術の麻酔経験. Cardiovascular Anesthesia 17(Suppl.):168, 2013
2. 徳若純子, 山下創一郎, 高橋伸二, 田中誠. 心室中隔欠損症と肺動脈狭窄症を合併した
18 トリソミー患者の胃食道逆流症に対する腹腔鏡下噴門形成術の麻酔経験. 麻酔
62(3):326-329, 2013
3. 中山慎. 小児の鎮痛・鎮静モニタリング・リスク管理. 小児科臨床 66(12):227-234, 2013
4. 村田雄哉, 高橋宏, 徳若純子, 田中誠. 麻酔器の気化器接続部からのリーク. 麻酔
62(12):1472-1475, 2013173

ソーシャルインクルージョン	
 1) 英文論文	
 1. Ichikawa M, Inada H, Kumeji M. Reconsidering the effects of blue-light installation forprevention of railway suicides. J Affect Disord doi: 10.1016/j.jad.2013.09.006, 2013
2. Ichikawa M, Nakahara S, Phommachanh S, Mayxay M, Kimura A. Roadside observation of
secondary school students' commuting to school in Vientiane, Laos. Int J Inj Contr Saf
Promot doi:10.1080/17457300.2013.843570, 2013
3. Kaneko H, Ohi Y, Doki S, Hirai Y, Suzuki S, Kobayashi N, Seki A, Sho N, Usami K,
Tomotsune Y, Sasahara S, Matsuzaki I.. Conditions Surrounding Potential Suicide Victims inJapan: an Analysis of Calls to Ibaraki Inochi No Denwa. Journal of Physical Fitness,
Nutrition and Immunology 23(2):72-86, 2013
4. Kobayashi N, Haoka T, Usami K, Yoshino S, Kikuchi A, Suzuki S, Doki S, Hirai Y, Kaneko
H, Seki A, Sho N, Ohi Y, Tomotsune Y, Sasahara S, Matsuzaki I. Long-term Variability in
the Sense of Coherence among Return-to-Work Program. Journal of Physical Fitness,
Nutrition and Immunology 23(2):56-63, 2013
5. Morita N, Nomoto Y, Ukeda E, Sufu K. How does trauma caused by violence influence therisk of relapse in and effects of cognitive behavioral therapy for drug addicts in prison? Acta
Criminologiae et Medicinae Legalis Japonica 179(1):3-15, 2013
6. Nakahara S, Ichikawa M. Mortality in the 2011 tsunami in Japan. J Epidemiol 23(1):70-73,
2013
7. Nakahara S, Katanoda K, Ichikawa M. Onset of a declining trend in fatal motor vehicle
crashes involving drunk-driving in Japan. J Epidemiol 23(3):195-204, 2013
8. Nakahara S, Tomio J, Takahashi H, Ichikawa M, Nishida M, Morimura N, Sakamoto T.
Evaluation of pre-hospital administration of adrenaline (epinephrine) by emergency medical
services for patients with out of hospital cardiac arrest in Japan: controlled propensity
matched retrospective cohort study. BMJ 347:f6829, 2013
9. Seki A, Tomotsune Y, Ohi Y, Hirai Y, Suzuki S, Doki S, Kaneko H, Sho N, Usami K,
Sasahara S, Matsuzaki I. A Relationship between Sense of Coherence and Psycho-social
Work Characteristics -Validation of Causal Relationship Using Structural Equation
Modeling-. Journal of Physical Fitness, Nutrition and Immunology 23(2):64-71, 2013
10. Southivong B, Ichikawa M, Nakahara S, Southivong C. A cross-sectional community studyof post-traumatic stress disorder and social support in Lao People's Democratic Republic.
Bull World Health Organ 91(10):765-772, 20131742) 英文以外の論文
1. 新井清美, 森田展彰, 韮澤博一. プレアルコホリックの認識における変化のプロセス	
 アルコール依存症患者とその家族の語りからの分析. 日本アルコール・薬物医学会雑誌 48(3):198-215, 2013
2. 大脇由紀子, 森田展彰, 大谷保和, 梁京賢, 松山紀子, 藤田教子, 川畠弘子. 消化器内科入院患者におけるアルコール依存症と有害使用の実態および支援に関する研究. 日本ア
ルコール・薬物医学会雑誌 48(2):126-144, 2013
3. 須賀朋子, 森田展彰, 斎藤環. 中学生のための DV 予防教育プログラム開発と効果研究.
思春期学 31(4):384-393, 2013
4. 菅原田鶴子, 森田展彰, 中谷陽二. アルコール依存症異性愛評価尺度の開発. 日本アルコール・薬物医学会雑誌 48(5):261-281, 2013
5. 菅原田鶴子, 森田展彰, 中谷陽二. アルコール依存症者の異性愛と回復について−施設
スタッフの認識調査−. 日本アルコール・薬物医学会雑誌 48(6):389-406	
  2013
6. 菅原田鶴子, 森田展彰, 中谷陽二. 依存症者本人が認識するアルコール依存症に対するパートナーの態度尺度の作成. 日本アルコール・薬物医学会雑誌 48(6):373-388	
  2013
7. 玉井紀子, 森田展彰, 大谷保和. 児童養護施設におけるリービングケアに関する研究	
 生活担当職員を対象とした中高生のケアに関する調査. 子どもの虐待とネグレクト
15(1):66-77, 2013
8. 友常祐介, 平井康仁, 小林直紀, 大井雄一, 笹原信一朗, 松崎一葉. 心の健康問題を抱えた労働者への対応における産業医−精神科医間の意識差に関する研究. 体力・栄養・免疫学雑誌 23(2):87-94, 2013
9. 西村香, 森田展彰. 大学生における支配的恋愛関係チェックリストの作成、および信頼性、妥当性の検討	
  「束縛」に焦点化した dating violence 調査票. アディクションと家族 29(3):244-253, 2013
10. 羽岡健史, 吉野聡, 鈴木瞬, 小林直紀, 宇佐見和哉, 友常祐介. うつ病による長期休業者のリワークプログラム利用中の認知機能の変化. 臨床精神医学 42(4):497-503, 20134) 英文以外の著書
1. 斎藤環. 承認をめぐる病. 日本評論社 2013 年 (全 279 ページ)
2. 友常祐介. 正しく知る	
  会社「うつ」の治し方・接し方	
  -知っておきたいメンタルヘ
ルス対策. 技術評論社 2013 年 (全 192 ページ)
3. 森田展彰. 第 6 章４. 暴力などのトラウマ問題を抱えた薬物依存症者に対する治療; "175

依存と嗜癖: どう理解し,どう対処するか (第 1 版)” (編集 和田清), 医学書院 (東京)2013; pp35-40
4. 森田展彰. 第 5 章. 家庭内の暴力に関する安全保障-ドメスティックバイオレンスに対する包括的対応; "ヒューマン・セキュリティ-ヒューマン・ケアの視点から (第 1 版)”(編集 松田ひとみ, 大久保一郎, 岩浅昌幸, 柏木志保), 医学評論社 (東京) 2013; pp65-82
5. 森田展彰. 第 28 章. 親が暴力をふるう; "中高生のためのメンタル系サバイバルガイト(第 1 版)” (編集 松本俊彦), 日本評論社 (東京) 2013; pp179-183

176

ニュートリゲノミクス	
 1) 英文論文	 1. Fujimoto Y, Nakagawa Y, Satoh A, Okuda K, Shingyouchi A, Naka A, Matsuzaka T, Iwasaki
H, Kobayashi K, Yahagi N, Shimada M, Yatoh S, Suzuki H, Yogosawa S, Izumi T, Sone H,
Urayama O, Yamada N, Shimano H. TFE3 controls lipid metabolism in adipose tissue ofmale mice by suppressing lipolysis and thermogenesis. Endocrinology 154(10):3577-3588,
2013
2. Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Sowa N,
Yahagi N, Shimano H, Matsumura S, Inoue K, Marusawa H, Nakamura T, Hasegawa K,
Kume N, Yokode M, Kita T, Kimura T, Ono K. MicroRNA-33 regulates sterol regulatory
element-binding protein 1 expression in mice. Nat Commun 4:2883, 2013
3. Izumida Y, Yahagi N, Takeuchi Y, Nishi M, Shikama A, Takarada A, Masuda Y, Kubota M,
Matsuzaka T, Nakagawa Y, Iizuka Y, Itaka K, Kataoka K, Shioda S, Niijima A, Yamada T,
Katagiri H, Nagai R, Yamada N, Kadowaki T, Shimano H. Glycogen shortage during fasting
triggers liver-brain-adipose neurocircuitry to facilitate fat utilization. Nat Commun 4:2316,
2013
4. Naka A, Iida KT, Nakagawa Y, Iwasaki H, Takeuchi Y, Satoh A, Matsuzaka T, Ishii KA,
Kobayashi K, Yatoh S, Shimada M, Yahagi N, Suzuki H, Sone H, Yamada N, Shimano H.
TFE3 inhibits myoblast differentiation in C2C12 cells via down-regulating gene expressionof myogenin. Biochem Biophys Res Commun 430(2):664-669, 2013	 2) 英文以外の論文
1. 矢作直也.	
  脂肪酸の量・質と細胞応答. 肥満研究 19(3):162-166, 2013
2. 矢 作 直 也.	
  ス タ チ ン 薬 に よ る 糖 尿 病 発 症 リ ス ク. 内 分 泌 ・ 糖 尿 病 ・ 代 謝 内 科
37(3):313-315, 2013
3. 矢作直也. ダイエットの最新戦略(第 3 回)	  肥満・ダイエットと検査. アニムス
18(2):41-43, 20134) 英文以外の著書
1. 泉田欣彦, 矢作直也. リパーゼ; "糖尿病の分子標的と治療薬事典 (第 1 版)” (編集 春日雅人, 綿田裕孝, 松本道宏), 羊土社 (東京) 2013; pp232-233
2. 大崎芳典, 矢作直也. URAT1; "糖尿病の分子標的と治療薬事典 (第 1 版)” (編集 春日雅人, 綿田裕孝, 松本道宏), 羊土社 (東京) 2013; pp230-231
177

3. 久芳素子, 矢作直也. CETP; "糖尿病の分子標的と治療薬事典 (第 1 版)” (編集 春日雅人,
綿田裕孝, 松本道宏), 羊土社 (東京) 2013; pp236-238
4. 煙山紀子, 矢作直也. GPR120; "糖尿病の分子標的と治療薬事典 (第 1 版)” (編集 春日雅人, 綿田裕孝, 松本道宏), 羊土社 (東京) 2013; pp234-235
5. 志鎌明人, 矢作直也. SGLT2; "糖尿病の分子標的と治療薬事典 (第 1 版)” (編集 春日雅人, 綿田裕孝, 松本道宏), 羊土社 (東京) 2013; pp228-229
6. 矢作直也. 筑波大学附属病院とクックパッドのおいしく治す「糖尿病食」講談社 2013
年 (全 200 ページ)178

脳腫瘍研究	 1) 英文論文
1. Hara T, Akutsu H, Yamamoto T, Ishikawa E, Matsuda M, Matsumura A. Cushing’s disease
presenting with gastrointestinal perforation: a case report. Endocrinology, diabetes andmetabolism. Case reports Nov:1-4, 2013
2. Hara T, Matsuda M, Watanabe S, Nakai K, Yamamoto T, Matsumura A. Remote cerebellar
hemorrhage after removal of a supratentorial glioma without perioperative CSF loss: A casereport. Case Rep Surg 2013:305039, 2013
3. Kin H, Ishikawa E, Takano S, Ayuzawa S, Matsushita A, Muragaki Y, Aiyama H, Sakamoto
N, Yamamoto T, Matsumura A. Language areas involving the inferior temporal cortex on
intraoperative mapping in a bilingual patient with glioblastoma. Neurol Med Chir (Tokyo)
53(4):256-258, 2013
4. Mizumoto M, Okumura T, Ishikawa E, Yamamoto T, Takano S, Matsumura A, Oshiro Y,
Ishikawa H, Sakurai H, Tsuboi K. Reirradiation for recurrent malignant brain tumor withradiotherapy or proton beam therapy. Technical considerations based on experience at asingle institution. Strahlenther Onkol 189(8):656-663, 2013
5. Onuma K, Ishikawa E, Matsuda M, Hirata K, Osuka S, Yamamoto T, Masumoto T,
Zaboronok A, Matsumura A. Clinical characteristics and neuroimaging findings in 12 casesof recurrent glioblastoma with communicating hydrocephalus. Neurol Med Chir (Tokyo)
53(7):474-481, 2013
6. Sakamoto N, Akutsu H, Takano S, Yamamoto T, Matsumura A. Useful 'sliding-lock-knot'
technique for suturing dural patch to prevent cerebrospinal fluid leakage after extended
transsphenoidal surgery. Surg Neurol Int 4:19, 2013
7. Takano S, Kimu H, Tsuda K, Osuka S, Nakai K, Yamamoto T, Ishikawa E, Akutsu H,
Matsuda M, Matsumura A. Decrease in the apparent diffusion coefficient in peritumoral
edema for the assessment of recurrent glioblastoma treated by bevacizumab. Acta Neurochir
Suppl 118:185-189, 2013
8. Tsuda K, Tsurushima H, Takano S, Tsuboi K, Matsumura A. Brain metastasis from papillary
thyroid carcinomas. Molecular and clinical oncology 1:817-819, 2013
9. Yamamoto T, Tsuboi K, Nakai K, Kumada H, Sakurai H, Matsumura A. Boron neutron
capture therapy for brain tumors. Transl Cancer Res 2:80-86, 2013
10. Zaboronok A, Isobe T, Yamamoto T, Sato E, Takada K, Sakae T, Tsurushima H, Matsumura
A. Proton beam irradiation stimulates migration and invasion of human U87 malignant
179glioma cells. J Radiat Res doi: 10.1093/jrr/rrt119, 2013
11. Zaboronok A, Tsurushima H, Yamamoto T, Isobe T, Takada K, Sakae T, Yoshida F,
Matsumura A. Size-dependent radiosensitization effects of gold nanoparticles on humanU251 malignant glioma cells. Nanosci nanotech lett 5(9):9904, 2013	 2) 英文以外の論文
1. 坪井康次, 水本斉志. 【悪性脳腫瘍の治療-最新のトピックス】 放射線治療のトピックス	  陽子線・重粒子線治療. Clinical Neuroscience 31(10):1169-1172, 20132 原拓真, 阿久津博義, 高野晋吾, 山本哲哉, 鈴木浩明, 松村明. Cushing 病に対する手術および放射線照射例の長期予後. 日本内分泌学会雑誌 89(Suppl.HPT):63-64, 20134) 英文以外の著書
1. 阿久津博義. 第 7 章. 神経内視鏡における止血・凝固機器; "先端医療シリーズ 45	
  臨
床医のための最新脳神経外科 (第 1 版)” (編集 橋本信夫, 寺本明, 小川彰, 嘉山孝正),(株)寺田国際事務所/先端医療技術研究所 (東京) 2013
2. 磯辺智範. Chapter3. 核医学検査; "若葉マーク 臨床検査学エッセンス・ノート 3 臨床生
物化学分析検査 (第 1 版)” (編集 山内一由), メジカルビュー社 (東京) 2013; pp169-189
3. 磯辺智範. I -7. MRS; "MRI 応用自在 (第 3 版)” (編集 高橋光幸, 堀江朋彦, 中村理宣, 北川久, 高原太郎), メジカルビュー社 (東京) 2013; pp28-33
4. 松村明, 松田真秀.脳神経外科分野における陽子線治療の適用; "定位放射線治療 17”(編集 好本裕平), 定位放射線治療学会 (東京) 2013; pp11-19
5. 松村明, 山本哲哉. 小児脳腫瘍に対する放射線治療; “小児脳神経外科診療ガイドブッ
ク（第 1 版）” (編集 新井一, 伊達裕昭, 西本博) メディカルビュー社 (東京) 2013;
pp14-21180

放射線基礎医学	 1) 英文論文	
 1. Abei M, Okumura T, Fukuda K, Hashimoto T, Araki M, Ishige K, Hyodo I, Kanemoto A,
Numajiri H, Mizumoto M, Sakae T, Sakurai H, Zenkoh J, Ariungerel G, Sogo Y, Ito A, Ohno
T, Tsuboi K. A phase I study on combined therapy with proton-beam radiotherapy and in situ
tumor vaccination for locally advanced recurrent hepatocellular carcinoma. Radiat Oncol
8:239, 2013
2. Davis AJ, Chen DJ. DNA double strand break repair via non-homologous end-joining. Transl
Cancer Res 2(3):130-143, 2013
3. Davis AJ, Lee KJ, Chen DJ. The N-terminal region of the DNA-dependent protein kinasecatalytic subunit is required for its DNA double-stranded break-mediated activation. J Biol
Chem 288(10):7037-7046, 2013
4. Ding N, Pei H, He J, Furusawa Y, Hirayama R, Cuihua Liu, Matsumoto Y, Li H, Hu W, Li Y,
Wang J, Wang T, Zhou G. Simulated studies on the biological effects of space radiation onquiescent human fibroblasts. Advances in Space Research 52:1314-1319, 2013
5. Hirayama R, Ito A, Noguchi M, Matsumoto Y, Uzawa A, Kobashi G, Okayasu R, Furusawa
Y. OH radicals from the indirect actions of X-rays induce cell lethality and mediate themajority of the oxygen enhancement effect. Radiat Res 180(5):514-523, 2013
6. Hirayama R, Uzawa A, Takase N, Matsumoto Y, Noguchi M, Koda K, Ozaki M, Yamashita
K, Li H, Kase Y, Matsufuji N, Koike S, Masunaga S, Ando K, Okayasu R, Furusawa Y.
Evaluation of SCCVII tumor cell survival in clamped and non-clamped solid tumors exposed
to carbon-ion beams in comparison to X-rays. Mutat Res 756(1-2):146-151, 2013
7. Hong Z, Kase Y, Moritake T, Gerelchuluun A, Sun L, Suzuki K, Terunuma T, Yasuoka K,
Kumada H, Anzai K, Sakurai H, Sakae T, Tsuboi K. Lineal energy-based evaluation ofoxidative DNA damage induced by proton beams and X-rays. Int J Radiat Biol 89(1):36-43,
2013
8. Isobe T, Mori Y, Takada K, Sato E, Sakurai H, Sakae T. Robust technique using an imaging
plate to detect environmental radioactivity. Health Phys 104(4):362-365, 2013
9. Isobe T, Mori Y, Takada K, Sato E, Takahashi H, Sekiguchi T, Yoshimura Y, Sakurai H, Sakae
T. Evaluation of vegetables in Tsukuba for contamination with radioactive materials from theaccident at Fukushima Daiichi nuclear power plant. Health Phys 105(4):311-317, 2013
10. Kageji T, Mizobuchi Y, Nagahiro S, Nakagawa Y, Kumada H. Correlation between radiationdose and histopathological findings in patients with gliblastoma treated with boron neutron
181

capture therapy (BNCT). Appl Radiat Isot doi: 10.1016/j.apradiso.2013.12.014, 2013
11. Kanemoto A, Okumura T, Ishikawa H, Mizumoto M, Oshiro Y, Kurishima K, Homma S,
Hashimoto T, Ohkawa A, Numajiri H, Ohno T, Moritake T, Tsuboi K, Sakae T, Sakurai H.
Outcomes and prognostic factors for recurrence after high-dose proton beam therapy forcentrally and peripherally located stage I non--small-cell lung cancer. Clin Lung Cancer doi:
10.1016/j.cllc.2013.11.002, 2013
12. Kawamura H, Sakae T, Terunuma T, Ishida M, Shibata Y, Matsumura A. Evaluation of
three-dimensional polymer gel dosimetry using X-ray CT and R2 MRI. Appl Radiat Isot
77:94-102, 2013
13. Masunaga S, Sakurai Y, Tanaka H, Hirayama R, Matsumoto Y, Uzawa A, Suzuki M, Kondo
N, Narabayashi M, Maruhashi A, Ono K. Radiosensitivity of pimonidazole-unlabelled
intratumour quiescent cell population to γ−rays, accelerated carbon ion beams and boron
neutron capture reaction. Br J Radiol 86(1021):20120302, 2013
14. Mizumoto M, Hashii H, Senarita M, Sakai S, Wada T, Okumura T, Tsuboi K, Sakurai H.
Proton beam therapy for malignancy in Bloom syndrome. Strahlenther Onkol
189(4):335-338, 2013
15. Mizumoto M, Okumura T, Ishikawa E, Yamamoto T, Takano S, Matsumura A, Oshiro Y,
Ishikawa H, Sakurai H, Tsuboi K. Reirradiation for recurrent malignant brain tumor withradiotherapy or proton beam therapy. Technical considerations based on experience at asingle institution. Strahlenther Onkol 189(8):656-663, 2013
16. Nakajima NI, Brunton H, Watanabe R, Shrikhande A, Hirayama R, Matsufuji N, Fujimori A,
Murakami T, Okayasu R, Jeggo P, Shibata A. Visualisation of gammaH2AX foci caused byheavy ion particle traversal; distinction between core track versus non-track damage. PLoS
One 8(8):e70107, 2013
17. Oliveira DV, Kato A, Nakamura K, Ikura T, Okada M, Kobayashi J, Yanagihara H, Saito Y,
Tauchi H, Komatsu K. Histone chaperone FACT regulates homologous recombination bychromatin remodeling through interaction with RNF20. J Cell Sci doi: 10.1242/jcs.135855,
2013
18. Oshiro Y, Mizumoto M, Okumura T, Sugahara S, Fukushima T, Ishikawa H, Nakao T,
Hashimoto T, Tsuboi K, Ohkawa H, Kaneko M, Sakurai H. Clinical results of proton beam
therapy for advanced neuroblastoma. Radiat Oncol 8(1):142, 2013
19. Oshiro Y, Okumura T, Mizumoto M, Fukushima T, Ishikawa H, Hashimoto T, Tsuboi K,
Kaneko M, Sakurai H. Proton beam therapy for unresectable hepatoblastoma in children:182

survival in one case. Acta Oncol 52(3):600-603, 2013
20. Oshiro Y, Sakurai H. The use of proton-beam therapy in the treatment of non-small-cell lungcancer. Expert Rev Med Devices 10(2):239-245, 2013
21. Shimada M, Hirayama R, Komatsu K. High LET radiation amplifies centrosome
overduplication through a pathway of γ−tubulin monoubiquitination. Int J Radiat Oncol Biol
Phys 86(2):358-365, 2013
22. Shimizu N, Nakajima NI, Tsunematsu T, Ogawa I, Kawai H, Hirayama R, Fujimori A,
Yamada A, Okayasu R, Ishimaru N, Takata T, Kudo Y. Selective enhancing effect of early
mitotic inhibitor 1 (Emi1) depletion on the sensitivity of doxorubicin or X-ray treatment in
human cancer cells. J Biol Chem 288(24):17238-17252, 2013
23. Sun L, Moritake T, Zheng YW, Suzuki K, Gerelchuluun A, Hong Z, Zenkoh J, Taniguchi H,
Tsuboi K. In vitro stemness characterization of radio-resistant clones isolated from a
medulloblastoma cell line GNS-76. J Radiat Res 54(1):61-69, 201324. Suzuki K, Gerelchuluun A, Hong Z, Sun L, Zenkoh J, Moritake T, Tsuboi K. Celecoxib
enhances radiosensitivity of hypoxic glioblastoma cells through endoplasmic reticulum
stress. Neuro Oncol 15(9):1186-1199, 2013
25. Wang H, Shi LZ, Wong CC, Han X, Hwang PY, Truong LN, Zhu Q, Shao Z, Chen DJ, Berns
MW, Yates JR, 3rd, Chen L, Wu X. The interaction of CtIP and Nbs1 connects CDK and
ATM to regulate HR-mediated double-strand break repair. PLoS Genet 9(2):e1003277, 2013
26. Zaboronok A, Isobe T, Yamamoto T, Sato E, Takada K, Sakae T, Tsurushima H, Matsumura
A. Proton beam irradiation stimulates migration and invasion of human U87 malignant
glioma cells. J Radiat Res doi: 10.1093/jrr/rrt119, 2013	 2) 英文以外の論文
1. 阿部孝憲, 江原威, 原田耕作, 白井克幸, 塩谷真里子, 鈴木義行, 櫻井英幸, 中野隆史. 温
熱放射線療法が著効した多形性脂肪肉腫の 1 例	  A Case of Recurrent Pleomorphic
Liposarcoma that Exhibited a Remarkable Response to Hyperthermoradiotherapy. Thermal
Medicine 29(3):63-67, 2013
2. 井垣浩, 櫻井英幸. 【肝胆膵領域への放射線療法 as of 2013】 肝臓領域の放射線療法	
 肝細胞癌治療アルゴリズムからみた放射線治療. 肝・胆・膵 67(2):211-219, 2013
3. 井垣浩, 櫻井英幸, 肝癌診療ガイドライン第 3 版改訂委員会. 肝癌診療ガイドライン	
 第3 版試案	
  公聴会 放射線治療. 肝臓 54(Suppl.1):A11, 2013
4. 石川仁, 奥村敏之, 大西かよ子, 大城佳子, 水本斉志, 櫻井英幸. 早期肺癌に対する治療
183

戦略(外科治療 vs.非外科治療、重粒子線、陽子線、SRT、ラジオ波、凍結療法) 粒子線治療(陽子線治療、重粒子線治療). 肺癌 53(5):371, 2013
5. 石川仁, 橋本孝之, 牧島弘和, 水本斉志, 奥村敏之, 櫻井英幸. 高精度放射線治療の現状と Adaptive Therapy の展望	
  前立腺がんに対する放射線治療を中心に. 医学物理
32(3):138-147, 2013
6. 今川和生, 福島敬, 鈴木涼子, 福島紘子, 小林千恵, 遠藤幹也, 前田美穂, 岩井艶子, 櫻井英幸, 須磨崎亮. 難治 Ewing 肉腫ファミリー腫瘍例への医療連携による陽子線併用療法は効果的である. 日本小児科学会雑誌 117(2):288, 2013
7. 大久保英樹, 中山雅博, 廣瀬由紀, 田中秀峰, 西村文吾, 星野朝文, 上前泊功, 飛田忠道,
辻茂希, 田渕経司, 和田哲郎, 原晃, 橋井晴子,石川仁, 水本斉志, 奥村敏之, 櫻井英幸. 過去 10 年間に当科で陽子線治療を行った頭頸部癌に関する検討. 耳鼻咽喉科展望 56(補冊 1):118-122, 2013
8. 大城佳子, 水本斉志, 石川仁, 奥村敏之, 坪井康次, 榮武二, 福島敬, 須磨崎亮, 増本幸二,
金子道夫, 櫻井英幸. 固形腫瘍の治療の進歩 小児固形がんに対する陽子線治療. 日本
小児血液・がん学会雑誌 50(3):331-334, 2013
9. 奥村敏之, 水本斉志, 福光延吉, 大西かよ子, 沼尻晴子, 石川仁, 粟飯原輝人, 坪井康次,
榮武二, 櫻井英幸. 【肝胆膵領域への放射線療法 as of 2013】 肝臓領域の放射線療法	
 肝腫瘍に対する陽子線療法の現状と成績. 肝・胆・膵 67(2):271-278, 201310. 兼安祐子, 藤原久也, 西村哲夫, 大野達也, 櫻井英幸, 生島仁史, 楮本智子, 宇野隆, 播磨
洋子, 戸板孝文, 徳丸直郎, 五味弘道, 喜多みどり, 中野隆史, 高橋健夫, 加藤眞吾, 新部譲, 野田真永, 清原浩樹, 永田靖. 子宮頸癌放射線治療の新展開 子宮頸癌治療後のQOL に関する全国調査	  放射線療法群と手術療法群の比較. 日本婦人科腫瘍学会雑誌
31(3):413, 2013
11. 北島柚衣子, 布施拓, 瀬川達也, 志田晃一, 石川仁, 榮武二, 櫻井英幸. 前立腺 IMRT における CBCT を用いた Interfraction error の評価. 日本放射線技術学会雑誌 69(9):1007,
2013
12. 釼持明, 久倉勝治, 栗盛洸, 松村英樹, 田野井智倫, 高野恵輔, 稲川智, 大河内信弘, 橋井晴子, 櫻井英幸. 陽子線治療適応拡大のためのスペーサー挿入術. 茨城県臨床医学雑誌
48:47, 2013
13. 斎藤高, 石川仁, 水本斉志, 福光延吉, 奥村敏之, 櫻井英幸. 切除不能篩骨洞扁平上皮癌に対する陽子線治療の初期経験. 頭頸部癌 39(2):183, 2013
14. 櫻井英幸. 【肝臓がん-標準治療と先進医療】 標準治療と先進医療	  先進医療	  手術やラジオ波で治療できない肝臓がんに成果をあげる陽子線治療	
 肝臓がんで世界一の
184

症例数を誇る筑波大学陽子線センター. ライフライン 21 がんの先進医療 11:26-28,
2013
15. 櫻井英幸. 【食道がん】 標準治療と先進医療	  先進医療	  手術ができない食道がんに対する化学陽子線治療	
 X 線による化学放射線治療に比べ心臓と肺の副作用が軽減.
ライフライン 21 がんの先進医療 10:20-22, 2013
16. 櫻井英幸. 【婦人科腫瘍に対する三次元画像誘導小線源治療】 小線源治療と粒子線治療に関する事例と考察. 臨床放射線 58(3):425-431, 2013
17. 櫻井英幸, 大川綾子, 沼尻晴子, 菅原香織, 瀧澤大地, 牧島弘和, 大野豊然貴, 石川仁, 奥村敏之. 【婦人科がん放射線治療の最新知見】 放射線治療の最新技術	
  陽子線治療の概要と婦人科腫瘍への応用について. 産婦人科の実際 62(7):943-949, 2013
18. 櫻井英幸, 奥村敏之, 石川仁, 福光延吉, 粟飯原輝人, 大西かよ子, 水本斉志, 大城佳子,
沼尻晴子, 盛武敬, 高田健太, 照沼利之, 安岡聖, 磯辺智範, 熊田博明, 坪井康次, 榮武二.
【Radiotherapy Today 2013	
 粒子線治療最前線-進化する粒子線治療の現況と展望-】 粒
子線治療の現状と展望	
  粒子線治療実施施設からの報告	
  筑波大学陽子線医学利用研究センター	
  PMRC. INNERVISION 28(7):19-21, 201319. 孫略, 水野祐介, 岩本眞理, 後藤隆久, 小口靖弘, 坪井康次, 千田浩一, 盛武敬. 小児心カテーテル術中の患者の入射皮膚線量の直接測定法	
  Direct measurement of patient's
entrance skin dose during pediatric cardiac catheterization. 日本放射線技術学会雑誌
69(9):1070, 2013
20. 竹内秀輔, 鈴木涼子, 福島敬, 福島紘子, 岩淵敦, 中尾朋平, 山口玲子, 工藤寿子, 杉田真太朗, 稲留征典, 佐藤豊実, 櫻井英幸, 金子道夫, 須磨崎亮. 進行期卵巣小細胞癌に対して集学的治療を施行した女児例. 日本小児血液・がん学会雑誌 50(2):269-273, 2013
21. 坪井康次, 水本斉志. 【悪性脳腫瘍の治療-最新のトピックス】 放射線治療のトピックス	  陽子線・重粒子線治療. Clinical Neuroscience 31(10):1169-1172, 2013
22. 増永慎一郎, 松本孔貴, 平山亮一, 櫻井良憲, 田中浩基, 鵜澤玲子, 鈴木実, 近藤夏子, 楢林正流, 丸橋晃, 小野公二. 【基礎と臨床の対話】 放射線治療に資する転移研究	
  通常
放射線照射および中性子捕捉療法後の局所腫瘍効果と肺転移抑制効果における腫瘍
内酸素状況修飾処置併用の意義. 癌の臨床 59(2):149-153, 2013
23. 吉田由香里, 安藤興一, 武者篤, 大野達也, 中野隆史, 鵜澤玲子, 松本孔貴, 平山亮一, 古澤佳也, 小池幸子, 安藤謙, 村田和俊, 吉本由哉, 久保亘輝, 河村英将, 高橋健夫. 正常組
織と腫瘍の炭素線分割照射効果の比較. The Kitakanto Medical Journal 63(3):285, 2013185

肺高血圧症・肺循環障害	 1) 英文論文
1. Doki K, Homma M, Kuga K, Aonuma K, Kohda Y. SCN5A promoter haplotype affects thetherapeutic range for serum flecainide concentration in Asian patients. Pharmacogenet
Genomics 23 (7):349-355, 2013
2. Hoshi T, Sato A, Hiraya D, Kimura T, Wang Z, Aonuma K. Multimodality intracoronary
imaging in spontaneous coronary artery dissection: impacts of intravascular ultrasound,
potical coherence tomography, and coronary angioscopy. Catheter Cardiovasc Interv 81(3):E151-154, 2013
3. Katsumata T, Oishi H, Sekiguchi Y, Nagasaki H, Daassi D, Tai PH, Ema M, Kudo T,
Takahashi S. Bioluminescence imaging of β cells and intrahepatic insulin gene activity undernormal and pathological conditions. PLoS One 8(4):e60411, 2013
4. Kawamura R, Seo Y, Ishizu T, Atsumi A, Yamamoto M, Machino-Ohtsuka T, Nakajima H,
Sakai S, Tanaka YO, Minami M, Aonuma K. Feasibility of left ventricular volume
measurements by three-dimensional speckle tracking echocardiography depends on image
quality and degree of left ventricular enlargement: validation study with cardiac magnetic
resonance imaging. J Cardiol doi: 10.1016/j.jjcc.2013.08.010, 2013
5. Seto K, Uchida F, Baba O, Yamatoji M, Karube R, Warabi E, Sakai S, Hasegawa S, Yamagata
K, Yanagawa T, Onizawa K, Miyoshi E, Shoda J, Bukawa H. Negative expression of
N-acetylglucosaminyltransferase V in oral squamous cell carcinoma correlates with poor
prognosis. Springerplus 2:657, 2013
6. Tajiri K, Shimojo N, Sakai S, Machino-Ohtsuka T, Imanaka-Yoshida K, Hiroe M, TsujimuraY, Kimura T, Sato A, Yasutomi Y, Aonuma K. Pitavastatin regulates helper T-celldifferentiation and ameliorates autoimmune myocarditis in mice. Cardiovasc Drugs Ther
27(5):413-424, 2013
7. Tsuboi H, Hagiwara S, Asashima H, Umehara H, Kawakami A, Nakamura H, Sano H,
Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T,
Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T. Validation of different sets of criteria
for the diagnosis of Sjogren's syndrome in Japanese patients. Mod Rheumatol 23(2):219-225,
2013
8. Umeda N, Matsumoto I, Ito I, Kawasaki A, Tanaka Y, Inoue A, Tsuboi H, Suzuki T, Hayashi
T, Ito S, Tsuchiya N, Sumida T. Anti-citrullinated glucose-6-phosphate isomerase peptide
antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared186

epitope alleles and disease activity. Clin Exp Immunol 172(1):44-53, 2013187

脊髄脊椎疾患	 1) 英文論文
1. Tsuda K, Akutsu H, Yamamoto T, Ishikawa E, Saito A, Nakai K, Takano S, Matsumura A.
Benign spinal meningioma without dural attachment presenting delayed CSF disseminationand malignant transformation. Brain Tumor Pathol 30(3):185-191, 2013	 3) 英文著書
1. Nakai K, Matsumura A. 23. Feasibility for Intramedullary spinal Glioma; in "Neutron
Capture Therapy (1st edition)" (edited by Sauerwein W, Wittig A, Moss R, Nakagawa Y),
Springer Berlin Heidelberg (Berlin) 2013; pp407-415

188角化制御因子	 1) 英文論文	
 1. Arai M, Ikawa Y, Chujo S, Hamaguchi Y, Ishida W, Shirasaki F, Hasegawa M, Mukaida N,
Fujimoto M, Takehara K. Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in
the mouse model of cytokine-induced systemic sclerosis. J Dermatol Sci 69(3):250-258,
2013
2. Fujimoto M, Matsushita T, Hamaguchi Y, Kaji K, Asano Y, Ogawa F, Yamaoka T, Fujikawa
K, Tsukada T, Sato K, Echigo T, Hasegawa M, Takehara K. Autoantibodies to small
ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis:
comparison with a UK Caucasian cohort. Ann Rheum Dis 72(1):151-153, 2013
3. Fujisawa Y, Miyazono Y, Kawachi Y, Otsuka F. A case of sterile transient neonatal pustulosispresenting with large flaccid pustules. Pediatr Dermatol 30(6):e238-239, 2013
4. Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F. Docetaxel was effective in the managementof metastatic angiosarcoma associated with disseminated intravascular coagulation
syndrome. Int J Dermatol doi: 10.1111/j.1365-4632.2012.05671.x, 2013
5. Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F. Comparison between taxane-based
chemotherapy with conventional surgery-based therapy for cutaneous angiosarcoma: asingle-center experience. J Dermatolog Treat doi: 10.3109/09546634.2012.754839, 2013
6. Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M,
Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M.
Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase
antibodies: heterogeneity within the syndrome. PLoS One 8(4):e60442, 2013
7. Hamaguchi Y, Fujimoto M, Oishi K, Kitajima S, Wada T, Takehara K. Cutaneous
Mycobacterium chelonae infection in a rheumatoid arthritis patient treated with etanercept.
Eur J Dermatol 23(5):700-701, 2013
8. Hamaguchi Y, Yamada K, Kawano M, Fujimoto M, Takehara K. Prurigo nodularis-like skineruptions in a patient with IgG4-related disease. Eur J Dermatol 23(4):541-542, 2013
9. Hara S, Henmi T, Kawakami A, Fujikawa K, Mukae H, Ishimatsu Y, Sakamoto N, Kakugawa
T, Kaji K, Fujimoto M, Kuwana M, Tsukada T, Satoh K, Motomura M, Tamai M, Nakamura
H, Ida H, Hayashi T, Origuchi T, Eguchi K, Kohno S. Clinical, serologic and magnetic
resonance imaging of 3 cases of inflammatory myopathy with abundant macrophages in theJapanese population. Rheumatol Int 33(4):1059-1064, 2013
10. Hasegawa M, Asano Y, Endo H, Fujimoto M, Goto D, Ihn H, Inoue K, Ishikawa O,
189

Kawaguchi Y, Kuwana M, Ogawa F, Takahashi H, Tanaka S, Sato S, Takehara K. Serumchemokine levels as prognostic markers in patients with early systemic sclerosis: amulticenter, prospective, observational study. Mod Rheumatol 23(6):1076-1084, 2013
11. Hasegawa M, Fujimoto M, Matsushita T, Hamaguchi Y, Takehara K. Augmented ICOS
expression in patients with early diffuse cutaneous systemic sclerosis. Rheumatology(Oxford) 52(2):242-251, 2013
12. Hasegawa M, Hatta Y, Matsushita T, Hamaguchi Y, Fujimoto M, Takehara K. Clinical andlaboratory features dependent on age at onset in Japanese systemic sclerosis. Mod
Rheumatol 23(5):913-919, 2013
13. Hasegawa M, Higashi K, Matsushita T, Hamaguchi Y, Saito K, Fujimoto M, Takehara K.
Dermokine inhibits ELR(+)CXC chemokine expression and delays early skin wound healing.
J Dermatol Sci 70(1):34-41, 2013
14. Hasegawa M, Imura-Kumada S, Matsushita T, Hamaguchi Y, Fujimoto M, Takehara K.
Anti-topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis.
J Dermatol 40(2):89-93, 2013
15. Honda N, Jinnin M, Kira-Etoh T, Makino K, Kajihara I, Makino T, Fukushima S, Inoue Y,
Okamoto Y, Hasegawa M, Fujimoto M, Ihn H. miR-150 down-regulation contributes to theconstitutive type I collagen overexpression in scleroderma dermal fibroblasts via the
induction of integrin β3. Am J Pathol 182(1):206-216, 2013
16. Horai Y, Isomoto E, Koga T, Okada A, Kawashiri SY, Tamai M, Yamasaki S, Nakamura H,
Origuchi T, Hamaguchi Y, Fujimoto M, Kuwana M, Kawakami A. Early diagnosis andtreatment for remission of clinically amyopathic dermatomyositis complicated by rapid
progress interstitial lung disease: a report of two cases. Mod Rheumatol 23(1):190-194, 2013
17. Huu DL, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Fujimoto M.
FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting
expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.
Arthritis Rheum 65(6):1624-1635, 2013
18. Ishitsuka Y, Kawachi Y, Maruyama H, Taguchi S, Fujisawa Y, Furuta J, Nakamura Y, Ishii
Y, Otsuka F. Pituitary tumor transforming gene 1 induces tumor necrosis factor-alphaproduction from keratinocytes: implication for involvement in the pathophysiology ofpsoriasis. J Invest Dermatol 133(11):2566-2575, 2013
19. Ishitsuka Y, Kawachi Y, Taguchi S, Maruyama H, Nakamura Y, Fujisawa Y, Furuta J,
Nakamura Y, Ishii Y, Otsuka F. Pituitary tumor-transforming gene 1 as a proliferation marker
190

lacking prognostic value in cutaneous squamous cell carcinoma. Exp Dermatol
22(5):318-322, 2013
20. Ito K, Imafuku S, Hamaguchi Y, Fujimoto M, Nakayama J. Case report of anti-transcription
intermediary factor-1-γ/α antibody-positive dermatomyositis associated with gastric cancer
and immunoglobulin G4-positive pulmonary inflammatory pseudotumor. J Dermatol
40(7):567-569, 2013
21. Ito T, Kimura S, Seto K, Warabi E, Kawachi Y, Shoda J, Tabuchi K, Yamagata K, Hasegawa
S, Bukawa H, Ishii T, Yanagawa T. Peroxiredoxin I plays a protective role against UVA
irradiation

through

reductionofoxidative

stress.

J

Dermatol

Sci

doi:

10.1016/j.jdermsci.2013.12.002, 2013
22. Jin G, Hamaguchi Y, Matsushita T, Hasegawa M, Le Huu D, Ishiura N, Naka K, Hirao A,
Takehara K, Fujimoto M. B-cell linker protein expression contributes to controlling allergic
and autoimmune diseases by mediating IL-10 production in regulatory B cells. J Allergy Clin
Immunol 131(6):1674-1682, 2013
23. Kasuya A, Hamaguchi Y, Fujimoto M, Tokura Y. TIF1γ-overexpressing, highly progressive
endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associatedanti-p155/140 autoantibody. Acta Derm Venereol 93(6):715-716, 2013
24. Kawachi Y, Ishitsuka Y, Maruyama H, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Ichikawa
E, Otsuka F. The POU domain transcription factors Oct-6 and Oct-11 negatively regulate
loricrin gene expression in keratinocytes: association with AP-1 and Sp1/Sp3. Arch Dermatol
Res 305(5):371-378, 2013
25. Kawachi Y, Maruyama H, Ishitsuka Y, Fujisawa Y, Furuta J, Nakamura Y, Ichikawa E,
Furumura M, Otsuka F. NF1 gene silencing induces upregulation of vascular endothelial
growth factor expression in both Schwann and non-Schwann cells. Exp Dermatol
22(4):262-265, 2013
26. Kawachi Y, Obara S, Nakamura Y, Fujisawa Y, Nakamura Y, Ishii Y, Ichikawa E, Otsuka F.
Ischemic leg ulcer due to vasculopathy associated with neurofibromatosis type 1. Eur J
Dermatol 23(4):522-523, 2013
27. Kawashima H, Kawachi Y, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y, Ichikawa E, Otsuka
F. Circumscribed palmar hypokeratosis: implication of suppression of early epidermal
differentiation. Eur J Dermatol 23(2):261-262, 2013
28. Le Huu D, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Tedder TF,
Fujimoto M. Donor-derived regulatory B cells are important for suppression of murine
191sclerodermatous chronic graft-versus-host disease. Blood 121(16):3274-3283, 2013
29. Maruyama H, Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F. Penile preservation surgery
in a case of erythroplasia of Queyrat involving the glans penis and distal urethra. Int J
Dermatol doi: 10.1111/ijd.12103, 2013
30. Nakamura Y, Fujisawa Y, Nakamura Y, Maruyama H, Furuta J, Kawachi Y, Otsuka F.
Improvement of the sentinel lymph node detection rate of cervical sentinel lymph nodebiopsy using real-time fluorescence navigation with indocyanine green in head and neck skincancer. J Dermatol 40(6):453-457, 2013
31. Nakamura Y, Iino Y, Nakamura Y, Fujisawa Y, Kawachi Y, Otsuka F. Intraneural granularcell tumor of the dorsal ramus of a thoracic nerve. Indian J Dermatol Venereol Leprol
79(2):258-260, 2013
32. Nakamura Y, Kawachi Y, Nakamura Y, Iino Y, Fujisawa Y, Otsuka F. Linear lupus
erythematosus profundus involving the muscle with an intractable deep ulcer, successfully
treated with surgical excision. Eur J Dermatol 23(4):535-536, 2013
33. Nakamura Y, Nakamura Y, Saito A, Fujisawa Y, Kawachi Y, Otsuka F. High-grade
mucoepidermoid carcinoma of the columella successfully reconstructed using bilateralnasolabial flaps set up in a sandwich shape and an auricular cartilage graft after surgicalresection. J Dermatol 40(11):911-914, 2013
34. Taguchi S, Kawachi Y, Fujisawa Y, Nakamura Y, Furuta J, Otsuka F. Psoriasiform eruption
associated with graft-versus-host disease. Cutis 92(3):151-153, 2013
35. Ueda-Hayakawa I, Hasegawa M, Hamaguchi Y, Takehara K, Fujimoto M. Circulating γ/δ T
cells in systemic sclerosis exhibit activated phenotype and enhance gene expression ofproalpha2(I) collagen of fibroblasts. J Dermatol Sci 69(1):54-60, 2013
36. Ueda-Hayakawa I, Kusuyama T, Isei T, Ozaki Y, Hamaguchi Y, Fujimoto M, Takehara K,
Okamoto H. Cutaneous necrotizing vasculitis in a patient with dermatomyositis positive foranti-PL-7 antibody. Eur J Dermatol 23(6):889-890, 2013	 2) 英文以外の論文
1. 飯野由佳, 中村泰大, 中村貴之, 藤澤康弘, 川内康弘, 大塚藤男, 鈴木英雄, 小田竜也, 野
口恵美子. 鼻背の有棘細胞癌を合併した Muir-Torre 症候群. Skin Cancer 27(3):367-372,
2013
2. 石井良征, 境野昌行, 藤澤康弘, 中村泰大, 川内康弘, 大塚藤男. 基底細胞癌の全国調査.
Skin Cancer 28(2):205-211, 2013192

3. 石井良征, 境野昌行, 渡邉真也, 久保田典子, 鬼澤沙織, 丸山浩, 藤澤康弘, 中村泰大, 川内 康 弘, 大 塚 藤 男. 有 棘 細 胞 癌 お よ び ボ ー エ ン 病 の 全 国 調 査. Skin Cancer
28(2):195-204, 2013
4. 小川文秀, 浅野善英, 石井貴之, 川上民裕, 小寺雅也, 藤本学. 創傷・熱傷ガイドライン	 第 1 版の課題と改訂に向けた取り組み	
 膠原病・血管炎に伴う皮膚潰瘍診療ガイドラ
インについて. 日本皮膚科学会雑誌 123(13):2888-2891, 2013
5. 小原佐恵子, 石井良征, 川内康弘, 大塚藤男. 【代謝異常症】 硬化性粘液水腫の 1 例. 皮膚科の臨床 55(13):1867-1870, 2013
6. 小原佐惠子, 中村泰大, 斉藤明允, 中村貴之, 藤澤康弘, 川内康弘, 大塚藤男. 隆起性皮膚
線 維 肉 腫 転 移 巣 に 対 し て メ シ ル 酸 イ マ チ ニ ブ に て 加 療 し た 2 例. Skin Cancer
28(1):103-107, 2013
7. 小原佐惠子, 中村泰大, 藤澤康弘, 中村貴之, 川内康弘, 大塚藤男. 有棘細胞癌原発巣に対する放射線療法の治療成績. Skin Cancer 28(1):94-97, 2013
8. 川内康弘. 新・皮膚科セミナリウム	  角化症診療のカッティング・エッジ	
  表皮の酸化ストレスとその防御機構. 日本皮膚科学会雑誌 123(10):1915-1921, 20139. 齊藤明允, 石井良征, 小金丸博, 人見重美, 中村貴之, 古田淳一, 川内康弘, 大塚藤男.【細菌・抗酸菌・スピロヘータ感染症】 神経梅毒を併発した悪性梅毒の 1 例. 皮膚科の臨
床 55(11):1382-1385, 201310. 齊藤明允, 中村貴之, 越田隆介, 下條信威, 中村泰大, 藤澤康弘, 古田淳一, 川内康弘, 大塚藤男. 高齢者に生じた灯油皮膚炎の 1 例. 皮膚科の臨床 55(5):619-622, 201311. 齊藤明允, 中村泰大, 小原佐恵子, 中村貴之, 小林桂子, 藤澤康弘, 川内康弘, 大塚藤男.
放射線療法が奏功した Merkel 細胞癌の 3 例. Skin Cancer 27(3):373-378, 2013
12. 斎藤佑希, 小林忠弘, 熊田朗子, 水野美幸, 平野貴士, 濱口儒人, 長谷川稔, 藤本学, 竹原
和彦. 早期の治療によって救命できた急速進行性間質性肺炎合併抗 CADM-140 抗体
陽性皮膚筋炎の 2 例. 皮膚科の臨床 55(2):187-192, 2013
13. 葉山愛弥, 石黒直子, 川島眞, 小関由美, 山中寿, 濱口儒人, 藤本学. 抗 MDA5 抗体(抗CADM-140 抗体)陽性例にみられた一過性の皮膚筋炎症状. 日本皮膚科学会雑誌
123(11):2079-2083, 201314. 藤澤康弘. 「『術後補助療法(DAVFeron、フェロン療法、フェロン維持療法)は悪性黒色腫ステージ II・III 患者の予後を改善するか	  831 例の解析』への質問」の回答. 日本皮膚科学会雑誌 123(2):155-156, 201315. 藤本学.【リウマチ・膠原病における重要臓器障害と難治性病態-病態と治療の進歩】
トピックス	
  重要な臓器障害	  皮膚・粘膜. 日本内科学会雑誌 102(10):2591-2599, 2013193

16. 松本優香, 中村友紀, 正畠千夏, 飯岡弘至, 大黒奈津子, 宮川史, 福本隆也, 小林信彦, 浅田秀夫, 杉江和馬, 濱口儒人, 藤本学. 抗 TIF1 抗体陽性皮膚筋炎の 3 例. 皮膚の科学
12(4):285-291, 201317. 丸山浩, 石井良征, 川島英恵, 田口詩路麻, 古田淳一, 川内康弘, 大塚藤男. 自家接種型を呈したスポロトリコーシス	
 当科におけるスポロトリコーシスの 10 年間の集計. 皮膚科の臨床 55(8):987-991, 2013
18. 山田延未, 伊藤美佳子, 小林桂子, 藤澤康弘. 著明な石灰化を伴った踵部の血管平滑筋腫の 1 例. 皮膚科の臨床 55(2):223-227, 20134) 英文以外の著書
1. 川内康弘. 第 4 章. Rud 症候群; "忘れてはならない皮膚科症候群 (第 1 版)” (編集 古江増孝, 土田哲也), 中山書店 (東京) 2013; pp114-117
2. 藤澤康弘, 大塚藤男. 第 1 章. 皮膚悪性腫瘍の疫学調査	
  日本と外国の国際比較; "皮膚悪性腫瘍-基礎と臨床の最新研究動向” (編集 日本臨牀 ), 日本臨牀 (大阪) 2013; pp 7-12
3. 藤澤康弘. 第 5 章 4. 基底細胞癌の発癌機序と関連遺伝子; "皮膚悪性腫瘍-基礎と臨床の最新研究動向” (編集 日本臨牀 ), 日本臨牀 (大阪) 2013; pp598-602
4. 古田淳一. リバスチグミン使用で痒みや紅斑などの皮膚症状が出現し困っています．
皮膚症状に対する有効な対策を教えて下さい; "治療特別編集	
  認知症でお困りです
か？−かかりつけ医のギモンにお答えします！− (第 1 版)” (編集 川畑信也), 南山堂 (東京) 2013; pp95-98

194気候変動と健康	 1) 英文論文
1. Fujii N, Ichinose M, Honda Y, Tsuji B, Watanabe K, Kondo N, Nishiyasu T. Changes inarterial blood pressure elicited by severe passive heating at rest is associated withhyperthermia-induced hyperventilation in humans. Eur J Appl Physiol 113(1):51-62, 2013
2. Honda Y, Kondo M, Kovats S, Hales S, Kim H, Leon Guo YL. Will the Global Warming
Alleviate Coldrelated Mortality? Conference Proceedings of International Conference on
Climate Change Effects, "Impacts World 2013" 275-281, 2013
3. Honda Y, Kondo M, McGregor G, Kim H, Guo YL, Hijioka Y, Yoshikawa M, Oka K, Takano
S, Hales S, Kovats RS. Heat-related mortality risk model for climate change impact
projection. Environ Health Prev Med doi: 10.1007/s12199-013-0354-6, 2013
4. Hoshi SL, Kondo M, Okubo I. Economic evaluation of vaccination programme of 13-valentpneumococcal conjugate vaccine to the birth cohort in Japan. Vaccine 31(25):2762-2771,
2013
5. Kondo M, Ono M, Nakazawa K, Kayaba M, Minakuchi E, Sugimoto K, Honda Y. Population
at high-risk of indoor heatstroke: the usage of cooling appliances among urban elderlies inJapan. Environ Health Prev Med 18(3):251-257, 2013
6. Kundzewicz ZW, Kanae S, Seneviratne SI, Handmer J, Nicholls N, Peduzzi P, Mechler R,
Bouwer LM, Arnell N, Mach K, Muir-Wood R, Brakenridge GR, Kron W, Benito G, Honda
Y, Takahashi K, Sherstyukov B. Flood risk and climate change: global and regional
perspectives. Hydrological Sciences Journal 59(1):1-28, 2013
7. Lee H, Kim H, Honda Y, Lim YH, Yi S. Effect of Asian Dust Storms on Daily Mortality inSeven Metropolitan Cities of Korea. Atmospheric Environment 79:510-517, 2013
8. Okubo R, Kai H, Kondo M, Saito C, Yoh K, Morito N, Usui J, Yamagata K. Health-related
quality of life and prognosis in patients with chronic kidney disease: a 3-year follow-up
study. Clin Exp Nephrol doi:10.1007/s10157-013-0901-x, 2013 	 	 2) 英文以外の論文
1. 加藤尚子, 近藤正英, 大久保一郎, 長谷川敏彦. 病院機能分化施策に応じた私的病院の変遷について	 福岡県私設病院を対象とした 1998 年・2012 年の繰り返し調査から. 日
本医療マネジメント学会雑誌 14(1):9-13, 2013
2. 萱場桃子, 中澤浩一, 近藤正英, 小野雅司, 水口恵美子, 杉本和俊, 本田靖. 夏期における高齢者の夜間のエアコン使用に関する研究. 民族衛生 79(2):47-53, 2013195

3. 星淑玲, 近藤正英, 大久保一郎. 23 価肺炎球菌ワクチンの再接種およびインフルエンザ
ワクチンとの同時接種に関する実態	
 自治体の接種に対する助成の有無による相違について. 厚生の指標 60(8):23-29, 20134) 英文以外の著書
1. 近藤正英. 医療経済; "最新医学別冊新しい診断と治療の ABC11 CKD（慢性腎臓病）慢性腎不全 (第 2 版)” (編集 佐々木成), 最新医学社 (大阪) 2013; pp227-234
2. 本田靖. 第 4 章. 4.3 熱中症から身を守るまちづくり; "気候変動に適応する社会 (第 1版)” (編集 田中誠, 白井信雄), 技報堂出版 (東京) 2013; pp120-123

196